chlorpromazine has been researched along with Schizophrenia in 1641 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One-hundred and sixty individuals with treatment-naive, first episode schizophrenia or schizophreniform disorder in a mental health centre in Beijing, China were randomised to clozapine or chlorpromazine treatment for up to 2 years,followed by up to an additional 7 years of naturalistic treatment." | 9.15 | Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. ( Duan, N; Girgis, RR; Jiang, H; Li, K; Li, X; Lieberman, JA; Niu, Y; Phillips, MR; Wu, C, 2011) |
| "This multicentre, parallel-group study compared the efficacy and tolerability of ziprasidone and chlorpromazine in treatment-resistant schizophrenia (at least three treatment periods of at least 6 weeks each with two or more antipsychotic agents during the past 5 years without significant response) that was unresponsive to 6 weeks of open-label haloperidol ( | 9.12 | Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia. ( Giller, E; Kane, JM; Khanna, S; Rajadhyaksha, S, 2006) |
| "We compared the effect of levomepromazine (LMP) with chlorpromazine (CPZ) in treatment-resistant schizophrenia (TRS)." | 9.12 | Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial. ( Annable, L; Gabriel, A; Lal, S; Nair, NP; Ng Ying Kin, NM; Schwartz, G; Thavundayil, JX, 2006) |
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 9.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "This prospective, 1-year, open-label study of ziprasidone (40-160 mg/day) was conducted in subjects who had participated in a previous randomized 12-week comparison of ziprasi-done and chlorpromazine in treatment-resistant schizophrenia (DSM-III-R criteria)." | 9.12 | Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study. ( Giller, E; Khanna, S; Loebel, AD; Potkin, SG; Rajadhyaksha, S; Siu, CO, 2007) |
| " chlorpromazine in severe chronic active psychotic hospitalized schizophrenia patients." | 9.11 | Clotiapine compared with chlorpromazine in chronic schizophrenia. ( Belmaker, RH; Bersudsky, Y; Geller, V; Gorzaltsan, I; Shleifer, T, 2005) |
| " Therefore, we conducted a 12-week double-blind comparison study to assess the efficacy and tolerability of clozapine and chlorpromazine in a group of elderly inpatients with chronic schizophrenia." | 9.09 | The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. ( Eisenstein, N; Engelhart, C; Howanitz, E; Losonczy, MF; Pardo, M; Smelson, DA; Stern, RG, 1999) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 9.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "Clozapine has been shown to have superior effectiveness compared with classic neuroleptics in treating refractory schizophrenia in Caucasians, but its efficacy and safety in Chinese have not been adequately studied." | 9.08 | A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia. ( Chen, JY; Chiu, HJ; Hong, CJ; Sim, CB, 1997) |
| "A 6-week, double-blind, randomized, multicentre, parallel-group study was conducted to compare the efficacy of quetiapine ('Seroquel') (n=101) with that of chlorpromazine (n=100) in hospitalized patients with acute exacerbation of subchronic or chronic schizophrenia, or schizophreniform disorder." | 9.08 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. ( Link, CG; Peuskens, J, 1997) |
| "The purpose of this study was to compare the efficacy of olanzapine with that of chlorpromazine plus benztropine in patients with treatment-resistant schizophrenia." | 9.08 | Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. ( Bartko, JJ; Conley, RR; Gounaris, C; Hegerty, J; Lingle, J; Love, R; Peszke, M; Richardson, C; Tamminga, CA; Zaremba, S, 1998) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 9.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 9.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
| "Propranolol contributed usefully to the practical management of patients with chronic schizophrenia whose florid symptoms had not remitted with major tranquillisers." | 9.04 | Propranolol as an adjunct to the treatment of schizophrenia. ( Gruzelier, JH; Hollander, D; Pitcher, DR; Sergeant, HG; Yorkston, NJ; Zaki, SA, 1977) |
| "In a material of 71 patients admitted because of acute or chronic psychoses, 32 were treated with sulpiride (up to 1,800 mg per day) and 39 with chlorpromazine (up to 675 mg)." | 9.04 | Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study. ( Bratfos, O; Haug, JO, 1979) |
| "To assess the clinical and side effects of chlorpromazine for people with schizophrenia and schizophrenia-like psychoses in comparison with piperacetazine." | 8.98 | Chlorpromazine versus piperacetazine for schizophrenia. ( Dehnavieh, R; Eslami Shahrbabaki, M; Sharafkhani, R; Vali, L, 2018) |
| "Chlorpromazine, a widely available and inexpensive antipsychotic drug, is considered the benchmark treatment for schizophrenia worldwide." | 8.95 | Chlorpromazine versus metiapine for schizophrenia. ( Bazrafshan, A; Zare, M, 2017) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 8.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| "To determine chlorpromazine dose response and dose side-effect relationships for schizophrenia and schizophrenia-like psychoses." | 8.95 | Chlorpromazine dose for people with schizophrenia. ( De Haan, S; Dudley, K; Liu, X, 2017) |
| "To assess the clinical effects of chlorpromazine compared with penfluridol for adults with schizophrenia." | 8.95 | Chlorpromazine versus penfluridol for schizophrenia. ( Khalili, N; Nikvarz, N; Vahedian, M, 2017) |
| "To compare the effects of chlorpromazine with atypical or second generation antipsychotic drugs, for the treatment of people with schizophrenia." | 8.93 | Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. ( Bo, L; Saha, KB; Sampson, S; Xia, J; Zaman, RU; Zhao, S, 2016) |
| " Chlorpromazine is also an old drug but it is still used for treatment of people with schizophrenia." | 8.93 | Chlorpromazine versus reserpine for schizophrenia. ( Adams, CE; Nur, S, 2016) |
| "Groups of nonrefractory patients with schizophrenia, taking antipsychotics other than clozapine, show distinct trajectories of treatment response over time." | 8.91 | Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia. ( Barr, AM; Honer, WG; Jones, AA; Procyshyn, RM; Thornton, AE; Vila-Rodriguez, F, 2015) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 8.90 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, GA; Rathbone, J; Soares-Weiser, K; Thornley, B, 2014) |
| " We therefore conducted a meta-analysis of randomised controlled trials on the efficacy of chlorpromazine versus any other antipsychotic in the treatment of schizophrenia." | 8.90 | Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. ( Cao, H; Davis, JM; Helfer, B; Leucht, S; Samara, MT, 2014) |
| "To review the effects in clinical response of flupenthixol and low-potency antipsychotics for people with schizophrenia." | 8.90 | Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. ( Dold, M; Engel, RR; Leucht, S; Tardy, M, 2014) |
| "To determine chlorpromazine dose response and dose adverse effect relationships for schizophrenia and schizophrenia-like psychoses." | 8.85 | Chlorpromazine dose for people with schizophrenia. ( De Haan, S; Liu, X, 2009) |
| "Chlorpromazine, one of the first generation of antipsychotic drugs, is effective in the treatment of schizophrenia." | 8.84 | Cessation of medication for people with schizophrenia already stable on chlorpromazine. ( Alkhateeb, H; Almerie, MQ; Essali, A; Matar, HE; Rezk, E, 2007) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 8.84 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Rathbone, J; Thornley, B, 2007) |
| "To compare the effects of haloperidol and chlorpromazine for people with schizophrenia and schizophrenia-like psychoses." | 8.84 | Haloperidol versus chlorpromazine for schizophrenia. ( Chua, L; Kane, J; Kitzmantel, M; Leucht, C; Leucht, S, 2008) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 8.82 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Rathbone, J; Thornley, B, 2003) |
| "Chlorpromazine (CPZ) remains one of the most common drugs used for people with schizophrenia worldwide, and a benchmark against which other treatments can be evaluated." | 8.82 | Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials. ( Adams, CE; Awad, AG; Borrill, J; Clarke, M; Rathbone, J; Thornley, B; Wahlbeck, K, 2005) |
| "Research on the impact of nicotine on schizophrenia and antipsychotic medications was reviewed to determine ways to improve treatment planning for patients with schizophrenia who smoke and to evaluate smoking cessation programs for this population." | 8.80 | A review of the effects of nicotine on schizophrenia and antipsychotic medications. ( Lyon, ER, 1999) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for those with schizophrenia." | 8.80 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Thornley, B, 2000) |
| "The present study was aimed to examine the effects of chlorpromazine on sleep quality, clinical and emotional measures in people suffering from schizophrenia." | 7.88 | Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia. ( Hou, F; Li, R; Meng, Q; Zhang, Q, 2018) |
| "We report a case of a patient who developed eosinophilia shortly after clozapine use, and then developed parotitis." | 7.81 | Eosinophilia and parotitis occurring early in clozapine treatment. ( Ben Hadj Ali, B; Ben Salem, C; Bouhlel, S; Saguem, BN, 2015) |
| "We measured BOLD-response during a WM task in a longitudinal fMRI-study in eleven schizophrenia patients first when they received conventional antipsychotics (T1) and a second time after they had been switched to aripiprazole (T2)." | 7.76 | Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. ( Beck, A; Dembler, T; Dinges, M; Friedel, E; Gallinat, J; Heinz, A; Juckel, G; Sarkar, R; Schlagenhauf, F; Wrase, J; Wüstenberg, T, 2010) |
| " To fully evaluate SLC6A3 as a therapeutic antipshycotic target we investigated association of the gene with responses to chlorpromazine and clozapine and with chlorpromazine-induced extrapyramidal syndrome (EPS) in the Chinese schizophrenia population." | 7.76 | Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. ( Du, J; Feng, G; Gao, R; Guo, T; He, G; He, L; Li, S; Li, X; Lin, Z; Liu, J; St Clair, D; Wang, L; Wu, S; Xing, Q; Xu, M; Xu, Y; Xuan, J; Yang, Y; Yu, L; Zhang, A; Zhao, X; Zheng, Y; Zhou, J, 2010) |
| "These findings suggest that BDNF plays an important role in the susceptibility to schizophrenia and that the (GT)n repeat polymorphism of the BDNF gene may be an independent contributor to the chlorpromazine treatment-sensitive form of schizophrenia." | 7.74 | BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population. ( Feng, GY; He, G; He, L; Li, X; Lin, ZG; St Clair, D; Xu, MQ, 2008) |
| "To study the role of dopamine neurotransmission in schizophrenia and its drug treatment by assessing the relationship of plasma homovanillic acid (pHVA), a major central dopamine metabolite to various clinical parameters in schizophrenic patients." | 7.71 | Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia. ( Peet, M; Ramchand, C; Reynolds, GP; Shah, S; Zhang, ZJ, 2001) |
| "A 40-year-old patient being treated for schizophrenia developed elevated plasma levels of haloperidol (HAL) in combination with chlorpromazine (CPZ) and during overlap treatment with clozapine." | 7.70 | Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia. ( Allen, SA, 2000) |
| "A case is presented of Torsade de Pointes (TDP) with T wave alternans in a 31-year-old female receiving a moderate dose of chlorpromazine." | 7.68 | [Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case]. ( Ishikawa, T; Kashiwagi, M; Ochiai, H; Oyama, Y; Tokita, Y; Usui, T, 1990) |
| "A 49-year-old man with severe hypertension and chronic schizophrenia developed marked hypotension with postural syncope following therapy with the combination of chlorpromazine and captopril." | 7.67 | Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. ( White, WB, 1986) |
| " A case of recurrent thrombocytopenia due to the repeated exposure to chlorpromazine (twice), haloperidol (four times) and thiothixene (twice) in a 59 year old female treated for schizophrenia is reported." | 7.67 | Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report. ( Balon, R; Berchou, R; Zethelius, M, 1987) |
| "Melanosis observed in association with prolonged chlorpromazine therapy has become a serious problem in mental institutions." | 7.64 | THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT. ( BAKER, RA; GREINER, AC; NICOLSON, GA, 1964) |
| "In a double blind chlorpromazine-controlled trial, high dosage haloperidol (100 mg daily) given for three months, appreciably improved the mental state of male chronic 'drug resistant' schizophrenic inpatients in the rehabilitation/long-stay unit of one psychiatric hospital." | 6.64 | High dosage haloperidol in chronic schizophrenia. ( MacDonald, IM; McCreadie, RG, 1977) |
| "Baclofen was superior to placebo in the treatment of anxiety, which is of particular interest in view of the recent theories on the mechanism of action of benzodiazepines." | 6.64 | A double-blind trial of baclofen against placebo in the treatment of schizophrenia. ( Andersen, B; Bahr, B; Eliassen, HM; Gulmann, NC, 1976) |
| "Loxapine succinate was compared to chlorpromazine in a 12-week double-blind study of 50 hospitalized chronic schizophrenic patients." | 6.64 | Loxapine succinate: a controlled double-blind study in chronic schizophrenia. ( Schiele, BC, 1975) |
| "Schizophrenia is a chronic mental disorder reported to compromise about 1% of the world's population." | 5.48 | Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences. ( Cysne Filho, FMS; de Almeida, JC; de Sousa, CNS; Diniz, DDS; Macêdo, D; Patrocínio, CFV; Patrocínio, MCA; Sampaio, LRL; Vasconcelos, SMM, 2018) |
| "Stuttering Priapism is a recurrent, persistent penile erection in the absence of sexual desire due to altered genital hemodynamics, affecting the arterial component (high flow, non-ischemic) or the veno-occlusive mechanism (low flow, ischemic)." | 5.48 | Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia. ( Birur, B; Nagaraja, S; Pandurangi, A; Thippaiah, SM, 2018) |
| " The present study aimed to investigate the effects of the typical antipsychotic chlorpromazine (CP) alone or combined with the natural antioxidant alpha-lipoic acid (ALA) on changes in the hippocampal average spectral power induced by ketamine (KET)." | 5.46 | Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats. ( Barbosa, TM; Borges, LTN; Gularte, VN; Lima, RF; Macêdo, D; Matos, NCB; Oliveira, MN; Patrocínio, MCA; Sampaio, LRL; Vale, OCD; Vasconcelos, SMM, 2017) |
| " Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication." | 5.33 | Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. ( Goghari, VM; Honer, WG; Khorram, B; Kopala, LC; Lang, DJ; Rui, Q; Smith, GN; Vandorpe, RA, 2006) |
| "Thirty-seven newly admitted schizophrenic patients were treated with an open and flexible dosage of chlorpromazine for 3 months after receiving a test dose." | 5.30 | Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine. ( Minami, H; Miyahara, A; Nakahara, T; Nakane, Y, 1997) |
| "The population pharmacokinetic parameters of chlorpromazine (CPZ) in chronic schizophrenic patients were evaluated using 189 plasma concentration measurements from 31 patients." | 5.29 | Smoking and body weight influence the clearance of chlorpromazine. ( Chetty, M; Miller, R; Moodley, SV, 1994) |
| " Eventual discontinuation of cimetidine therapy led to a return of schizophrenic symptoms, which responded to an increase in chlorpromazine dosage to previous levels." | 5.28 | Adverse interaction between cimetidine and chlorpromazine in two cases of chronic schizophrenia. ( Byrne, A; O'Shea, B, 1989) |
| "This study aimed to evaluate the efficacy and safety of quetiapine fumarate extended-release (XR) in the treatment of Chinese patients with acute schizophrenia." | 5.27 | A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophren ( Gu, N; Li, H; Li, K; Ma, C; Shen, Y; Shi, J; Wang, G; Wang, X; Xie, S; Xu, X; Zhang, H, 2018) |
| "Propranolol was found to facilitate habituation in slow habituators and to reinstate responses in half of non-responders, especially when given as the sole drug." | 5.26 | Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia. ( Connolly, J; Eves, F; Gruzelier, J; Hirsch, S; Weller, M; Yorkston, N; Zaki, S, 1981) |
| "Propranolol was found to share the properties of the racemate in facilitating habituation of the electrodermal orienting reflex in schizophrenic patients." | 5.26 | Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia. ( Gruzelier, JH; Hirsch, SR; Murphy, C; Weller, M, 1979) |
| " Measurement of response to a single test dose may prove potentially more fruitful in predicting outcome and in establishing drug and dosage choice for a given patient than simple attempts to correlate sustained dosage levels with clinical response." | 5.26 | Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature. ( May, PR; Van Putten, T, 1978) |
| "One-hundred and sixty individuals with treatment-naive, first episode schizophrenia or schizophreniform disorder in a mental health centre in Beijing, China were randomised to clozapine or chlorpromazine treatment for up to 2 years,followed by up to an additional 7 years of naturalistic treatment." | 5.15 | Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. ( Duan, N; Girgis, RR; Jiang, H; Li, K; Li, X; Lieberman, JA; Niu, Y; Phillips, MR; Wu, C, 2011) |
| "This multicentre, parallel-group study compared the efficacy and tolerability of ziprasidone and chlorpromazine in treatment-resistant schizophrenia (at least three treatment periods of at least 6 weeks each with two or more antipsychotic agents during the past 5 years without significant response) that was unresponsive to 6 weeks of open-label haloperidol ( | 5.12 | Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia. ( Giller, E; Kane, JM; Khanna, S; Rajadhyaksha, S, 2006) |
| "We compared the effect of levomepromazine (LMP) with chlorpromazine (CPZ) in treatment-resistant schizophrenia (TRS)." | 5.12 | Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial. ( Annable, L; Gabriel, A; Lal, S; Nair, NP; Ng Ying Kin, NM; Schwartz, G; Thavundayil, JX, 2006) |
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 5.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "This prospective, 1-year, open-label study of ziprasidone (40-160 mg/day) was conducted in subjects who had participated in a previous randomized 12-week comparison of ziprasi-done and chlorpromazine in treatment-resistant schizophrenia (DSM-III-R criteria)." | 5.12 | Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study. ( Giller, E; Khanna, S; Loebel, AD; Potkin, SG; Rajadhyaksha, S; Siu, CO, 2007) |
| "High-dose antipsychotic regimes (defined as the prescription of more than 1000 chlorpromazine-equivalents milligrams of antipsychotic per day) in the management of patients with schizophrenia are not uncommon, but most reports are from western countries." | 5.11 | High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. ( Chong, MY; Chung, EK; Fujii, S; Kua, EH; Leong, JY; Shinfuku, N; Si, T; Sim, K; Su, A; Tan, CH; Tsang, HY; Ungvari, GS; Yang, S; Yip, K, 2004) |
| " chlorpromazine in severe chronic active psychotic hospitalized schizophrenia patients." | 5.11 | Clotiapine compared with chlorpromazine in chronic schizophrenia. ( Belmaker, RH; Bersudsky, Y; Geller, V; Gorzaltsan, I; Shleifer, T, 2005) |
| " Therefore, we conducted a 12-week double-blind comparison study to assess the efficacy and tolerability of clozapine and chlorpromazine in a group of elderly inpatients with chronic schizophrenia." | 5.09 | The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. ( Eisenstein, N; Engelhart, C; Howanitz, E; Losonczy, MF; Pardo, M; Smelson, DA; Stern, RG, 1999) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 5.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "Clozapine has been shown to have superior effectiveness compared with classic neuroleptics in treating refractory schizophrenia in Caucasians, but its efficacy and safety in Chinese have not been adequately studied." | 5.08 | A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia. ( Chen, JY; Chiu, HJ; Hong, CJ; Sim, CB, 1997) |
| "A 6-week, double-blind, randomized, multicentre, parallel-group study was conducted to compare the efficacy of quetiapine ('Seroquel') (n=101) with that of chlorpromazine (n=100) in hospitalized patients with acute exacerbation of subchronic or chronic schizophrenia, or schizophreniform disorder." | 5.08 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. ( Link, CG; Peuskens, J, 1997) |
| "The clinical efficacy of two intensive treatment packages (one including the new antipsychotic risperidone and the other not doing so) was compared with that of standard management in 43 patients with long-standing treatment-resistant schizophrenia." | 5.08 | A study of enhanced management in patients with treatment-resistant schizophrenia. ( Finlayson, A; Johnstone, EC; Mercer, G; Murray, C; Owens, DG, 1997) |
| "The purpose of this study was to compare the efficacy of olanzapine with that of chlorpromazine plus benztropine in patients with treatment-resistant schizophrenia." | 5.08 | Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. ( Bartko, JJ; Conley, RR; Gounaris, C; Hegerty, J; Lingle, J; Love, R; Peszke, M; Richardson, C; Tamminga, CA; Zaremba, S, 1998) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 5.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 5.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
| "Propranolol contributed usefully to the practical management of patients with chronic schizophrenia whose florid symptoms had not remitted with major tranquillisers." | 5.04 | Propranolol as an adjunct to the treatment of schizophrenia. ( Gruzelier, JH; Hollander, D; Pitcher, DR; Sergeant, HG; Yorkston, NJ; Zaki, SA, 1977) |
| "In a double-blind trial in which 45 patients with acute schizophrenia took part the alpha-isomer of flupenthixol (which blocks the dopamine receptor) was found to be significantly more effective than both beta-flupenthixol (which does not) and placebo." | 5.04 | Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. ( Carney, MW; Crow, TJ; Frith, CD; Johnstone, EC; Price, JS, 1978) |
| "In a material of 71 patients admitted because of acute or chronic psychoses, 32 were treated with sulpiride (up to 1,800 mg per day) and 39 with chlorpromazine (up to 675 mg)." | 5.04 | Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study. ( Bratfos, O; Haug, JO, 1979) |
| "The discovery of chlorpromazine in the early 1950s revolutionized the clinical treatment of schizophrenia, galvanized the development of psychopharmacology, and standardized protocols used for testing the clinical efficacy of antipsychotics." | 5.01 | Classics in Chemical Neuroscience: Chlorpromazine. ( Boyd-Kimball, D; Gonczy, K; Lewis, B; Mason, T; Siliko, N; Wolfe, J, 2019) |
| "To assess the clinical and side effects of chlorpromazine for people with schizophrenia and schizophrenia-like psychoses in comparison with piperacetazine." | 4.98 | Chlorpromazine versus piperacetazine for schizophrenia. ( Dehnavieh, R; Eslami Shahrbabaki, M; Sharafkhani, R; Vali, L, 2018) |
| "Chlorpromazine, a widely available and inexpensive antipsychotic drug, is considered the benchmark treatment for schizophrenia worldwide." | 4.95 | Chlorpromazine versus metiapine for schizophrenia. ( Bazrafshan, A; Zare, M, 2017) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 4.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| "To determine chlorpromazine dose response and dose side-effect relationships for schizophrenia and schizophrenia-like psychoses." | 4.95 | Chlorpromazine dose for people with schizophrenia. ( De Haan, S; Dudley, K; Liu, X, 2017) |
| "To assess the clinical effects of chlorpromazine compared with penfluridol for adults with schizophrenia." | 4.95 | Chlorpromazine versus penfluridol for schizophrenia. ( Khalili, N; Nikvarz, N; Vahedian, M, 2017) |
| "To compare the effects of chlorpromazine with atypical or second generation antipsychotic drugs, for the treatment of people with schizophrenia." | 4.93 | Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. ( Bo, L; Saha, KB; Sampson, S; Xia, J; Zaman, RU; Zhao, S, 2016) |
| " Chlorpromazine is also an old drug but it is still used for treatment of people with schizophrenia." | 4.93 | Chlorpromazine versus reserpine for schizophrenia. ( Adams, CE; Nur, S, 2016) |
| "Groups of nonrefractory patients with schizophrenia, taking antipsychotics other than clozapine, show distinct trajectories of treatment response over time." | 4.91 | Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia. ( Barr, AM; Honer, WG; Jones, AA; Procyshyn, RM; Thornton, AE; Vila-Rodriguez, F, 2015) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 4.90 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, GA; Rathbone, J; Soares-Weiser, K; Thornley, B, 2014) |
| " We therefore conducted a meta-analysis of randomised controlled trials on the efficacy of chlorpromazine versus any other antipsychotic in the treatment of schizophrenia." | 4.90 | Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. ( Cao, H; Davis, JM; Helfer, B; Leucht, S; Samara, MT, 2014) |
| "To review the effects in clinical response of flupenthixol and low-potency antipsychotics for people with schizophrenia." | 4.90 | Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. ( Dold, M; Engel, RR; Leucht, S; Tardy, M, 2014) |
| "To determine chlorpromazine dose response and dose adverse effect relationships for schizophrenia and schizophrenia-like psychoses." | 4.85 | Chlorpromazine dose for people with schizophrenia. ( De Haan, S; Liu, X, 2009) |
| "Chlorpromazine, one of the first generation of antipsychotic drugs, is effective in the treatment of schizophrenia." | 4.84 | Cessation of medication for people with schizophrenia already stable on chlorpromazine. ( Alkhateeb, H; Almerie, MQ; Essali, A; Matar, HE; Rezk, E, 2007) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 4.84 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Rathbone, J; Thornley, B, 2007) |
| "To compare the effects of haloperidol and chlorpromazine for people with schizophrenia and schizophrenia-like psychoses." | 4.84 | Haloperidol versus chlorpromazine for schizophrenia. ( Chua, L; Kane, J; Kitzmantel, M; Leucht, C; Leucht, S, 2008) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia." | 4.82 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Rathbone, J; Thornley, B, 2003) |
| "Chlorpromazine (CPZ) remains one of the most common drugs used for people with schizophrenia worldwide, and a benchmark against which other treatments can be evaluated." | 4.82 | Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials. ( Adams, CE; Awad, AG; Borrill, J; Clarke, M; Rathbone, J; Thornley, B; Wahlbeck, K, 2005) |
| "Research on the impact of nicotine on schizophrenia and antipsychotic medications was reviewed to determine ways to improve treatment planning for patients with schizophrenia who smoke and to evaluate smoking cessation programs for this population." | 4.80 | A review of the effects of nicotine on schizophrenia and antipsychotic medications. ( Lyon, ER, 1999) |
| "Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for those with schizophrenia." | 4.80 | Chlorpromazine versus placebo for schizophrenia. ( Adams, CE; Awad, G; Thornley, B, 2000) |
| "Loxapine is a dibenzoxazepine, tricyclic compound recommended for the treatment of acute and chronic schizophrenia." | 4.75 | Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| "The present study was aimed to examine the effects of chlorpromazine on sleep quality, clinical and emotional measures in people suffering from schizophrenia." | 3.88 | Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia. ( Hou, F; Li, R; Meng, Q; Zhang, Q, 2018) |
| "Chlorpromazine is a low potency "typical" antipsychotic agent used to treat schizophrenia." | 3.85 | Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series. ( Gowda, GS; Hegde, A; Jaisoorya, TS; Narayanaswamy, JC; Shanbhag, V, 2017) |
| "When choosing between first-generation antipsychotics, clinicians should consider haloperidol as the first-line agent for schizophrenia." | 3.81 | A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda. ( Babigumira, JB; Lubinga, SJ; Mutamba, BB; Nganizi, A, 2015) |
| "We report a case of a patient who developed eosinophilia shortly after clozapine use, and then developed parotitis." | 3.81 | Eosinophilia and parotitis occurring early in clozapine treatment. ( Ben Hadj Ali, B; Ben Salem, C; Bouhlel, S; Saguem, BN, 2015) |
| "One hundred and sixty-three first-episode inpatients with schizophrenia were recruited, to whom one of three conventional antipsychotics (perphenazine, sulpiride, and chlorpromazine) or one of three atypical antipsychotics (clozapine, quetiapine, and aripiprazole) was prescribed for 12 months as appropriate." | 3.80 | Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study. ( Cao, B; Hou, R; Jian, J; Mi, G; Qiu, H; Tang, M; Wang, M, 2014) |
| "Chlorpromazine initiated effective pharmacotherapy for schizophrenia 60 years ago." | 3.78 | Another view of the history of antipsychotic drug discovery and development. ( Carpenter, WT; Davis, JM, 2012) |
| "A facile fluorometric assay using D-kynurenine as a substrate was utilized for evaluating the inhibition of D-amino acid oxidase (DAAO), which is one of the products of a susceptibility gene for schizophrenia, by commercial antipsychotic drugs, namely, chlorpromazine (CPZ), carbamazepine, sulpiride, quetiapine, and imipramine." | 3.77 | Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate. ( Fukushima, T; Iwasa, S; Nakabayashi, M; Song, Z; Tabara, H; Yokoyama, Y, 2011) |
| "We measured BOLD-response during a WM task in a longitudinal fMRI-study in eleven schizophrenia patients first when they received conventional antipsychotics (T1) and a second time after they had been switched to aripiprazole (T2)." | 3.76 | Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. ( Beck, A; Dembler, T; Dinges, M; Friedel, E; Gallinat, J; Heinz, A; Juckel, G; Sarkar, R; Schlagenhauf, F; Wrase, J; Wüstenberg, T, 2010) |
| " To fully evaluate SLC6A3 as a therapeutic antipshycotic target we investigated association of the gene with responses to chlorpromazine and clozapine and with chlorpromazine-induced extrapyramidal syndrome (EPS) in the Chinese schizophrenia population." | 3.76 | Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. ( Du, J; Feng, G; Gao, R; Guo, T; He, G; He, L; Li, S; Li, X; Lin, Z; Liu, J; St Clair, D; Wang, L; Wu, S; Xing, Q; Xu, M; Xu, Y; Xuan, J; Yang, Y; Yu, L; Zhang, A; Zhao, X; Zheng, Y; Zhou, J, 2010) |
| "Our study suggests that AKT1 is a susceptibility gene for schizophrenia in the Chinese population and that the AKT1 gene may play no major role in the therapeutic response to antipsychotics or in chlorpromazine-induced extrapyramidal syndrome." | 3.74 | Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. ( Feng, GY; Gao, JJ; Guo, TW; He, G; He, L; Li, S; Xing, QH; Xu, F; Xu, MQ; Zheng, YL, 2007) |
| "These findings suggest that BDNF plays an important role in the susceptibility to schizophrenia and that the (GT)n repeat polymorphism of the BDNF gene may be an independent contributor to the chlorpromazine treatment-sensitive form of schizophrenia." | 3.74 | BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population. ( Feng, GY; He, G; He, L; Li, X; Lin, ZG; St Clair, D; Xu, MQ, 2008) |
| " The present study examines the correlation between these two polymorphisms and the therapeutic response to chlorpromazine, a typical antipsychotic drug, in 135 inpatients with schizophrenia." | 3.73 | Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. ( Feng, G; Gao, R; Gu, N; He, L; Li, X; Wu, S; Xing, Q, 2005) |
| "A 26-year-old woman with schizophrenia gained 7 kg over the course of 1 year after starting treatment with olanzapine." | 3.73 | Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved. ( Koga, M; Nakayama, K, 2005) |
| "Our results did not lend strong support to the view that the genetic variation of the DRD2 gene plays a major role in the individually variable adverse effect induced by chlorpromazine, at least in Chinese patients with schizophrenia." | 3.73 | Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients. ( Feng, GY; Gao, R; Gu, NF; He, L; Li, HF; Shen, YF; Wu, SN; Xing, QH, 2006) |
| " In a first genome scan on obesity under antipsychotics in SZ and BP, we analyzed 21 multigenerational kindreds (508 family members) including several patients treated for a minimum of 3 years mainly with haloperidol or chlopromazine." | 3.72 | A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. ( Bouchard, RH; Chagnon, YC; Emond, C; Maziade, M; Mérette, C; Roy, MA, 2004) |
| "To study the role of dopamine neurotransmission in schizophrenia and its drug treatment by assessing the relationship of plasma homovanillic acid (pHVA), a major central dopamine metabolite to various clinical parameters in schizophrenic patients." | 3.71 | Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia. ( Peet, M; Ramchand, C; Reynolds, GP; Shah, S; Zhang, ZJ, 2001) |
| "Olanzapine (Zyprexa), a neuroleptic, has obtained marketing authorization for treatment of schizophrenia." | 3.70 | Olanzapine. Keep an eye on this neuroleptic. ( , 2000) |
| "Elevated cerebrospinal fluid (CSF) angiotensin I-converting enzyme (ACE) levels have been evidenced in patients with schizophrenia who have been treated with antipsychotics." | 3.70 | Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients. ( Ahokas, A; Nikkilä, H; Rimón, R; Wahlbeck, K, 2000) |
| "A 40-year-old patient being treated for schizophrenia developed elevated plasma levels of haloperidol (HAL) in combination with chlorpromazine (CPZ) and during overlap treatment with clozapine." | 3.70 | Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia. ( Allen, SA, 2000) |
| "Although several published studies suggest that little benefit accrues from raising doses of conventional antipsychotic drugs above 500-800 chlorpromazine equivalents per day (CPZeq/day), institutionalized patients with schizophrenia often receive larger doses." | 3.69 | A decision analysis approach to neuroleptic dosing: insights from a mathematical model. ( Mossman, D, 1997) |
| " We report here two LA-positive cases (a 29-year-old male taking chlorpromazine for schizophrenia, and a 44-year-old female diagnosed as systemic lupus erythematosus) who underwent surgical procedures without complications." | 3.68 | Surgical experience on patients with serum lupus anticoagulants. A report of two cases. ( Ichikawa, Y; Minezaki, T, 1993) |
| "60 schizophrenia patients were treated with electro-acupuncture and chlorpromazine therapy in comparison with chlorpromazine therapy alone, 30 patients for each group, and their curative effects evaluated according to the brief psychiatric rating scale (BPRS)." | 3.68 | [Comparison between electro-acupuncture with chlorpromazine and chlorpromazine alone in 60 schizophrenic patients]. ( Chen, JK; Zhuge, DY, 1993) |
| "A case is presented of Torsade de Pointes (TDP) with T wave alternans in a 31-year-old female receiving a moderate dose of chlorpromazine." | 3.68 | [Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case]. ( Ishikawa, T; Kashiwagi, M; Ochiai, H; Oyama, Y; Tokita, Y; Usui, T, 1990) |
| "Nineteen male patients, under 35 years of age, newly admitted with a diagnosis of schizophrenia, were treated with either chlorpromazine or haloperidol at a fixed dosage for 25 days." | 3.67 | Total and free plasma neuroleptic levels in schizophrenic patients. ( Davidson, L; Glaister, J; Jeffries, JJ; Seeman, P; Tang, SW; Toth, R, 1984) |
| " Many such patients respond to a trial of lithium therapy; responders are usually better able to work or attend school and to live independently, and they less often show the degree of personality deterioration present in classical schizophrenia." | 3.67 | Acutely psychotic patients: a treatment approach. ( Cade, JR; Lippmann, S; Wagemaker, H, 1985) |
| "Agranulocytosis developed in three patients subsequent to chlorpromazine therapy and in one patient following treatment with methotrimeprazine and trifluoperazine." | 3.67 | Agranulocytosis in the course of phenothiazine therapy: case reports. ( Yassa, R, 1985) |
| "A 49-year-old man with severe hypertension and chronic schizophrenia developed marked hypotension with postural syncope following therapy with the combination of chlorpromazine and captopril." | 3.67 | Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. ( White, WB, 1986) |
| " To evaluate the effects of antipsychotic drugs on plasma vasopressin, we measured vasopressin response to a single dose of intramuscular chlorpromazine or intravenous haloperidol in normal individuals and to 2 weeks of oral antipsychotics in patients with acute schizophrenia." | 3.67 | Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. ( Backus, FI; Bokan, JA; Courtney, N; Dorsa, DM; Murburg, MM; Raskind, MA; Ries, RK; Weitzman, RE, 1987) |
| " A case of recurrent thrombocytopenia due to the repeated exposure to chlorpromazine (twice), haloperidol (four times) and thiothixene (twice) in a 59 year old female treated for schizophrenia is reported." | 3.67 | Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report. ( Balon, R; Berchou, R; Zethelius, M, 1987) |
| "The effects of chlorpromazine treatment on spinal motor asymmetry was studied in right-handed chronic schizophrenia patients." | 3.67 | Modulation of spinal motor asymmetry by neuroleptic medication of schizophrenia patients. ( Gürgen, F; Tan, U, 1986) |
| "Prolactin (PRL) serum levels in a group of patients with acute schizophrenia (AS) and in a group of patients with chronic schizophrenia (CS) have been investigated in order to differentiate the dopaminergic sensitivity in response to chlorpromazine (CPZ) treatment." | 3.66 | Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment. ( Almoguera, MI; Borque, M; Cabranes, JA; Fuentenebro, F; Recio, MN, 1982) |
| "Patients who presented with acute psychoses and were treated with chlorpromazine were first divided into 2 groups with good (23) and poor (13) outcome." | 3.66 | Drug-related and illness-related factors in the outcome of chlorpromazine treatment: testing a model. ( Gelder, MG; Kolakowska, T; Orr, MW, 1980) |
| "Plasma chlorpromazine (CPZ) levels were studied in children 8 to 15 yr of age who were receiving CPZ for mental disorders." | 3.66 | Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness. ( Griesbach, PH; Perlmutter, R; Rivera-Calimlim, L, 1979) |
| "The authors studied basal HGH levels and HGH response to insulin-induced hypoglycemia in 12 schizophrenic patients who had been treated with 200--450 mg/day of chlorpromazine for 6 months to 4 years compared with 12 schizophrenic patients who had received no drugs and 15 normal control subjects." | 3.66 | Effect of chlorpromazine on human growth hormone. ( Beg, AA; Dash, RJ; Varma, VK, 1979) |
| "A 42-year-old woman with a long-standing diagnosis of schizophrenia experienced two toxic reactions to 1200 mg of chlorpromazine while awaiting surgery for a locally metastatic carcinoma of the cervix." | 3.66 | An anticholinergic toxicity reaction to chlorpromazine activated by psychological stress. ( Cameron, OG; Wimer, L, 1979) |
| "Nineteen patients with acute psychoses, the majority schizophrenics, were studied in the course of chlorpromazine (CPZ) treatment." | 3.66 | Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study. ( Franklin, M; Gelder, M; Heggie, M; Kolakowska, T; Orr, M; Wiles, D, 1979) |
| "The author reviews the impact of neuroleptic chemotherapy on various forms of schizophrenia in the 25 years since the introduction of chlorpromazine in psychiatry." | 3.66 | Impact of neuroleptic chemotherapies on schizophrenic psychoses. ( Deniker, P, 1978) |
| "In this report we have described three patients with chronic schizophrenia on long-term chlorpromazine therapy who developed asymptomatic IgM inhibitors of the intrinsic phase of blood coagulation." | 3.66 | IgM inhibitors of the contact activation phase of coagulation in chlorpromazine-treated patients. ( Miller, F; Romano, GS; Zarrabi, MH; Zucker, S, 1978) |
| "Plasma chlorpromazine (CPZ) levels of 50 psychotic inpatients were measured by gas liquid chromatography; the clinical progress of 29 of these patients with acute psychoses was also assessed." | 3.65 | Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. ( Lasagna, L; Nasrallah, H; Rivera-Calimlim, L; Strauss, J, 1976) |
| "Clinical experience gained in the Soviet Union shows that Triphthazine (Trifluoperazine) is among the most useful drugs for mass treatment of psychoses." | 3.65 | [Use of triphthazine in the treatment of mentae disorders]. ( Awruzki, GJ; Gurowitsch, IJ, 1975) |
| "Three patients, aged 23-33 years, with the diagnosis of schizophrenia, developed symptoms of tardive dyskinesia while receiving neuroleptic treatment, mostly with haloperidol." | 3.65 | Diazepam in the treatment of tardive dyskinesia. Preliminary observations. ( Singh, MM, 1976) |
| "Melanosis observed in association with prolonged chlorpromazine therapy has become a serious problem in mental institutions." | 3.64 | THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT. ( BAKER, RA; GREINER, AC; NICOLSON, GA, 1964) |
| " This would mean a daily consumption of at least 300 chlorpromazine (CPZ) units in the long run and should lead to an increase of the antipsychotic dosage in comparison to patients with treatment as usual (TAU)." | 2.82 | Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study. ( Bäuml, J; Jahn, T; Kissling, W; Lüscher, S; Pitschel-Walz, G; Rentrop, M; Volz, A, 2016) |
| "Chlorpromazine was the most commonly prescribed drug." | 2.68 | Neuroleptic drug utilisation for acute schizophrenia. ( Hasanah, CI; Razali, MS, 1996) |
| " Thirty two patients of them treated with the Shuizhi (leech)-Dahuang (rhubarb) mixture mainly with low dosage of antipsychotic drugs (combined therapy group), while other 35 cases were treated with antipsychotic drugs only (control group)." | 2.68 | [Clinical study of shuizhi-dahuang mixture in treating schizophrenics with blood stasis syndrome]. ( Kang, B; Zhu, QQ; Zhu, YZ, 1996) |
| "The aim of this study was to determine if the severity of paranoid/belligerence was a major determinant of neuroleptic dosage in newly admitted patients with acute or exacerbated schizophrenia." | 2.68 | Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients. ( de Angelis, F; Pasini, A; Spalletta, G; Troisi, A, 1997) |
| "Chlorpromazine was found to be significantly better than remoxipride on the dropout rate due to inefficacy, Clinical Global Impression (CGI) of severity of illness and Brief Psychiatric Rating Scale (BPRS)." | 2.67 | A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. ( Chouinard, G, 1990) |
| "Sulpiride was superior to CPZ in reducing the autistic symptoms." | 2.66 | Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations. ( Alfredsson, G; Härnryd, C; Wiesel, FA, 1985) |
| "Short-term use of neuroleptics as well established for many psychotic disorders; details about long-term use remain less clear." | 2.65 | What is the best maintenance dose of neuroleptics in schizophrenia? ( Baldessarini, RJ; Davis, JM, 1980) |
| " In both men and women there tended to be a significant correlation between the initial log plasma PRL level while on neuroleptic maintenance treatment and the dosage received converted to chlorpromazine equivalents." | 2.65 | Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system. ( Annable, L; Chouinard, G; Collu, R; Jones, BD, 1981) |
| "Sulpiride-treated patients with extrapyramidal side effects had significantly higher drug concentrations in serum." | 2.65 | Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. ( Alfredsson, G; Bjerkenstedt, L; Edman, G; Härnryd, C; Oxenstierna, G; Sedvall, G; Wiesel, FA, 1984) |
| "Treatment with sulpiride or chlorpromazine resulted in a significant reduction of psychotic morbidity as estimated by CPRS and global ratings." | 2.65 | Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine. ( Aberg-Wistedt, A; Bjerkenstedt, L; Björk, K; Gullberg, B; Härnryd, C; Oxenstierna, G; Sedvall, G; Wiesel, FA; Wik, G, 1984) |
| "Pimozide was found to exert somewhat less of an overall therapeutic effect than chlorpromazine, particularly in highly agitated patients." | 2.65 | Pimozide in the treatment of newly admitted schizophrenic patients. ( Annable, L; Chouinard, G, 1982) |
| " There appeared to be no difference between the viloxazine-treated group and the placebo-treated group, although the study raised some question as to the adequacies of the dosage utilized since there was an absence of any apparent side effects." | 2.65 | Viloxazine and the depressed schizophrenic--methodological issues. ( Kurland, AA; Nagaraju, A, 1981) |
| "Twenty-one chronic schizophrenics were stabilized with chlorpromazine therapy at their therapeutic dosage for one month." | 2.65 | Effect of antiparkinsonian medication on plasma levels of chlorpromazine. ( Bark, N; Cooper, TB; Lee, JH; Simpson, GM; Sud, I, 1980) |
| "Penfluridol is a diphenylbutylpiperdine derivative with a half-life of sixty-six (66) hours." | 2.65 | Penfluridol: a long acting oral antipsychotic drug. ( Claghorn, JL; Mathew, RJ; Mirabi, M, 1979) |
| " Improvement was recorded in a double blind study of 18 patients treated with maximum tolerated dosage (mean 18." | 2.64 | Tardive dyskinesia treated with pimozide. ( Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF, 1975) |
| "In a double blind chlorpromazine-controlled trial, high dosage haloperidol (100 mg daily) given for three months, appreciably improved the mental state of male chronic 'drug resistant' schizophrenic inpatients in the rehabilitation/long-stay unit of one psychiatric hospital." | 2.64 | High dosage haloperidol in chronic schizophrenia. ( MacDonald, IM; McCreadie, RG, 1977) |
| "Baclofen was superior to placebo in the treatment of anxiety, which is of particular interest in view of the recent theories on the mechanism of action of benzodiazepines." | 2.64 | A double-blind trial of baclofen against placebo in the treatment of schizophrenia. ( Andersen, B; Bahr, B; Eliassen, HM; Gulmann, NC, 1976) |
| " The dose-response relationship for the different doses of alpha-methyldopa in combination with chlorpromazine, suggested an optimal response to 300 mg chlorpromazine--500 mg alpha-methyldopa." | 2.64 | Alpha-methyldopa-chlorpromazine combination in schizophrenic patients. ( Annable, L; Chouinard, G, 1976) |
| "Hallucinations were significantly more frequent among patients with low MAO activity." | 2.64 | Platelet monoamine oxidase activity in schizophrenic patients. ( Becker, RE; Shaskan, EG, 1977) |
| "Loxapine succinate was compared to chlorpromazine in a 12-week double-blind study of 50 hospitalized chronic schizophrenic patients." | 2.64 | Loxapine succinate: a controlled double-blind study in chronic schizophrenia. ( Schiele, BC, 1975) |
| "Amitriptyline alone was not substantially better than placebo and could not be considered an efficacious medication for the maintenance treatment of these patients." | 2.64 | Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction. ( Albert, JM; Annable, L; Charette, R; Chouinard, G; Serrano, M, 1975) |
| "Schizophrenia is an incurable neuropsychiatric disorder managed mostly by treatment of the patients with antipsychotics." | 2.53 | Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia. ( Cassoli, JS; Guest, PC; Martins-de-Souza, D; Santana, AG, 2016) |
| "The first relatively specific treatment of schizophrenia started about 60 years ago with the antipsychotic chlorpromazine." | 2.53 | Improving Current Treatments for Schizophrenia. ( Jovicic, MJ; Maric, NP; Mihaljevic, M; Miljevic, C, 2016) |
| "Risperidone was better for CGI endpoint scores (n=42, 1 RCT, RR 2." | 2.46 | Levomepromazine for schizophrenia. ( Jayaram, MB; Rattehalli, RD; Sivaraman, P, 2010) |
| " The atypicals cause fewer extrapyramidal symptoms and tardive dyskinesia, but there is growing concern regarding the significant long-term metabolic and cardiac adverse effects of these novel antipsychotics." | 2.42 | From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma. ( Abidi, S; Bhaskara, SM, 2003) |
| "Schizophrenia is a seriously disturbing disorder, both for the victim and for their families." | 2.41 | Schizophrenia: an illness of distorted reality. ( Dean, B, 2000) |
| "(ii) The effect of schizophrenia is to increase MAE duration, and this is not due to some peripheral artefact." | 2.39 | The duration of the movement aftereffect as an index of psychiatric illness. ( Harris, J, 1994) |
| "We found widespread cortical thinning in patients with SSDs compared to HCs." | 1.91 | Differential effects of parental socioeconomic status on cortical thickness in patients with schizophrenia spectrum disorders and healthy controls. ( Cheraghi, S; Chung, YC; Kang, C; Kim, WS; Odkhuu, S; Shen, J; Tsogt, U; Zahra Rami, F, 2023) |
| "Polydipsia was the most prevalent (24, 60." | 1.51 | Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi. ( Chikowe, I; Domingo, M; Kampira, E; Mafuta, C; Mwakaswaya, V; Parveen, S, 2019) |
| "Schizophrenia is a chronic mental disorder reported to compromise about 1% of the world's population." | 1.48 | Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences. ( Cysne Filho, FMS; de Almeida, JC; de Sousa, CNS; Diniz, DDS; Macêdo, D; Patrocínio, CFV; Patrocínio, MCA; Sampaio, LRL; Vasconcelos, SMM, 2018) |
| "Stuttering Priapism is a recurrent, persistent penile erection in the absence of sexual desire due to altered genital hemodynamics, affecting the arterial component (high flow, non-ischemic) or the veno-occlusive mechanism (low flow, ischemic)." | 1.48 | Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia. ( Birur, B; Nagaraja, S; Pandurangi, A; Thippaiah, SM, 2018) |
| "Patients received 1 of 4 of the following ECT modalities: bitemporal ECT with age-based dosing, right unilateral ECT with seizure threshold-based dosing, bitemporal ECT with seizure threshold-based dosing, and bifrontal ECT with seizure threshold-based dosing ECT." | 1.46 | Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy. ( Ang, CP; Ho, NF; Loo, C; Lu, VJM; Martin, D; Mok, YM; Simpson, B; Tan, C; Tor, PC; Wang, M; Yap, LS; Ying, J, 2017) |
| " The present study aimed to investigate the effects of the typical antipsychotic chlorpromazine (CP) alone or combined with the natural antioxidant alpha-lipoic acid (ALA) on changes in the hippocampal average spectral power induced by ketamine (KET)." | 1.46 | Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats. ( Barbosa, TM; Borges, LTN; Gularte, VN; Lima, RF; Macêdo, D; Matos, NCB; Oliveira, MN; Patrocínio, MCA; Sampaio, LRL; Vale, OCD; Vasconcelos, SMM, 2017) |
| "Schizophrenia is a widespread mental disease with a prevalence of about 1% in the world population." | 1.43 | Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. ( He, L; Huang, H; Li, M; Minica, C; Qin, S; Shen, L; Shi, Y; Wang, G; Wu, X; Xing, Q; Xu, Q; Yi, Z, 2016) |
| "Chlorpromazine (CPZ) is a widely used antipsychotic drug with antagonistic effect on dopamine receptors." | 1.43 | Chlorpromazine inhibits mitochondrial apoptotic pathway via increasing expression of tissue factor. ( Li, A; Li, J; Li, X; Li, Y; Ogutu, JO; Song, W; Tang, R; Wang, J; Wang, Y; Wu, J; Zhang, F; Zhang, Q, 2016) |
| "Antipsychotic medication and dosage were collected in our sample of 83 patients with schizophrenia spectrum disorders of a homogeneous European background." | 1.43 | Polygenic risk score prediction of antipsychotic dosage in schizophrenia. ( Cole, CB; De Luca, V; Hettige, NC; Khalid, S, 2016) |
| " Though often not considered in pharmacogenetic studies, dosage plays an important role in treatment outcome." | 1.43 | Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage. ( De Luca, V; de Moraes, GH; Hettige, NC; Kennedy, JL, 2016) |
| "Chlorpromazine is known to cause ocular pigmentary deposits." | 1.43 | A Case Report: Anti-Psychotic Agents Related Ocular Toxicity. ( Choy, BNK; Fan, MCY; Lai, JSM; Ng, ALK; Shum, JWH, 2016) |
| "Chlorpromazine is known to cause abnormal oculocutaneous pigmentation in sun-exposed areas." | 1.40 | Chlorpromazine-induced skin pigmentation with corneal and lens opacities. ( Dunnick, CA; Huff, LS; Lucas, LM; Pederson, JF; Prado, R, 2014) |
| "Auditory hallucinations are one of the central symptoms in schizophrenia." | 1.40 | Study of the inferior colliculus in patients with schizophrenia by magnetic resonance spectroscopy. ( Aguilar, EJ; Celda, B; Marti-Bonmati, L; Martinez-Bisbal, MC; Martinez-Granados, B; Molla, E; Sanjuan, J, 2014) |
| "Schizophrenia is associated with cortical thickness reductions in the brain, but it is unclear whether these are present before illness onset, and to what extent they are driven by genetic factors." | 1.39 | Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison. ( Conlon, GA; Hall, J; Honold, S; Job, D; Johnstone, EC; Lawrie, SM; McIntosh, AM; Moorhead, TW; Owens, DC; Papmeyer, M; Smyth, AM; Sprooten, E; Vincenz, D; Whalley, HC, 2013) |
| " We used Medicaid pharmacy data to measure annual and average antipsychotic continuity, to calculate chlorpromazine (CPZ) dosing equivalents, and to examine anti-Parkinson medication use." | 1.39 | Guideline-concordant antipsychotic use and mortality in schizophrenia. ( Cullen, BA; Daumit, GL; Dosreis, SC; Guallar, E; McGinty, EE; Steinwachs, DM; Zhang, Y, 2013) |
| "On arrival, the Japan coma scale, pulse, respiratory rate, body temperature, and Sp(O2) were 300, 114 beats x min(-1), 26 breaths x min(-1), 39." | 1.38 | [Comatose patient with neuroleptic malignant syndrome brought by ambulance]. ( Kuroda, Y; Takinami, Y, 2012) |
| "Patients with schizophrenia have widespread cognitive impairments, with selective deficits in relational memory." | 1.38 | Revised associative inference paradigm confirms relational memory impairment in schizophrenia. ( Armstrong, K; Heckers, S; Williams, LE, 2012) |
| "Metabolic syndrome was evaluated with fasting laboratory measurements, and dietary and lifestyle assessments." | 1.38 | DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences. ( Bly, MJ; Burghardt, KJ; Ellingrod, VL; Pilsner, JR, 2012) |
| " Individuals carrying the favorable homozygous genotypes of rs1045642 and rs2032582 displayed better response with increased dosage while those carrying risk genotype manifested refractoriness on increased dosage." | 1.38 | Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective. ( Allencherry, PM; Balan, S; Banerjee, M; Mathew, A; Nair, CM; Natarajan, C; Vijayan, NN, 2012) |
| "Chlorpromazine has antipsychotic and antimanic properties, and it revolutionized the therapeutics of psychotic illnesses." | 1.35 | Neurosyphilis, malaria, and the discovery of antipsychotic agents. ( Baldessarini, RJ; Frankenburg, FR, 2008) |
| " Chlorpromazine therapy in a 59-year-old schizophrenic man with a cumulative dosage exceeding 2500 g resulted in multiple white deposits in both corneas especially in the endothelium." | 1.35 | In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy. ( Amini, N; Nowroozzadeh, MH; Razeghinejad, MR; Zamani, M, 2008) |
| "Patients with schizophrenia are impaired in both emotion perception and contextual processing, however these two processes have not been thoroughly assessed simultaneously in adults with schizophrenia." | 1.34 | A social cognitive approach to emotional intensity judgment deficits in schizophrenia. ( Barrett, JA; Glahn, DC; Green, MJ; Monkul, ES; Robinson, JL; Velligan, DI, 2007) |
| "Common adverse effect measures in psychiatric trials are typically analysed with repeated measures ANOVA, despite having distributions which violate key assumptions of that method; moreover, some adverse effects may be concentrated in vulnerable subgroups of participants." | 1.33 | More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk. ( Arndt, S; Conley, RR; McMahon, RP, 2005) |
| "A point prevalence study of prescription dosage was made among psychiatric inpatients in Japan with the following aims: (i) to analyze whether total chlorpromazine equivalent dose was related to patient characteristics or hospital and physician characteristics; and (ii) to analyze whether the usage of the two major categories of antipsychotics, butyrophenone and phenothiazine, were related to their expected pharmacological reactions." | 1.33 | Factors related to prescription dosage in Japanese psychiatric hospitals. ( Ikegami, N; Nawata, S; Yamauchi, K, 2005) |
| "Priapism is a urologic emergency, and a urologic consultation should be obtained as early as possible." | 1.33 | Priapism associated with typical and atypical antipsychotic medications. ( Chen, CD; Kao, WT; Lung, FW; Tung, YP; Wang, CS, 2006) |
| " Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication." | 1.33 | Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. ( Goghari, VM; Honer, WG; Khorram, B; Kopala, LC; Lang, DJ; Rui, Q; Smith, GN; Vandorpe, RA, 2006) |
| "Patients with catatonic schizophrenia are highly vulnerable to negative symptoms related to neuroleptic drugs, probably because of a defect in their dopaminergic neuronal pathways." | 1.32 | Negative symptoms and neuroleptics in catatonic schizophrenia. ( Hietala, J; Honkonen, T; Koivisto, AM; Salokangas, RK; Stengård, E, 2003) |
| " While typical antipsychotics are often switched to atypical agents when adverse effects become limiting, there is little preclinical information to support this strategy, both in terms of efficacy and side effects." | 1.32 | Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. ( Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M, 2004) |
| " This article describes oral antipsychotic dosing patterns and psychotropic treatments using computerized Medicaid claims data for individuals who were diagnosed with schizophrenia and received treatment on an outpatient basis during 1991." | 1.31 | Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia. ( Buchanan, RW; dosReis, S; Lehman, AF; Zito, JM, 2002) |
| "In addition to the diagnosis of chronic pseudoakathisia, five patients (62." | 1.31 | Prevalence and characteristics of patients with pseudoakathisia. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP, 2000) |
| "Risperidone (4 mg/day) was added to her drug regimen and after increasing the dosage to 6 mg/day, she began to exhibit retrocollis." | 1.31 | Tardive dystonia provoked by concomitantly administered risperidone. ( Hori, M; Hori, T; Kawanishi, Y; Shiraishi, H; Suzuki, T; Tachikawa, H, 2000) |
| "Daily dosages of antipsychotic medications were evaluated to determine whether current guidelines advocating lower dosing are being followed." | 1.31 | Antipsychotic dosing patterns for schizophrenia in three treatment settings. ( Lawrence, R; Remington, G; Sethna, R; Shammi, CM, 2001) |
| " Chlorpromazine therapy in a cumulative dosage exceeding 1,100 g resulted in dramatic skin discoloration and multiple crystalline deposits in both corneas." | 1.31 | Corneal deposition after high-dose chlorpromazine hydrochloride therapy. ( Domniz, Y; Lawless, MA; Rogers, CM; Sutton, GL; Webber, SK, 2001) |
| " These data suggest that there was considerable delay in the adoption of evidence-based dosing of conventional antipsychotics." | 1.31 | Delays in adopting evidence-based dosages of conventional antipsychotics. ( Blow, F; Copeland, L; Owen, R; Valenstein, M; Visnic, S, 2001) |
| " Dose-response (mean lobe number) plots were significant for patients medicated with both chlorpromazine and clozapine." | 1.31 | Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients. ( Badawoud, M; Delieu, JM; Duguid, JK; Horobin, RW; Williams, MA, 2001) |
| "To evaluate neuroleptic dosing patterns in individuals with schizophrenia over a 10-year interval." | 1.30 | Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up. ( Bezchlibnyk-Butler, KZ; Prendergast, P; Remington, GJ, 1997) |
| "Thirty-seven newly admitted schizophrenic patients were treated with an open and flexible dosage of chlorpromazine for 3 months after receiving a test dose." | 1.30 | Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine. ( Minami, H; Miyahara, A; Nakahara, T; Nakane, Y, 1997) |
| " The neuroleptic doses administered in our hospital were similar to those found in other survey reports but higher than those recommended by the controlled dose-response studies." | 1.29 | Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices. ( Caro, F; Cuesta, MJ; Martinez-Larrea, A; Peralta, V, 1994) |
| "We report a case of neuroleptic malignant syndrome where the catatonia clearly followed the administration of neuroleptics and where the neurovegetative disturbance was remarkably severe, including episodes of tracheal spasm, apnoea and episodes of bradycardia, and sinus arrest requiring insertion of a temporary external pacing wire." | 1.29 | Recurrent sinus arrest in association with neuroleptic malignant syndrome. ( Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT, 1994) |
| "The population pharmacokinetic parameters of chlorpromazine (CPZ) in chronic schizophrenic patients were evaluated using 189 plasma concentration measurements from 31 patients." | 1.29 | Smoking and body weight influence the clearance of chlorpromazine. ( Chetty, M; Miller, R; Moodley, SV, 1994) |
| "The seizure was brief and subsided spontaneously." | 1.29 | Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. ( Vohra, SB, 1994) |
| " Since these metabolites have been associated with in vitro activity and occur in significant concentrations, it is recommended that all six metabolites be measured in studies correlating drug levels with pharmacodynamic effects." | 1.29 | Important metabolites to measure in pharmacodynamic studies of chlorpromazine. ( Chetty, M; Miller, R; Moodley, SV, 1994) |
| " The combined therapy of Xuefu Zhuyu Decoction and low dosage of antipsychotic drug could relieve the mental symptoms and the abnormal hemorheologic index normalized." | 1.29 | [Xuefu zhuyu decoction in treating blood stasis syndrome of schizophrenia]. ( Niu, ZX; Tang, YY; Zhang, JZ, 1993) |
| "The fulminant pulmonary edema in the three cases resolved within 18 to 40 h." | 1.28 | Acute pulmonary edema induced by overdosage of phenothiazines. ( Gefter, WB; Li, C, 1992) |
| "Treatment with chlorpromazine (100 or 150 mg daily) significantly increased the debrisoquine metabolic ratio in nine patients (P less than 0." | 1.28 | Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients. ( Benitez, J; Calandra, S; Campo, GM; Caputi, AP; Carrillo, JA; Spina, E, 1992) |
| "Five patients with neuroleptic malignant syndrome (NMS) are described." | 1.28 | Neuroleptic malignant syndrome. ( Krishnamurthy, SG; Murugappan, M; Sayeed, ZA; Srinivasan, AV, 1990) |
| " The trihexphenidyl-induced increase in CPZ plasma levels was independent of CPZ oral dosage and of CPZ plasma levels." | 1.28 | Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. ( Cooper, T; Rockland, L; Schwartz, F; Sullivan, T; Weber, D, 1990) |
| "The sulpiride group had lower metabolic rates than the controls and the schizophrenic patients later treated with chlorpromazine." | 1.28 | Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. ( Blomqvist, G; Greitz, T; Sjögren, I; Stone-Elander, S; Wiesel, FA; Wik, G, 1989) |
| " Factors of dosage and time of treatment were non-significant." | 1.28 | [Cardiotoxicity of antipsychotic drugs: abnormal ECG in 1266 cases]. ( Song, SY, 1989) |
| " Eventual discontinuation of cimetidine therapy led to a return of schizophrenic symptoms, which responded to an increase in chlorpromazine dosage to previous levels." | 1.28 | Adverse interaction between cimetidine and chlorpromazine in two cases of chronic schizophrenia. ( Byrne, A; O'Shea, B, 1989) |
| "The problems were erectile impotence, frigidity, premature ejaculation, no ejaculation, vaginismus and pain on coitus." | 1.28 | [A pilot study of sexual problems in chronic schizophrenia: a report on 51 cases]. ( Guo, GY, 1989) |
| "Treatment with chlorpromazine (CPZ) for 2 weeks further decreased the Bmax for both ligands." | 1.27 | Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment. ( Rice, HE; Rosen, J; Silk, KR; Smith, CB, 1984) |
| "The authors studied high-potency versus low-potency neuroleptic dosing practices for 110 Boston-area psychiatric inpatients and compared the findings with the dosing practices reported in surveys of nearly 16,000 Veterans Administration patients." | 1.27 | Dissimilar dosing with high-potency and low-potency neuroleptics. ( Baldessarini, RJ; Cotton, P; Katz, B, 1984) |
| " Four to 5 Cmin were monitored just before the morning valproic acid dose for 3 to 4 days preceding the kinetic study." | 1.27 | The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients. ( Chiba, K; Iizuka, R; Ishizaki, T; Kobayashi, K; Saito, M, 1984) |
| "Of these patients, 85% experienced withdrawal symptoms, mainly insomnia, anxiety, and tensional restlessness." | 1.27 | Withdrawal symptoms after long-term treatment with low-potency neuroleptics. ( Annable, L; Bradwejn, J; Chouinard, G; Jones, BD; Ross-Chouinard, A, 1984) |
| "Chlorpromazine-E levels were significantly higher in females than males, but this finding could be accounted for by differences in body weight." | 1.27 | Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. ( Busch, DA; Fang, VS; Meltzer, HY, 1983) |
| "Marked worsening of adverse effects and increased chlorpromazine plasma levels were observed in a 25-year-old schizophrenic outpatient who abruptly stopped smoking cigarettes." | 1.27 | Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report. ( Falloon, IR; Stimmel, GL, 1983) |
| "Relationships of neuroleptic dosage and tardive dyskinesia with measures of attentional, information-processing, and psychophysiological dysfunctions in medicated chronic schizophrenics were explored by correlational and stepwise multiple-regression analysis." | 1.27 | Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. ( Coyne, L; Hayes, K; Lacoursiere, R; Mazur, D; Spohn, HE, 1985) |
| " While the mean age and mean duration of hospitalization in the skin-pigmented population was slightly higher and larger than in the total population of our survey, no definitive relationships between sex, diagnosis, drugs and dosage of medication were revealed." | 1.27 | Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. ( Ban, TA; Guy, W; Wilson, WH, 1985) |
| " Data were analyzed to determine the effect of anticholinergic prophylaxis, age, sex, and type and dosage of neuroleptic on the incidence of dystonic reactions." | 1.27 | Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. ( Heiser, JF; Morrison, RL; Simpson, GM; Sramek, JJ, 1986) |
| "A historical review of the adverse reactions to neuroleptic agents--extrapyramidal side effects--is presented." | 1.27 | Extrapyramidal side effects: a historical perspective. ( Rifkin, A, 1987) |
| "Haloperidol was given to 8 patients for 10 days (group A: 0." | 1.27 | Effects of neuroleptic treatments on peripheral opioid secretion. ( Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E, 1987) |
| "A case of sudden death following chlorpromazine administration in a schizophrenic patient is presented." | 1.27 | Chlorpromazine accumulation and sudden death in a patient with renal insufficiency. ( Crismon, ML; Dorson, PG, 1988) |
| "Rats treated with chlorpromazine (CPZ) (1 mg/kg/day i." | 1.27 | Amphetamine and chlorpromazine modify cerebral insulin levels in rats. ( Benedi, J; Cantón, R; Grande, C; Manzanares, J; Zaragozá, F, 1988) |
| "A case of neuroleptic malignant syndrome (NMS) treated successfully with electroconvulsive therapy (ETC) is described." | 1.27 | A successful electroconvulsive treatment of neuroleptic malignant syndrome. ( Aizenberg, D; Hermesh, H; Weizman, A, 1987) |
| "Priapism is a rare but serious adverse effect of psychotropic drugs resulting from their peripheral alpha-adrenoreceptor blocking action." | 1.27 | Priapism and psychotropic medication. ( de Alwis, C; Kogeorgos, J, 1986) |
| "Thioridazine levels were substantially higher than those of other neuroleptics." | 1.26 | Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients. ( Creese, I; DePaulo, JR; Slavney, PR; Snyder, SH; Tune, LE, 1981) |
| "Propranolol was found to facilitate habituation in slow habituators and to reinstate responses in half of non-responders, especially when given as the sole drug." | 1.26 | Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia. ( Connolly, J; Eves, F; Gruzelier, J; Hirsch, S; Weller, M; Yorkston, N; Zaki, S, 1981) |
| " After the fixed-dose period, the dosage of CPZ was increased in the "non-responders" by physician's choice." | 1.26 | Does a plasma level of chlorpromazine help? ( Jenden, DJ; May, PR; Van Putten, T, 1981) |
| "The determinants of relapse have been elusive." | 1.26 | Low serum neuroleptic levels predict relapse in schizophrenic patients. ( Brown, WA; Chisholm, E; Laughren, T; Williams, BW, 1982) |
| "Plasma and saliva levels of chlorpromazine hydrochloride were measured by gas chromatography-mass spectrometry, after a standard dosage had been administered to 48 newly admitted schizophrenic patients over 28 days." | 1.26 | Chlorpromazine levels and the outcome of treatment in schizophrenic patients. ( Dixon, WJ; Jenden, DJ; May, PR; Van Putten, T; Yale, C, 1981) |
| " Assessment of the pharmacokinetic parameters was provided by the use of a mathematical modelling of pharmacokinetic processes." | 1.26 | [Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy]. ( Beliaev, BS; Lukanina, SK; Minsker, EI; Panteleeva, GP; Tsirkin, SIu, 1980) |
| "Chlorpromazine was measured in plasma and saliva at 1, 2, 3 (saliva only), 4, 6, 8, 12 (saliva only), and 24 hours by gas chromatography-mass spectography." | 1.26 | Plasma and saliva levels of chlorpromazine and subjective response. ( Cho, AK; Jenden, DJ; May, PR; Van Putten, T; Yale, C, 1980) |
| "The chlorpromazine therapy was then begun and continued for three months." | 1.26 | Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients. ( Ikenaga, H; Nakahara, T; Sakurai, Y; Takahashi, R, 1980) |
| "The dosage of the whole tryptophan and of the free tryptophan was conducted in 16 normal subjects to establish reference values and in 12 schizophrenic subjects among whom 7 were under treatment and 5 were not." | 1.26 | [Study of free and total tryptophan in the plasma. It value in psychiatry]. ( Bousquet, B; Deniker, P; Dreux, C; Escande, C; Lôo, H; Zarifian, E, 1976) |
| " The described methodology opens avenues for performing bioavailability and generic equivalence studies in humans." | 1.26 | Chlorpromazine metabolism VIII: blood levels of chlorpromazine and its sulfoxide in schizophrenic patients. ( Clark, ML; Kaul, PN; Whitfield, LR, 1976) |
| "These episodes are differentiated from nocturnal wanderings and epileptic attacks during sleep; they occurred within two to three hours after sleep onset and were characterized by the patients appearing confused and walking about in a quiet, detached and clumsy manner." | 1.26 | Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. ( Charney, DS; Kales, A; Nelson, JC; Soldatos, CR, 1979) |
| "The chronic administration of phenothiazines has come under increasing scrutiny recently, and the uncritical use of this form of treatment has been criticized." | 1.26 | Schizophrenia following withdrawal from chronic phenothiazine administration: a case report. ( Sale, I, 1978) |
| "Propranolol was found to share the properties of the racemate in facilitating habituation of the electrodermal orienting reflex in schizophrenic patients." | 1.26 | Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia. ( Gruzelier, JH; Hirsch, SR; Murphy, C; Weller, M, 1979) |
| " Measurement of response to a single test dose may prove potentially more fruitful in predicting outcome and in establishing drug and dosage choice for a given patient than simple attempts to correlate sustained dosage levels with clinical response." | 1.26 | Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature. ( May, PR; Van Putten, T, 1978) |
| " Chlorpromazine showed only a modest advantage over L-dopa and only on some Brief Psychiatric Rating Scale factor scores, and at maximum dosage the thought disturbance factor score in the L-dopa-treated group was not worse than at baseline." | 1.26 | Paradoxical reaction to L-dopa in schizophrenic patients. ( Alpert, M; Diamond, F; Friedhoff, AJ; Marcos, LR, 1978) |
| "Plasma immunoreactive beta-melanocyte-stimulating hormone (beta-MSH) concentrations were normal in schizophrenic patients on prolonged and high dosage phenothiazine therapy." | 1.26 | Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses. ( Burton, JL; Goolamali, SK; Pye, RJ; Shuster, S; Smith, AG; Thody, AJ, 1977) |
| "Penfluridol-treated patients experienced less drowsiness than those treated with chlorpromazine, but the severity of extrapyramidal symptoms appeared to be greater with penfluridol." | 1.26 | Penfluridol in the treatment of newly admitted schizophrenic patients in a brief therapy unit. ( Annable, L; Chouinard, G, 1976) |
| "Penfluridol has the clear practical advantage of being the only long-acting drug for oral administration so far available." | 1.26 | Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes. ( Edenius, B; Jacobsson, L; Kettner, B; Magnusson, KE; Mattsson, B; Perris, C; Rapp, W; Villemoes, P; Von Knorring, L, 1976) |
| " The risk of using chlorpromazine in moderate dosage is slight." | 1.26 | Deposits in the lens and cornea of the eye during long-term chlorpromazine medication. ( Faurbye, A; Kirk, L; Rasmussen, K, 1976) |
| " There were, however, significant negative correlations between dopamin beta-hydroxylase activity and the tim spent in the morgue before autopsy, and between enzyme activity of schizophrenics and dosage of chlorpromazine or its equivalent." | 1.25 | Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients. ( Barchas, JD; Erdelyi, E; Schwartz, MA; Wyatt, RJ, 1975) |
| "As outpatient treatment of schizophrenia increases, cases of over-dose with phenothiazine drugs may be expected to increase also." | 1.25 | Phenothiazine poisoning. A review of 48 cases. ( Barry, D; Becker, CE; Meyskens, FL, 1973) |
| " Each was used in four dosage levels (thioridazine and chlorpromazine: 200, 400, 800 and 1200 mg." | 1.24 | THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM. ( BAN, TA; STJEAN, A, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1274 (77.64) | 18.7374 |
| 1990's | 125 (7.62) | 18.2507 |
| 2000's | 131 (7.98) | 29.6817 |
| 2010's | 101 (6.15) | 24.3611 |
| 2020's | 10 (0.61) | 2.80 |
| Authors | Studies |
|---|---|
| Juza, R | 1 |
| Vojtechova, I | 1 |
| Stefkova-Mazochova, K | 1 |
| Dehaen, W | 1 |
| Petrasek, T | 1 |
| Prchal, L | 1 |
| Kobrlova, T | 1 |
| Janousek, J | 1 |
| Vlcek, P | 1 |
| Mezeiova, E | 1 |
| Svozil, D | 1 |
| Karasova, JZ | 1 |
| Pejchal, J | 1 |
| Stark, H | 1 |
| Satala, G | 1 |
| Bojarski, AJ | 1 |
| Kubacka, M | 1 |
| Mogilski, S | 1 |
| Randakova, A | 1 |
| Musilek, K | 1 |
| Soukup, O | 1 |
| Korabecny, J | 1 |
| Kurokawa, Y | 1 |
| Watanabe, S | 1 |
| Miyabe, S | 1 |
| Ishibashi, K | 1 |
| Yamamoto, S | 1 |
| Goto, M | 1 |
| Hasegawa, S | 1 |
| Miyachi, H | 1 |
| Fujita, K | 2 |
| Nagao, T | 1 |
| Brown, JS | 1 |
| Haddad, C | 3 |
| Salameh, P | 1 |
| Sacre, H | 2 |
| Clément, JP | 1 |
| Calvet, B | 1 |
| Wadhwa, A | 1 |
| Beainy, C | 1 |
| Fekih-Romdhane, F | 1 |
| Hallit, S | 2 |
| Haddad, G | 1 |
| Zahra Rami, F | 1 |
| Kim, WS | 1 |
| Shen, J | 1 |
| Tsogt, U | 1 |
| Odkhuu, S | 1 |
| Cheraghi, S | 1 |
| Kang, C | 1 |
| Chung, YC | 1 |
| López-Herrero, F | 1 |
| Contreras-Díaz, M | 1 |
| Sánchez-Vicente, JL | 1 |
| Monteleone, P | 1 |
| Cascino, G | 1 |
| Monteleone, AM | 1 |
| Rocca, P | 1 |
| Rossi, A | 2 |
| Bertolino, A | 1 |
| Aguglia, E | 1 |
| Amore, M | 1 |
| Collantoni, E | 1 |
| Corrivetti, G | 1 |
| Cuomo, A | 1 |
| Bellomo, A | 1 |
| D'Ambrosio, E | 1 |
| Dell'Osso, L | 1 |
| Frascarelli, M | 1 |
| Giordano, GM | 1 |
| Giuliani, L | 1 |
| Marchesi, C | 1 |
| Montemagni, C | 1 |
| Oldani, L | 1 |
| Pinna, F | 1 |
| Pompili, M | 1 |
| Roncone, R | 1 |
| Rossi, R | 1 |
| Siracusano, A | 1 |
| Vita, A | 1 |
| Zeppegno, P | 1 |
| Galderisi, S | 2 |
| Maj, M | 1 |
| Hajj, A | 1 |
| Chamoun, K | 1 |
| Obeid, S | 1 |
| Dollfus, S | 3 |
| Khabbaz, LR | 1 |
| Zare, M | 2 |
| Bazrafshan, A | 2 |
| Mazhari, S | 1 |
| Esmailian, S | 1 |
| Shah-Esmaeili, A | 1 |
| Goughari, AS | 1 |
| Dudley, K | 1 |
| Liu, X | 3 |
| De Haan, S | 3 |
| Abe, C | 1 |
| Nishimura, S | 1 |
| Mori, A | 2 |
| Niimi, Y | 1 |
| Yang, Y | 2 |
| Hane, M | 1 |
| Kitajima, K | 1 |
| Sato, C | 1 |
| Tor, PC | 1 |
| Ying, J | 1 |
| Ho, NF | 1 |
| Wang, M | 2 |
| Martin, D | 1 |
| Ang, CP | 1 |
| Tan, C | 1 |
| Yap, LS | 1 |
| Lu, VJM | 1 |
| Simpson, B | 1 |
| Mok, YM | 1 |
| Loo, C | 1 |
| Deng, H | 1 |
| Xu, J | 1 |
| Nikvarz, N | 1 |
| Vahedian, M | 1 |
| Khalili, N | 1 |
| Li, H | 1 |
| Shen, Y | 1 |
| Wang, G | 2 |
| Shi, J | 1 |
| Ma, C | 1 |
| Xie, S | 1 |
| Zhang, H | 1 |
| Wang, X | 1 |
| Li, K | 2 |
| Xu, X | 1 |
| Gu, N | 2 |
| Sampaio, LRL | 2 |
| Cysne Filho, FMS | 1 |
| de Almeida, JC | 1 |
| Diniz, DDS | 1 |
| Patrocínio, CFV | 1 |
| de Sousa, CNS | 1 |
| Patrocínio, MCA | 2 |
| Macêdo, D | 2 |
| Vasconcelos, SMM | 2 |
| Meng, Q | 1 |
| Li, R | 1 |
| Hou, F | 1 |
| Zhang, Q | 2 |
| Thippaiah, SM | 1 |
| Nagaraja, S | 1 |
| Birur, B | 1 |
| Pandurangi, A | 1 |
| Hasegawa, T | 1 |
| Hashimoto, T | 1 |
| Kanahara, N | 2 |
| Yamanaka, H | 2 |
| Ishige, M | 2 |
| Sato, Y | 2 |
| Iyo, M | 3 |
| Boyd-Kimball, D | 1 |
| Gonczy, K | 1 |
| Lewis, B | 1 |
| Mason, T | 1 |
| Siliko, N | 1 |
| Wolfe, J | 1 |
| Pich, J | 1 |
| Eslami Shahrbabaki, M | 1 |
| Dehnavieh, R | 1 |
| Vali, L | 1 |
| Sharafkhani, R | 1 |
| Beloti, LGM | 1 |
| Miranda, LFC | 1 |
| Queiroz, MEC | 1 |
| Gong, J | 1 |
| Luo, C | 1 |
| Li, X | 6 |
| Jiang, S | 1 |
| Khundrakpam, BS | 1 |
| Duan, M | 1 |
| Chen, X | 1 |
| Yao, D | 1 |
| Zajicek, B | 1 |
| Chikowe, I | 1 |
| Domingo, M | 1 |
| Mwakaswaya, V | 1 |
| Parveen, S | 1 |
| Mafuta, C | 1 |
| Kampira, E | 1 |
| Basta-Kaim, A | 2 |
| Szczęsny, E | 1 |
| Leśkiewicz, M | 2 |
| Głombik, K | 1 |
| Slusarczyk, J | 1 |
| Budziszewska, B | 2 |
| Regulska, M | 2 |
| Kubera, M | 2 |
| Nowak, W | 1 |
| Wędzony, K | 2 |
| Lasoń, W | 2 |
| Suzuki, H | 1 |
| Gen, K | 1 |
| Inoue, Y | 2 |
| Wobrock, T | 1 |
| Falkai, P | 1 |
| Schneider-Axmann, T | 1 |
| Hasan, A | 1 |
| Davidson, M | 1 |
| Kahn, RS | 1 |
| Derks, EM | 1 |
| Boter, H | 1 |
| Rybakowski, JK | 1 |
| Libiger, J | 1 |
| López-Ibor, JJ | 1 |
| Peuskens, J | 2 |
| Hranov, LG | 1 |
| Gaebel, W | 2 |
| Fleischhacker, WW | 1 |
| Sprooten, E | 1 |
| Papmeyer, M | 1 |
| Smyth, AM | 1 |
| Vincenz, D | 1 |
| Honold, S | 1 |
| Conlon, GA | 1 |
| Moorhead, TW | 1 |
| Job, D | 1 |
| Whalley, HC | 1 |
| Hall, J | 1 |
| McIntosh, AM | 2 |
| Owens, DC | 1 |
| Johnstone, EC | 7 |
| Lawrie, SM | 2 |
| Scher, JU | 1 |
| Abramson, SB | 1 |
| Yasuda, M | 1 |
| Kobayashi, T | 1 |
| Kato, S | 2 |
| Kishi, K | 1 |
| Adams, CE | 7 |
| Awad, GA | 1 |
| Rathbone, J | 4 |
| Thornley, B | 5 |
| Soares-Weiser, K | 1 |
| Rodewald, K | 1 |
| Holt, DV | 1 |
| Rentrop, M | 2 |
| Roesch-Ely, D | 1 |
| Liebrenz, M | 1 |
| Funke, J | 1 |
| Weisbrod, M | 1 |
| Kaiser, S | 1 |
| Sukegawa, T | 1 |
| Inagaki, A | 1 |
| Yamanouchi, Y | 1 |
| Inada, T | 2 |
| Yoshio, T | 1 |
| Yoshimura, R | 1 |
| Iwata, N | 1 |
| Hou, R | 1 |
| Jian, J | 1 |
| Mi, G | 1 |
| Qiu, H | 1 |
| Cao, B | 1 |
| Tang, M | 1 |
| Samara, MT | 1 |
| Cao, H | 1 |
| Helfer, B | 1 |
| Davis, JM | 14 |
| Leucht, S | 5 |
| Huff, LS | 1 |
| Prado, R | 1 |
| Pederson, JF | 1 |
| Dunnick, CA | 1 |
| Lucas, LM | 1 |
| Martinez-Granados, B | 1 |
| Martinez-Bisbal, MC | 1 |
| Sanjuan, J | 1 |
| Aguilar, EJ | 1 |
| Marti-Bonmati, L | 1 |
| Molla, E | 1 |
| Celda, B | 1 |
| Husa, AP | 1 |
| Rannikko, I | 1 |
| Moilanen, J | 1 |
| Haapea, M | 2 |
| Murray, GK | 1 |
| Barnett, J | 1 |
| Jones, PB | 1 |
| Isohanni, M | 1 |
| Koponen, H | 1 |
| Miettunen, J | 2 |
| Jääskeläinen, E | 2 |
| Lui, S | 1 |
| Yao, L | 1 |
| Xiao, Y | 1 |
| Keedy, SK | 1 |
| Reilly, JL | 1 |
| Keefe, RS | 1 |
| Tamminga, CA | 2 |
| Keshavan, MS | 2 |
| Pearlson, GD | 1 |
| Gong, Q | 1 |
| Sweeney, JA | 3 |
| Tardy, M | 1 |
| Dold, M | 1 |
| Engel, RR | 1 |
| Ansoleaga, B | 1 |
| Garcia-Esparcia, P | 1 |
| Pinacho, R | 1 |
| Haro, JM | 1 |
| Ramos, B | 1 |
| Ferrer, I | 1 |
| Chang, WC | 1 |
| Chan, TC | 1 |
| Chiu, SS | 1 |
| Hui, CL | 1 |
| Chan, SK | 1 |
| Lee, EH | 1 |
| Chen, EY | 1 |
| Jouali, T | 1 |
| Boukatta, B | 1 |
| Bechri, B | 1 |
| Houari, N | 1 |
| Bouazzaoui, A | 1 |
| Sbai, H | 1 |
| Kanjaa, N | 1 |
| Honer, WG | 4 |
| Jones, AA | 1 |
| Thornton, AE | 2 |
| Barr, AM | 1 |
| Procyshyn, RM | 1 |
| Vila-Rodriguez, F | 1 |
| Lubinga, SJ | 1 |
| Mutamba, BB | 1 |
| Nganizi, A | 1 |
| Babigumira, JB | 1 |
| Matosin, N | 1 |
| Fernandez-Enright, F | 1 |
| Lum, JS | 1 |
| Andrews, JL | 1 |
| Engel, M | 1 |
| Huang, XF | 1 |
| Newell, KA | 1 |
| Udawela, M | 1 |
| Money, TT | 1 |
| Neo, J | 1 |
| Seo, MS | 1 |
| Scarr, E | 3 |
| Dean, B | 4 |
| Everall, IP | 1 |
| Xu, Q | 1 |
| Wu, X | 1 |
| Li, M | 1 |
| Huang, H | 1 |
| Minica, C | 1 |
| Yi, Z | 1 |
| Shen, L | 1 |
| Xing, Q | 3 |
| Shi, Y | 1 |
| He, L | 7 |
| Qin, S | 1 |
| Kornfeld, DS | 1 |
| Molina-Ruiz, AM | 1 |
| Pulpillo, Á | 1 |
| Molina-Ruiz, RM | 1 |
| Sagrario, T | 1 |
| Requena, L | 1 |
| Saguem, BN | 1 |
| Bouhlel, S | 1 |
| Ben Salem, C | 1 |
| Ben Hadj Ali, B | 1 |
| Wu, J | 1 |
| Li, A | 1 |
| Li, Y | 2 |
| Song, W | 1 |
| Wang, Y | 1 |
| Ogutu, JO | 1 |
| Wang, J | 1 |
| Li, J | 1 |
| Tang, R | 1 |
| Zhang, F | 1 |
| Cassoli, JS | 1 |
| Guest, PC | 1 |
| Santana, AG | 1 |
| Martins-de-Souza, D | 1 |
| Hettige, NC | 2 |
| Cole, CB | 1 |
| Khalid, S | 1 |
| De Luca, V | 2 |
| de Moraes, GH | 1 |
| Kennedy, JL | 1 |
| Bourgou, S | 1 |
| Halayem, S | 1 |
| Amado, I | 1 |
| Triki, R | 1 |
| Bourdel, MC | 1 |
| Franck, N | 1 |
| Krebs, MO | 1 |
| Tabbane, K | 1 |
| Bouden, A | 1 |
| Bäuml, J | 1 |
| Pitschel-Walz, G | 1 |
| Volz, A | 1 |
| Lüscher, S | 1 |
| Kissling, W | 1 |
| Jahn, T | 1 |
| Saha, KB | 1 |
| Bo, L | 1 |
| Zhao, S | 1 |
| Xia, J | 1 |
| Sampson, S | 1 |
| Zaman, RU | 1 |
| Choy, BNK | 1 |
| Ng, ALK | 1 |
| Shum, JWH | 1 |
| Fan, MCY | 1 |
| Lai, JSM | 1 |
| Nur, S | 2 |
| Moilanen, JM | 1 |
| Veijola, JM | 1 |
| Isohanni, MK | 1 |
| Koponen, HJ | 1 |
| Kimura, H | 1 |
| Sasaki, T | 2 |
| Komatsu, N | 1 |
| Muneoka, K | 1 |
| Ino, H | 1 |
| Yoshimura, K | 1 |
| Suzuki, T | 3 |
| Komatsu, H | 1 |
| Watanabe, H | 2 |
| Shimizu, E | 1 |
| Maric, NP | 1 |
| Jovicic, MJ | 1 |
| Mihaljevic, M | 1 |
| Miljevic, C | 2 |
| Borges, LTN | 1 |
| Barbosa, TM | 1 |
| Matos, NCB | 1 |
| Lima, RF | 1 |
| Oliveira, MN | 1 |
| Gularte, VN | 1 |
| Vale, OCD | 1 |
| Sacchi, S | 3 |
| Cappelletti, P | 2 |
| Pirone, L | 1 |
| Smaldone, G | 1 |
| Pedone, E | 1 |
| Pollegioni, L | 3 |
| Biagiarelli, M | 1 |
| Curto, M | 1 |
| Di Pomponio, I | 1 |
| Comparelli, A | 1 |
| Baldessarini, RJ | 5 |
| Ferracuti, S | 1 |
| Gowda, GS | 1 |
| Hegde, A | 1 |
| Shanbhag, V | 1 |
| Narayanaswamy, JC | 1 |
| Jaisoorya, TS | 1 |
| Correll, CU | 2 |
| Frederickson, AM | 1 |
| Figen, V | 1 |
| Ginn-Scott, EJ | 1 |
| Pantaleon Moya, RA | 1 |
| Kane, JM | 3 |
| Manu, P | 1 |
| Iwana, S | 1 |
| Kawazoe, T | 1 |
| Park, HK | 1 |
| Tsuchiya, K | 1 |
| Ono, K | 1 |
| Yorita, K | 1 |
| Sakai, T | 2 |
| Kusumi, T | 1 |
| Fukui, K | 1 |
| Leucht, C | 2 |
| Kitzmantel, M | 2 |
| Chua, L | 2 |
| Kane, J | 7 |
| Shim, G | 1 |
| Kang, DH | 1 |
| Kwon, JS | 2 |
| Wheeler, A | 1 |
| Humberstone, V | 1 |
| Robinson, E | 1 |
| Frankenburg, FR | 1 |
| Forbes, NF | 1 |
| Carrick, LA | 1 |
| Razeghinejad, MR | 1 |
| Nowroozzadeh, MH | 1 |
| Zamani, M | 1 |
| Amini, N | 1 |
| Takizawa, R | 1 |
| Hashimoto, K | 2 |
| Tochigi, M | 1 |
| Kawakubo, Y | 1 |
| Marumo, K | 1 |
| Fukuda, M | 1 |
| Kasai, K | 1 |
| Al Hadithy, AF | 1 |
| Ivanova, SA | 1 |
| Pechlivanoglou, P | 1 |
| Semke, A | 1 |
| Fedorenko, O | 1 |
| Kornetova, E | 1 |
| Ryadovaya, L | 1 |
| Brouwers, JR | 1 |
| Wilffert, B | 1 |
| Bruggeman, R | 1 |
| Loonen, AJ | 1 |
| Kroken, RA | 1 |
| Johnsen, E | 1 |
| Ruud, T | 1 |
| Wentzel-Larsen, T | 1 |
| Jørgensen, HA | 1 |
| Yeh, TL | 1 |
| Lee, IH | 1 |
| Chen, PS | 1 |
| Yu, L | 2 |
| Cheng, SH | 1 |
| Yao, WJ | 1 |
| Yang, YK | 1 |
| Lu, RB | 1 |
| Chiu, NT | 1 |
| Ravanic, DB | 1 |
| Dejanovic, SM | 1 |
| Janjic, V | 1 |
| Jovic, SD | 1 |
| Milovanovic, DR | 1 |
| Jakovljevic, V | 1 |
| Pantovic, V | 1 |
| Ravanic, B | 1 |
| Pantovic, M | 1 |
| Pantovic, MM | 1 |
| Nemoto, T | 1 |
| Yamazawa, R | 1 |
| Kobayashi, H | 1 |
| Fujita, N | 1 |
| Chino, B | 1 |
| Fujii, C | 1 |
| Kashima, H | 2 |
| Rassovsky, Y | 1 |
| Green, MF | 2 |
| Mizuno, M | 1 |
| Fallon, P | 1 |
| Schlagenhauf, F | 1 |
| Dinges, M | 1 |
| Beck, A | 1 |
| Wüstenberg, T | 1 |
| Friedel, E | 1 |
| Dembler, T | 1 |
| Sarkar, R | 1 |
| Wrase, J | 1 |
| Gallinat, J | 2 |
| Juckel, G | 1 |
| Heinz, A | 1 |
| Satterthwaite, TD | 1 |
| Wolf, DH | 1 |
| Loughead, J | 1 |
| Ruparel, K | 1 |
| Valdez, JN | 1 |
| Siegel, SJ | 1 |
| Kohler, CG | 1 |
| Gur, RE | 1 |
| Gur, RC | 1 |
| Iakimova, G | 1 |
| Passerieux, C | 1 |
| Denhière, G | 1 |
| Laurent, JP | 1 |
| Vistoli, D | 1 |
| Vilain, J | 1 |
| Hardy-Baylé, MC | 2 |
| Suzuki, Y | 2 |
| Watanabe, J | 1 |
| Ono, S | 1 |
| Fukui, N | 1 |
| Sugai, T | 1 |
| Tsuneyama, N | 1 |
| Someya, T | 3 |
| Knowles, EE | 1 |
| David, AS | 1 |
| Reichenberg, A | 1 |
| Yagmur, F | 1 |
| Ulusoy, HB | 1 |
| Buyukoglan, H | 1 |
| Kaya, MG | 1 |
| Nikolić-Kokić, A | 1 |
| Saicić, ZS | 1 |
| Milosavljević, M | 1 |
| Blagojević, D | 1 |
| Tosevski, DL | 1 |
| Jones, DR | 1 |
| Spasić, MB | 1 |
| Lee, J | 1 |
| Jiang, J | 1 |
| Sim, K | 3 |
| Chong, SA | 1 |
| Coker, AO | 1 |
| Caldinelli, L | 2 |
| Molla, G | 2 |
| Bracci, L | 1 |
| Lelli, B | 1 |
| Pileri, S | 1 |
| Xu, M | 1 |
| Li, S | 2 |
| Zheng, Y | 1 |
| Wu, S | 2 |
| Gao, R | 3 |
| Guo, T | 1 |
| Liu, J | 2 |
| Zhang, A | 1 |
| Zhao, X | 1 |
| He, G | 3 |
| Zhou, J | 1 |
| Wang, L | 1 |
| Xuan, J | 1 |
| Du, J | 1 |
| Feng, G | 2 |
| Lin, Z | 2 |
| Xu, Y | 1 |
| St Clair, D | 2 |
| Vonnegut, M | 1 |
| Sivaraman, P | 1 |
| Rattehalli, RD | 1 |
| Jayaram, MB | 1 |
| Fijał, K | 1 |
| Feifel, D | 1 |
| Shilling, PD | 1 |
| Melendez, G | 1 |
| Eren, E | 1 |
| Yeğin, A | 1 |
| Yilmaz, N | 1 |
| Herken, H | 1 |
| Girgis, RR | 1 |
| Phillips, MR | 1 |
| Jiang, H | 1 |
| Wu, C | 1 |
| Duan, N | 1 |
| Niu, Y | 1 |
| Lieberman, JA | 3 |
| Bola, J | 1 |
| Kao, D | 1 |
| Soydan, H | 2 |
| Iwasa, S | 1 |
| Tabara, H | 1 |
| Song, Z | 1 |
| Nakabayashi, M | 1 |
| Yokoyama, Y | 1 |
| Fukushima, T | 2 |
| Pringsheim, T | 1 |
| Lam, D | 1 |
| Tano, DS | 1 |
| Patten, SB | 1 |
| Bola, JR | 1 |
| Kao, DT | 1 |
| Davidson, CA | 1 |
| Kuroki, N | 1 |
| Alvarado, JL | 1 |
| Niznikiewicz, MA | 2 |
| McCarley, RW | 1 |
| Levitt, JJ | 1 |
| Kendall, T | 1 |
| Jürgens, G | 1 |
| Rasmussen, HB | 1 |
| Werge, T | 1 |
| Dalhoff, K | 1 |
| Nordentoft, M | 1 |
| Andersen, SE | 1 |
| Nebhinani, N | 1 |
| Grover, S | 1 |
| Takinami, Y | 1 |
| Kuroda, Y | 1 |
| McKenna, P | 1 |
| Sherwood, M | 1 |
| Armstrong, K | 1 |
| Williams, LE | 1 |
| Heckers, S | 1 |
| Burghardt, KJ | 1 |
| Pilsner, JR | 1 |
| Bly, MJ | 1 |
| Ellingrod, VL | 1 |
| Carpenter, WT | 2 |
| Vijayan, NN | 1 |
| Mathew, A | 1 |
| Balan, S | 1 |
| Natarajan, C | 1 |
| Nair, CM | 1 |
| Allencherry, PM | 1 |
| Banerjee, M | 1 |
| Ikezawa, S | 1 |
| Corbera, S | 1 |
| Wexler, BE | 1 |
| Cullen, BA | 1 |
| McGinty, EE | 1 |
| Zhang, Y | 1 |
| Dosreis, SC | 1 |
| Steinwachs, DM | 1 |
| Guallar, E | 1 |
| Daumit, GL | 1 |
| Koh, V | 1 |
| Khor, WB | 1 |
| Lim, L | 1 |
| Nardini, M | 1 |
| Shean, G | 2 |
| Burnett, T | 1 |
| Eckman, FS | 1 |
| Salokangas, RK | 1 |
| Honkonen, T | 1 |
| Stengård, E | 1 |
| Koivisto, AM | 1 |
| Hietala, J | 1 |
| Higashima, M | 1 |
| Nagasawa, T | 1 |
| Kawasaki, Y | 1 |
| Oka, T | 1 |
| Sakai, N | 1 |
| Tsukada, T | 1 |
| Koshino, Y | 1 |
| Youn, T | 1 |
| Park, HJ | 1 |
| Kim, JJ | 1 |
| Kim, MS | 1 |
| Perlstein, WM | 1 |
| Dixit, NK | 1 |
| Carter, CS | 1 |
| Noll, DC | 1 |
| Cohen, JD | 1 |
| Hagh-Shenas, H | 1 |
| Toobai, S | 1 |
| Makaremi, A | 1 |
| Harris, DS | 1 |
| Wolkowitz, OM | 1 |
| Reus, VI | 1 |
| Zhang, ZJ | 4 |
| Yao, ZJ | 2 |
| Zhang, XB | 2 |
| Chen, JF | 1 |
| Sun, J | 2 |
| Yao, H | 1 |
| Hou, G | 1 |
| Durham, RC | 1 |
| Guthrie, M | 1 |
| Morton, RV | 1 |
| Reid, DA | 1 |
| Treliving, LR | 1 |
| Fowler, D | 1 |
| Macdonald, RR | 1 |
| Copolov, DL | 1 |
| Seal, ML | 1 |
| Maruff, P | 1 |
| Ulusoy, R | 1 |
| Wong, MT | 1 |
| Tochon-Danguy, HJ | 1 |
| Egan, GF | 1 |
| Phillips, M | 1 |
| Gu, H | 1 |
| Stroup, S | 1 |
| Zhang, P | 1 |
| Kong, L | 1 |
| Ji, Z | 1 |
| Koch, G | 1 |
| Hamer, RM | 1 |
| Addington, J | 1 |
| Leriger, E | 1 |
| Addington, D | 1 |
| Azuma, T | 1 |
| Shimizu, A | 1 |
| Yamashita, K | 1 |
| Iwase, M | 1 |
| Kajimoto, O | 1 |
| Tatsumoto, Y | 1 |
| Sumitsuji, N | 1 |
| dosReis, S | 1 |
| Zito, JM | 1 |
| Buchanan, RW | 2 |
| Lehman, AF | 1 |
| Awad, G | 3 |
| Woods, SW | 1 |
| Morishita, S | 1 |
| KELLEY, JW | 1 |
| LABHARDT, F | 2 |
| LEON, CA | 3 |
| GEIGER, H | 1 |
| FINKEISTEIN, BA | 1 |
| KURLAND, AA | 6 |
| ANDERMANN, K | 1 |
| LINDSAY, JS | 1 |
| NUZUM, JW | 1 |
| REES, EL | 1 |
| VALLAT, JN | 1 |
| THERIAULT, JC | 1 |
| WATTERSON, DJ | 1 |
| SCHLICHTHER, W | 1 |
| BRISTOW, ME | 1 |
| SCHULTZ, S | 1 |
| HENDERSON, AL | 1 |
| HAASE, HJ | 2 |
| MITCHELL, PH | 1 |
| HALL, RA | 2 |
| DUNLAP, DJ | 1 |
| ROSENOW, EC | 1 |
| BONETTI, U | 1 |
| PEDRINONI, L | 1 |
| COWDEN, RC | 1 |
| ZAX, M | 1 |
| HAGUE, JR | 1 |
| FINNEY, RC | 1 |
| ELLIOTT, RN | 1 |
| SCHRUT, AH | 1 |
| MARRA, JJ | 1 |
| JACKSON, RB | 1 |
| SWAIN, JM | 1 |
| JATZKEWITZ, H | 1 |
| ADDISON, R | 1 |
| FREEMAN, H | 2 |
| ARNOLD, AL | 1 |
| CLINE, HS | 1 |
| SEREISKII, MIa | 1 |
| TOLMASKAIA, ES | 1 |
| GOLODETS, RG | 1 |
| SAMTER, NF | 1 |
| LAPTEVA, NN | 1 |
| ZYDOWO, M | 1 |
| KAMINSKI, Z | 1 |
| POSTEL, J | 1 |
| COSSA, P | 1 |
| PETELSKI, M | 2 |
| BARBIER, A | 2 |
| LECONTE, M | 2 |
| DELGADO, H | 2 |
| SCHNEIDER, G | 2 |
| RIVAS, M | 2 |
| JANZARIK, W | 2 |
| BAUDRAND, C | 2 |
| BLANCHARD, M | 2 |
| RACAMIER, PC | 2 |
| D'AULNAY, J | 2 |
| MALINEAU, R | 2 |
| CARRIE, J | 2 |
| FOURNY, L | 2 |
| GAYRAL, L | 2 |
| HERVE, Y | 2 |
| WATT, DB | 2 |
| ABRIC, J | 2 |
| COMELADE, P | 2 |
| DUC, N | 5 |
| LAFON, R | 5 |
| POUGET, R | 2 |
| BARRES, P | 2 |
| LABOUCARIE, J | 3 |
| RASCOL, A | 3 |
| GERLE, B | 3 |
| MINVIELLE, J | 2 |
| PASSOUANT, P | 2 |
| STECK, H | 2 |
| COIRAULT, R | 2 |
| HAINAUT, J | 2 |
| LABORIT, H | 2 |
| WEBER, B | 2 |
| LABAUGE, R | 2 |
| TEMPLE, JP | 2 |
| CLARK, LD | 3 |
| ELLSWORTH, RB | 4 |
| COULOMBE, M | 2 |
| ROULEAU, Y | 2 |
| LOCH, W | 2 |
| NERI, A | 2 |
| PACHTER, M | 2 |
| TUTEUR, W | 1 |
| STILLER, R | 1 |
| WHITEHILL, O | 1 |
| SCHMIDT, KE | 1 |
| COULLAUT MENDIGUTIA, R | 1 |
| COLINA LEONES, MJ | 1 |
| FERRIO, L | 1 |
| ALTSCHULE, MD | 1 |
| GONCZ, RM | 1 |
| HOLLIDAY, PD | 1 |
| BARRETT, WW | 1 |
| ENNISS, J | 1 |
| LIDDELL, DW | 1 |
| RETTERSTOL, N | 1 |
| SANO, I | 2 |
| KAKIMOTO, Y | 2 |
| OKAMOTO, T | 1 |
| NAKAJIMA, H | 1 |
| KUDO, Y | 1 |
| LOMAS, JL | 1 |
| HENNEMANN, HH | 1 |
| THOMAS, TH | 1 |
| QUEROL, M | 2 |
| CHICATA, MA | 1 |
| AYD, FJ | 3 |
| SULESTROWSKI, W | 1 |
| WDOWIAK, L | 1 |
| HAQ, SM | 1 |
| SMYTH, VO | 1 |
| BRADLEY, PB | 1 |
| JEAVONS, PM | 1 |
| SALISBURY, BJ | 1 |
| HARE, EH | 2 |
| TRILLOT, J | 2 |
| BERNARDY, J | 1 |
| MARMILLON, F | 1 |
| ABRAMS, J | 1 |
| BRUCK, MA | 2 |
| SAMANEZ, F | 1 |
| ALMEIDA, M | 1 |
| BILY, D | 1 |
| MAGHERINI, G | 1 |
| DEAN, EF | 1 |
| BUKER, S | 1 |
| ELGAZINA, LM | 1 |
| POPOVA, AN | 2 |
| GOULDMAN, C | 2 |
| HENDERSON, H | 1 |
| CHRISTIAN, D | 1 |
| SMITH, JA | 4 |
| MARCHAND, L | 1 |
| BOREL, J | 2 |
| FRECOURT, J | 1 |
| COIFFU, B | 1 |
| SMITH, K | 1 |
| ULETT, GA | 1 |
| JOHNSON, L | 1 |
| JOHNSON, M | 1 |
| MEFFERD, RB | 1 |
| LABROSSE, EH | 1 |
| GAWIENOWSKI, AM | 1 |
| WILLIAMS, RJ | 1 |
| GADE, EB | 1 |
| HEINRICH, K | 1 |
| KING, PD | 3 |
| GOOD, WW | 1 |
| STERLING, M | 1 |
| HOLTZMAN, WH | 1 |
| MOSS, CS | 1 |
| JENSEN, RE | 1 |
| MORROW, W | 1 |
| FREUND, HG | 1 |
| DASTON, PG | 2 |
| BAKER, AA | 2 |
| GAME, JA | 1 |
| THORPE, JG | 2 |
| HINE, FR | 1 |
| HORMIA, A | 1 |
| MEAD, BT | 1 |
| GRIMMETT, JO | 1 |
| KACZYNSKI, M | 1 |
| KANEVSKAIA, FO | 1 |
| TARASOV, GK | 1 |
| TSUTSUL'KOVSKAIA, MIa | 2 |
| RUTHERFORD, A | 1 |
| WOLFORD, J | 1 |
| MEURICE, E | 1 |
| PEARL, D | 1 |
| HERMAN, L | 2 |
| VANDER KAMP, H | 1 |
| OLSEN, A | 1 |
| ARMITAGE, SG | 1 |
| LANGSLEY, DG | 1 |
| ENTERLINE, JD | 1 |
| HICKERSON, GX | 1 |
| WEINBERGER, W | 1 |
| SAUCER, RT | 1 |
| LEVIN, ML | 1 |
| KORNETSKY, C | 4 |
| PETTIT, M | 1 |
| WYNNE, R | 1 |
| EVARTS, EV | 1 |
| WALSH, GP | 1 |
| WALTON, D | 1 |
| BLACK, DA | 1 |
| LANDO, LI | 1 |
| ROMEL', TE | 1 |
| NEVZOROVA, TA | 3 |
| ALEKSANIANTS, RA | 1 |
| GRATSIANSKII, AA | 1 |
| STROIKOVA, KV | 1 |
| FLEMING, BG | 1 |
| SPENCER, AM | 1 |
| WHITELAW, EM | 1 |
| GILMORE, TH | 1 |
| SHATIN, L | 1 |
| HEILIZER, F | 2 |
| GREMBOWICZ, Z | 1 |
| LEJA, Z | 1 |
| VOSSELER, R | 1 |
| MacIntyre, DJ | 1 |
| ASHCROFT, GW | 1 |
| MACDOUGALL, EJ | 1 |
| BARKER, PA | 1 |
| CAPPELEN, T | 1 |
| MONRAD, LH | 1 |
| CASEY, JF | 3 |
| HOLLISTER, LE | 9 |
| KLETT, CJ | 9 |
| LASKY, JJ | 2 |
| CAFFEY, EM | 8 |
| CLARK, ML | 21 |
| RAY, TS | 6 |
| PAREDES, A | 3 |
| COSTILOE, JP | 5 |
| CHAPPELL, JS | 1 |
| HAGANS, JA | 1 |
| WOLF, S | 2 |
| COOPER, B | 1 |
| FRIEDHOFF, AJ | 5 |
| ALPERT, M | 4 |
| GILGASH, CA | 1 |
| SCHIPKOWENSKY, N | 1 |
| KAZANETS, EF | 1 |
| KULIKOV, LS | 1 |
| KUTIN, VP | 2 |
| KIVIMIAGI, EA | 1 |
| IUDOVICH, EA | 1 |
| MOROZOVA, TN | 1 |
| WALDROP, FN | 1 |
| ROBERTSON, RH | 1 |
| VOURLEKIS, A | 1 |
| WECKOWICZ, TE | 1 |
| WARD, T | 1 |
| WILSON, IC | 2 |
| McKAY, J | 1 |
| SANDIFER, MG | 2 |
| ZELEVA, MS | 1 |
| BARSA, JA | 3 |
| SAUNDERS, JC | 4 |
| BLAIR, D | 1 |
| BOROWITZ, AH | 1 |
| BENNETT, IF | 1 |
| LINDLEY, CJ | 1 |
| GORDON, MH | 1 |
| SPRINGER, NN | 1 |
| STUPOCHENKO, MV | 2 |
| TASSIS, JA | 1 |
| WOLD, PN | 2 |
| WYNNE, RD | 1 |
| ZOLOTNITSKII, RI | 4 |
| BLEIKHER, VM | 1 |
| BRANDUS, DA | 1 |
| PISANETS, OT | 1 |
| CHILDERS, RT | 2 |
| THERRIEN, R | 1 |
| GRADILLAS REGODON, V | 1 |
| HAYDU, GG | 1 |
| SHAWVER, JR | 1 |
| SCARBOROUGH, JS | 1 |
| FRANK, TV | 3 |
| SKUGAREVSKII, AF | 3 |
| SVENDSEN, BB | 1 |
| FAURBYE, A | 4 |
| KRISTJANSEN, P | 2 |
| TERRELL, MS | 1 |
| VESTRE, ND | 1 |
| HUANG, CL | 3 |
| POIRIER, LJ | 1 |
| RICHER, CL | 1 |
| BERTHIAUME, M | 1 |
| GRAVEL, G | 1 |
| BEAULNES, R | 1 |
| MARTEL, P | 1 |
| HERMAN, E | 1 |
| PLEASURE, H | 1 |
| GALENKO, VE | 1 |
| KEL'MISHKEIT, EG | 1 |
| IL'INSKII, IuA | 4 |
| BENNETT, JL | 1 |
| HAMILTON, LD | 1 |
| SAMPSON, PH | 1 |
| PUGH, LA | 4 |
| ZAL'TSMAN, GI | 1 |
| LENSKII, GP | 1 |
| VETSNER, VE | 1 |
| ZHISLIN, SG | 1 |
| ZENEVICH, GV | 1 |
| LAUZEL, JP | 1 |
| HANUS, M | 1 |
| ISRAEL, P | 1 |
| BORTNIK, TL | 1 |
| KALANDARISHVILI, AS | 1 |
| DONNINI, L | 1 |
| IGNESTI, C | 1 |
| CIAMPI, G | 1 |
| TAKESADA, M | 1 |
| KANEKO, Z | 1 |
| KLEIN, DF | 12 |
| FINK, M | 2 |
| LYNN, R | 1 |
| GALLANT, DM | 14 |
| BISHOP, MP | 13 |
| TIMMONS, E | 2 |
| STEELE, CA | 3 |
| PEPPEL, HH | 1 |
| JOYNES, T | 1 |
| ENGELHARDT, DM | 10 |
| FREEDMAN, N | 12 |
| HANKOFF, LD | 1 |
| MANN, D | 5 |
| MARGOLIS, R | 10 |
| CHAPPLE, ED | 1 |
| CHAMBERLAIN, A | 1 |
| ESSER, AH | 1 |
| KLINE, NS | 2 |
| ENGELHARDT, D | 2 |
| ALANEN, YO | 1 |
| WASIK, A | 3 |
| WARZEL, B | 1 |
| STANISZEWSKI, L | 1 |
| RAVKIN, IG | 1 |
| BLUMBERG, AG | 2 |
| ROSEN, B | 7 |
| POLLITT, J | 1 |
| SAARIMAA, HA | 1 |
| SOURANDER, C | 1 |
| RINNE, UK | 1 |
| SCHUCHS, V | 1 |
| CHARALAMPOUS, KD | 2 |
| FORREST, IS | 2 |
| MCCABE, WS | 1 |
| HABOVICK, JA | 1 |
| MARKS, J | 1 |
| ALLEGRANZA, A | 3 |
| BOZZI, R | 3 |
| BRUNO, A | 4 |
| AFANASEV, IN | 1 |
| SHILO, BF | 1 |
| CIALZETA, BA | 1 |
| NOYER, J | 1 |
| ROSATI, D | 1 |
| SUGERMAN, AA | 3 |
| GOLDSTEIN, L | 3 |
| MURPHREE, HB | 3 |
| PFEIFFER, CC | 3 |
| JENNEY, EH | 2 |
| SAKAOKA, U | 1 |
| HACHIYA, H | 1 |
| POLLACK, M | 2 |
| ZELICKSON, AS | 1 |
| ZELLER, HC | 1 |
| WHITAKER, LH | 1 |
| ALNAES, R | 1 |
| KRISTIANSEN, J | 1 |
| ZAKHARIN, IuL | 1 |
| MACULANS, GA | 1 |
| WINKELMAN, NW | 1 |
| STRATAS, NE | 1 |
| POUGETOUX, J | 1 |
| VIADER, A | 1 |
| CAMPAGNOLLE, A | 1 |
| JENKINS, SB | 1 |
| SAMBORSKI, AH | 1 |
| DERZSI, S | 1 |
| FENYVESI, T | 1 |
| GUSHANSKII, EL | 1 |
| UEBERSCHLAG, H | 1 |
| PETROCHENKOV, PG | 1 |
| PUZYNSKI, S | 2 |
| ROGOWSKA, J | 1 |
| INVERNIZZI, G | 1 |
| DIAMOND, LS | 1 |
| GRASBERGER, JC | 1 |
| ROTHSTEIN, C | 1 |
| RAGLAND, RE | 2 |
| CHAPMAN, LJ | 1 |
| KNOWLES, RR | 1 |
| SIMPSON, GM | 9 |
| FARKAS, T | 1 |
| HEYMAN, JJ | 1 |
| HALPERN, S | 1 |
| MERLIS, S | 6 |
| BUIS, C | 1 |
| FLOHIL, JM | 1 |
| STABENAU, JR | 1 |
| GRINOLS, DR | 1 |
| HEIJBEL, J | 1 |
| GITTELMAN, RK | 1 |
| DEVITO, C | 1 |
| WHATMORE, GB | 1 |
| ELLIS, RM | 1 |
| KANE, FJ | 3 |
| ANDERSON, WB | 1 |
| AYCRIGG, JB | 1 |
| FORREST, FM | 2 |
| GEITER, CW | 1 |
| SNOW, HL | 1 |
| STEINBACH, M | 1 |
| RUDY, LH | 1 |
| BARRON, A | 1 |
| POELDINGER, W | 1 |
| GRANTHAM, J | 1 |
| NEEL, W | 1 |
| BROWN, RW | 1 |
| ECKMANN, F | 1 |
| IMMICH, H | 1 |
| FISCHER-WILLIAMS, M | 1 |
| COOPER, RA | 1 |
| STROEMGREN, E | 1 |
| NISTRI, M | 1 |
| DELUCA, PL | 1 |
| VOLMAT, R | 1 |
| BEAUDOUIN, JL | 1 |
| COLLIN, J | 1 |
| NICOLAS-CHARLES, PJ | 1 |
| ALLERS, G | 1 |
| COZZO, G | 1 |
| OVERALL, JE | 3 |
| MEYER, F | 1 |
| KIMBELL, I | 3 |
| SHELTON, J | 2 |
| BENTE, D | 1 |
| HOFFMANN, FA | 1 |
| HARTUNG, H | 1 |
| HARTUNG, ML | 1 |
| FISH, F | 1 |
| SCHOU, M | 1 |
| KOPYLOVA, TV | 3 |
| NOBLIN, CD | 1 |
| COHEN, S | 1 |
| LEONARD, CV | 1 |
| FARBEROW, NL | 1 |
| SHNEIDMAN, ES | 1 |
| BAN, TA | 15 |
| STJEAN, A | 1 |
| ZSCHUCKE, CF | 1 |
| GISSEN, LD | 1 |
| REECE, JC | 1 |
| PRICE, S | 1 |
| MARTIN, HF | 1 |
| GUDZINOWICZ, BJ | 1 |
| FARETRA, G | 1 |
| GOZUN, C | 1 |
| FELDMAN, PE | 1 |
| FRIERSON, BD | 1 |
| FOX, W | 1 |
| GOBBLE, IF | 1 |
| CLOS, M | 1 |
| DENISON, E | 1 |
| GREINER, AC | 3 |
| NICOLSON, GA | 2 |
| BAKER, RA | 1 |
| YABUKI, Y | 1 |
| LLOYD, DN | 1 |
| NEWBROUGH, JR | 1 |
| PRATT, JP | 2 |
| Clausen, J | 1 |
| SHEPPARD, C | 2 |
| BHATTACHARYYA, A | 1 |
| DIGIACOMO, M | 1 |
| JOHNSON, FP | 1 |
| BOYD, DA | 1 |
| SAYRE, GP | 1 |
| TYCE, FA | 1 |
| RASHKIS, HA | 1 |
| HARRIS, C | 1 |
| KELLY, DH | 1 |
| SARGANT, W | 2 |
| GRUNBAUM, BW | 1 |
| KIRK, PL | 1 |
| ACKER, CW | 2 |
| BUCOVE, A | 1 |
| KLERMAN, GL | 3 |
| DAVIDSON, EM | 1 |
| KAYCE, MM | 1 |
| GONZALEZ, JR | 1 |
| IMAHARA, JK | 1 |
| PLACHTA, A | 1 |
| CAIRNS, RJ | 1 |
| CAPOORE, HS | 1 |
| GREGORY, ID | 1 |
| TALBOT, DR | 1 |
| RASCH, PJ | 2 |
| WEIDTMANN, W | 1 |
| ZHARIKOV, NM | 1 |
| LEVIT, VG | 2 |
| POPOVA, MS | 1 |
| RATNER, IO | 1 |
| STANKEVICH, LA | 1 |
| SHMAONOVA, LM | 1 |
| ZUBAREV, FG | 1 |
| MOSIN, NI | 1 |
| NOSHCHENKO, GV | 1 |
| ARUTIUNOV, ES | 2 |
| ROSE, RM | 1 |
| DIMASCIO, A | 1 |
| ITIL, TM | 2 |
| LEHMANN, HE | 10 |
| KOSTIKOVA, LF | 1 |
| GANTZ, RS | 1 |
| BIRKETT, DP | 1 |
| DENCKER, SJ | 3 |
| JANSSON, L | 1 |
| MARGOLIS, LH | 1 |
| GOBLE, JL | 1 |
| HALLAM, KJ | 1 |
| HANLON, TE | 2 |
| GOLDENBERG, H | 1 |
| FISHMAN, V | 1 |
| LUTZ, EG | 1 |
| LONDON, S | 1 |
| CIANI, N | 2 |
| DONINI, G | 1 |
| SCHRAMM, LP | 1 |
| EGOROV, VA | 1 |
| Walaas, E | 1 |
| Lingjaerde, O | 1 |
| Soevik, O | 1 |
| Alertsen, AR | 1 |
| Walaas, O | 1 |
| BENICHOU, L | 1 |
| RIBSTEIN, M | 1 |
| PAGES, H | 1 |
| BLEULER, M | 1 |
| STOLL, WA | 1 |
| KINROSS-WRIGHT, V | 1 |
| EVRARD, A | 1 |
| VANDIERENDONCK, R | 1 |
| DUPONT, A | 1 |
| Letailleur, M | 1 |
| Morin, J | 2 |
| Demay, J | 1 |
| HYVERT, M | 1 |
| FAGARD, H | 1 |
| HUCHON, J | 1 |
| KEUP, W | 1 |
| HAMILTON, M | 1 |
| SMITH, AL | 1 |
| LAPIDUS, HE | 1 |
| CADOGAN, EP | 1 |
| HURST, L | 2 |
| KIM, K | 1 |
| MANCINI, P | 1 |
| UGHI, R | 1 |
| OLLENDORFF, RH | 1 |
| SCHIELE, BC | 4 |
| MENDELSOHN, RM | 1 |
| PENMAN, AS | 1 |
| SCHOFIELD, W | 1 |
| MOSKOVCHENKO, KP | 1 |
| NAHUNEK, K | 2 |
| RAY, SD | 1 |
| Ghose, S | 1 |
| Weickert, CS | 1 |
| Colvin, SM | 1 |
| Coyle, JT | 3 |
| Herman, MM | 1 |
| Hyde, TM | 1 |
| Kleinman, JE | 1 |
| Quartesan, R | 1 |
| Abidi, S | 1 |
| Bhaskara, SM | 1 |
| Bowers, L | 1 |
| Callaghan, P | 1 |
| Clark, N | 1 |
| Evers, C | 1 |
| Uchida, H | 1 |
| Watanabe, K | 1 |
| Yagi, G | 2 |
| Bajbouj, M | 1 |
| Niehaus, L | 1 |
| Lang, UE | 1 |
| Roricht, S | 1 |
| Meyer, BU | 1 |
| Centorrino, F | 1 |
| Goren, JL | 1 |
| Hennen, J | 1 |
| Salvatore, P | 1 |
| Kelleher, JP | 1 |
| Heresco-Levy, U | 1 |
| Javitt, DC | 1 |
| Tada, M | 1 |
| Shirakawa, K | 1 |
| Matsuoka, N | 1 |
| Mutoh, S | 1 |
| Su, A | 2 |
| Chan, YH | 1 |
| Shinfuku, N | 2 |
| Kua, EH | 2 |
| Tan, CH | 2 |
| Meaney, AM | 1 |
| Smith, S | 1 |
| Howes, OD | 1 |
| O'Brien, M | 1 |
| Murray, RM | 3 |
| O'Keane, V | 1 |
| Chagnon, YC | 1 |
| Mérette, C | 1 |
| Bouchard, RH | 1 |
| Emond, C | 1 |
| Roy, MA | 1 |
| Maziade, M | 1 |
| Matsumoto, M | 1 |
| Konno, T | 1 |
| Tamba, K | 1 |
| Abe, T | 1 |
| Kajii, E | 1 |
| Leong, JY | 1 |
| Yip, K | 1 |
| Chong, MY | 1 |
| Fujii, S | 1 |
| Yang, S | 1 |
| Ungvari, GS | 2 |
| Si, T | 1 |
| Chung, EK | 1 |
| Tsang, HY | 1 |
| McMahon, RP | 1 |
| Arndt, S | 1 |
| Conley, RR | 2 |
| Nadeem, Z | 2 |
| McIntosh, A | 3 |
| Lawrie, S | 3 |
| Appelberg, B | 1 |
| Tuisku, K | 1 |
| Joffe, G | 1 |
| Nardi, AE | 1 |
| Nawata, S | 1 |
| Yamauchi, K | 1 |
| Ikegami, N | 1 |
| Prikryl, R | 1 |
| Ceskova, E | 1 |
| Kasparek, T | 1 |
| Kucerova, H | 1 |
| Patel, JK | 1 |
| McCarley, R | 1 |
| Sutton, J | 1 |
| Chau, DT | 1 |
| Wojcik, J | 1 |
| Green, AI | 1 |
| Koga, M | 1 |
| Nakayama, K | 1 |
| Schuepbach, D | 1 |
| Hill, SK | 1 |
| Sanders, RD | 1 |
| Hell, D | 1 |
| Cohen, D | 1 |
| Batstra, MR | 1 |
| Gispen-de Wied, CC | 1 |
| Park, S | 4 |
| Ross-Degnan, D | 1 |
| Adams, AS | 1 |
| Sabin, J | 1 |
| Kanavos, P | 1 |
| Soumerai, SB | 1 |
| Geller, V | 1 |
| Gorzaltsan, I | 1 |
| Shleifer, T | 1 |
| Belmaker, RH | 5 |
| Bersudsky, Y | 2 |
| Kwok, JS | 1 |
| Chan, TY | 1 |
| Mou, XD | 1 |
| Liu, W | 1 |
| Zhang, XR | 1 |
| Shi, JB | 1 |
| Clarke, M | 1 |
| Borrill, J | 1 |
| Wahlbeck, K | 3 |
| Awad, AG | 5 |
| Khanna, S | 2 |
| Rajadhyaksha, S | 2 |
| Giller, E | 2 |
| Morrison, PD | 1 |
| Nagy, O | 1 |
| Kelemen, O | 1 |
| Erdélyi, R | 1 |
| Pataki, M | 1 |
| Janka, Z | 1 |
| Myers, CE | 1 |
| Gluck, MA | 1 |
| Kéri, S | 1 |
| Healy, D | 1 |
| Pillai, A | 1 |
| Parikh, V | 1 |
| Terry, AV | 1 |
| Mahadik, SP | 1 |
| Wang, CS | 1 |
| Kao, WT | 1 |
| Chen, CD | 1 |
| Tung, YP | 1 |
| Lung, FW | 1 |
| Chen, Y | 1 |
| Levy, DL | 1 |
| Sheremata, S | 1 |
| Holzman, PS | 2 |
| Lal, S | 6 |
| Thavundayil, JX | 2 |
| Nair, NP | 2 |
| Annable, L | 11 |
| Ng Ying Kin, NM | 1 |
| Gabriel, A | 1 |
| Schwartz, G | 1 |
| Wu, SN | 1 |
| Xing, QH | 2 |
| Li, HF | 1 |
| Shen, YF | 1 |
| Gu, NF | 1 |
| Feng, GY | 4 |
| Pavey, G | 1 |
| Thomas, D | 1 |
| Khorram, B | 1 |
| Lang, DJ | 1 |
| Kopala, LC | 1 |
| Vandorpe, RA | 1 |
| Rui, Q | 1 |
| Goghari, VM | 1 |
| Smith, GN | 2 |
| La, YJ | 1 |
| Wan, CL | 1 |
| Zhu, H | 1 |
| Yang, YF | 1 |
| Chen, YS | 1 |
| Pan, YX | 1 |
| Almerie, MQ | 2 |
| Alkhateeb, H | 2 |
| Essali, A | 2 |
| Matar, HE | 2 |
| Rezk, E | 2 |
| Tomiya, M | 1 |
| Fukami, G | 1 |
| Fujisaki, M | 1 |
| Mitsuhashi, S | 1 |
| Toyo'oka, T | 1 |
| Tong, Y | 1 |
| Wang, XY | 1 |
| Yao, SM | 1 |
| Jin, GX | 1 |
| Wang, XP | 1 |
| Timdahl, K | 1 |
| Carlsson, A | 3 |
| Stening, G | 1 |
| Monkul, ES | 1 |
| Green, MJ | 1 |
| Barrett, JA | 1 |
| Robinson, JL | 1 |
| Velligan, DI | 1 |
| Glahn, DC | 1 |
| Dossenbach, M | 1 |
| Treuer, T | 1 |
| Kryzhanovskaya, L | 1 |
| Saylan, M | 1 |
| Dominguez, S | 1 |
| Huang, X | 1 |
| Toshida, H | 1 |
| Uesugi, Y | 1 |
| Ebihara, N | 1 |
| Murakami, A | 1 |
| Reschke, RW | 1 |
| Burdock, EI | 4 |
| Gershon, S | 14 |
| Hardesty, AS | 1 |
| Linden, KJ | 1 |
| Loebel, AD | 1 |
| Siu, CO | 1 |
| Potkin, SG | 1 |
| Xu, MQ | 2 |
| Zheng, YL | 1 |
| Gao, JJ | 1 |
| Guo, TW | 1 |
| Xu, F | 1 |
| Bhatia, MS | 1 |
| Gupta, R | 1 |
| Dhawan, J | 1 |
| Lerner, V | 1 |
| Miodownik, C | 1 |
| Kaptsan, A | 1 |
| Libov, I | 1 |
| Sela, BA | 1 |
| Witztum, E | 1 |
| Digney, A | 1 |
| Sundram, S | 1 |
| Thomas, E | 1 |
| Silverstein, SM | 1 |
| Spaulding, WD | 1 |
| Menditto, AA | 1 |
| Savitz, A | 1 |
| Liberman, RP | 4 |
| Berten, S | 1 |
| Starobin, H | 1 |
| Watzke, S | 1 |
| Brieger, P | 1 |
| Kuss, O | 1 |
| Schoettke, H | 1 |
| Wiedl, KH | 1 |
| Lin, ZG | 1 |
| Weiden, PJ | 1 |
| Polesia, GV | 1 |
| Lugovskiĭ, BK | 2 |
| Kuznetsov, MT | 1 |
| Mikhaĭlova, KM | 1 |
| Neduva, SSh | 1 |
| Barshteĭn, EI | 1 |
| Eryshev, OF | 1 |
| Beznosikov, BO | 1 |
| Il'in, II | 1 |
| Heath, RG | 1 |
| Johnson, AW | 3 |
| Buffaloe, WJ | 3 |
| Moroji, T | 2 |
| Endo, M | 3 |
| Yamazaki, K | 2 |
| Kato, H | 2 |
| Gombos, GM | 1 |
| Yarden, PE | 1 |
| Mathalone, MB | 2 |
| Fox, JT | 1 |
| Ecanow, B | 2 |
| Gold, B | 1 |
| Touquan, S | 1 |
| Stanaszek, W | 1 |
| Hsu, JJ | 2 |
| Yap, AT | 1 |
| Wilson, JD | 1 |
| Enoch, MD | 1 |
| Herbert, ME | 1 |
| Jacobson, S | 1 |
| Trick, KL | 1 |
| Sletten, I | 2 |
| Cazenave, M | 1 |
| Markowe, M | 1 |
| Steinert, J | 1 |
| Heyworth-Davis, F | 1 |
| Meier-Ewert, K | 1 |
| Baumgart, HH | 1 |
| Friedenberg, P | 1 |
| Brzezińska, I | 1 |
| Giergun, S | 1 |
| Goldberg, SC | 11 |
| Mattsson, N | 2 |
| Cole, JO | 9 |
| Logothetis, J | 1 |
| Pritchard, M | 2 |
| Wechsler, MB | 1 |
| Wharton, RN | 1 |
| Tanaka, E | 1 |
| Malitz, S | 1 |
| Rice, HE | 2 |
| Smith, CB | 2 |
| Silk, KR | 2 |
| Rosen, J | 2 |
| Rinieris, P | 3 |
| Christodoulou, GN | 2 |
| Souvatzoglou, A | 2 |
| Koutras, DA | 2 |
| Stefanis, C | 2 |
| Young, MA | 1 |
| Meltzer, HY | 21 |
| Rubin, RT | 1 |
| Hays, SE | 1 |
| Phillipson, OT | 2 |
| Baker, J | 2 |
| Williams, M | 1 |
| Rovinskaia, SA | 1 |
| Revva, LI | 1 |
| Peet, M | 5 |
| Middlemiss, DN | 2 |
| Yates, RA | 3 |
| Tune, LE | 3 |
| Creese, I | 1 |
| DePaulo, JR | 1 |
| Slavney, PR | 1 |
| Snyder, SH | 5 |
| Nurnberg, HG | 2 |
| Greenwald, B | 1 |
| Ringwald, E | 1 |
| Lustig, A | 1 |
| Moscovici, M | 1 |
| Spiegel, R | 1 |
| Vamos, E | 1 |
| Brockington, IF | 3 |
| Kendell, RE | 2 |
| Wainwright, S | 2 |
| Gruzelier, J | 2 |
| Connolly, J | 1 |
| Eves, F | 1 |
| Hirsch, S | 1 |
| Zaki, S | 1 |
| Weller, M | 2 |
| Yorkston, N | 1 |
| Randall, PL | 1 |
| Kolakowska, T | 6 |
| Fraser, S | 1 |
| Franklin, M | 2 |
| Knox, J | 1 |
| Mitkevich, SP | 1 |
| Koliaskina, GI | 1 |
| Bowers, MB | 5 |
| Heninger, GR | 1 |
| Tune, L | 1 |
| Gale, K | 1 |
| Casu, M | 1 |
| Brown, WA | 4 |
| Laughren, TP | 1 |
| Van Putten, T | 12 |
| May, PR | 10 |
| Jenden, DJ | 5 |
| Dikiĭ, NT | 1 |
| Bochkarev, VK | 1 |
| Paniushkina, SV | 1 |
| Cabranes, JA | 1 |
| Fuentenebro, F | 1 |
| Recio, MN | 1 |
| Borque, M | 1 |
| Almoguera, MI | 1 |
| Chouinard, G | 14 |
| Jones, BD | 3 |
| Collu, R | 1 |
| Laughren, T | 1 |
| Chisholm, E | 1 |
| Williams, BW | 1 |
| Buravlev, VM | 1 |
| Nishikawa, T | 1 |
| Tsuda, A | 1 |
| Tanaka, M | 2 |
| Koga, I | 2 |
| Uchida, Y | 2 |
| Baron, M | 4 |
| Gruen, R | 3 |
| Levitt, M | 3 |
| Berrios, GE | 1 |
| Nakahara, T | 5 |
| Hirano, M | 1 |
| Uchimura, H | 1 |
| Saito, M | 3 |
| Kim, JS | 1 |
| Matsumoto, T | 1 |
| Yokoo, H | 1 |
| Shimomura, M | 1 |
| Mukai, A | 1 |
| Hertrich, O | 1 |
| Levy, MI | 1 |
| Kendler, KS | 1 |
| Mathé, AA | 1 |
| Mohs, RC | 1 |
| Denigris, Y | 1 |
| Trigos, GG | 1 |
| Axiotis, A | 1 |
| Rothpearl, A | 1 |
| Davis, KL | 1 |
| Goodnick, PJ | 1 |
| Tong, C | 1 |
| Duncavage, MB | 1 |
| Lindenmayer, JP | 1 |
| Smith, D | 1 |
| Katz, I | 1 |
| Kiriike, N | 1 |
| Uete, T | 1 |
| Motomura, K | 1 |
| Enomoto, M | 1 |
| Murata, K | 1 |
| Katz, B | 1 |
| Cotton, P | 1 |
| Ishizaki, T | 1 |
| Chiba, K | 1 |
| Kobayashi, K | 1 |
| Iizuka, R | 1 |
| Bradwejn, J | 1 |
| Ross-Chouinard, A | 1 |
| Aziz, AA | 1 |
| Leeming, RJ | 1 |
| Blair, JA | 1 |
| Sedvall, G | 14 |
| Rastogi, RB | 1 |
| Singhal, RL | 1 |
| Lapierre, YD | 2 |
| Kaiya, H | 1 |
| Tamura, Y | 1 |
| Adachi, S | 1 |
| Moriuchi, I | 1 |
| Namba, M | 1 |
| Yoshida, H | 1 |
| Yanaihara, N | 1 |
| Yanaihara, C | 1 |
| Alfredsson, G | 5 |
| Bjerkenstedt, L | 3 |
| Edman, G | 1 |
| Härnryd, C | 5 |
| Oxenstierna, G | 3 |
| Wiesel, FA | 7 |
| Gullberg, B | 4 |
| Lykouras, E | 1 |
| Varsou, E | 1 |
| Stefanis, CN | 1 |
| Erban, L | 2 |
| Prokes, J | 1 |
| Richtrová, E | 1 |
| Becker, RE | 3 |
| Apter, A | 1 |
| Dickerman, Z | 2 |
| Gonen, N | 1 |
| Assa, S | 1 |
| Prager-Lewin, R | 1 |
| Kaufman, H | 1 |
| Tyano, S | 2 |
| Laron, Z | 2 |
| Siris, SG | 2 |
| Björk, K | 1 |
| Wik, G | 4 |
| Aberg-Wistedt, A | 1 |
| Epstein, LH | 1 |
| Arora, RC | 2 |
| Luchins, DJ | 1 |
| Jackman, H | 1 |
| Busch, DA | 3 |
| Fang, VS | 4 |
| Busch, D | 1 |
| Tang, SW | 3 |
| Glaister, J | 1 |
| Davidson, L | 1 |
| Toth, R | 1 |
| Jeffries, JJ | 1 |
| Seeman, P | 1 |
| Tildesley, HD | 1 |
| Toth, E | 1 |
| Crockford, PM | 1 |
| Stimmel, GL | 1 |
| Falloon, IR | 1 |
| Schorah, CJ | 1 |
| Morgan, DB | 1 |
| Hullin, RP | 1 |
| Bagadia, VN | 2 |
| Abhyankar, RR | 1 |
| Doshi, J | 1 |
| Pradhan, PV | 1 |
| Shah, LP | 2 |
| Ayers, T | 1 |
| Wallace, CJ | 2 |
| Kitamura, T | 1 |
| Kahn, A | 1 |
| Kumar, R | 1 |
| Mackintosh, JH | 1 |
| Levinson, DF | 1 |
| Edelberg, R | 1 |
| Bridger, WH | 1 |
| Clody, DE | 1 |
| Carlton, PL | 2 |
| Gil-Ad, I | 1 |
| Weizman, R | 1 |
| Weizman, A | 2 |
| Hershey, LA | 1 |
| Gift, T | 2 |
| Atkins, RW | 1 |
| Rivera-Calimlim, L | 4 |
| Young, SN | 2 |
| Gauthier, S | 1 |
| Anderson, GM | 1 |
| Purdy, WC | 1 |
| Rotman, A | 1 |
| Zemishlany, Z | 1 |
| Munitz, H | 1 |
| Wijsenbeek, H | 1 |
| Braden, W | 1 |
| Fink, EB | 1 |
| Qualls, CB | 1 |
| Ho, CK | 1 |
| Samuels, WO | 1 |
| Metz, J | 1 |
| Holcomb, HH | 1 |
| Canoso, RT | 2 |
| Lewis, ME | 1 |
| Yunis, EJ | 1 |
| Stadnyk, AN | 1 |
| Glezos, JD | 1 |
| Calev, A | 1 |
| Venables, PH | 1 |
| Monk, AF | 1 |
| Creese, IR | 1 |
| Sahai, S | 1 |
| Gammond, GD | 1 |
| Hafez, H | 1 |
| Docherty, JP | 2 |
| Domashneva, IV | 1 |
| Minsker, EI | 2 |
| Panteleeva, GP | 2 |
| Tsirkin, SIu | 2 |
| Nagaraju, A | 1 |
| Yorkston, NJ | 2 |
| Zaki, SA | 2 |
| Weller, MP | 1 |
| Gruzelier, JH | 6 |
| Hirsch, SR | 2 |
| Mathur, S | 1 |
| Hall, JN | 2 |
| Bethell, MS | 1 |
| Coates, A | 1 |
| Khamnee, AK | 1 |
| Hall, P | 1 |
| Cooper, SJ | 4 |
| King, DJ | 4 |
| Wilson, LG | 1 |
| Roberts, RW | 1 |
| Gerber, CJ | 1 |
| Johnson, MH | 1 |
| Pecknold, JC | 4 |
| McClure, DJ | 1 |
| Allan, T | 1 |
| Wrzesinski, L | 1 |
| McHugh, PR | 2 |
| Dixon, PA | 2 |
| Oforah, E | 2 |
| Makanjuola, R | 1 |
| Castellani, S | 1 |
| Ziegler, MG | 1 |
| van Kammen, DP | 1 |
| Alexander, PE | 1 |
| Lake, CR | 1 |
| Fishbain, DA | 1 |
| Crossen, PE | 1 |
| Morgan, WF | 1 |
| Gardos, G | 4 |
| LaBrie, RA | 1 |
| Rybakowski, J | 1 |
| Banaś, M | 1 |
| Lezańska, M | 1 |
| Lis, B | 1 |
| Mierzejewski, A | 1 |
| Ziółkowski, M | 1 |
| Janakiramaiah, N | 1 |
| Channabasavanna, SM | 1 |
| Murthy, NS | 1 |
| Solomon, PR | 1 |
| Crider, A | 1 |
| Winkelman, JW | 1 |
| Turi, A | 1 |
| Kamer, RM | 1 |
| Kaplan, LJ | 1 |
| Yale, C | 3 |
| Dixon, WJ | 1 |
| Smith, JM | 1 |
| Burke, MP | 1 |
| Moon, CO | 1 |
| Sturgeon, D | 1 |
| Kuipers, L | 1 |
| Berkowitz, R | 1 |
| Turpin, G | 1 |
| Leff, J | 1 |
| Okuma, T | 2 |
| Stephens, RM | 1 |
| Matson, JL | 1 |
| Westmoreland, T | 1 |
| Kulpa, J | 1 |
| Youdim, MB | 2 |
| Hefez, A | 2 |
| Oppenheim, B | 2 |
| Owen, F | 2 |
| Bourne, RC | 2 |
| Crow, TJ | 7 |
| Fadhli, AA | 1 |
| Ewing, DG | 1 |
| Einarson, TR | 2 |
| Tasman, A | 1 |
| Hale, MS | 1 |
| Simon, RH | 1 |
| Krasik, ED | 2 |
| Semin, IR | 2 |
| Marconi Tassara, J | 1 |
| Diaz, JP | 1 |
| Mourgues, C | 1 |
| Cooper, TB | 3 |
| Bark, N | 1 |
| Sud, I | 1 |
| Lee, JH | 3 |
| Silberman, EK | 1 |
| Post, RM | 2 |
| Gelder, MG | 5 |
| Orr, MW | 5 |
| Falterman, CG | 1 |
| Richardson, CJ | 1 |
| Marder, SR | 2 |
| Beliaev, BS | 1 |
| Lukanina, SK | 1 |
| Cho, AK | 2 |
| Sakurai, Y | 3 |
| Takahashi, R | 4 |
| Ikenaga, H | 2 |
| Hammond, NV | 3 |
| Wilkins, JN | 1 |
| Stein, PB | 1 |
| Inwood, MJ | 1 |
| Bustillo, JR | 1 |
| Kirkpatrick, B | 1 |
| Mitchell, AC | 1 |
| Brown, KW | 1 |
| Matsui, M | 1 |
| Kurachi, M | 1 |
| Minezaki, T | 1 |
| Ichikawa, Y | 1 |
| Kopala, L | 1 |
| MacEwan, GW | 1 |
| Altman, S | 1 |
| Smith, A | 1 |
| Shaikh, S | 1 |
| Hodgkinson, S | 1 |
| Pilowsky, L | 1 |
| Van Os, J | 1 |
| Vallada, H | 1 |
| Collier, D | 1 |
| Gill, M | 1 |
| Rasheed, A | 1 |
| Javed, MA | 1 |
| Nazir, S | 1 |
| Khawaja, O | 1 |
| Thara, R | 1 |
| Henrietta, M | 1 |
| Joseph, A | 1 |
| Rajkumar, S | 1 |
| Eaton, WW | 1 |
| Peralta, V | 1 |
| Cuesta, MJ | 1 |
| Caro, F | 1 |
| Martinez-Larrea, A | 1 |
| Slaghuis, WL | 1 |
| Bakker, VJ | 1 |
| Harris, J | 1 |
| Parry, AK | 1 |
| Ormerod, LP | 1 |
| Hamlin, GW | 1 |
| Saleem, PT | 1 |
| Chetty, M | 5 |
| Miller, R | 5 |
| Moodley, SV | 4 |
| O'Croinin, F | 1 |
| Zibin, T | 1 |
| Vohra, SB | 1 |
| Bloom, D | 1 |
| Krishnan, B | 1 |
| Delahunty, A | 1 |
| Morice, R | 1 |
| Frost, B | 1 |
| Zhang, JZ | 1 |
| Niu, ZX | 1 |
| Tang, YY | 1 |
| Zhuge, DY | 1 |
| Chen, JK | 1 |
| Pigache, RM | 6 |
| Cecyre, D | 1 |
| Quirion, R | 1 |
| Heikkinen, H | 1 |
| Outakoski, J | 1 |
| Meriläinen, V | 1 |
| Tuomi, A | 1 |
| Huttunen, MO | 1 |
| Galletly, CA | 2 |
| Jordan, S | 1 |
| Torrance, C | 1 |
| Smith, M | 2 |
| de Souza, MA | 1 |
| Pugliese, S | 1 |
| Mari, Jde J | 1 |
| Wölwer, W | 1 |
| Streit, M | 1 |
| Polzer, U | 1 |
| Pillay, VL | 1 |
| Chengappa, KN | 1 |
| Nimgaonkar, VL | 3 |
| Bachert, C | 1 |
| Yang, ZW | 1 |
| Rabin, BS | 1 |
| Ganguli, R | 1 |
| Zelaschi, NM | 1 |
| Delucchi, GA | 1 |
| Rodriguez, JL | 1 |
| Albus, M | 1 |
| Hubmann, W | 1 |
| Wahlheim, C | 1 |
| Sobizack, N | 1 |
| Franz, U | 1 |
| Mohr, F | 1 |
| Ramchand, CN | 1 |
| Davies, JI | 1 |
| Tresman, RL | 1 |
| Griffiths, IC | 1 |
| Howland, RH | 1 |
| Hamner, MB | 1 |
| Arvanitis, LA | 1 |
| Miller, BG | 1 |
| Link, CG | 2 |
| Hong, WW | 1 |
| Passman, TE | 1 |
| Remington, GJ | 1 |
| Prendergast, P | 1 |
| Bezchlibnyk-Butler, KZ | 1 |
| Mossman, D | 1 |
| Wyatt, RJ | 10 |
| Tuma, AH | 1 |
| Sanchez-Sweatman, LR | 1 |
| Razali, MS | 1 |
| Hasanah, CI | 1 |
| Ahokas, A | 2 |
| Nikkilä, H | 2 |
| Miettinen, K | 1 |
| Rimón, R | 3 |
| Hong, CJ | 2 |
| Chen, JY | 1 |
| Chiu, HJ | 1 |
| Sim, CB | 1 |
| Minami, H | 1 |
| Miyahara, A | 1 |
| Nakane, Y | 1 |
| Malla, AK | 1 |
| Norman, RM | 1 |
| Aguilar, O | 1 |
| Cortese, L | 1 |
| Brazo, P | 1 |
| Levine, J | 5 |
| Caspi, N | 1 |
| Laufer, N | 1 |
| Mercer, G | 1 |
| Finlayson, A | 1 |
| Murray, C | 1 |
| Owens, DG | 1 |
| Vargas-Alarcón, G | 1 |
| Yamamoto-Furusho, JK | 1 |
| Zuñiga, J | 1 |
| Canoso, R | 1 |
| Granados, J | 1 |
| Trichard, C | 1 |
| Paillère-Martinot, ML | 1 |
| Attar-Levy, D | 1 |
| Recassens, C | 1 |
| Monnet, F | 1 |
| Martinot, JL | 1 |
| Yip, KC | 1 |
| Cheung, HK | 1 |
| Ng, FS | 1 |
| Lau, ST | 1 |
| Bartko, JJ | 1 |
| Richardson, C | 1 |
| Peszke, M | 1 |
| Lingle, J | 1 |
| Hegerty, J | 1 |
| Love, R | 1 |
| Gounaris, C | 1 |
| Zaremba, S | 1 |
| Leung, CM | 1 |
| Lee, G | 1 |
| Cheung, B | 1 |
| Kwong, E | 1 |
| Wing, YK | 1 |
| Kan, CS | 1 |
| Lau, J | 1 |
| Shindler, N | 1 |
| Zhu, YZ | 1 |
| Kang, B | 1 |
| Zhu, QQ | 1 |
| Hatzimanolis, J | 1 |
| Lykouras, L | 1 |
| Markianos, M | 2 |
| Oulis, P | 1 |
| Nadkarni, PM | 1 |
| Puri, BK | 1 |
| Barnes, TR | 1 |
| Chapman, MJ | 1 |
| Hutton, SB | 1 |
| Joyce, EM | 1 |
| Howanitz, E | 1 |
| Pardo, M | 1 |
| Smelson, DA | 1 |
| Engelhart, C | 1 |
| Eisenstein, N | 1 |
| Stern, RG | 1 |
| Losonczy, MF | 1 |
| Gouws, E | 1 |
| Ikebuchi, E | 1 |
| Nakagome, K | 1 |
| Takahashi, N | 1 |
| Knott, V | 1 |
| Mahoney, C | 1 |
| Labelle, A | 1 |
| Ripley, C | 1 |
| Cavazzoni, P | 1 |
| Jones, B | 2 |
| Potwarka, JJ | 1 |
| Drost, DJ | 1 |
| Williamson, PC | 1 |
| Carr, T | 1 |
| Canaran, G | 1 |
| Rylett, WJ | 1 |
| Neufeld, RW | 1 |
| Higuchi, H | 1 |
| Kamata, M | 1 |
| Yoshimoto, M | 1 |
| Shimisu, T | 1 |
| Hishikawa, Y | 1 |
| Ducloux, D | 1 |
| Florea, A | 1 |
| Fournier, V | 1 |
| Rebibou, JM | 1 |
| Chalopin, JM | 1 |
| Hudson, C | 1 |
| Gotowiec, A | 1 |
| Seeman, M | 1 |
| Warsh, J | 1 |
| Ross, BM | 1 |
| Evans, JD | 1 |
| Negron, AE | 1 |
| Palmer, BW | 1 |
| Paulsen, JS | 1 |
| Heaton, RK | 1 |
| Jeste, DV | 2 |
| Lyon, ER | 1 |
| Lançon, C | 1 |
| Aghababian, V | 1 |
| Llorca, PM | 1 |
| Bernard, D | 1 |
| Auquier, P | 1 |
| Meincke, U | 1 |
| Töpper, R | 1 |
| Hoff, P | 1 |
| Cancro, R | 2 |
| Honigfeld, G | 6 |
| Lavori, PW | 1 |
| Sugarman, J | 1 |
| Tweed, J | 1 |
| Raniwalla, J | 1 |
| Butler, A | 1 |
| Welch, C | 1 |
| Watanabe, E | 1 |
| Takano, H | 1 |
| Krausz, M | 1 |
| Moritz, S | 1 |
| Lambert, M | 1 |
| Naber, D | 1 |
| Arolt, V | 1 |
| Rothermundt, M | 1 |
| Wandinger, KP | 1 |
| Kirchner, H | 1 |
| Arduini, L | 1 |
| Prosperini, P | 1 |
| Kalyvoka, A | 1 |
| Stratta, P | 1 |
| Daneluzzo, E | 1 |
| Huguelet, P | 1 |
| Zanello, A | 1 |
| Nicastro, R | 1 |
| Troisi, A | 1 |
| Pasini, A | 1 |
| de Angelis, F | 1 |
| Spalletta, G | 1 |
| Havaki-Kontaxaki, BJ | 1 |
| Kontaxakis, VP | 1 |
| Tachikawa, H | 1 |
| Kawanishi, Y | 1 |
| Hori, M | 1 |
| Hori, T | 1 |
| Shiraishi, H | 1 |
| Shioiri, T | 1 |
| Hamakawa, H | 1 |
| Kato, T | 2 |
| Fujii, K | 1 |
| Murashita, J | 1 |
| Inubushi, T | 1 |
| Ruigómez, A | 1 |
| García Rodríguez, LA | 1 |
| Dev, VJ | 1 |
| Arellano, F | 1 |
| Raniwala, J | 1 |
| Allen, SA | 1 |
| Oades, RD | 1 |
| Rao, ML | 1 |
| Bender, S | 1 |
| Sartory, G | 1 |
| Müller, BW | 1 |
| Remington, G | 1 |
| Shammi, CM | 1 |
| Sethna, R | 1 |
| Lawrence, R | 1 |
| Webber, SK | 1 |
| Domniz, Y | 1 |
| Sutton, GL | 1 |
| Rogers, CM | 1 |
| Lawless, MA | 1 |
| Lobana, A | 1 |
| Mattoo, SK | 1 |
| Basu, D | 1 |
| Gupta, N | 1 |
| Shimoda, K | 1 |
| Hirokane, G | 1 |
| Morita, S | 1 |
| Yokono, A | 1 |
| Takahashi, S | 1 |
| Liao, DL | 1 |
| Yeh, YC | 1 |
| Chen, HM | 1 |
| Chen, H | 1 |
| Tsai, SJ | 1 |
| Valenstein, M | 1 |
| Copeland, L | 1 |
| Owen, R | 1 |
| Blow, F | 1 |
| Visnic, S | 1 |
| Delieu, JM | 1 |
| Badawoud, M | 1 |
| Williams, MA | 1 |
| Horobin, RW | 1 |
| Duguid, JK | 1 |
| Reynolds, GP | 1 |
| Ramchand, C | 1 |
| Shah, S | 1 |
| Oh, PI | 1 |
| Iskedjian, M | 1 |
| Addis, A | 1 |
| Lanctôt, K | 1 |
| Rosenbloom, M | 1 |
| Darvesh, S | 1 |
| MacKnight, C | 1 |
| Rockwood, K | 1 |
| Owen, RR | 1 |
| Thrush, CR | 1 |
| Hudson, TJ | 1 |
| Mallory, SR | 1 |
| Fischer, EP | 1 |
| Clardy, JA | 1 |
| Williams, DK | 1 |
| Ketai, R | 1 |
| Kramer, M | 1 |
| Roth, T | 1 |
| Goldstein, S | 1 |
| Ryan, MS | 1 |
| Blackwell, B | 1 |
| Carlsson, VA | 1 |
| Vatsek, Ia | 1 |
| Nasrallah, H | 1 |
| Strauss, J | 1 |
| Lasagna, L | 2 |
| Prein, RF | 1 |
| Deniker, P | 3 |
| Lôo, H | 2 |
| Zarifian, E | 2 |
| Bousquet, B | 1 |
| Dreux, C | 1 |
| Escande, C | 1 |
| Kaul, PN | 6 |
| Whitfield, LR | 2 |
| Gosenfeld, L | 1 |
| Tsai, CC | 1 |
| Wiles, DH | 2 |
| McNeilly, AS | 2 |
| Gallien, M | 1 |
| Schnetzler, JP | 1 |
| Harper, P | 2 |
| Chacon, C | 2 |
| Vinar, O | 4 |
| Taussigová, D | 1 |
| Bastecký, J | 1 |
| Vinarová, E | 1 |
| Dunnett, CW | 1 |
| Kiltie, H | 1 |
| Buchan, T | 1 |
| Page, JD | 1 |
| Gandah, P | 1 |
| Slaven, JP | 1 |
| Hudson, GJ | 1 |
| Ebert, JN | 2 |
| Ewing, JH | 1 |
| Rogers, MH | 1 |
| Reynolds, DJ | 1 |
| Ananth, JV | 2 |
| Casper, R | 1 |
| Hippius, H | 1 |
| Gruen, PH | 2 |
| Sachar, EJ | 5 |
| Langer, G | 2 |
| Altman, N | 1 |
| Leifer, M | 1 |
| Frantz, A | 1 |
| Halpern, FS | 2 |
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Saffir, JS | 1 |
| Pietzcker, A | 1 |
| Goode, DJ | 2 |
| Mazura, TA | 1 |
| Ziemba, T | 1 |
| Singh, MM | 10 |
| Kay, SR | 13 |
| Ambrosini, PJ | 1 |
| Cross, AJ | 1 |
| Poulter, M | 1 |
| Waddington, JL | 1 |
| Charney, DS | 1 |
| Kales, A | 1 |
| Soldatos, CR | 1 |
| Nelson, JC | 1 |
| Frederiksen, PK | 1 |
| Bender, DA | 3 |
| Deakin, JF | 1 |
| Longden, A | 1 |
| Pitcher, DR | 1 |
| Hollander, D | 1 |
| Sergeant, HG | 1 |
| Reches, A | 1 |
| Ebstein, RP | 1 |
| Frith, CD | 1 |
| Carney, MW | 1 |
| Price, JS | 1 |
| McGuffin, P | 1 |
| McCreadie, RG | 2 |
| Main, CJ | 1 |
| Dunlop, RA | 1 |
| Bailey, E | 1 |
| Bond, PA | 1 |
| Brooks, BA | 1 |
| Dimitrakoudi, M | 1 |
| Jenner, FA | 1 |
| Judd, A | 1 |
| Lee, CR | 1 |
| Lenton, EA | 1 |
| McNeil, S | 1 |
| Pollitt, RJ | 1 |
| Sampson, GA | 1 |
| Thompson, EA | 1 |
| Gilbert, JC | 1 |
| Müller, P | 1 |
| Hartmann, W | 2 |
| Hogarty, GE | 8 |
| Ulrich, R | 1 |
| Goldberg, S | 2 |
| Schooler, N | 2 |
| Price, J | 1 |
| Karim, I | 1 |
| Ulrich, RF | 3 |
| Horodnicki, J | 1 |
| Libíkowa, H | 1 |
| Stancek, D | 1 |
| Wiedermann, V | 1 |
| Hasto, J | 1 |
| Breier, S | 1 |
| Ferguson, RM | 1 |
| Schmidtke, JR | 1 |
| Simmons, RL | 1 |
| Rifkin, A | 2 |
| Quitkin, F | 1 |
| Struve, F | 1 |
| Study, RE | 1 |
| Linn, MW | 1 |
| Lamb, HR | 1 |
| Claveria, LE | 1 |
| Teychenne, PF | 1 |
| Calne, DB | 1 |
| Haskayne, L | 1 |
| Petrie, A | 1 |
| Pallis, CA | 1 |
| Lodge-Patch, IC | 1 |
| Giordano, J | 1 |
| Canter, JW | 1 |
| Huang, A | 1 |
| Martin, IC | 1 |
| Kuschinsky, K | 1 |
| Mosher, LR | 1 |
| Menn, A | 1 |
| Matthew, SM | 1 |
| Simeon, J | 1 |
| Wadud, A | 1 |
| Itil, T | 2 |
| Sterlin, C | 3 |
| Climan, M | 3 |
| Leff, JP | 3 |
| Zhang, ZY | 1 |
| Sale, I | 1 |
| Zarrabi, MH | 2 |
| Zucker, S | 2 |
| Miller, F | 2 |
| Derman, RM | 1 |
| Romano, GS | 2 |
| Hartnett, JA | 1 |
| Varma, AO | 1 |
| Comar, D | 1 |
| Verhas, M | 1 |
| Soussaline, F | 1 |
| Maziere, M | 1 |
| Berger, G | 1 |
| Cuche, H | 1 |
| Kellershohn, C | 1 |
| Buchsbaum, MS | 1 |
| Spohn, HE | 4 |
| Lacoursiere, RB | 3 |
| Thompson, K | 1 |
| Coyne, L | 2 |
| Deutsch, M | 3 |
| Amin, MM | 1 |
| Greenblatt, M | 1 |
| MacDonald, IM | 1 |
| Wode-Helgodt, B | 6 |
| Eneroth, P | 1 |
| Fyrö, B | 5 |
| Sakalis, G | 5 |
| Chan, TL | 4 |
| Sathananthan, G | 1 |
| Rickels, K | 2 |
| Byrdy, H | 1 |
| Valentine, J | 1 |
| Postel, W | 1 |
| Norstad, N | 1 |
| Downing, R | 1 |
| Rompel, H | 1 |
| Segal, H | 1 |
| Raskin, A | 4 |
| Boothe, H | 2 |
| Reatig, N | 2 |
| Schulterbrandt, JG | 2 |
| Lonowski, DJ | 1 |
| Sterling, FE | 1 |
| Kennedy, JC | 1 |
| Guy, W | 2 |
| Petrie, W | 1 |
| Cleary, P | 1 |
| Chouinard, Q | 1 |
| Sourkes, TL | 1 |
| Rappaport, M | 4 |
| Hopkins, HK | 1 |
| Hall, K | 1 |
| Belleza, T | 1 |
| Silverman, J | 1 |
| Pope, HG | 1 |
| Lipinski, JF | 1 |
| Kellett, JM | 1 |
| Curry, SH | 7 |
| Diamond, F | 2 |
| Weisenfreund, J | 1 |
| Taleporos, E | 1 |
| Borg, S | 2 |
| Cotes, PM | 1 |
| Bartlett, W | 1 |
| Claghorn, JL | 3 |
| Mathew, RJ | 1 |
| Mirabi, M | 1 |
| Bigelow, LB | 1 |
| Walls, P | 1 |
| Gillin, JC | 3 |
| Gelenberg, AJ | 1 |
| Doller, JC | 1 |
| Shopsin, B | 4 |
| Klein, H | 1 |
| Aaronsom, M | 1 |
| Collora, M | 1 |
| Knight, RG | 1 |
| Harrison, A | 1 |
| Bratfos, O | 1 |
| Haug, JO | 1 |
| Griesbach, PH | 1 |
| Perlmutter, R | 1 |
| Beg, AA | 1 |
| Varma, VK | 1 |
| Dash, RJ | 1 |
| Cameron, OG | 1 |
| Wimer, L | 1 |
| Murphy, C | 1 |
| Simpson, LL | 1 |
| Vogt, M | 1 |
| Schyve, PM | 1 |
| Young, M | 1 |
| Orr, M | 1 |
| Gelder, M | 1 |
| Heggie, M | 1 |
| Wiles, D | 1 |
| Kobashi, H | 1 |
| Miyoshi, I | 1 |
| Kimura, I | 1 |
| Sakato, J | 1 |
| Saino, S | 1 |
| Suwaki, H | 1 |
| Otsuki, S | 1 |
| Tsoi, WF | 1 |
| Chen, AJ | 1 |
| Adebimpe, VR | 1 |
| Schweitzer, JW | 1 |
| Armour, M | 1 |
| Arató, M | 1 |
| Varadi, A | 1 |
| McLeod, MN | 1 |
| Fisher, P | 1 |
| Eastman, M | 1 |
| Ito, T | 1 |
| Maruta, K | 1 |
| Teradaira, R | 1 |
| Beppu, H | 1 |
| Nakagami, Y | 1 |
| Kato, Y | 1 |
| Nagatsu, T | 1 |
| Anavi, R | 1 |
| Witz, IP | 1 |
| Nasrallah, HA | 1 |
| Schooler, NR | 10 |
| Collins, PJ | 1 |
| Marcos, LR | 1 |
| Levinson, P | 1 |
| Malen, R | 1 |
| Hogben, G | 1 |
| Smith, H | 1 |
| Storrie, MC | 1 |
| Scher, M | 1 |
| McGuire, J | 1 |
| Bokan, J | 1 |
| Boullin, DJ | 4 |
| Know, JM | 1 |
| Peters, JR | 1 |
| Grahame-Smith, DG | 3 |
| Weinreb, M | 1 |
| Kraus, V | 1 |
| Krausová, J | 1 |
| Hudcová, T | 1 |
| Andrews, P | 1 |
| Snaith, RP | 1 |
| Maloney, MP | 1 |
| Sloane, RB | 1 |
| Whipple, K | 1 |
| Rzani, J | 1 |
| Eaton, EM | 1 |
| Brambilla, F | 2 |
| Rovere, C | 1 |
| Guastalla, A | 1 |
| Guerrini, A | 1 |
| Riggi, F | 1 |
| Woods, HF | 1 |
| Grimes, RP | 1 |
| Gulmann, NC | 1 |
| Bahr, B | 1 |
| Andersen, B | 1 |
| Eliassen, HM | 1 |
| Chiu, E | 1 |
| Burrows, G | 1 |
| Stevenson, J | 1 |
| Anumonye, A | 1 |
| Onibuwe-Johnson, T | 1 |
| Marinho, AA | 1 |
| Moore, DF | 1 |
| Gurowitsch, IJ | 1 |
| Awruzki, GJ | 1 |
| Mielke, DH | 1 |
| Kessler, C | 1 |
| Roniger, JJ | 1 |
| Smeraldi, E | 2 |
| Bellodi, L | 2 |
| Sacchetti, E | 1 |
| Cazzullo, CL | 1 |
| Shader, RI | 1 |
| Jackson, AH | 1 |
| Harmatz, JS | 1 |
| Appelbaum, PS | 1 |
| Strayhorn, JM | 1 |
| Nash, JL | 1 |
| Levin, SL | 1 |
| Roper, M | 1 |
| Shaskan, EG | 2 |
| Smith, AG | 1 |
| Goolamali, SK | 1 |
| Thody, AJ | 1 |
| Shuster, S | 1 |
| Pye, RJ | 1 |
| Burton, JL | 1 |
| Gautier, J | 2 |
| Jus, A | 2 |
| Villeneuve, A | 3 |
| Jus, K | 2 |
| Pires, P | 2 |
| Villeneuve, R | 2 |
| Serrano, M | 2 |
| Charette, R | 2 |
| Hutton, RA | 1 |
| Deykin, D | 1 |
| Hurt, SW | 1 |
| Swett, C | 2 |
| Shapiro, S | 1 |
| Slone, D | 1 |
| Olgiati, SG | 1 |
| Ghali, AY | 1 |
| McKeown, JM | 1 |
| Healey, AF | 1 |
| Gottlieb, JI | 1 |
| Lustberg, T | 1 |
| Bennie, FH | 1 |
| Henley, SH | 1 |
| Dixon, NF | 1 |
| Jacobsson, L | 2 |
| Von Knorring, L | 1 |
| Mattsson, B | 1 |
| Perris, C | 2 |
| Rapp, W | 2 |
| Edenius, B | 1 |
| Kettner, B | 1 |
| Magnusson, KE | 1 |
| Villemoes, P | 1 |
| Carlsson, C | 2 |
| Grimby, G | 2 |
| Häggendal, J | 2 |
| Johnsson, G | 1 |
| Ebstein, R | 1 |
| Benbenisty, D | 1 |
| Mussare, F | 1 |
| Aristigueta, N | 1 |
| Aronson, JK | 1 |
| Boulin, DJ | 1 |
| McGlashan, TH | 1 |
| Siris, S | 1 |
| Zurabashvilli, A | 1 |
| Butchukuri, DA | 1 |
| Black, S | 1 |
| Franklin, LM | 1 |
| de Silva, FP | 1 |
| Wijewickrama, HS | 1 |
| Robinson, RG | 1 |
| Folstein, MF | 1 |
| Kaplan, J | 3 |
| Stillman, R | 2 |
| Nerad, V | 1 |
| Skaunic, V | 1 |
| Vencovský, E | 1 |
| Peterová, E | 1 |
| Baudis, P | 1 |
| Wray, SR | 1 |
| Johnson, DA | 2 |
| Malik, NA | 1 |
| Chabot, M | 1 |
| Dick, P | 1 |
| Rémy, M | 1 |
| Rey-Bellet, JJ | 1 |
| Hamill, WT | 1 |
| Fontana, AF | 1 |
| Albert, JM | 3 |
| Steinbook, RM | 2 |
| Goldstein, BJ | 2 |
| Brauzer, B | 2 |
| Jacobson, AF | 2 |
| Moreno, SS | 2 |
| Hoffer, J | 1 |
| Galvan, L | 2 |
| Torres, A | 1 |
| Nieto, D | 1 |
| Ruiz-Navarro, JF | 1 |
| Vergara, L | 1 |
| Nelson, AA | 1 |
| Gold, BH | 2 |
| Hutchinson, RA | 1 |
| Benezra, E | 1 |
| Schwartz, MA | 1 |
| Erdelyi, E | 1 |
| Barchas, JD | 1 |
| Elmore, JL | 1 |
| Monroe, RR | 2 |
| Frantz, AG | 2 |
| Subrahmanyam, S | 1 |
| Wildman, RW | 2 |
| Fontaine, R | 1 |
| Payne, P | 1 |
| Turner, WJ | 6 |
| Goodwin, FK | 1 |
| Belmaker, R | 1 |
| Murphy, D | 1 |
| Siabra-Dinish, T | 1 |
| Schwartz, CC | 1 |
| Myers, JK | 1 |
| Astrachan, BM | 1 |
| Hersen, M | 1 |
| Turner, SM | 1 |
| Edelstein, BA | 1 |
| Pinkston, SG | 1 |
| Hammond, N | 1 |
| Robertson, D | 1 |
| Michelakis, AM | 1 |
| Axelsson, S | 1 |
| Jönsson, S | 1 |
| Nordgren, L | 1 |
| Evans, S | 1 |
| Rasmussen, K | 1 |
| Kirk, L | 2 |
| Nystrup, J | 1 |
| Kong, D | 1 |
| Feng, ZY | 1 |
| Sandyk, R | 2 |
| Zilberman-Kaufman, M | 1 |
| Agam, G | 1 |
| Moscowits, L | 1 |
| Livne, AA | 1 |
| Bichoński, R | 1 |
| Tabarowski, Z | 1 |
| Dabrowski, Z | 1 |
| Eitan, N | 1 |
| Levin, Y | 1 |
| Ben-Artzi, E | 1 |
| Levy, A | 1 |
| Neumann, M | 1 |
| Collins, EJ | 1 |
| Hogan, TP | 3 |
| Mortensen, PB | 1 |
| Wang, C | 1 |
| Nagase, Y | 1 |
| Okubo, Y | 1 |
| Matsuura, M | 1 |
| Kojima, T | 1 |
| Beckmann, H | 1 |
| Fritze, J | 1 |
| Franzek, E | 1 |
| Sachdev, P | 1 |
| Tang, WM | 1 |
| Oke, AF | 1 |
| Putz, C | 1 |
| Adams, RN | 1 |
| Bird, ED | 2 |
| de Boer, C | 1 |
| Gaete, HP | 1 |
| Warkentin, S | 1 |
| Nilsson, A | 1 |
| Karlson, S | 1 |
| Risberg, J | 1 |
| Franze'n, G | 1 |
| Gustafson, L | 1 |
| Kaslow, KA | 1 |
| Rosse, RB | 1 |
| Zeller, JA | 1 |
| Nagy, MS | 1 |
| Deustch, SI | 1 |
| Perlick, D | 1 |
| Stastny, P | 1 |
| Mattis, S | 1 |
| Teresi, J | 1 |
| Wang, H | 1 |
| Ghodhbane, T | 1 |
| McClelland, HA | 2 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Wirshing, WC | 1 |
| Aravagiri, M | 1 |
| Chabert, N | 1 |
| Herrmann, WM | 2 |
| Schärer, E | 2 |
| Delini-Stula, A | 2 |
| Li, C | 1 |
| Gefter, WB | 1 |
| Brooks, JG | 1 |
| Matoba, AY | 1 |
| Spina, E | 2 |
| Campo, GM | 1 |
| Calandra, S | 1 |
| Caputi, AP | 2 |
| Carrillo, JA | 1 |
| Benitez, J | 2 |
| Goldman, RS | 1 |
| Tandon, R | 1 |
| Liberzon, I | 1 |
| Goodson, J | 1 |
| Greden, JF | 1 |
| Hubschmid, T | 1 |
| Perrin, N | 1 |
| Ciompi, L | 1 |
| Wendt, G | 1 |
| Robinson, S | 1 |
| Rosca, P | 1 |
| Durst, R | 1 |
| Shai, U | 1 |
| Ghinea, C | 1 |
| Schmidt, U | 1 |
| Nir, I | 1 |
| Luo, S | 1 |
| Rajendran, MY | 1 |
| Whatley, SA | 1 |
| Srinivasan, AV | 1 |
| Murugappan, M | 1 |
| Krishnamurthy, SG | 1 |
| Sayeed, ZA | 1 |
| Mackert, A | 2 |
| Woyth, C | 2 |
| Flechtner, KM | 2 |
| Frick, K | 1 |
| Burrell, MF | 1 |
| Fewster, C | 1 |
| Szabadi, E | 1 |
| Cashman, M | 1 |
| Ochiai, H | 1 |
| Kashiwagi, M | 1 |
| Usui, T | 1 |
| Oyama, Y | 1 |
| Tokita, Y | 1 |
| Ishikawa, T | 1 |
| Rockland, L | 1 |
| Cooper, T | 1 |
| Schwartz, F | 1 |
| Weber, D | 1 |
| Sullivan, T | 1 |
| Hawton, K | 1 |
| Shepstone, B | 1 |
| Soper, N | 1 |
| Reznek, L | 1 |
| Volz, HP | 1 |
| Merriam, AE | 1 |
| Opler, LA | 3 |
| Kushner, SF | 1 |
| van Praag, HM | 1 |
| Sjögren, I | 1 |
| Blomqvist, G | 1 |
| Greitz, T | 1 |
| Stone-Elander, S | 1 |
| Inderbitzin, LB | 1 |
| Lewine, RR | 1 |
| Gloersen, BA | 1 |
| Rosen, PB | 1 |
| McDonald, SC | 1 |
| Vidanagama, BP | 1 |
| Motomura, N | 1 |
| Asaba, H | 1 |
| Rea, MM | 1 |
| Solomon, CM | 1 |
| Walsh, V | 1 |
| Frances, A | 1 |
| Goswami, U | 1 |
| Dutta, S | 1 |
| Kuruvilla, K | 1 |
| Papp, E | 1 |
| Perenyi, A | 1 |
| Vieweg, WV | 2 |
| Godleski, LS | 2 |
| Hundley, PL | 2 |
| Yank, GR | 2 |
| Sarai, M | 1 |
| Matsunaga, H | 1 |
| Song, SY | 1 |
| Young, AS | 1 |
| Faraone, SV | 1 |
| Bersani, G | 1 |
| Valeri, M | 1 |
| Bersani, I | 1 |
| Piazza, A | 1 |
| Adorno, D | 1 |
| Casciani, CU | 1 |
| Tůma, I | 1 |
| Zapletálek, M | 1 |
| Krejsek, J | 1 |
| Pidrman, V | 1 |
| Byrne, A | 1 |
| O'Shea, B | 1 |
| Guo, GY | 2 |
| Lehmann, H | 1 |
| Potter, WZ | 1 |
| Ko, GN | 1 |
| Zhang, LD | 2 |
| Yan, WW | 1 |
| Doherty, MM | 1 |
| Mitchell, M | 1 |
| Kishimoto, T | 1 |
| Hirai, M | 1 |
| Ohsawa, H | 1 |
| Terada, M | 1 |
| Matsuoka, I | 1 |
| Ikawa, G | 1 |
| Zarebinski, JM | 1 |
| Williams, AO | 1 |
| Ardern, M | 1 |
| Reveley, MA | 1 |
| Jambor, K | 1 |
| Mandelbrote, BM | 1 |
| Wagemaker, H | 1 |
| Lippmann, S | 1 |
| Cade, JR | 1 |
| Eastwood, MR | 1 |
| Yassa, R | 2 |
| Lacoursiere, R | 1 |
| Mazur, D | 1 |
| Hayes, K | 1 |
| Wilson, WH | 1 |
| Sramek, JJ | 3 |
| Sayles, MA | 1 |
| MacMillan, JF | 1 |
| Johnson, AL | 1 |
| Krska, J | 2 |
| Sampath, G | 1 |
| Shah, A | 1 |
| Soni, SD | 2 |
| Morrison, RL | 1 |
| Heiser, JF | 1 |
| Vital-Herne, J | 1 |
| Gerbino, L | 1 |
| Katz, IR | 1 |
| Heinrichs, DW | 1 |
| Bartkó, G | 1 |
| Mayláth, E | 1 |
| Herczeg, I | 1 |
| Dinan, TG | 1 |
| Kamisada, M | 1 |
| Waki, Y | 1 |
| Nakajima, S | 1 |
| Tateyama, M | 1 |
| Hayes, G | 1 |
| Sramek, J | 1 |
| Facchinetti, F | 1 |
| Petraglia, F | 1 |
| Brancato, V | 1 |
| Genazzani, AR | 1 |
| Higuchi, T | 1 |
| Komoda, T | 1 |
| Sugishita, M | 1 |
| Yamazaki, J | 1 |
| Miura, M | 1 |
| Sakagishi, Y | 1 |
| Yamauchi, T | 1 |
| Dufresne, RL | 1 |
| Wagner, RL | 1 |
| Wessely, S | 1 |
| Buemi, AL | 1 |
| Cobaleda, J | 1 |
| Garcia, MA | 1 |
| Llerena, A | 1 |
| Piña, B | 1 |
| Galdi, J | 1 |
| Bonato, RR | 1 |
| Gruenke, LD | 1 |
| Craig, JC | 1 |
| Klein, FD | 1 |
| Nguyen, TL | 1 |
| Hitzemann, BA | 1 |
| Holaday, JW | 1 |
| Loh, HH | 1 |
| Braff, L | 1 |
| Fischer, A | 1 |
| Glick, ID | 2 |
| Wolf, AP | 1 |
| Brodie, JD | 1 |
| Arnett, CD | 1 |
| Barouche, F | 1 |
| Shiue, CY | 1 |
| Fowler, JS | 1 |
| Russell, JA | 1 |
| MacGregor, RR | 1 |
| Wolkin, A | 1 |
| Singer, J | 1 |
| Meltzer, H | 2 |
| Bao, XQ | 1 |
| Yang, WJ | 1 |
| Kaufman, KR | 1 |
| Weekes, ME | 1 |
| Bucci, L | 5 |
| Witz, L | 1 |
| Shapiro, MS | 1 |
| Shenkman, L | 1 |
| Martinos, A | 1 |
| Papachristou, DN | 1 |
| Tang, YH | 1 |
| Zhu, WB | 1 |
| Xu, SH | 1 |
| Wang, SB | 1 |
| Shafique, M | 1 |
| Khan, IA | 1 |
| Akhtar, MH | 1 |
| Hussain, I | 1 |
| Thompson, TR | 1 |
| Gerstein, W | 1 |
| Zhang, MD | 1 |
| Dorson, PG | 1 |
| Crismon, ML | 1 |
| Kuang, RY | 1 |
| Jones, EE | 1 |
| Manzanares, J | 1 |
| Cantón, R | 1 |
| Grande, C | 1 |
| Benedi, J | 1 |
| Zaragozá, F | 1 |
| Claghorn, J | 1 |
| Abuzzahab, FS | 2 |
| Wang, R | 1 |
| Steinbook, R | 1 |
| Tuason, V | 1 |
| Klerman, G | 1 |
| Svendsen, CN | 1 |
| Hrbek, CC | 1 |
| Casendino, M | 1 |
| Nichols, RD | 1 |
| Makanjuola, RO | 1 |
| Tu, JJ | 1 |
| Xie, Y | 1 |
| Wang, YG | 1 |
| Herrera, JN | 1 |
| Costa, JF | 1 |
| Roy, S | 1 |
| Heh, CW | 1 |
| Nguyen, BN | 1 |
| Bindoli, A | 1 |
| Rigobello, MP | 1 |
| Cavallini, L | 1 |
| Dalla Libera, A | 1 |
| Galzigna, L | 1 |
| Yang, CL | 1 |
| Smith, CS | 1 |
| Morgan, SL | 1 |
| Greene, SV | 1 |
| Abramson, RK | 1 |
| Zhang, XP | 1 |
| Steinberg, S | 1 |
| White, WB | 1 |
| Raskind, MA | 1 |
| Courtney, N | 1 |
| Murburg, MM | 1 |
| Backus, FI | 1 |
| Bokan, JA | 1 |
| Ries, RK | 1 |
| Dorsa, DM | 1 |
| Weitzman, RE | 1 |
| Balon, R | 1 |
| Berchou, R | 1 |
| Zethelius, M | 1 |
| Hermesh, H | 1 |
| Aizenberg, D | 1 |
| Ota, T | 1 |
| Maeshiro, H | 1 |
| Ishido, H | 1 |
| Shimizu, Y | 1 |
| Uchida, R | 1 |
| Toyoshima, R | 1 |
| Ohshima, H | 1 |
| Takazawa, A | 1 |
| Motomura, H | 1 |
| Noguchi, T | 1 |
| Devaney, NM | 1 |
| Liu, ZZ | 1 |
| Wang, YJ | 1 |
| Zhang, SZ | 1 |
| He, AG | 1 |
| Chen, YD | 1 |
| Liu, XH | 1 |
| Yannitsi, S | 1 |
| Liakos, A | 1 |
| Papakostas, Y | 1 |
| Small, JG | 1 |
| Milstein, V | 1 |
| Small, IF | 1 |
| Miller, MJ | 1 |
| Kellams, JJ | 1 |
| Corsaro, CJ | 1 |
| Schreiber, G | 1 |
| Jiang, ZN | 1 |
| Chen, RM | 1 |
| Tan, U | 1 |
| Gürgen, F | 1 |
| Kogeorgos, J | 1 |
| de Alwis, C | 1 |
| Addison, GM | 1 |
| Prange, AJ | 1 |
| Tripodianakis, J | 1 |
| Swahn, CG | 1 |
| Thaler, JS | 1 |
| Curinga, R | 1 |
| Kiracofe, G | 1 |
| Fabius, AJ | 1 |
| Gaulhofer, WK | 1 |
| Adamson, L | 1 |
| Johnson, AC | 1 |
| Kulkarni, AS | 3 |
| Keegan, DL | 1 |
| Rajput, AH | 1 |
| Hakola, A | 1 |
| Elley, JH | 1 |
| Petersen, JH | 1 |
| Máthé, V | 1 |
| Kassay, G | 1 |
| Tüske, M | 1 |
| Kaz'mina, SA | 1 |
| Pokorny, A | 1 |
| Kamianov, IM | 1 |
| Kupisk, AG | 1 |
| Katsen, IZ | 1 |
| Tobias, LL | 1 |
| MacDonald, ML | 1 |
| Iversen, LL | 1 |
| Snyder, S | 1 |
| Greenberg, D | 2 |
| Yamamura, HI | 1 |
| Dynes, JB | 1 |
| Niturad, A | 1 |
| Ciurezu, T | 1 |
| Cucu, I | 1 |
| Ekblom, B | 1 |
| Haggstrom, JE | 1 |
| Matthysse, S | 3 |
| Avrutskii, GIa | 2 |
| Gurovich, IIa | 3 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 2 |
| Yamumura, HI | 1 |
| Gottfries, CG | 2 |
| Gottfries, I | 1 |
| Noren, MB | 1 |
| Daly, RJ | 1 |
| Ewing, JA | 1 |
| Afifi, AK | 1 |
| Van Allen, MW | 1 |
| Greer, S | 1 |
| Parsons, V | 1 |
| Gendron, JL | 1 |
| Zimmermann, RL | 2 |
| Elie, R | 1 |
| Gagnon, MA | 1 |
| Lamontagne, Y | 1 |
| Tetreault, L | 6 |
| Ibsen, KK | 1 |
| Varga, E | 1 |
| Reiss, M | 1 |
| Bergner, PE | 1 |
| Kolivakis, T | 2 |
| Azim, H | 1 |
| Kingstone, E | 2 |
| Pineau, R | 1 |
| Drolet, A | 1 |
| Cote, M | 1 |
| Richardson, HL | 1 |
| Graupner, KI | 1 |
| Richardson, ME | 1 |
| Ramsey, HR | 3 |
| Rahhal, DK | 2 |
| Serafetinides, EA | 13 |
| Pouliquen, Y | 1 |
| Graf, B | 1 |
| Bisson, J | 1 |
| Feuvrier, YM | 1 |
| Delattre, A | 1 |
| Vacaflor, L | 1 |
| Kekhwa, G | 1 |
| Malakhov, BB | 1 |
| Cho, HW | 1 |
| Cutler, SJ | 1 |
| Greenhouse, SW | 1 |
| Cornfield, J | 1 |
| Schneiderman, MA | 1 |
| Zingales, I | 1 |
| Friedman, S | 1 |
| Yamashita, I | 1 |
| Sakashita, A | 1 |
| Gamburg, AL | 1 |
| Komel'kevtsch, IuN | 1 |
| Aronov, EL | 1 |
| Feinberg, I | 1 |
| Wender, PH | 1 |
| Koresko, RL | 1 |
| Gottlieb, F | 1 |
| Piehuta, JA | 1 |
| Kupfer, DJ | 1 |
| Synder, F | 1 |
| Franzén, G | 1 |
| Persson, T | 2 |
| Roos, BE | 2 |
| Wålinder, J | 1 |
| Saldanha, VF | 1 |
| Havard, CW | 1 |
| Bird, R | 1 |
| Gardner, R | 1 |
| Dawson, S | 1 |
| Vaughan, T | 1 |
| Green, R | 1 |
| Udabe, RU | 1 |
| Reznikoff, M | 1 |
| Toomey, LC | 1 |
| St Jean, A | 1 |
| Noe, W | 1 |
| Seeman, MV | 1 |
| Denber, HC | 2 |
| Goldner, F | 1 |
| Teller, DN | 1 |
| Semanovskaia, EI | 1 |
| Ikuta, T | 1 |
| Gross, A | 1 |
| Thiele, K | 1 |
| Schuler, WA | 1 |
| von Schlichtegroll, A | 1 |
| Uhlenhuth, EH | 1 |
| Lipman, RS | 1 |
| Covi, L | 1 |
| Fischer, R | 1 |
| Ristine, LP | 1 |
| Wisecup, P | 1 |
| Stille, G | 1 |
| Schnee, J | 1 |
| Hekimian, LJ | 4 |
| Floyd, A | 3 |
| Bilikiewicz, A | 1 |
| Góra, S | 1 |
| Stevenson, IH | 1 |
| O'Malley, K | 1 |
| Turnbull, MJ | 1 |
| Ballinger, BR | 1 |
| Altman, H | 2 |
| Evenson, RC | 2 |
| Sletten, IW | 2 |
| Cho, DW | 1 |
| Nybäck, H | 2 |
| Robins, AH | 1 |
| Behrman, S | 1 |
| Barry, D | 1 |
| Meyskens, FL | 1 |
| Becker, CE | 1 |
| Bamji, AN | 1 |
| Almazov, BN | 1 |
| Seifertová, D | 1 |
| Richter, M | 1 |
| Hogarty, G | 1 |
| Aherwadkar, SJ | 1 |
| Efendigil, MC | 1 |
| Coulshed, N | 1 |
| Domino, EF | 2 |
| Krause, RR | 2 |
| Gillbe, C | 2 |
| Wise, CD | 3 |
| Baden, MM | 1 |
| Stein, L | 3 |
| Kabanov, IP | 1 |
| Turano, P | 4 |
| March, JE | 3 |
| Donato, D | 2 |
| Narasimhachari, N | 1 |
| Lin, RL | 1 |
| Collins, S | 1 |
| Frosch, WA | 2 |
| Drossman, AK | 1 |
| Johnson, GF | 1 |
| Willis, D | 5 |
| Bankier, RG | 1 |
| Mathewson, FA | 1 |
| Feldman, S | 3 |
| Pieschl, D | 1 |
| Hamid, TA | 1 |
| Wertz, WJ | 1 |
| Karimov, RK | 1 |
| Prien, RF | 6 |
| Gillis, RD | 1 |
| Mehta, D | 1 |
| Os'makova, EI | 1 |
| Norris, HN | 1 |
| Haher, EJ | 1 |
| Herkert, E | 1 |
| Enelow, AJ | 1 |
| Gang, RG | 1 |
| Huber, WK | 3 |
| Sullivan, J | 1 |
| Wood, F | 1 |
| Blessed, G | 1 |
| Bhate, S | 1 |
| Ali, N | 1 |
| Clarke, PA | 1 |
| Davies, AL | 1 |
| O'Leary, J | 1 |
| Ruíz Ruíz, M | 1 |
| Mandel, L | 1 |
| Ahn, HS | 1 |
| VandenHeuvel, WJ | 1 |
| Walker, RW | 1 |
| Fischer-Cornelssen, K | 1 |
| Ferner, U | 1 |
| Steiner, H | 2 |
| Gonçalves, N | 1 |
| Fieguth, G | 1 |
| Johnstone, EE | 1 |
| Cook, TH | 1 |
| Itschner, L | 1 |
| Kelly, JT | 1 |
| Kiev, A | 1 |
| Güclü, B | 1 |
| Pearson, E | 1 |
| Collins, P | 1 |
| Janowsky, DS | 3 |
| el-Yousel, MK | 1 |
| Sekerke, HJ | 2 |
| Pinard, G | 1 |
| Prenoveau, Y | 1 |
| Cooper, SF | 1 |
| Hillel, J | 2 |
| Caille, G | 1 |
| Amkraut, A | 1 |
| Solomon, GF | 1 |
| Allansmith, M | 1 |
| McClellan, B | 1 |
| Rudorfer, L | 2 |
| Paley, HM | 2 |
| Ticku, MK | 3 |
| Aghajanian, GK | 1 |
| Palestine, ML | 1 |
| Mitchell, HC | 1 |
| Marley, E | 1 |
| Conway, MW | 2 |
| Watts, CA | 1 |
| German, GA | 1 |
| Angle, HV | 1 |
| Malkin, MD | 1 |
| Weiss, MS | 1 |
| Gittleson, NL | 1 |
| Richardson, TD | 1 |
| Manian, AA | 1 |
| Grant, FW | 1 |
| Cowen, MA | 1 |
| Ozerengin, MF | 1 |
| Bigelow, N | 1 |
| Davis, J | 1 |
| Moon, W | 1 |
| Moore, J | 1 |
| Man, PL | 2 |
| Chen, CH | 1 |
| Greenblatt, DJ | 1 |
| Greenblatt, GR | 1 |
| Rochester, SR | 1 |
| Crane, GE | 4 |
| Spensley, J | 1 |
| Kelsey, MI | 1 |
| Moscatelli, EA | 1 |
| Ambani, LM | 1 |
| Van Woert, MH | 2 |
| Levit, RA | 1 |
| Sutton, S | 1 |
| Zubin, J | 1 |
| Shah, DK | 1 |
| Wig, NN | 1 |
| Chaudhury, RR | 1 |
| Bazhin, EF | 1 |
| Rafalovich, EG | 1 |
| Hargreaves, WA | 1 |
| Goldfield, MD | 1 |
| Snodgrass, RE | 1 |
| Holy, PA | 1 |
| Williams, RO | 1 |
| Bishop, M | 1 |
| Guerrero-Figueroa, R | 1 |
| Platz, AR | 1 |
| Letemendia, FJ | 1 |
| Harris, AD | 1 |
| Michaux, L | 1 |
| Gallot, HM | 1 |
| Schneider, JJ | 1 |
| Morton, MR | 1 |
| Kammerer, M | 1 |
| Wartel, R | 1 |
| Gurfein, L | 1 |
| Weil, J | 1 |
| Wysoki, V | 1 |
| Gelb, F | 1 |
| Kordas, SK | 1 |
| Kazamias, NG | 1 |
| Georgas, JG | 1 |
| Papadokostakis, JG | 1 |
| De Long, SL | 1 |
| Mattsson, NB | 1 |
| Ragland, R | 2 |
| Segal, B | 1 |
| Winslow, WW | 1 |
| Stone, WN | 1 |
| Hofling, CK | 1 |
| Johnson, G | 4 |
| Soyka, D | 1 |
| Margolis, RA | 2 |
| Bordeleau, JM | 3 |
| Gauthier, R | 2 |
| Vulpe, M | 1 |
| Lapointe, L | 1 |
| Saarma, J | 2 |
| Rajotte, P | 1 |
| Lunde, DT | 1 |
| Marjerrison, G | 1 |
| Keogh, RP | 1 |
| Jarvik, LF | 1 |
| Callaway, E | 1 |
| Cutler, R | 2 |
| Kossatz, I | 1 |
| McKeon, JJ | 1 |
| Kyriakopoulos, AA | 1 |
| Colmore, JP | 2 |
| Remr, J | 3 |
| Aronoff, MS | 1 |
| Epstein, RS | 1 |
| Maccario, M | 1 |
| Korein, J | 1 |
| Park, LC | 1 |
| Imboden, JB | 1 |
| Goldberg, GJ | 1 |
| Brooke, G | 1 |
| Townsend, HR | 1 |
| Brahma, RK | 1 |
| Hill, GB | 1 |
| Szafranek, J | 1 |
| Szafranek, K | 1 |
| Naranjo, ER | 1 |
| Engelhart, DM | 1 |
| Hekimian, L | 1 |
| Fracchia, J | 1 |
| Wing, JK | 1 |
| Van Wyk, AJ | 1 |
| Marais, GF | 1 |
| Usdin, E | 1 |
| Kim, SS | 1 |
| Trousdale, W | 1 |
| Jones, IH | 2 |
| Pikler, N | 1 |
| Battegay, R | 1 |
| Kaplan, HI | 1 |
| Sadock, BJ | 1 |
| Pichardo, J | 1 |
| Korol, B | 1 |
| Kerzeniewski, L | 1 |
| Schoolar, JC | 1 |
| Kinross-Wright, J | 1 |
| O'Meallie, L | 1 |
| Chen, CP | 1 |
| Tsuang, MM | 1 |
| Saxena, BM | 1 |
| Goldman, D | 1 |
| Nouri, A | 1 |
| Cuendet, JF | 1 |
| Oktem, MR | 1 |
| Oktem, N | 1 |
| Lampe, WT | 1 |
| Neal, CD | 1 |
| Collis, MP | 1 |
| Imlah, NW | 1 |
| Fish, B | 1 |
| Campbell, M | 1 |
| Shapiro, T | 1 |
| Wadzisz, FJ | 1 |
| Gundersen, HJ | 1 |
| Amdisen, A | 1 |
| Kalberer, M | 1 |
| Atar, Z | 1 |
| Bider, E | 1 |
| Vasar, H | 1 |
| Bartlett, C | 1 |
| Case, WG | 1 |
| Ryder, BL | 1 |
| Dhopeshwarkar, VP | 1 |
| Pereira-Ogan, JA | 1 |
| Naneishvili, BR | 1 |
| Zurabashvili, ZA | 1 |
| Eliava, LA | 1 |
| Darchia, NS | 1 |
| Krystof, J | 1 |
| Zyg, J | 1 |
| Mitkiewicz, S | 1 |
| Kaczyński, J | 1 |
| Aleem, A | 1 |
| Jefferson, JW | 1 |
| Sved, S | 2 |
| Perales, A | 2 |
| Houle, HP | 1 |
| Jovanović, T | 1 |
| Marković, A | 1 |
| Smith, RC | 1 |
| Carlin, J | 1 |
| Walter, CJ | 2 |
| Mitchell-Heggs, N | 1 |
| el-Yosef, MK | 1 |
| Wood, FD | 1 |
| Roth, WT | 1 |
| Cannon, EH | 1 |
| Khmelevskiĭ, DL | 1 |
| Mukhin, AS | 1 |
| Lucas, AR | 1 |
| Warner, K | 1 |
| Gottlieb, JS | 1 |
| Demers, RG | 1 |
| Horodnicki, JM | 1 |
| Uno, M | 1 |
| Angel, C | 1 |
| Burkett, ML | 1 |
| Polak, P | 1 |
| Laycob, L | 1 |
| Ermolina, LA | 1 |
| West, N | 1 |
| Vogel, WH | 1 |
| Boehme, DH | 1 |
| Gold, S | 1 |
| Teo, SK | 1 |
| Cheah, JS | 1 |
| Harder, A | 1 |
| Modestin, J | 1 |
| Palaic, D | 1 |
| Murakami, K | 1 |
| Hanzliĉek, L | 1 |
| Leider, M | 1 |
| Lichko, AE | 2 |
| Horn, AS | 1 |
| Ikeuchi, S | 1 |
| Barone, P | 2 |
| Müller, W | 1 |
| Gol'dovskaia, IL | 1 |
| Latz, A | 1 |
| Saretsky, T | 1 |
| Mirsky, AF | 1 |
| Goldschmidt, L | 1 |
| Bruno, SC | 1 |
| Satanove, A | 1 |
| McIntosh, JS | 1 |
| Spiegel, DE | 1 |
| Keith-Spiegel, P | 1 |
| Knorr, W | 2 |
| Rennert, H | 1 |
| Barton, R | 1 |
| Akimoto, H | 1 |
| Shimazaki, T | 1 |
| Shibata, N | 1 |
| Marjot, DH | 1 |
| Simopoulos, AM | 1 |
| Radzuweit, H | 1 |
| Kutsenok, BM | 1 |
| Gastev, MD | 1 |
| Steinberg, HR | 2 |
| Skarbek, A | 1 |
| Fleĭs, EP | 1 |
| Yaryura-Tobias, JA | 2 |
| Wolpert, A | 2 |
| Dana, L | 1 |
| Marshall, JH | 1 |
| Chase, TN | 1 |
| Schnur, JA | 1 |
| Gordon, EK | 1 |
| Glass, GS | 1 |
| Hustmyer, FE | 1 |
| Weil, AT | 1 |
| Waitzkin, L | 1 |
| Braverman, LB | 1 |
| Henderson, JG | 1 |
| Dawson, AA | 1 |
| Minns, RA | 1 |
| Wilder, R | 1 |
| Sikes, JC | 1 |
| Sikes, SC | 1 |
| Isayama, Y | 1 |
| Yasui, T | 1 |
| Dawson-Butterworth, K | 2 |
| Turano, PA | 1 |
| DeLong, SL | 1 |
| Rice, JK | 1 |
| Malm, U | 1 |
| Ozola, MIa | 1 |
| Pearlman, T | 1 |
| Giliadova, LA | 1 |
| Moore, MT | 1 |
| Book, MH | 1 |
| Konstantinova, TP | 1 |
| Klokov, EA | 1 |
| Dogliani, P | 1 |
| Senini, G | 1 |
| Bertuzzi, F | 1 |
| Tchertkoff, V | 1 |
| Lewis, DM | 1 |
| Samuel, G | 1 |
| Bragg, DG | 2 |
| Hussar, AE | 2 |
| Schipper, JA | 1 |
| Shastri, PC | 1 |
| Dave, KP | 1 |
| Siegel, M | 1 |
| Tefft, H | 1 |
| Irwin, DS | 1 |
| Weitzel, WD | 1 |
| Morgan, DW | 1 |
| Beszterczey, A | 1 |
| Safonov, GA | 1 |
| Morozova, TV | 1 |
| Fedorovskiĭ, IuN | 1 |
| Baronov, VF | 1 |
| Kogan, RD | 1 |
| Khrekov, PA | 1 |
| Altshuler, KZ | 1 |
| Deming, WE | 1 |
| Mandel, A | 1 |
| Gross, M | 1 |
| Jones, HS | 1 |
| Robinson, J | 1 |
| Smulevich, AB | 1 |
| Golovan', LI | 1 |
| Sokolova, ED | 1 |
| West, ED | 1 |
| Cohen, M | 1 |
| Galbrecht, CR | 1 |
| Gyllerup, T | 1 |
| Arons, B | 1 |
| Kosek, JC | 1 |
| Timofeev, NN | 1 |
| Kondrashenko, VT | 1 |
| Nemtseva, NIa | 1 |
| Zlotlow, M | 1 |
| Rodríguez Suárez, FJ | 1 |
| Concepción Pérez, A | 1 |
| Tunkunas, P | 1 |
| Borowski, T | 1 |
| Tolwinski, T | 1 |
| Brophy, JJ | 1 |
| Cardone, SS | 1 |
| Olson, RE | 1 |
| Rab, SM | 1 |
| Alam, MN | 1 |
| Sadequzzaman, MD | 1 |
| Kennedy, PF | 1 |
| Falicki, Z | 1 |
| Lysiak, W | 1 |
| Abenson, MH | 1 |
| Belkin, NF | 1 |
| DeVito, RA | 1 |
| Sykes, DE | 1 |
| McDonald, EK | 1 |
| Larson, JL | 1 |
| Zweig, A | 1 |
| White, L | 1 |
| Koluch, J | 1 |
| Tabarka, K | 1 |
| Hildebrandt, HJ | 1 |
| Willcox, DR | 1 |
| Gillan, R | 1 |
| Kramer, MD | 1 |
| Goulding, R | 1 |
| Wise, S | 1 |
| Lideman, RR | 1 |
| Ir'ianov, IuI | 1 |
| Smaga, MF | 1 |
| Sandvig, K | 1 |
| Harman, C | 1 |
| Winn, DA | 1 |
| Popkowska, N | 1 |
| Cymbala, J | 1 |
| Zakrzewska, F | 1 |
| Valentine, M | 1 |
| Jardine, P | 1 |
| Gibbard, BA | 1 |
| Downing, RW | 1 |
| Boruchow, JK | 1 |
| Valentine, JH | 1 |
| Efron, HY | 1 |
| Balter, AM | 1 |
| Lundon, JR | 1 |
| Barnett, HJ | 1 |
| Barnes, GJ | 1 |
| Cameron, ME | 1 |
| Gold, N | 1 |
| Reardon, JD | 1 |
| Abrams, S | 1 |
| Baumgold, J | 1 |
| Rosenblatt, S | 1 |
| Chanley, JD | 1 |
| Greenberg, LM | 1 |
| Roth, S | 1 |
| Hrushka, M | 1 |
| Bruck, M | 1 |
| Heninger, G | 1 |
| Speck, LB | 1 |
| Pind, K | 1 |
| Heller, B | 1 |
| Ekdawi, MY | 1 |
| Fowke, R | 1 |
| Amuso, D | 1 |
| Inferrera, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Adjunctive Siltuximab in Schizophrenia[NCT02796859] | Phase 1/Phase 2 | 30 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | ||
| Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)[NCT01198509] | 178 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Pinpointing the Factors Affecting Clinical Study Experiences of Schizophrenia Patients[NCT05870722] | 500 participants (Anticipated) | Observational | 2024-06-30 | Not yet recruiting | |||
| Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population Followed in Mental Health Outpatient and Inpatient Clinical Settings (MEMAS Prospective Study)[NCT04395326] | 120 participants (Anticipated) | Observational | 2017-01-01 | Recruiting | |||
| A Randomized, Double-Blind, Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Combined With Low Dose of Haloperidol in the Treatment of Schizophrenic Disorder[NCT00998608] | Phase 4 | 88 participants (Actual) | Interventional | 2007-08-31 | Terminated (stopped due to terminated) | ||
| The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070] | 68 participants (Actual) | Interventional | 2007-08-31 | Completed | |||
| Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine[NCT02304432] | Early Phase 1 | 2 participants (Actual) | Interventional | 2015-09-27 | Completed | ||
| A Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia[NCT00505765] | Phase 2 | 63 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| MK-0777 for the Treatment of Cognitive Impairments in Patients With Schizophrenia[NCT00505076] | Phase 2 | 63 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone[NCT01173874] | Phase 3 | 120 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| Effectiveness Trial of Attention Shaping for Schizophrenia[NCT00391677] | 120 participants (Actual) | Interventional | 2007-01-31 | Completed | |||
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia[NCT03075657] | Phase 4 | 120 participants (Actual) | Interventional | 2017-05-01 | Completed | ||
| Switching Antipsychotics: Abrupt Discontinuation Versus Overlap[NCT02640300] | Phase 4 | 33 participants (Actual) | Interventional | 1999-05-31 | Completed | ||
| Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)[NCT01138618] | 85 participants (Actual) | Observational | 2010-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"DAS28 (disease activity score with 28 joint count). Possible score range: 0 to 10. This is a composite index calculated from 4 measures: two from a physician (28 tender joint count, 28 swollen joint count), one from the patient (patient global estimate of disease activity), and one laboratory biomarker (erythrocyte sedimentation rate or ESR). A score of 0 represents best possible health status (no apparent disease activity) and 10 represents worst possible.~The outcome is reported as mean change in DAS28 score from baseline to 6 months. The mean changes reported are negative values for downward change in score (i.e., improvement in health status)." (NCT01198509)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Rheumatoid Arthritis (RA) - Doxycycline | -1.3 |
| Rheumatoid Arthritis (RA) - Vancomycin | -1.5 |
| Rheumatoid Arthritis (RA) Randomized to no Treatment | -2.5 |
"Oral and intestinal microbiota, and T cell function and activation, will be assessed at baseline, and at 1, 2, 3, 4 and 5 months after baseline, to determine whether changes are associated with vancomycin treatment versus doxycycline treatment versus no treatment.~Results are reported as number of participants who experienced changes in oral/intestinal microbiota, T cell function/activation.~Methods/criteria to assess change in microbiota: change in relative abundance of microorganisms at genus and species level (as assessed high-throughput 16S rDNA sequencing).~Methods/criteria to assess change in T cell function/activation: change in percentage of inhibition of regulatory T cells as measured by interferon gamma levels in in-vitro assays." (NCT01198509)
Timeframe: 6 months
| Intervention | participants (Number) | |
|---|---|---|
| Change in oral/intestinal microbiota | Change in T cell function/activation | |
| Early RA Cross-sectional Cohort | 0 | 0 |
| Healthy Volunteers | 0 | 0 |
| Psoriatic Arthritis (PsA) | 0 | 0 |
| Rheumatoid Arthritis (RA) - Doxycycline | 4 | 2 |
| Rheumatoid Arthritis (RA) - Vancomycin | 10 | 6 |
| Rheumatoid Arthritis (RA) Randomized to no Treatment | 2 | 19 |
Auditory evoked potential amplitude: P50 ratio (P50 S2/S1) (NCT02304432)
Timeframe: Baseline and Week 8 of DCS treatment
| Intervention | ratio (Number) | |
|---|---|---|
| P50 ratio: Baseline | P50 ratio: Week 8 of DCS | |
| First Open Label DCS | 44.51 | 30 |
Auditory evoked potential amplitude: P300 at fz, cz, and pz; N100 at fz and cz; P200 at fz and cz; P50 S1 and S2; mismatch negativity (MMN) at fz and cz. (NCT02304432)
Timeframe: Baseline and Week 8 of DCS treatment
| Intervention | microvolts (Number) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P300 at fz: Baseline | P300 at cz: Baseline | P300 at pz: Baseline | N100 at fz: Baseline | N100 at cz: Baseline | P200 at fz: Baseline | P200 at cz: Baseline | P50 S1: Baseline | P50 S2: Baseline | MMN at fz: Baseline | MMN at cz: Baseline | P300 at fz: Week 8 of DCS | P300 at cz: Week 8 of DCS | P300 at pz: Week 8 of DCS | N100 at fz: Week 8 of DCS | N100 at cz: Week 8 of DCS | P200 at fz: Week 8 of DCS | P200 at cz: Week 8 of DCS | P50 S1: Week 8 of DCS | P50 S2: Week 8 of DCS | MMN at fz: Week 8 of DCS | MMN at cz: Week 8 of DCS | |
| First Open Label DCS | -0.635 | 6.529 | 5.340 | -3.926 | -3.615 | 1.662 | 6.591 | 2.759 | 1.23 | -3.356 | -4.130 | 3.030 | 6.810 | 6.620 | -3.260 | -3.940 | 8.200 | 8.160 | 1.36 | 0.4 | -3.330 | -1.540 |
Auditory evoked potential gamma: G40 hz phase locking at fz and cz; G30 hz phase locking at fz and cz; G20 hz phase locking at fz and cz (NCT02304432)
Timeframe: Baseline and Week 8 of DCS treatment
| Intervention | microvolts squared (Number) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G40 hz phase locking at fz: Baseline | G40 hz phase locking at cz: Baseline | G30 hz phase locking at fz: Baseline | G30 hz phase locking at cz: Baseline | G20 hz phase locking at fz: Baseline | G20 hz phase locking at cz: Baseline | G40 hz phase locking at fz: Week 8 of DCS | G40 hz phase locking at cz: Week 8 of DCS | G30 hz phase locking at fz: Week 8 of DCS | G30 hz phase locking at cz: Week 8 of DCS | G20 hz phase locking at fz: Week 8 of DCS | G20 hz phase locking at cz: Week 8 of DCS | |
| First Open Label DCS | 0.135 | 0.168 | 0.190 | 0.163 | 0.023 | 0.030 | 0.344 | 0.381 | 0.168 | 0.19 | 0.01 | -0.01 |
Auditory evoked potential latency: P300 at fz, cz, and pz; N100 at fz and cz; P200 at fz and cz. (NCT02304432)
Timeframe: Baseline and Week 8 of DCS treatment
| Intervention | msec (Number) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P300 at fz: Baseline | P300 at cz: Baseline | P300 at pz: Baseline | N100 at fz: Baseline | N100 at cz: Baseline | P200 at fz: Baseline | P200 at cz: Baseline | P300 at fz: Week 8 of DCS | P300 at cz: Week 8 of DCS | P300 at pz: Week 8 of DCS | N100 at fz: Week 8 of DCS | N100 at cz: Week 8 of DCS | P200 at fz: Week 8 of DCS | P200 at cz: Week 8 of DCS | |
| First Open Label DCS | 279.297 | 279.297 | 279.297 | 97.656 | 91.797 | 197.266 | 193.359 | 294.920 | 294.000 | 294 | 87.9 | 88.000 | 212.890 | 212.000 |
Proton magnetic resonance spectroscopy at 4T: brain glycine/CR ratio. Participants were assessed at baseline (pre-glycine challenge dose and 60, 80, 100 and 120 minutes post glycine dose) and in week 8 of of open-label DCS treatment: pre-DCS dose, and 60, 80, 100 and 120 minutes post DCS dose. Measured in posterior occipital cortex. (NCT02304432)
Timeframe: Baseline and Week 8 of DCS treatment
| Intervention | ratio (Median) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Baseline at 60 minutes | Baseline at 80 minutes | Baseline at 100 minutes | Baseline at 120 minutes | Week 8 of DCS: Baseline | Week 8 of DCS: 60 minutes | Week 8 of DCS: 80 minutes | Week 8 of DCS: 100 minutes | Week 8 of DCS: 120 minutes | |
| Open Label DCS | 0.41245 | 0.50375 | 0.65295 | 0.61505 | 0.8256 | 0.10977 | 0.248885 | 0.32609 | 0.32052 | 0.312155 |
Total BPRS score measures severity of 18 psychiatric symptoms. Each symptom is scored 1-7 with the total score ranging from 18-126. 18 means no symptoms and 126 means very severe symptoms. (NCT02304432)
Timeframe: Baseline & at 2, 4, 6 & 8 Weeks during open-label phase 1 and every 2 weeks up to 24 weeks during open label phase 2
| Intervention | units on a scale (Median) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline BPRS | 2 weeks BPRS | 4 weeks BPRS | 6 weeks BPRS | 8 weeks BPRS | 10 weeks BPRS | 12 weeks BPRS | 14 weeks BPRS | 16 weeks BPRS | 18 weeks BPRS | 20 weeks BPRS | 22 weeks BPRS | 24 weeks BPRS | |
| First Open Label DCS | 37 | 25 | 26 | 24 | 24.5 | NA | NA | NA | NA | NA | NA | NA | NA |
| Second Open Label DCS | 31.5 | 30.5 | 28 | 25.5 | 26 | 26.5 | 26 | 25.5 | 28.5 | 27 | 25 | 24.5 | 26.5 |
Total BPRS score measures severity of 18 psychiatric symptoms. Each symptom is scored 1-7 with the total score ranging from 18-126. 18 means no symptoms and 126 means very severe symptoms. (NCT02304432)
Timeframe: Baseline, 2, 4, & 6 weeks (crossover periods)
| Intervention | units on a scale (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline BPRS for first intervention | 2 weeks BPRS for first intervention | 4 weeks BPRS for first intervention | 6 weeks BPRS for first intervention | Baseline BPRS for second intervention | 2 weeks BPRS for second intervention | 4 weeks BPRS for second intervention | 6 weeks BPRS for second intervention | |
| DCS First, Then Placebo | 26 | 25 | 25 | 26 | 39 | 45 | 45 | 38 |
| Placebo First, Then DCS | 29 | 35 | 33 | 35 | 36 | 30 | 27 | 28 |
CGI severity scores measure severity of mental illness on a scale of 1-7 where 1 means normal, not at all ill, 2 means borderline mentally ill, 3 means mildly ill, 4 means moderately ill, 5 means markedly ill, 6 means severely ill and 7 means among the most extremely ill patients. (NCT02304432)
Timeframe: Baseline & at 2, 4, 6 & 8 Weeks during open-label phase 1 and every 2 weeks up to 24 weeks during open label phase 2
| Intervention | units on a scale (Median) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline CGI | 2 weeks CGI | 4 weeks CGI | 6 weeks CGI | 8 weeks CGI | 10 weeks CGI | 12 weeks CGI | 14 weeks CGI | 16 weeks CGI | 18 weeks CGI | 20 weeks CGI | 22 weeks CGI | 24 weeks CGI | |
| First Open Label DCS | 4 | 2 | 2 | 2 | 2 | NA | NA | NA | NA | NA | NA | NA | NA |
| Second Open Label DCS | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 3 | 2.5 | 2 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
CGI severity scores measure severity of mental illness on a scale of 1-7 where 1 means normal, not at all ill, 2 means borderline mentally ill, 3 means mildly ill, 4 means moderately ill, 5 means markedly ill, 6 means severely ill and 7 means among the most extremely ill patients. (NCT02304432)
Timeframe: Baseline, 2, 4, & 6 weeks (crossover periods)
| Intervention | units on a scale (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline CGI for first intervention | 2 weeks CGI for first intervention | 4 weeks CGI for first intervention | 6 weeks CGI for first intervention | Baseline CGI for second intervention | 2 weeks CGI for second intervention | 4 weeks CGI for second intervention | 6 weeks CGI for second intervention | |
| DCS First, Then Placebo | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Placebo First, Then DCS | 1 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
Hamilton Depression Scale (HAM) measures severity of depression symptoms. The sum of the ratings for 9 depression symptoms is measured on a scale of 0-2 with 0 meaning no depression symptoms and 2 meaning some level of severity of that specific symptom. The rating for one depression symptom is measured on a scale of 0-3 with 0 meaning no depression symptoms and 3 meaning a severe level of that specific symptom. The sum of ratings for 11 depression symptoms is measured on a scale of 0-4, with 0 meaning no symptoms and 4 meaning a severe level of that specific symptom. The three sums are added to produce an overall depression rating scale score ranging from 0-65. Higher scores indicate worse depression symptoms. (NCT02304432)
Timeframe: Baseline & at 2, 4, 6 & 8 Weeks during open-label phase 1 and every 2 weeks up to 24 weeks during open label phase 2
| Intervention | units on a scale (Median) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline HAM | 2 weeks HAM | 4 weeks HAM | 6 weeks HAM | 8 weeks HAM | 10 weeks HAM | 12 weeks HAM | 14 weeks HAM | 16 weeks HAM | 18 weeks HAM | 20 weeks HAM | 22 weeks HAM | 24 weeks HAM | |
| First Open Label DCS | 5 | 1.5 | 1 | 0.5 | 1.5 | NA | NA | NA | NA | NA | NA | NA | NA |
| Second Open Label DCS | 0.5 | 1 | 1 | 0 | 2.5 | 0 | 0 | 0 | 3.5 | 0 | 0 | 0 | 0 |
Hamilton Depression Scale (HAM) measures severity of depression symptoms. The sum of the ratings for 9 depression symptoms is measured on a scale of 0-2 with 0 meaning no depression symptoms and 2 meaning some level of severity of that specific symptom. The rating for one depression symptom is measured on a scale of 0-3 with 0 meaning no depression symptoms and 3 meaning a severe level of that specific symptom. The sum of ratings for 11 depression symptoms is measured on a scale of 0-4, with 0 meaning no symptoms and 4 meaning a severe level of that specific symptom. The three sums are added to produce an overall depression rating scale score ranging from 0-65. Higher scores indicate worse depression symptoms. (NCT02304432)
Timeframe: Baseline, 2, 4, & 6 weeks (crossover periods)
| Intervention | units on a scale (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline HAM for first intervention | 2 weeks HAM for first intervention | 4 weeks HAM for first intervention | 6 weeks HAM for first intervention | Baseline HAM for second intervention | 2 weeks HAM for second intervention | 4 weeks HAM for second intervention | 6 weeks HAM for second intervention | |
| DCS First, Then Placebo | 0 | 1 | 0 | 0 | 2 | 12 | 9 | 2 |
| Placebo First, Then DCS | 4 | 5 | 2 | 10 | 0 | 0 | 0 | 0 |
Young Mania Rating Scale (YMRS) measures severity of manic symptoms. The sum of the ratings for 7 symptoms of mania is measured on a scale of 0-4 and the sumof 4 symptoms of mania is measured on a scale of 0-8 to yield a total score ranging from 0-60, with 0 meaning no manic symptoms and 60 meaning severe manic symptoms. (NCT02304432)
Timeframe: Baseline & at 2, 4, 6 & 8 Weeks during open-label phase 1 and every 2 weeks up to 24 weeks during open label phase 2
| Intervention | units on a scale (Median) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline YMRS | 2 weeks YMRS | 4 weeks YMRS | 6 weeks YMRS | 8 weeks YMRS | 10 weeks YMRS | 12 weeks YMRS | 14 weeks YMRS | 16 weeks YMRS | 18 weeks YMRS | 20 weeks YMRS | 22 weeks YMRS | 24 weeks YMRS | |
| First Open Label DCS | 2 | 1 | 1 | 0 | 0 | NA | NA | NA | NA | NA | NA | NA | NA |
| Second Open Label DCS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Young Mania Rating Scale (YMRS) measures severity of manic symptoms. The sum of the ratings for 7 symptoms of mania is measured on a scale of 0-4 and the sumof 4 symptoms of mania is measured on a scale of 0-8 to yield a total score ranging from 0-60, with 0 meaning no manic symptoms and 60 meaning severe manic symptoms. (NCT02304432)
Timeframe: Baseline, 2, 4, & 6 weeks (crossover periods)
| Intervention | units on a scale (Number) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline YMRS for first intervention | 2 weeks YMRS for first intervention | 4 weeks YMRS for first intervention | 6 weeks YMRS for first intervention | Baseline YMRS for second intervention | 2 weeks YMRS for second intervention | 4 weeks YMRS for second intervention | 6 weeks YMRS for second intervention | |
| DCS First, Then Placebo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Placebo First, Then DCS | 1 | 0 | 0 | 0 | 4 | 1 | 1 | 1 |
Scores on each of 8 domains of cognitive function (speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning/problem solving, social cognition, overall composite). Scores are T scores ranging from 0-100, with 50 representing the mean for a population based on a normal distribution, standard deviation of 10. Higher scores signify better functioning. (NCT02304432)
Timeframe: Baseline and Week 8 of open-label DCS treatment
| Intervention | T scores (Median) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline Processing Speed | Baseline Attention/Vigilance | Baseline Working Memory | Baseline Verbal Learning | Baseline Visual Learning | Baseline Reasoning/Problem Solving | Baseline Social Cognition | Baseline Overall Composite Score | Week 8 of open-label DCS Processing Speed | Week 8 of open-label DCS Attention/Vigilance | Week 8 of open-label DCS Working Memory | Week 8 of open-label DCS Verbal Learning | Week 8 of open-label DCS Visual Learning | Week 8 of open-label DCS Reasoning/Problem Solving | Week 8 of open-label DCS Social Cognition | Week 8 of open-label DCS Overall Composite Score | |
| Open Label DCS | 48.5 | 44.5 | 38.5 | 54 | 50.5 | 52.5 | 48 | 46.5 | 52.5 | 47.5 | 50.5 | 43.5 | 54.5 | 66.5 | 44.5 | 51.5 |
Positive and Negative Symptom Scale (PANSS) measures positive and negative symptoms of schizophrenia. The sum of ratings for seven positive symptoms is measured on a scale from 7-49 with 7 meaning no symptoms and 49 meaning severe symptoms.The sum of ratings for seven negative symptoms is measured on a scale from 7-49 with 7 meaning no symptoms and 49 meaning severe symptoms. (NCT02304432)
Timeframe: Baseline & at 2, 4, 6 & 8 Weeks during open-label phase 1 and every 2 weeks up to 24 weeks during open label phase 2
| Intervention | units on a scale (Median) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline positive | Baseline negative | 2 weeks positive | 2 weeks negative | 4 weeks positive | 4 weeks negative | 6 weeks positive | 6 weeks negative | 8 weeks positive | 8 weeks negative | 10 weeks positive | 10 weeks negative | 12 weeks positive | 12 weeks negative | 14 weeks positive | 14 weeks negative | 16 weeks positive | 16 weeks negative | 18 weeks positive | 18 weeks negative | 20 weeks positive | 20 weeks negative | 22 weeks positive | 22 weeks negative | 24 weeks positive | 24 weeks negative | |
| First Open Label DCS | 14.5 | 14.5 | 10 | 12 | 10.5 | 12 | 9 | 12 | 9 | 12 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Second Open Label DCS | 11 | 14 | 11 | 14 | 10.5 | 13.5 | 9 | 13 | 9.5 | 12 | 10.5 | 13 | 11 | 12 | 10 | 12 | 10.5 | 12 | 10.5 | 12 | 10.5 | 12 | 9.5 | 12 | 10 | 12 |
Positive and Negative Symptom Scale (PANSS) measures positive and negative symptoms of schizophrenia. The sum of ratings for seven positive symptoms is measured on a scale from 7-49 with 7 meaning no symptoms and 49 meaning severe symptoms.The sum of ratings for seven negative symptoms is measured on a scale from 7-49 with 7 meaning no symptoms and 49 meaning severe symptoms. (NCT02304432)
Timeframe: Baseline, 2, 4, & 6 weeks (crossover periods)
| Intervention | units on a scale (Number) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline positive for first intervention | Baseline negative symptoms for first intervention | 2 weeks positive for first intervention | 2 weeks negative for first intervention | 4 weeks positive for first intervention | 4 weeks negative for first intervention | 6 weeks positive for first intervention | 6 weeks negative for first intervention | Baseline positive for second intervention | Baseline negative for second intervention | 2 weeks positive for second intervention | 2 weeks negative for second intervention | 4 weeks positive for second intervention | 4 weeks negative for second intervention | 6 weeks positive for second intervention | 6 weeks negative for second intervention | |
| DCS First, Then Placebo | 10 | 15 | 10 | 15 | 10 | 15 | 10 | 15 | 15 | 18 | 15 | 18 | 15 | 18 | 14 | 18 |
| Placebo First, Then DCS | 11 | 9 | 12 | 15 | 11 | 13 | 13 | 13 | 13 | 13 | 10 | 11 | 9 | 11 | 9 | 11 |
The MATRICS Consensus Cognitive Battery (MCCB) measures functioning across various cognitive domains and is comprised of ten tests that assess seven cognitive domains (speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning and problem solving, and social cognition) Its measurements are based on timed paper-and-pencil, computerized, and orally-administered tests, as well as spatial tests using geometric cubes. MCCB composite T scores are between 40 and 60 (normal range) and < 40 (below normal range). (NCT00505765)
Timeframe: Baseline, 12 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | 3.9 |
| AL-108, 5 mg/Day | 4.6 |
| Placebo | 3.2 |
The MATRICS Consensus Cognitive Battery (MCCB) measures functioning across various cognitive domains and is comprised of ten tests that assess seven cognitive domains (speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning and problem solving, and social cognition) Its measurements are based on timed paper-and-pencil, computerized, and orally-administered tests, as well as spatial tests using geometric cubes. MCCB composite T scores are between 40 and 60 (normal range) and < 40 (below normal range). (NCT00505765)
Timeframe: Baseline, week 6
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | 1.3 |
| AL-108, 5 mg/Day | 2.3 |
| Placebo | -0.2 |
Schizophrenia Cognition Rating Scale (SCoRS) assessed functional capacity by completing a 20-question rating scale via interviews with the subject and an informant, focusing on cognitive impairment and its impact on daily functioning. After the interview, the interviewer rated subject's overall difficulty on a Global Scale of 1-10. Higher scores indicate greater cognitive impairment. (NCT00505765)
Timeframe: Baseline, 12 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | -0.4 |
| AL-108, 5 mg/Day | -1.2 |
| Placebo | -0.3 |
Schizophrenia Cognition Rating Scale (SCoRS) assessed functional capacity by completing a 20-question rating scale via interviews with the subject and an informant, focusing on cognitive impairment and its impact on daily functioning. After the interview, the interviewer rated subject's overall difficulty on a Global Scale of 1-10. Higher scores indicate greater cognitive impairment. (NCT00505765)
Timeframe: Baseline, 6 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | 0.1 |
| AL-108, 5 mg/Day | -0.6 |
| Placebo | -0.1 |
UPSA includes 5 skill areas (subscales) with scores that each range from 0-20. The UPSA yields an overall total score which is the sum of the five subscales and ranges from 0-100. Higher scores are associated with more independent living. (NCT00505765)
Timeframe: Baseline, 12 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | 4.9 |
| AL-108, 5 mg/Day | 8.9 |
| Placebo | 0.3 |
UPSA includes 5 skill areas (subscales) with scores that each range from 0-20. The UPSA yields an overall total score which is the sum of the five subscales and ranges from 0-100. Higher scores are associated with more independent living. (NCT00505765)
Timeframe: Baseline, week 6
| Intervention | units on a scale (Mean) |
|---|---|
| AL-108, 30 mg/Day | 2.9 |
| AL-108, 5 mg/Day | 7.2 |
| Placebo | -0.9 |
The primary outcome measure is the composite score on the Matrics Consensus Cognitive Battery (MCCB). The MCCB composite score is a standardized mean of the seven domain scores. T-scores are standardized to normative data, and have an estimated mean of 50 and SD of 10 in the general healthy population. Data reduction for analysis of neurocognitive testing used the following steps: i) individual neurocognitive test scores at baseline and follow-up were converted to t-scores; ii) t-scores within the pre-specified cognitive domains measured by more than one test were averaged to obtain a domain-specific t-score; and iii) domain-specific t-scores were averaged to create the MCCB composite score. (NCT00505076)
Timeframe: 4 weeks
| Intervention | composite score (Mean) |
|---|---|
| MK-077 8 mg BID | 27.9 |
| MK-0777 3 mg BID | 31.3 |
| Placebo BID | 32.5 |
The Schizophrenia Cognition Rating Scale (SCoRS) assessed functional capacity. The SCoRS Interviewer Global Rating of function has a range 1 to 10. Higher ratings indicate greater impairment. (NCT00505076)
Timeframe: 4 Weeks (Baseline to End of Treatment)
| Intervention | SCoRS Score (Mean) | |
|---|---|---|
| Baseline | End of Treatment | |
| MK-077 8 mg BID | 4.1 | 4.0 |
| MK-0777 3 mg BID | 4.8 | 4.6 |
| Placebo BID | 3.8 | 3.6 |
The UCSD Performance-Based Skills Assessment assessed functional capacity. The UPSA Summary Score has a range from 0 to 120. A higher score indicates less impairment. (NCT00505076)
Timeframe: Baseline and end of treatment, a total of four weeks.
| Intervention | UPSA Summary Score (Mean) | |
|---|---|---|
| Baseline | End of Treatment | |
| MK-077 8 mg BID | 91.7 | 90.4 |
| MK-0777 3 mg BID | 85.0 | 86.3 |
| Placebo BID | 95.0 | 96.5 |
"Cognitive Assessment Interview was used to obtain information about cognitive functioning from both subject and an informant. Composite CAI scores were reported. Scale ranges from 1-7 with the following anchors:~Normal, no cognitive impairment~Borderline impairment~Mildly impaired~Moderately impaired~Markedly impaired~Severely impaired~Among the most extremely impaired" (NCT01173874)
Timeframe: 4-6 month period
| Intervention | units on a scale (Mean) |
|---|---|
| Cognitive Remediation | 2.74 |
| Cognitive Activity Control Group | 2.79 |
The UPSA-B assesses functional capacity to perform tasks similar to those in daily life. Raw scores are converted into scaled scores ranging from 0-100, with higher scores indicating better functional capacity. (NCT01173874)
Timeframe: 4-6 month period
| Intervention | units on a scale (Mean) |
|---|---|
| Cognitive Remediation | 79.74 |
| Cognitive Activity Control Group | 75.85 |
"The MATRICS Consensus Cognitive Battery (MCCB) will be used to assess cognitive function. The MCCB composite score is comprised of sub-scale measures of: a) working memory; b) attention and vigilance; c) verbal learning; d) visual learning; e) speed of processing; f) reason and problem solving; and g) social cognition. The MCCB takes 90 minutes or less to complete.~MCCB assessed 4 times: prestabilization (screening), randomization (after 6-8 weeks of lurasidone stabilization, prior to initial cognitive remediation), midpoint (after 20 cognitive remediation session), and study completion (final visit after 30 cognitive remediation sessions).~MCCB composite scores are reported as t-scores where a t-score = 50 is the population average. Every 10 points is one standard deviation. There is no range as scores are as far from population average." (NCT01173874)
Timeframe: 4-6 month period
| Intervention | units on a scale (Mean) |
|---|---|
| Cognitive Remediation | 35.39 |
| Cognitive Activity Control Group | 30.73 |
"Total PANSS score with 30 items. Each item is rated 1-7 so the minimum Total PANSS score =30 and the maximum is 210. Anchors for each item are as follows, the higher values represent an increase in severity of symptoms:~Absent~Minimal~Mild~Moderate~Moderately severe~Severe~Extremely severe" (NCT01173874)
Timeframe: 4-6 month period
| Intervention | units on a scale (Mean) |
|---|---|
| Cognitive Remediation | 58.79 |
| Cognitive Activity Control Group | 61.1 |
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
97 reviews available for chlorpromazine and Schizophrenia
| Article | Year |
|---|---|
Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Methylene Blue; Neoplasms; Phenothiazines; Reserpine; | 2022 |
Chlorpromazine versus metiapine for schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Humans; Parkinson Disease, Secondar | 2017 |
Chlorpromazine versus clotiapine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Intentio | 2017 |
Chlorpromazine dose for people with schizophrenia.
Topics: Antipsychotic Agents; Barbiturates; Chloral Hydrate; Chlorpromazine; Drug Administration Schedule; H | 2017 |
Wendan decoction (Traditional Chinese medicine) for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Drugs, Chinese Herbal; Dyskinesia, | 2017 |
Chlorpromazine versus penfluridol for schizophrenia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Humans; Length of Stay; Penflu | 2017 |
Classics in Chemical Neuroscience: Chlorpromazine.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Dopamine Antagonists; Humans; Schizophrenia; Structur | 2019 |
Review: Chlorpromazine Versus Penfluridol for Schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Humans; Penfluridol; Schizophrenia | 2018 |
Chlorpromazine versus piperacetazine for schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Phenothiazines; Randomized Contro | 2018 |
Chlorpromazine versus placebo for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Placebo Effect; Randomized Controlled Trials as Topic; | 2014 |
Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Schizophrenia; Treatment Outcome | 2014 |
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Flupenthixol; Humans; Randomized Cont | 2014 |
Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Humans; Outcome Assessment, Health Care; Sch | 2015 |
Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain; Chlorpromazine; Clozapine; Disease Models, Anima | 2016 |
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Humans; Olanzapine; Quetiapine Fumarat | 2016 |
Chlorpromazine vs Reserpine for Schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Reserpine; Schizophrenia | 2016 |
Chlorpromazine versus reserpine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Randomized Controlled Trials as Topic; Reserpine; Schi | 2016 |
Improving Current Treatments for Schizophrenia.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Cognitive Dysfunction; Dopamine Antagonist | 2016 |
Working memory in schizophrenia: a meta-analysis.
Topics: Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Humans; Memory; Memory Disorders; Psychol | 2009 |
Chlorpromazine dose for people with schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Humans; Randomized Controlle | 2009 |
Chlorpromazine dose for people with schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Randomized Controlled Trials as Topic; Schizophrenia | 2009 |
Processing speed deficits in schizophrenia: reexamining the evidence.
Topics: Antipsychotic Agents; Chi-Square Distribution; Chlorpromazine; Cognition; Humans; Intelligence Tests | 2010 |
Past and present progress in the pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Controlled Clinical Trials as Topic; Diabetes Melli | 2010 |
Levomepromazine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Methotrimeprazine; Randomized Controlled Trials as Top | 2010 |
Antipsychotic medication for early episode schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Fluphenazine; Humans; Patient Dropouts; Randomized Controlled | 2011 |
Antipsychotic medication for early-episode schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Early Medical Intervention; Fluphenazine; Humans; Schizophreni | 2012 |
A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Resistance; | 2012 |
Chlorpromazine versus placebo for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Placebo Effect; Randomized Controlled Trials as Topic; | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Respon | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Respon | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Respon | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Respon | 2003 |
[Late schizophrenia].
Topics: Adult; Age of Onset; Aged; Antipsychotic Agents; Chlorpromazine; Clozapine; Diagnostic and Statistic | 2003 |
A GP guide to schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Prognosis; Psychotherapy; Schizophrenia | 2003 |
RUSSIAN THEORY AND RESEARCH ON SCHIZOPHRENIA.
Topics: Amobarbital; Bromides; Caffeine; Cerebral Cortex; Chlorpromazine; Conditioning, Psychological; Convu | 1963 |
EFFECTS OF PSYCHOTROPIC DRUGS ON LONG-TERM ADJUSTMENT. A REVIEW.
Topics: Chlorpromazine; Electroconvulsive Therapy; Hospitals, Psychiatric; Imipramine; Mental Disorders; Phe | 1964 |
ASYPHYXIA RELATIVELY INHERENT TO TRANQUILIZATION. REVIEW OF THE LITERATURE AND REPORT OF SEVEN CASES.
Topics: Asphyxia; Barbiturates; Central Nervous System; Chlorpromazine; Esophagogastric Junction; Hypnotics | 1965 |
From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Diabetes Mellitus; Humans; Hyperlipidemias; Long QT | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; | 2004 |
Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Pl | 2005 |
Schizophrenia.
Topics: Antipsychotic Agents; Brain; Carrier Proteins; Chlorpromazine; Clozapine; Dopamine; Dopamine Antagon | 2005 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzot | 2005 |
Cessation of medication for people with schizophrenia already stable on chlorpromazine.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Randomized Controlled Trials as Topic; Schizophrenia; | 2007 |
Chlorpromazine versus placebo for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Placebo Effect; Randomized Controlled Trials as Topic; | 2007 |
An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Chlorproma | 2007 |
Cessation of medication for people with schizophrenia already stable on chlorpromazine.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Randomized Controlled Trials as Topic; Recurrence; Sch | 2008 |
Haloperidol versus chlorpromazine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Haloperidol; Humans; Randomized Controlled Trials as Topic; Sc | 2008 |
The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations.
Topics: Animals; Antipsychotic Agents; Blood-Brain Barrier; Cerebral Cortex; Chlorpromazine; Dopamine; Drug | 1980 |
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Topics: 4-Aminobutyrate Transaminase; Afferent Pathways; Aminocaproates; Animals; Basal Ganglia; Behavior, A | 1981 |
Neuroleptic-refractory patients and their drug plasma levels.
Topics: Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Drug Resistance; Humans; Kinetics | 1982 |
Prolactin levels and effects of neuroleptics.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Drug Tolerance; Dyskinesia, Drug-Indu | 1983 |
The nosology of schizoaffective psychosis.
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Diagnosis, Differential; Diseases in Twins; | 1983 |
Drug treatment of schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Chemical Phenomena; Ch | 1984 |
The direct effects of compliance on health outcome.
Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T | 1984 |
The duration of the movement aftereffect as an index of psychiatric illness.
Topics: Adult; Antiparkinson Agents; Attention; Chlorpromazine; Dopamine; Eye Movements; Female; Fixation, O | 1994 |
Psychomotor impairment and cognitive disturbances induced by neuroleptics.
Topics: Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Eye Movements; Humans; Neurolo | 1994 |
A review of the effects of nicotine on schizophrenia and antipsychotic medications.
Topics: Antipsychotic Agents; Auditory Perception; Chlorpromazine; Chronic Disease; Clozapine; Databases as | 1999 |
Chlorpromazine versus placebo for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Schizophrenia | 2000 |
Schizophrenia: an illness of distorted reality.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Delusions; Dopamine Antagonists; Female; GABA Antag | 2000 |
Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Cost-Benefit Analysis; Decision Support Techniques; | 2001 |
Psychopharmacological treatment of schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Chronic D | 1975 |
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Humans; Hyperkinesis; Movement Disorde | 1976 |
Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Drug Evaluation; Fluphenazine; Humans; Perphe | 1976 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Chlorpromazine; Dibenzoxazepines; Drug Interacti | 1978 |
[Long-term medication in schizophrenia (author's transl)].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Depression; Double-Blind Method; Drug | 1978 |
Evidence for neuroendocrine abnormalities in the major mental illnesses.
Topics: Adrenocorticotropic Hormone; Aged; Amphetamine; Bipolar Disorder; Chlorpromazine; Circadian Rhythm; | 1975 |
Maintenance therapy and schizophrenia.
Topics: Acute Disease; Adult; Ambulatory Care; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinic | 1975 |
Psychophysiology and schizophrenia.
Topics: Attention; Biological Availability; Brain; Chlorpromazine; Functional Laterality; Hand; Humans; Musc | 1977 |
Efficacy of ECT in affective and schizophrenic illness.
Topics: Amitriptyline; Chlorpromazine; Depression; Electroconvulsive Therapy; Evaluation Studies as Topic; H | 1977 |
Biological psychiatry: on the relationship of schizophrenia and dopaminergic hyperactivity.
Topics: Amphetamine; Animals; Chlorpromazine; Corpus Striatum; Dopamine; Environment; Hallucinogens; Haloper | 1975 |
Neuroleptic plasma levels.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Pe | 1991 |
Antipsychotic medication: clinical guidelines for maintenance therapy.
Topics: Administration, Oral; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Dise | 1985 |
The strategy and value of neuroleptic drug monitoring.
Topics: Antipsychotic Agents; Chlorpromazine; Chromatography, Gas; Chromatography, Liquid; Fluphenazine; For | 1985 |
Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.
Topics: Amoxapine; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Asian People; Chlorpromazine; Deb | 1986 |
Psychotropic drugs and the thyroid axis: a review of interactions.
Topics: Animals; Body Temperature; Brain; Chlorpromazine; Depressive Disorder; Desipramine; Drug Interaction | 1985 |
The importance of dosage in antipsychotic drug administration--a review of dose-response studies.
Topics: Adult; Age Factors; Behavior; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, | 1973 |
Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinical Trials a | 1974 |
Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Butyrophenones; Chemical Phenomena; Chemistry; Chlorpromazine; Dibenz | 1974 |
Implications of catecholamine systems of the brain in schizophrenia.
Topics: Amphetamine; Brain; Catecholamines; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Histamine H1 A | 1974 |
Defining schizophrenia with the techniques of molecular biology.
Topics: Animals; Binding Sites; Biology; Brain; Brain Chemistry; Centrifugation; Chlorpromazine; Chromatogra | 1968 |
Combined pharmacotherapy and psychotherapy.
Topics: Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Humans; Imipramine; Meprobamate; Methods | 1969 |
Lithium salts in the management of the manic-depressive syndrome.
Topics: Acute Disease; Bipolar Disorder; Catecholamines; Chlorpromazine; Depression; Diabetes Insipidus; Glu | 1972 |
Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.
Topics: Affective Symptoms; Behavior; Bipolar Disorder; Chlorpromazine; Drug Hypersensitivity; Drug-Related | 1972 |
[The cardiovascular effects of neuroleptics based on current knowledge].
Topics: Adolescent; Adult; Aged; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Ca | 1973 |
[The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Alcoholism; Catatonia; Chlorpromazine; Chronic Diseas | 1973 |
The use and abuse of the psychotropic drugs.
Topics: Adult; Amphetamine; Antidepressive Agents; Anxiety; Chlorpromazine; Depression; Drug Utilization; Fe | 1973 |
N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Topics: Animals; Avoidance Learning; Brain; Carbon Radioisotopes; Chlorpromazine; Chromatography, Gas; Condi | 1974 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
Results and trends of conditioning studies in schizophrenia.
Topics: Chlorpromazine; Conditioning, Classical; Haloperidol; Higher Nervous Activity; Humans; Insulin; Reac | 1968 |
Cytogenetic aspects of psychopathology.
Topics: Aggression; Animals; Body Height; Chlorpromazine; Chromosome Aberrations; Cytogenetics; Epilepsy; Hu | 1969 |
Schizophrenia and interference. An analogy with a malfunctioning computer.
Topics: Arousal; Chlorpromazine; Computers; Drive; Ego; Electroencephalography; Humans; Memory; Memory, Shor | 1970 |
[Differential indication for the use of neuroleptics].
Topics: Acetaminophen; Chlorpromazine; Drug Synergism; Fluphenazine; Hallucinations; Humans; Imipramine; Met | 1970 |
Clinical and heuristic value of clinical drug research.
Topics: Affective Symptoms; Amitriptyline; Amphetamine; Butyrophenones; Child Behavior Disorders; Chlorproma | 1970 |
[Tryptophan and its metabolism in schizophrenia].
Topics: Chlorpromazine; Drug Synergism; Haloperidol; Humans; Monoamine Oxidase Inhibitors; Neurologic Manife | 1970 |
The assay of chlorpromazine and metabolites in blood, urine, and other tissues.
Topics: Brain; Chemical Phenomena; Chemistry; Chlorpromazine; Chromatography; Chromatography, Thin Layer; Fe | 1971 |
Drug treatment in schizophrenia.
Topics: Butyrophenones; Chlorpromazine; Evaluation Studies as Topic; Humans; Phenothiazines; Phenylalanine; | 1971 |
On certain psychopharmacological and physiological differences between schizophrenic and normal persons.
Topics: Attention; Chlorpromazine; Humans; Reticular Formation; Schizophrenia; Secobarbital | 1966 |
345 trials available for chlorpromazine and Schizophrenia
| Article | Year |
|---|---|
A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophren
Topics: Acute Disease; Adult; Aggression; Antipsychotic Agents; Anxiety; Chlorpromazine; Delayed-Action Prep | 2018 |
Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Antisocial Personality Disorder; Chlorpromazine; | 2013 |
Predictors for improvement of problem-solving during cognitive remediation for patients with Schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Therapy; Fema | 2014 |
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clinical Protocols; Dose-Response Relationship, Drug; F | 2014 |
Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Follow-Up Studies; Germany; Humans; Male; Medic | 2016 |
The QTc interval and its dispersion in patients receiving two atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Electrocardiography; Female; | 2009 |
Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Drug Administration Schedule; Female; Halope | 2009 |
Cognitive training for divergent thinking in schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Therapy; Fema | 2009 |
Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.
Topics: Adolescent; Adult; Antipsychotic Agents; China; Chlorpromazine; Clozapine; Disease Progression; Doub | 2011 |
Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Chlorpromazine; Chronic Disease; | 2003 |
Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Fo | 2003 |
A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2004 |
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Topics: Adult; Antimetabolites; Antipsychotic Agents; Chlorpromazine; Cycloserine; Female; Glycine; Humans; | 2004 |
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Topics: Adult; Antimetabolites; Antipsychotic Agents; Chlorpromazine; Cycloserine; Female; Glycine; Humans; | 2004 |
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Topics: Adult; Antimetabolites; Antipsychotic Agents; Chlorpromazine; Cycloserine; Female; Glycine; Humans; | 2004 |
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Topics: Adult; Antimetabolites; Antipsychotic Agents; Chlorpromazine; Cycloserine; Female; Glycine; Humans; | 2004 |
High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study.
Topics: Adult; Age Factors; Antipsychotic Agents; Asia, Eastern; Catchment Area, Health; Chlorpromazine; Cro | 2004 |
Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Female; Humans; Male; | 2004 |
Clotiapine compared with chlorpromazine in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Cross-Over Studies; Dibenzothiazepines | 2005 |
Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Double-Blind Method; Dr | 2006 |
Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Double-Blind Method; Drug Resistance; Female; Humans; M | 2006 |
Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial.
Topics: Adolescent; Adult; Aged; Alkaloids; Antipsychotic Agents; Chlorpromazine; Cholinesterase Inhibitors; | 2007 |
Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa.
Topics: Adolescent; Adult; Africa, Northern; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Dyskines | 2007 |
Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Rela | 1974 |
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Diagnostic and Statisti | 2007 |
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Cross-Over Studies; Doubl | 2007 |
Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Cognitive Behavioral Th | 2009 |
Prediction of improvement in schizophrenia under four phenothiazines.
Topics: Chlorpromazine; Fluphenazine; Humans; Phenothiazines; Prognosis; Psychopharmacology; Schizophrenia; | 1967 |
Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.
Topics: Adult; Chlorpromazine; Drug Interactions; Female; Humans; Kinetics; Male; Middle Aged; Propranolol; | 1980 |
What is the best maintenance dose of neuroleptics in schizophrenia?
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relations | 1980 |
Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Chlorpromazine; Clinical Trials as Topic; Dose-Respo | 1981 |
Prophylactic effect of neuroleptics in symptom-free schizophrenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diazepam; Female; Haloperidol; Humans; Imipramine; Male | 1982 |
Antipsychotic efficacy of fluotracen: a clinical trial.
Topics: Adolescent; Adult; Anthracenes; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Huma | 1983 |
Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Homovanill | 1984 |
Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Ther | 1983 |
Antidepressants for depressed schizophrenic patients.
Topics: Antidepressive Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, | 1983 |
Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine.
Topics: Adolescent; Adult; Benzodiazepines; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; D | 1984 |
The direct effects of compliance on health outcome.
Topics: Alcoholism; Chlorpromazine; Chorionic Gonadotropin; Clofibrate; Coronary Disease; Disulfiram; Drug T | 1984 |
Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Chlorpromazine; Depression; Female; Humans; Male; Schizop | 1984 |
Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.
Topics: Adult; Behavior Therapy; Chlorpromazine; Combined Modality Therapy; Humans; Male; Patient Compliance | 1984 |
Pimozide in the treatment of newly admitted schizophrenic patients.
Topics: Acute Disease; Adult; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; | 1982 |
Effect of chlorpromazine on H-reflex recovery curves in normal subjects and schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Electric Stimulation; Female; H-Reflex; Humans; Male; Muscles; Re | 1982 |
Viloxazine and the depressed schizophrenic--methodological issues.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Therapy, Comb | 1981 |
DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Proprano | 1981 |
Phenothiazine withdrawal in schizophrenics in a hostel.
Topics: Chlorpromazine; Clinical Trials as Topic; Halfway Houses; Humans; Random Allocation; Recurrence; Sch | 1981 |
Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
Topics: Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; | 1981 |
Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Mi | 1981 |
Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Human | 1982 |
Comparison of pimozide and chlorpromazine in acute schizophrenia.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Dru | 1982 |
Human platelet function as a model for investigating the clinical efficacy of chlorpromazine.
Topics: Adult; Age Factors; Chlorpromazine; Female; Humans; Male; Platelet Aggregation; Prognosis; Schizophr | 1981 |
Effect of antiparkinsonian medication on plasma levels of chlorpromazine.
Topics: Chlorpromazine; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mal | 1980 |
Lateralized deficits and drug influences on the dichotic listening of schizophrenic patients.
Topics: Attention; Chlorpromazine; Dominance, Cerebral; Galvanic Skin Response; Humans; Mental Recall; Schiz | 1980 |
The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine.
Topics: Adult; Attention; Chlorpromazine; Chronic Disease; Dominance, Cerebral; Double-Blind Method; Humans; | 1993 |
Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study.
Topics: Adult; Attention; Chlorpromazine; Chronic Disease; Dominance, Cerebral; Dose-Response Relationship, | 1993 |
Molindone and weight loss.
Topics: Acute Disease; Basal Ganglia Diseases; Chlorpromazine; Double-Blind Method; Female; Humans; Male; Mo | 1993 |
Facial affect recognition in the course of schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Emotions; Facia | 1996 |
Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Energy Metabolism; Glucose; Humans; Hydrocortisone; Hypothalam | 1996 |
Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Double-Blind Method; Female; Humans | 1996 |
Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data.
Topics: Adolescent; Adult; Antipsychotic Agents; California; Chlorpromazine; Drug Administration Schedule; F | 1997 |
Neuroleptic drug utilisation for acute schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Racial Groups; Schizophre | 1996 |
A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Double-Blind Method; Drug Resistance; Female | 1997 |
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dibenzothiazepines; Double-Blin | 1997 |
Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Drug Administration S | 1997 |
A study of enhanced management in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Resistance; Female; Humans; Male; Psychiatric Stat | 1997 |
A survey of antipsychotic treatment for schizophrenia in Hong Kong.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Drug Adm | 1997 |
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; | 1998 |
Karaoke therapy in the rehabilitation of mental patients.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Anxiety; Case-Control Studies; China; Chlorpromazin | 1998 |
[Clinical study of shuizhi-dahuang mixture in treating schizophrenics with blood stasis syndrome].
Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Chlorpromazine; Drug Combinations; Drug Therapy, C | 1996 |
The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
Topics: Age Factors; Aged; Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clozapine; Double-Blind Me | 1999 |
The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Biotransformation; Blood Pressure; Chlorpromazine; Female; | 1999 |
A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Chronic Disease; Female; Humans; Magne | 1999 |
Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Chlorpromazine; Chronic Disease; Depression; Female; Humans; | 1999 |
Placebo revisited.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiepins; Double-Blind Method; Ethic | 2000 |
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiepins; Dose-Respon | 2000 |
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Hostility; Humans; Male; Midd | 1997 |
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; DNA; Dyskinesia, Drug-Induced; Female | 2001 |
Maintenance antipsychotic therapy: is the cure worse than the disease?
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1976 |
A double-blind evaluation of metiapine in hospitalized acute schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Atropine; Barbiturates; Blood Pressure; Body Weight; Chlorpromazin | 1975 |
Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Tolerance; Female; Humans; Male; Middle Aged; Park | 1976 |
Work performance versus clinical assessment in the evaluation of phenothiazine therapy.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Fluphenazine | 1976 |
Controlled comparison of therapeutic effects of oxyprothepin and chlorpromazine in schizophrenic patients [proceedings].
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzothiepins; Female; Humans; Male; Middle Aged; | 1976 |
Efficacy of loxapine in the treatment of paranoid schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; D | 1977 |
A standard-controlled clinical study with propericiazine in schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; F | 1977 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Propranolol as an adjunct to the treatment of schizophrenia.
Topics: Adult; Blood Pressure; Chlorpromazine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up | 1977 |
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Drug Th | 1978 |
Token economy, pimozide and chronic schizophrenia.
Topics: Behavior Therapy; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Ho | 1978 |
Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients.
Topics: Aftercare; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Longitudinal | 1977 |
Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal.
Topics: Adult; Aftercare; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; D | 1978 |
Day treatment and psychotropic drugs in the aftercare of schizophrenic patients. A Veterans Administration cooperative study.
Topics: Adult; Aftercare; Attitude; Chlorpromazine; Chronic Disease; Cost-Benefit Analysis; Day Care, Medica | 1979 |
Tardive dyskinesia treated with pimozide.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousnes | 1975 |
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
A comparison of phenothiazines in managing aggressive episodes in schizophrenic patients.
Topics: Adult; Aggression; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Humans; M | 1975 |
Comprehesiven clinical studies with thiothixene.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Drug Evaluation; Fe | 1975 |
Maintenance therapy and schizophrenia.
Topics: Acute Disease; Adult; Ambulatory Care; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinic | 1975 |
Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Co | 1977 |
A standard-controlled clinical study with trazodone in schizophrenic patients.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Human | 1977 |
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Evaluati | 1977 |
High dosage haloperidol in chronic schizophrenia.
Topics: Adult; Alkaline Phosphatase; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind | 1977 |
Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
Topics: Administration, Oral; Cerebrospinal Fluid Proteins; Chlorpromazine; Clinical Trials as Topic; Estrad | 1977 |
Negative findings with megavitamins in schizophrenic patients: preliminary report.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Ortho | 1977 |
Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female | 1977 |
Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Fem | 1978 |
A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Haloperidol; Huma | 1978 |
Initial response to drugs in depressive illness and psychiatric and community adjustment a year later.
Topics: Adjustment Disorders; Adult; Affective Disorders, Psychotic; Chlorpromazine; Clinical Trials as Topi | 1978 |
Laterality, attention and rate effects in the auditory temporal discrimination of chronic schizophrenics: the effect of treatment with chlorpromazine.
Topics: Adult; Attention; Auditory Perception; Chlorpromazine; Clinical Trials as Topic; Discrimination, Psy | 1978 |
Gradual reduction of neuroleptic drugs among chronic schizophrenics. A double-blind controlled study.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Administration | 1978 |
The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male; Pla | 1978 |
A controlled study of tryptophan-benserazide in schizophrenia.
Topics: Adult; Aged; Benserazide; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1978 |
Are there schizophrenics for whom drugs may be unnecessary or contraindicated?
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Hospitalization; Humans; Male; Patient | 1978 |
Chlorpromazine kinetics and clinical response [proceedings].
Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Kinetics; Male; Schizophrenia | 1978 |
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research.
Topics: Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Diagnosis, Differential; Double-Blind Me | 1978 |
Efficacy of clozapine.
Topics: Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Method; Humans; Sc | 1978 |
Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients.
Topics: Amitriptyline; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Humans; Lithium; Schiz | 1978 |
The neuroleptic hypothesis: study of the covariation of extrapyramidal and therapeutic drug effects.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Female; Humans; | 1978 |
Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
Topics: Adult; Biopharmaceutics; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1978 |
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinat | 1978 |
Penfluridol: a long acting oral antipsychotic drug.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Meth | 1979 |
Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Chlorpromazine; Chronic Disease; Clinical Trials | 1979 |
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
Topics: Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Metho | 1979 |
Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Bl | 1979 |
A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Hu | 1979 |
Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial.
Topics: Adult; Ambulatory Care; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double- | 1979 |
Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; Middl | 1979 |
Evidence of brain dopamine deficiency in schizophrenia.
Topics: Benserazide; Brain; Chlorpromazine; Dopamine; Double-Blind Method; Drug Therapy, Combination; Humans | 1979 |
Recent developments in the drug treatment of schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Drug Re | 1976 |
Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Topics: Adult; Anxiety; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans; Longitudinal | 1976 |
Comparison of scoring methods for tests of attention, including an error index for use with schizophrenic patients.
Topics: Attention; Chlorpromazine; Clinical Trials as Topic; Humans; Longitudinal Studies; Male; Placebos; P | 1976 |
A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients.
Topics: Administration, Oral; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Dose-Response Relat | 1976 |
Auditory attention in process and reactive schizophrenia.
Topics: Adult; Attention; Auditory Perception; Chlorpromazine; Clinical Trials as Topic; Female; Functional | 1976 |
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.
Topics: Adenosine Diphosphate; Chlorpromazine; Clinical Trials as Topic; Drug Interactions; Female; Humans; | 1975 |
A double-blind trial of baclofen against placebo in the treatment of schizophrenia.
Topics: Adult; Aminobutyrates; Anxiety; Baclofen; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; | 1976 |
Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
Topics: Adult; Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; D | 1976 |
Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepine | 1976 |
Clinical trial of pimozide.
Topics: Adolescent; Adult; Behavior; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Middle | 1976 |
Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Female; Humans; Lo | 1975 |
Lenperone: a controlled evaluation in chronic schizophrenic patients.
Topics: Adult; Butyrophenones; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Female; Humans; Ma | 1975 |
Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy.
Topics: Ambulatory Care; Chlorpromazine; Family Characteristics; Female; Humans; Male; Patient Compliance; P | 1977 |
Platelet monoamine oxidase activity in schizophrenic patients.
Topics: Ambulatory Care; Blood Platelets; Chlorpromazine; Hallucinations; Hospitalization; Humans; Imipramin | 1977 |
A controlled study of a dopa decarboxylase inhibitor (benserazide) in the treatment of schizophrenic patients.
Topics: Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Chlorpromazine; Female; Humans; Hy | 1977 |
Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
Topics: Adult; Aged; Chlorpromazine; Ethylene Glycols; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1977 |
[Comparison of therapeutic effect of clozapin and chlorpromazin (author's transl)].
Topics: Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Drug Evaluation; Drug Tolerance | 1975 |
A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Flupenthixol; Fluphenazine | 1975 |
Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
Topics: Adult; Aged; Amobarbital; Analysis of Variance; Chemical Phenomena; Chemistry; Chlorpromazine; Clini | 1975 |
Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
Topics: Adult; Affect; Attention; Benztropine; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Dr | 1975 |
Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.
Topics: Acridines; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Electroencephalography; Fema | 1975 |
Chlorpromazine-induced electrocardiogram abnormalities.
Topics: Adult; Age Factors; Chlorpromazine; Clinical Trials as Topic; Electrocardiography; Female; Heart; Hu | 1975 |
[Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].
Topics: Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Female; Humans; Ma | 1975 |
The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Hospita | 1975 |
Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.
Topics: Adult; Age Factors; Ambulatory Care; Amitriptyline; Chlorpromazine; Clinical Trials as Topic; Drug I | 1975 |
Metiapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzothiazepines; Female; Humans; | 1975 |
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
Topics: Adult; Affect; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Clinical Trials as Topi | 1975 |
A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
Topics: Adult; Affect; Antiparkinson Agents; Arousal; Chlorpromazine; Clinical Trials as Topic; Dose-Respons | 1975 |
Letter: Megavitamin treatment of schizophrenia.
Topics: Ascorbic Acid; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Schizophrenia; Sex Fa | 1975 |
Prediction of response to chlorpromazine treatment in schizophrenics.
Topics: Administration, Oral; Adult; Biotransformation; Chlorpromazine; Clinical Trials as Topic; Drug Evalu | 1975 |
A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Cyclic S-Oxides; Humans; Psychiatric Stat | 1975 |
Chlorpromazine metabolism and clinical response in acute schizophrenia: a preliminary report.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Humans; Schizophrenia; Time Factors | 1975 |
Proceedings: Clomacran in the treatment of schizophrenic patients--a comparison of two assessment methods.
Topics: Acridines; Adult; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Psychiatric Status | 1976 |
Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1976 |
Drug default among schizophrenic patients.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Humans; Middle Aged; Patient Compliance; Pharmacist | 1975 |
Anticonvulsants in the treatment of aggression.
Topics: Adult; Aggression; Anticonvulsants; Chlordiazepoxide; Chlorpromazine; Drug Therapy, Combination; Epi | 1975 |
Blood platelet monoamine oxidase activity in anergic schizophrenics.
Topics: Alcoholism; Blood Platelets; Chlorpromazine; Humans; Imipramine; Monoamine Oxidase; Schizophrenia; T | 1975 |
Effects of antipsychotic drugs on memory functions of schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Male; Mental Recall; Middl | 1992 |
Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures.
Topics: Adolescent; Adult; Anxiety Disorders; Chlorpromazine; Depressive Disorder; Female; Haloperidol; Huma | 1992 |
Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
Topics: Antipsychotic Agents; Brain Mapping; Chlorpromazine; Dibenzoxazepines; Double-Blind Method; Electroe | 1991 |
Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Topics: Adult; Chlorpromazine; Chronic Disease; Dibenzazepines; Double-Blind Method; Electroencephalography; | 1991 |
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Chlorpromazine; Clonazepam; Dose | 1990 |
Clozapine in China: a review and preview of US/PRC collaboration.
Topics: Adult; China; Chlorpromazine; Clozapine; Dibenzazepines; Double-Blind Method; Female; Homovanillic A | 1989 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
A randomised controlled trial of prophylactic neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Flu | 1986 |
Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Hospitalization; Huma | 1986 |
A comparative trial of pharmacologic strategies in schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; | 1987 |
Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Method; Fem | 1988 |
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Method; Fem | 1988 |
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Method; Fem | 1988 |
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Method; Fem | 1988 |
[A double-blind study on the effect of clozapine penfluridol and chlorpromazine in the treatment of schizophrenia].
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind | 1988 |
[Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind | 1988 |
[A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
Topics: Adolescent; Adult; Chlorpromazine; Double-Blind Method; Female; Humans; Middle Aged; Schizophrenia; | 1988 |
The risks and benefits of clozapine versus chlorpromazine.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; | 1987 |
[Application of NOSIE in the study of neuroleptic treatment].
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind | 1987 |
Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chloroquine; Chlorpromazine; Drug Combinations; Drug | 1988 |
High potency neuroleptics and violence in schizophrenics.
Topics: Adult; Akathisia, Drug-Induced; Chlorpromazine; Clozapine; Haloperidol; Humans; Schizophrenia; Schiz | 1988 |
A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
Topics: Adult; Age Factors; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Double-Blind M | 1986 |
Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
Topics: Adolescent; Adult; Alpha Rhythm; Benztropine; Beta Rhythm; Brain Mapping; Chlorpromazine; Clozapine; | 1987 |
Social skills training for patients with schizophrenia: a controlled clinical trial.
Topics: Adaptation, Psychological; Behavior Therapy; Chlorpromazine; Combined Modality Therapy; Family Thera | 1985 |
Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
Topics: Adolescent; Adult; Autistic Disorder; Behavior; Chlorpromazine; Clinical Trials as Topic; Double-Bli | 1985 |
Double-blind trial of fluphenazine decanoate.
Topics: Administration, Oral; Chlorpromazine; Clinical Trials as Topic; Fluphenazine; Humans; Injections, In | 1972 |
Piperacetazine and chlorpromazine: a comparison.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Ev | 1973 |
The importance of dosage in antipsychotic drug administration--a review of dose-response studies.
Topics: Adult; Age Factors; Behavior; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, | 1973 |
Pilot trials with long-acting pipotiazine injections.
Topics: Adolescent; Adult; Antipsychotic Agents; Catatonia; Chlorpromazine; Clinical Trials as Topic; Drug E | 1973 |
Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Topics: Acute Disease; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Chlorpromazine; Clinical Tr | 1973 |
Specific indications for different classes of phenothiazines.
Topics: Adult; Age Factors; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; | 1974 |
Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clinical Trials a | 1974 |
Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Evaluation Studies as Topic; Female; | 1974 |
Improved patient care.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Humans; Male; Mental Disorders; Plac | 1970 |
Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Benzodiazepines; Chlorpromazine; Chronic Disease; Clinica | 1974 |
A controlled trial of clothiapine and chlorpromazine in acute schizophrenic syndromes.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzothiazepines; Drug Evaluation; Fe | 1974 |
A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
Topics: Adolescent; Adult; Butyrophenones; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Hypoten | 1973 |
Bioequivalency of generic and brand-named chlorpromazine.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Body Weight; Carbon Radioisotopes; Chlorpromazi | 1974 |
A transcultural study with clomacran: comparison of two assessment methods.
Topics: Acridines; Adolescent; Adult; Canada; Chlorpromazine; Clinical Trials as Topic; Cross-Cultural Compa | 1974 |
A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delay | 1974 |
Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Body Weight; Chlorpromazine; Chronic Disease; C | 1974 |
Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
Topics: Adult; Agranulocytosis; Analysis of Variance; Anemia; Behavior; Chlorpromazine; Chronic Disease; Cli | 1970 |
Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Niac | 1972 |
The role of hypothesis testing in clinical trials. Biometrics seminar.
Topics: Biometry; Cardiovascular Diseases; Chlorpromazine; Clinical Trials as Topic; Coronary Disease; Estro | 1966 |
Chlorpromazine and sleep in psychiatric patients.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Depression; Electroencephalography; Electromyography; Elect | 1971 |
Plasma cortisol response to dexamethasone suppression in depressed and control patients.
Topics: Adjustment Disorders; Adult; Amines; Chlorpromazine; Circadian Rhythm; Depression; Depression, Chemi | 1971 |
Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.
Topics: Adolescent; Adult; Aftercare; Chlorpromazine; Counseling; Female; Humans; Male; Middle Aged; Outpati | 1973 |
Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Electroencephalography; Electroocu | 1974 |
Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.
Topics: Adolescent; Aftercare; Analysis of Variance; Chlorpromazine; Counseling; Female; Follow-Up Studies; | 1974 |
Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients.
Topics: Adaptation, Psychological; Adolescent; Adult; Aftercare; Chlorpromazine; Family; Female; Follow-Up S | 1974 |
Clinical studies with propericiazine (R.P. 8909).
Topics: Acute Disease; Adolescent; Adult; Aged; Association; Behavior; Chlorpromazine; Chronic Disease; Clin | 1967 |
Combined pharmacotherapy and psychotherapy.
Topics: Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Humans; Imipramine; Meprobamate; Methods | 1969 |
Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Humans; Phenothiazines; Piperazines; Psychi | 1970 |
[Neuroleptic therapy in schizophrenia].
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Carbon Isotopes; Catecholamines; Chlorpromazine | 1972 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Bilirubin; Blood Cell Count | 1972 |
Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Evaluation Studies as To | 1972 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Electroencephalograp | 1972 |
A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Blood Cell Count; Blood Sedimentation; Blood Urea | 1972 |
Clinical and work performance variables in phenothiazine therapy of schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Evalu | 1973 |
Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.
Topics: Acute Disease; Adolescent; Adult; Aged; Attitude; Chlorpromazine; Clinical Trials as Topic; Evaluati | 1973 |
Intermittent pharmacotherapy in chronic schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Costs and Cost Analysis; Hospitals, Veter | 1973 |
Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
Topics: Administration, Oral; Aged; Behavior; Chlorpromazine; Clinical Trials as Topic; Dementia; Evaluation | 1973 |
[Use of psychological methods for studying the particular psychotropic action of various psychopharmacologic drugs].
Topics: Adult; Amphetamine; Association; Attention; Chlorpromazine; Clinical Trials as Topic; Eye Movements; | 1972 |
Measurement of drug action in schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Humans; Male; Placebos; Psychiatric Status Rating Scales; | 1973 |
A controlled comparison of metiapine and chlorpromazine in chronic schizophrenia.
Topics: Analysis of Variance; Basal Ganglia Diseases; Blood Pressure; Body Weight; Cardiovascular Diseases; | 1973 |
Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; | 1973 |
Influence of selection of patients on results of clinical trials.
Topics: Amitriptyline; Chlorpromazine; Clinical Trials as Topic; Drug Therapy; Fluphenazine; Humans; Imipram | 1973 |
Psychological effects of single-dose antipsychotic medication.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Dose-Response Relationship, Drug; Fem | 1973 |
Critical study of the Organic Integrity Test as a diagnostic and therapeutic index in schizophrenia.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Cognition; Color Perception; Female; Form Perceptio | 1973 |
Evaluation of loxapine succinate in chronic schizophrenia.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Body Weight; Chlorpromazine; Cholesterol; Chron | 1972 |
The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Behavior; Chlorpromazine; Clinical Trials | 1974 |
The use of chlorpromazine in schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Humans; Male; Schizophrenia | 1973 |
[Comparative double blind study between chlozapine and chlorpromazine in schizophrenia].
Topics: Chlorpromazine; Clinical Trials as Topic; Dibenzazepines; Drug Evaluation; Female; Humans; Male; Pip | 1974 |
[Multispectral investigation of psychotropic drugs].
Topics: Azepines; Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Electronic Data | 1974 |
[Performance in attention tests in chronic schizophrenics treated with Mepiprazol (author's transl)].
Topics: Adult; Attention; Chlorobenzenes; Chlorpromazine; Clinical Trials as Topic; Female; Flicker Fusion; | 1973 |
Group therapy and maintenance treatment of schizophrenics.
Topics: Adult; Attitude to Health; Chlorpromazine; Cognition; Female; Humans; Interpersonal Relations; Male; | 1974 |
A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Benztropine; Capsules; Chlorpromazine; Clini | 1974 |
Are antipsychotic drugs interchangeable?
Topics: Attitude; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, | 1974 |
Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Topics: Acute Disease; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Evaluation Studies as Topic; H | 1972 |
A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
Topics: Acute Disease; Administration, Oral; Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials | 1972 |
Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.
Topics: Adolescent; Adult; Bipolar Disorder; Brain Chemistry; Chlorpromazine; Clinical Trials as Topic; Dopa | 1973 |
Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
Topics: Adult; Behavior; Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Female; | 1973 |
Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
Topics: Administration, Oral; Adult; Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Depression, C | 1973 |
Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
Topics: Administration, Oral; Adult; Analysis of Variance; Chlorpromazine; Chromatography, Gas; Chronic Dise | 1973 |
Prediction of psychiatric hospitalization. II. The Hospitalization Proneness Scale: a cross-validation.
Topics: Adolescent; Adult; Chlorpromazine; Hospitalization; Hospitals, Psychiatric; Humans; Placebos; Probab | 1972 |
[Neuroleptics in the treatment of psychoses].
Topics: Chlorpromazine; Humans; Milieu Therapy; Placebos; Psychotherapy; Psychotic Disorders; Schizophrenia; | 1972 |
Research design for analyzing drug-environment-behavior interactions.
Topics: Adult; Behavior Therapy; Chlorpromazine; Environment; Evaluation Studies as Topic; Extinction, Psych | 1973 |
A method of quantifying EEG for psychopharmacological research.
Topics: Alpha Rhythm; Chlorpromazine; Clopenthixol; Electroencephalography; Haloperidol; Humans; Methods; Mo | 1973 |
Short vs long hospitalization. A prospective controlled study. I. The preliminary results of a one-year follow-up schizophrenics.
Topics: Adolescent; Adult; Chlorpromazine; Costs and Cost Analysis; Day Care, Medical; Female; Follow-Up Stu | 1974 |
The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Chlorpromazine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Humans; Male; Ma | 1974 |
A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.
Topics: Adult; Affect; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Delusions; Hallucinations | 1967 |
Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
Topics: Acute Disease; Antidepressive Agents; Chlorpromazine; Clinical Trials as Topic; Haloperidol; Humans; | 1967 |
Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Paranoi | 1967 |
[Clinical studies and quantitative EEG data in experimental psychoses].
Topics: Acridines; Adult; Chlorpromazine; Clinical Trials as Topic; Drug Antagonism; Electroencephalography; | 1966 |
Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
Topics: Chlorpromazine; Clinical Trials as Topic; Fluphenazine; Humans; Paranoid Disorders; Phenothiazines; | 1967 |
Chlorpromazine and the untreated chronic schizophrenic: a long-term trial.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Placebo | 1967 |
Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
Topics: Adult; Age Factors; Cardiovascular System; Chlorpromazine; Chronic Disease; Clinical Trials as Topic | 1968 |
A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Hospitalization; Hospitals, Psychiatric; | 1968 |
EEG voltage as an indicator of drug-induced changes in schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Electroencephalography; Fluphenazine; Humans; Male; Psycho | 1968 |
[Clinical experiences with flupenthixol in psychiatric patients].
Topics: Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Paranoid D | 1967 |
[Clinical experimentation with desipramine with statistical control].
Topics: Adult; Aged; Anorexia Nervosa; Barbiturates; Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Cli | 1968 |
Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.
Topics: Adult; Analysis of Variance; Behavior; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Femal | 1968 |
Incidence and significance of chlorpromazine-induced eye changes.
Topics: Chlorpromazine; Clinical Trials as Topic; Cornea; Eye Diseases; Female; Granuloma; Humans; Lens, Cry | 1968 |
Schizophrenic subtypes defined by response to drugs and placebo.
Topics: Chlorpromazine; Clinical Trials as Topic; Factor Analysis, Statistical; Fluphenazine; Humans; Phenot | 1968 |
Prediction of drug effect by diagnostic decision tree.
Topics: Anxiety; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Factor Analysis, St | 1968 |
The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
Topics: Adult; Chlorpromazine; Cholesterol; Cholinesterases; Chronic Disease; Clinical Trials as Topic; Fema | 1968 |
Drug therapy.
Topics: Amphetamine; Antidepressive Agents; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Hallu | 1967 |
Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Lithium; Male; Mi | 1968 |
[The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus].
Topics: Amitriptyline; Apomorphine; Aporphines; Barbiturates; Chlordiazepoxide; Chlorpromazine; Clinical Tri | 1968 |
Psychiatric diagnosis and a typology of clinical drug effects.
Topics: Affective Symptoms; Analysis of Variance; Anger; Bipolar Disorder; Chlorpromazine; Clinical Trials a | 1968 |
Physician bias and the double-blind.
Topics: Adult; Attitude of Health Personnel; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; | 1969 |
Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Electrocardiography; Extrapyramidal Tract | 1969 |
[Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics].
Topics: Analysis of Variance; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Prep | 1969 |
High dose trifluoperazine therapy in chronic schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; | 1969 |
Integrated EEG. variability: drug effects in acute schizophrenics.
Topics: Adolescent; Adult; Brain; Chlorpromazine; Chlorprothixene; Clinical Trials as Topic; Electroencephal | 1969 |
High doses of trifluperazine and tardive dyskinesia.
Topics: Adult; Age Factors; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Movement Diso | 1970 |
On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines.
Topics: Adolescent; Adult; Aggression; Analysis of Variance; Chlorpromazine; Clinical Trials as Topic; Cogni | 1970 |
Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Aged; Aspartate Aminotransferases; Blood Pressure; Body Weight; Ch | 1970 |
Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
Topics: Adolescent; Adult; Age Factors; Aged; Anxiety; Chlorpromazine; Clinical Trials as Topic; Depression; | 1970 |
Evaluation of trifluperidol in chronic schizaphrenia.
Topics: Adult; Antidepressive Agents; Butyrophenones; Chlorpromazine; Chronic Disease; Clinical Trials as To | 1968 |
The effects of chlorpromazine on some components of psychomotor performance in schizophrenics.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Motor Skills; Placebos; Schiz | 1970 |
Factors associated with poor response to lithium carbonate: a clinical study.
Topics: 17-Hydroxycorticosteroids; Adult; Affective Symptoms; Behavior; Bipolar Disorder; Carbonates; Chlorp | 1970 |
The effects of lithium on electroencephalogram, behavior and serum electrolytes.
Topics: Administration, Oral; Adult; Behavior; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; E | 1970 |
Differential response to lithium carbonate in manic depressive and schizo-affective disorders.
Topics: Affective Symptoms; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Humans; Lithium; Sch | 1970 |
Clinical and heuristic value of clinical drug research.
Topics: Affective Symptoms; Amitriptyline; Amphetamine; Butyrophenones; Child Behavior Disorders; Chlorproma | 1970 |
A comparison of oxypertine and chlorpromazine in chronic schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Electroencephalography; Female; Galvanic | 1970 |
Indications for high dose chlorpromazine therapy in chronic schizophrenia.
Topics: Adult; Age Factors; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Female; Hospitalizati | 1970 |
Motor disorders induced by neuroleptics: a proposed new classification.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dystonia Musculorum Deformans; Factor A | 1971 |
[Comparative study of 2 drugs and a placebo in chronic schizophrenia].
Topics: Chlorpromazine; Clinical Trials as Topic; Extrapyramidal Tracts; Female; Humans; Middle Aged; Phenot | 1969 |
The dyskenesias: a new therapeutic approach.
Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Isocarboxazid; Male; Middle Aged; Monoamin | 1971 |
The hospitalization proneness scale as a predictor of response to phenothiazine treatment. II. Delay of psychiatric hospitalization.
Topics: Adolescent; Adult; Ambulatory Care; Analysis of Variance; Chlorpromazine; Cognition; Hospitalization | 1971 |
Comparative effects of lithium and chlorpromazine in the treatment of acute manic states.
Topics: Adult; Aged; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Enzymes; Female; Humans; Le | 1971 |
Combination medications in psychiatric treatment: patterns in a group of elderly hospital patients.
Topics: Age Factors; Aged; Amitriptyline; Antidepressive Agents; Antihypertensive Agents; Antisocial Persona | 1971 |
Trial of maintenance therapy in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Humans; Middle Aged; Out | 1971 |
Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzothiazepines; Humans; Male; Psychoses, Substa | 1971 |
The effects of chlorpromazine on fine psychomotor performance with a simultaneous secondary task in schizophrenics.
Topics: Aptitude Tests; Chlorpromazine; Clinical Trials as Topic; Humans; Learning; Motor Skills; Placebos; | 1971 |
A controlled study of lithium vs. chlorpromazine in acute schizophrenics.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Constipation; Female; Humans; Leukoc | 1971 |
Drug treatment in newly admitted schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Fluphenazine; Humans; Middle Aged; Plac | 1971 |
Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics.
Topics: Analysis of Variance; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Motor Skill | 1971 |
Psychoactive drugs and the group.
Topics: Aggression; Chlorpromazine; Clinical Trials as Topic; Humans; Mental Disorders; Placebos; Psychother | 1971 |
The EEG effects of chemically and clinically dissimilar antipsychotics--molindone vs. chlorpromazine.
Topics: Adult; Alpha Rhythm; Antidepressive Agents; Chlorpromazine; Clinical Trials as Topic; Electrodes; El | 1971 |
The EEG effects of dibenzoxazepines (loxapine succinate) as compared to CPZ: EEG changes as drug side effects.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzazepines; Drug Evaluation; Electroencephalogr | 1971 |
Competing voice messages. Effects of message load and drugs on the ability of acute schizophrenics to attend.
Topics: Adolescent; Adult; Attention; Chlorpromazine; Female; Humans; Middle Aged; Pentobarbital; Perphenazi | 1967 |
Pinoxepin vs. chlorpromazine: a double-blind comparison.
Topics: Chlorpromazine; Clinical Trials as Topic; Humans; Male; Piperazines; Schizophrenia; Tranquilizing Ag | 1967 |
BL-KR140: a controlled evaluation in chronic schizophrenic patients previously stabilized on chlorpromazine.
Topics: Adult; Antidepressive Agents; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Middle | 1967 |
Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.
Topics: Acridines; Analysis of Variance; Chlorpromazine; Female; Humans; Middle Aged; Schizophrenia; Tranqui | 1968 |
Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Drug Synergism; Female; Haloperidol; Humans; Male; | 1968 |
A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1969 |
Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
Topics: Acute Disease; Chlorpromazine; Chlorprothixene; Chronic Disease; Haloperidol; Humans; Schizophrenia | 1969 |
A double blind study of clomacran.
Topics: Acridines; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Middle Aged; Place | 1969 |
A comparative trial of oxypertine and chlorpromazine in chronic schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Indoles; Piperazines; Schizophren | 1969 |
Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
Topics: Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Schizophrenia; Tra | 1969 |
A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
Topics: Acute Disease; Adolescent; Adult; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Female | 1969 |
Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Ketones; Male; Middle Aged | 1970 |
Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
Topics: Adult; Aged; Capsules; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Delayed-Action Pre | 1971 |
Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
Topics: Acridines; Adolescent; Adult; Aged; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Femal | 1971 |
A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.
Topics: Adult; Affective Symptoms; Bipolar Disorder; Carbonates; Chlorpromazine; Evaluation Studies as Topic | 1972 |
Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
Topics: Adult; Age Factors; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Evaluation St | 1972 |
Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Family; Female; Fluphenazine; Hospitalization; Hum | 1971 |
The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects.
Topics: Adult; Attention; Chlorpromazine; Clinical Trials as Topic; Humans; Learning; Male; Middle Aged; Mot | 1965 |
An exploration of the autonomic effects of phenothiazines.
Topics: Autonomic Nervous System; Behavior; Blood Pressure; Body Temperature; Chlorpromazine; Clinical Trial | 1965 |
Behavior style categories of chronic schizophrenic women.
Topics: Adult; Chlorpromazine; Classification; Clinical Trials as Topic; Female; Humans; Middle Aged; Placeb | 1965 |
Observations of placebo response in chronic schizophrenic patients.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Phenobarbital; P | 1966 |
Effects of chlorpromazine on primary-process thought manifestations.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Humans; Male; Psychopharmacology; Rorschach Test; S | 1966 |
Importance of psychiatric diagnosis in prediction of clinical drug effects.
Topics: Antisocial Personality Disorder; Anxiety; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic | 1967 |
Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation.
Topics: Chlorpromazine; Clinical Trials as Topic; Hospitalization; Humans; Placebos; Promazine; Schizophreni | 1967 |
Studies on the effect of clinical dosages of chlorpromazine and other neurotropics on primaquine-sensitive Negro mental patients.
Topics: Adult; Anemia, Hemolytic; Black or African American; Chlorpromazine; Clinical Trials as Topic; Demen | 1966 |
Monoamino oxidase inhibitors and schizophrenia.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Monoamine Oxidase Inhibitors; Schiz | 1967 |
Effects of L-DOPA on pharmacological parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Haloper | 1966 |
Treatment of disorders of character and schizophrenia by pericyazine (Neulactil).
Topics: Adolescent; Adult; Antisocial Personality Disorder; Body Weight; Character; Chlorpromazine; Clinical | 1966 |
Phototoxic reactions induced by high doses of chlorpromazine and thioridazine.
Topics: Aminobenzoates; Chlorpromazine; Clinical Trials as Topic; Humans; Photosensitivity Disorders; Retini | 1967 |
Clinical evaluation of neuroleptic drug action, particularly considering butyrophenones.
Topics: Aged; Butyrophenones; Chlorpromazine; Clinical Trials as Topic; Electrocardiography; Female; Haloper | 1966 |
On the modification of paranoid symptomatology.
Topics: Adolescent; Adult; Aggression; Chlorpromazine; Cognition; Factor Analysis, Statistical; Humans; Para | 1967 |
The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
Topics: Adult; Autonomic Nervous System; Behavior; Blood Pressure; Body Temperature; Chlorpromazine; Clinica | 1967 |
Unnecessary use of tranquilizers in elderly patients.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Humans; Middle Aged; Placebos; Sch | 1966 |
Current status of pharmacotherapy in schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Humans; Methotrimeprazine; Middle | 1966 |
Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
Topics: Adolescent; Adult; Anxiety; Behavior; Chlorpromazine; Clinical Trials as Topic; Female; Fluphenazine | 1967 |
Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
Topics: Adult; Chlorpromazine; Cornea; Eye Diseases; Female; Humans; Lens, Crystalline; Male; Middle Aged; S | 1970 |
[Depot-neuroleptics in the treatment of schizophrenia].
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Middl | 1971 |
Agranulocytosis and phenothiazines.
Topics: Adolescent; Adult; Age Factors; Aged; Agranulocytosis; Chlorpromazine; Chronic Disease; Ethnology; F | 1968 |
Response time and electrodermal measures in chronic schizophrenia: the effects of chlorpromazine.
Topics: Adult; Anxiety; Arousal; Chlorpromazine; Ego; Female; Galvanic Skin Response; Humans; Middle Aged; P | 1968 |
Family interaction patterns, drug treatment, and change in social aggression.
Topics: Adolescent; Adult; Aggression; Analysis of Variance; Chlorpromazine; Conflict, Psychological; Family | 1968 |
Chlorpromazine and body image. Effects on chronic schizophrenics.
Topics: Adult; Affect; Analysis of Variance; Body Image; Chlorpromazine; Chronic Disease; Humans; Male; Midd | 1969 |
Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
Topics: Adult; Chlorpromazine; Chronic Disease; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; P | 1969 |
Drugs and motor activity in chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; M | 1969 |
Evaluation of treatment with recorded interviews.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Humans; Interview, Psychological; Male; Middle Aged; Placeb | 1966 |
Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
Topics: Chlorpromazine; Female; Humans; Male; Paranoid Disorders; Placebos; Schizophrenia; Trifluoperazine | 1966 |
Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.
Topics: Chlorpromazine; Humans; Male; Placebos; Schizophrenia; Statistics as Topic; Substance Withdrawal Syn | 1966 |
1208 other studies available for chlorpromazine and Schizophrenia
| Article | Year |
|---|---|
Novel D
Topics: Animals; Antipsychotic Agents; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Schizophrenia | 2022 |
Oral hygiene status and factors related to oral health in hospitalized patients with schizophrenia.
Topics: Activities of Daily Living; Chlorpromazine; Dental Caries; DMF Index; Female; Humans; Male; Oral Hea | 2022 |
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Cholinergic Antagonists; Cognition; Cross-Sectional Studies; H | 2023 |
The History of Drug Development in Psychiatry: A Lesson in Serendipity.
Topics: Chlorpromazine; Drug Development; Humans; Psychiatry; Psychotropic Drugs; Schizophrenia | 2023 |
Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study.
Topics: Chlorpromazine; Cross-Sectional Studies; Delusions; Female; Hallucinations; Humans; Male; Psychiatri | 2023 |
Differential effects of parental socioeconomic status on cortical thickness in patients with schizophrenia spectrum disorders and healthy controls.
Topics: Brain; Cerebral Cortex; Cerebral Cortical Thinning; Chlorpromazine; Humans; Magnetic Resonance Imagi | 2023 |
Corneal toxicity with endothelial deposits after prolonged combined use of two phenothiazine antipsychotics.
Topics: Antipsychotic Agents; Chlorpromazine; Endothelium, Corneal; Fluphenazine; Humans; Male; Middle Aged; | 2020 |
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life".
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Cognition; Female; Humans; Male | 2021 |
Negative symptoms in schizophrenia: correlation with clinical and genetic factors.
Topics: Antipsychotic Agents; Catechol O-Methyltransferase; Chlorpromazine; Female; Gene Frequency; Genotypi | 2021 |
Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Chlorpromazine; Humans; Mice; Neural Cell Adhesion | 2017 |
Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Cognition; Electroconvulsive Therapy; | 2017 |
Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
Topics: Animals; Antioxidants; Antipsychotic Agents; Chlorpromazine; Disease Models, Animal; Drug Therapy, C | 2018 |
Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia.
Topics: Actigraphy; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Emotions; Female; Humans; Male; Middl | 2018 |
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia.
Topics: Adult; Antipsychotic Agents; Bronchodilator Agents; Chlorpromazine; Humans; Male; Priapism; Pseudoep | 2018 |
Identifying improvable employment-related factors in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Employment; Female; Humans; Ma | 2018 |
Butyl Methacrylate-Co-Ethylene Glycol Dimethacrylate Monolith for Online in-Tube SPME-UHPLC-MS/MS to Determine Chlopromazine, Clozapine, Quetiapine, Olanzapine, and Their Metabolites in Plasma Samples.
Topics: Antipsychotic Agents; Chlorpromazine; Chromatography, High Pressure Liquid; Clozapine; Humans; Metab | 2019 |
Evaluation of functional connectivity in subdivisions of the thalamus in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cerebellum; Chlorpromazine; Female; Gyrus Cinguli; Humans; Magnetic Res | 2019 |
The Psychopharmacological Revolution in the USSR: Schizophrenia Treatment and the Thaw in Soviet Psychiatry, 1954-64.
Topics: Ambulatory Care; Antipsychotic Agents; Chlorpromazine; History, 20th Century; Hospitals, Psychiatric | 2019 |
Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Erectile Dysfuncti | 2019 |
Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs.
Topics: Age Factors; Aging; Animals; Antipsychotic Agents; Behavior, Animal; Cell Proliferation; Cells, Cult | 2012 |
Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
Topics: Adult; Algorithms; Antipsychotic Agents; Biotransformation; Brain; Chlorpromazine; Diagnostic and St | 2013 |
Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Case-Control Studies; Cerebral Cortex | 2013 |
Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease?
Topics: Chlorpromazine; Female; Humans; Male; Prolactin; Schizophrenia | 2013 |
Clinical features of late-onset schizophrenia in Japan: comparison with early-onset cases.
Topics: Adult; Age of Onset; Antipsychotic Agents; Chlorpromazine; Female; Humans; Inpatients; Interview, Ps | 2013 |
Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study.
Topics: Adult; Alkaline Phosphatase; Antipsychotic Agents; Aripiprazole; Bone Density; Chlorpromazine; Cloza | 2014 |
Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
Topics: Antipsychotic Agents; Chlorpromazine; Cornea; Corneal Opacity; Female; Humans; Pigmentation Disorder | 2014 |
Study of the inferior colliculus in patients with schizophrenia by magnetic resonance spectroscopy.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Chlorpromazine; Choline; Creatine; Female; Hallucination | 2014 |
Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cohort Studies; Dose-Response Relationship, Drug; Femal | 2014 |
Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Bipolar Disorder; Brain; Chlorpromazine; Fa | 2015 |
Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Case-Control Studies; Chlorpromazine; Chronic Disease | 2015 |
Self-perceived cognitive functioning and its relationship with objective performance in first-episode schizophrenia: the Subjective Cognitive Impairment Scale.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Chlorpromazine; Cognition; Cognition Disorder | 2015 |
[A neuroleptic malignant syndrome complicated by subarachnoid hemorrhage and revealing cerebral vasculitis].
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Neuroleptic Malignant Syndrome; Schizop | 2014 |
A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; | 2015 |
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; CA1 Region, Hippocampal; Carrier Proteins; Chlorprom | 2015 |
SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Case-Control Studies; Chlorpromazine; Depressive Di | 2015 |
Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Chi-Square Distribution; China; Chlorpromazin | 2016 |
Response to Review of Shrinks: The Untold Story of Psychiatry.
Topics: Antipsychotic Agents; Chlorpromazine; Europe; History, 20th Century; Humans; Psychiatry; Psychoanaly | 2015 |
Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia.
Topics: Biopsy, Needle; Chlorpromazine; Corneal Opacity; Female; Follow-Up Studies; Humans; Hyperpigmentatio | 2016 |
Eosinophilia and parotitis occurring early in clozapine treatment.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Eosinophilia; Humans; Leukocyte Count; Male; | 2015 |
Chlorpromazine inhibits mitochondrial apoptotic pathway via increasing expression of tissue factor.
Topics: Adult; Aged; Animals; Antipsychotic Agents; Apoptosis; Autopsy; bcl-2-Associated X Protein; Case-Con | 2016 |
Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
Topics: Alleles; Antipsychotic Agents; Chlorpromazine; Female; Genetic Loci; Genetic Predisposition to Disea | 2016 |
Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Genetic Association Studies; Humans; Male; Midd | 2016 |
Theory of mind in adolescents with early-onset schizophrenia: correlations with clinical assessment and executive functions.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Chlorpromazine; Executive Function; Female; Humans; | 2016 |
A Case Report: Anti-Psychotic Agents Related Ocular Toxicity.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Eye Diseases; Female; Humans; Olanzapin | 2016 |
Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Female; Finland; Foll | 2016 |
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Dopamine | 2016 |
Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; | 2017 |
Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility.
Topics: Amino Acid Substitution; Carrier Proteins; Cell Line, Tumor; Chlorpromazine; Circular Dichroism; D-A | 2017 |
Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Dose-Response Relationshi | 2017 |
Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
Topics: Adult; Antipsychotic Agents; Cataract; Chlorpromazine; Cornea; Female; Humans; Lens Capsule, Crystal | 2017 |
Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia.
Topics: Chlorpromazine; D-Amino-Acid Oxidase; Enzyme Inhibitors; Genetic Predisposition to Disease; Humans; | 2008 |
Haloperidol versus chlorpromazine for treatment of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Haloperidol; Humans; Psychotic Disorders; Randomized Controlle | 2008 |
Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient.
Topics: Adult; Antitubercular Agents; Chlorpromazine; Creatine Kinase; Drug Interactions; Enzyme Induction; | 2008 |
Ethnic comparisons of antipsychotic use in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Catchment Area, Health; Chlorpromazine; Clozapine; Cross-Cu | 2008 |
Neurosyphilis, malaria, and the discovery of antipsychotic agents.
Topics: Antimalarials; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Europe; History, 19th Century | 2008 |
In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Administration Schedule; Endothelium, Corneal; Epithelial | 2008 |
Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Brain Mapping; Chi-Square Distribution; Chlorprom | 2009 |
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
Topics: Adult; Aged; Akathisia, Drug-Induced; Chlorpromazine; Cross-Sectional Studies; Cystine; Disability E | 2009 |
Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; Clozapine; Cross-S | 2009 |
Social support and striatal dopaminergic activities: is there a connection?
Topics: 3-Iodobenzylguanidine; Adult; Chlorpromazine; Corpus Striatum; Dopamine; Dopamine Antagonists; Femal | 2009 |
The role of intrusive and other recent life events on symptomatology in relapses of schizophrenia: a community nursing investigation.
Topics: Adult; Age of Onset; Antipsychotic Agents; Chlorpromazine; Community Health Nursing; England; Female | 2009 |
Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Brain Mapping; Chlorpromazine; Fema | 2010 |
Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia.
Topics: Affect; Antipsychotic Agents; Cerebral Cortex; Cerebrovascular Circulation; Chlorpromazine; Facial E | 2010 |
The influence of idiomatic salience during the comprehension of ambiguous idioms by patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Comprehensio | 2010 |
Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: is a short-period ECG during daytime sufficient?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Circadian Rhythm; Electrocardiography; Female; Humans; | 2010 |
Acute respiratory distress due to antipsychotic drugs.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Drug Therapy, Co | 2010 |
Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication.
Topics: Adult; Analysis of Variance; Antioxidants; Antipsychotic Agents; Case-Control Studies; Catalase; Chl | 2010 |
The prevalence of tardive dyskinesia in Chinese Singaporean patients with schizophrenia: revisited.
Topics: Adult; Aged; Antipsychotic Agents; Asian People; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 2010 |
Bilateral gynaecomastia in a Nigerian patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Gynecomastia; Humans; Male; Nigeria; Schizophrenia; Thi | 2010 |
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment.
Topics: Antipsychotic Agents; Benzoates; Chlorpromazine; D-Amino-Acid Oxidase; Drug Design; Enzyme Stability | 2010 |
Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Clozapine; Dopamine Plasma Memb | 2010 |
Personal reflections on diagnosis.
Topics: Adaptation, Psychological; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; | 2010 |
Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: effects of antipsychotic drugs.
Topics: Amphetamine; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Corticosterone; Female; Front | 2011 |
Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Diazepam; Disease Models, Animal; Female; Imipramine; | 2011 |
Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Case-Control Studies; Chlorpromazine; Chronic Disease; Dose | 2010 |
Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate.
Topics: Antipsychotic Agents; Chlorpromazine; D-Amino-Acid Oxidase; Dibenzothiazepines; Dose-Response Relati | 2011 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Femal | 2011 |
An MRI study of septi pellucidi in relation to hippocampus volume and fornix integrity in schizophrenia.
Topics: Adult; Anisotropy; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Diffusion Tensor I | 2012 |
The rise and fall of the atypical antipsychotics.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Male; Schizophrenia | 2011 |
Are all antipsychotic drugs the same?
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Male; Schizophrenia | 2011 |
Does the medication pattern reflect the CYP2D6 genotype in patients with diagnoses within the schizophrenic spectrum?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Denma | 2012 |
Clozapine v. chlorpromazine in treatment-naive first-episode schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Male; Schizophrenia | 2012 |
[Comatose patient with neuroleptic malignant syndrome brought by ambulance].
Topics: Adult; Ambulances; Basal Ganglia Diseases; Chlorpromazine; Coma; Dantrolene; Drug Overdose; Female; | 2012 |
The fall of the atypicals?
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Male; Schizophrenia | 2012 |
Revised associative inference paradigm confirms relational memory impairment in schizophrenia.
Topics: Adult; Antipsychotic Agents; Association Learning; Chlorpromazine; Concept Formation; Face; Female; | 2012 |
DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; DNA Methylation; D | 2012 |
Another view of the history of antipsychotic drug discovery and development.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Discovery; History, 20th Century; History, 21st Century; | 2012 |
Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective.
Topics: Adult; Alleles; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cas | 2012 |
Empathy in electrodermal responsive and nonresponsive patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Electroencephalography; Empathy; | 2012 |
Guideline-concordant antipsychotic use and mortality in schizophrenia.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Drug Administration Schedule; Fem | 2013 |
Chlorpromazine-induced corneal toxicity.
Topics: Antipsychotic Agents; Chlorpromazine; Cornea; Corneal Diseases; Diagnosis, Differential; Humans; Mal | 2012 |
Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
Topics: Apoptosis; Blotting, Western; Carrier Proteins; Caspases; Cell Line, Tumor; Cell Survival; Chlorprom | 2013 |
Symptoms of schizophrenia and neurocognitive test performance.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Female; Follow-Up Stud | 2002 |
Negative symptoms and neuroleptics in catatonic schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; | 2003 |
Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.
Topics: Adult; Antipsychotic Agents; Brain; Chlorpromazine; Cross-Sectional Studies; Electroencephalography; | 2003 |
Altered hemispheric asymmetry and positive symptoms in schizophrenia: equivalent current dipole of auditory mismatch negativity.
Topics: Adult; Antipsychotic Agents; Auditory Perceptual Disorders; Chlorpromazine; Cognition Disorders; Ele | 2003 |
Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Delayed-Action Preparations; Femal | 2003 |
Selective, sustained, and shift in attention in patients with diagnoses of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Diagnostic | 2002 |
Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dehydroepiandrosterone; Female; Humans; Hydrocort | 2001 |
No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Chlorpromazine; Female; Gene Frequency; Genotype; Huma | 2003 |
Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Cerebrovascular Circulation; Chlorpromazine; Female; H | 2003 |
Symptom outcome 1 year after admission to an early psychosis program.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Depressive Disorder, Major; Diagnostic and Statistical | 2003 |
The inappropriate smile and zygomatic muscle activity.
Topics: Antipsychotic Agents; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Electro | 2003 |
Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Dru | 2002 |
Thorazine-chlorpromazine.
Topics: Autonomic Agents; Chlorpromazine; Schizophrenia | 1954 |
[Largactil therapy in schizophrenia and other psychotic conditions].
Topics: Chlorpromazine; Psychotic Disorders; Schizophrenia | 1954 |
The use of thorazine as an adjunct in the treatment of schizophrenia.
Topics: Chlorpromazine; Schizophrenia | 1954 |
[Largactil in the treatment of tuberculosis].
Topics: Autonomic Agents; Chlorpromazine; Lung; Schizophrenia; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Chlorpromazine in the treatment of schizophrenia; a study of 75 cases.
Topics: Chlorpromazine; Humans; Schizophrenia | 1955 |
Chlorpromazine.
Topics: Chlorpromazine; Schizophrenia | 1955 |
The successful treatment of a post-gastrectomy schizophrenic psychosis with chlorpromazine; report of a case.
Topics: Chlorpromazine; Digestive System Surgical Procedures; Gastrectomy; Medical Records; Psychotic Disord | 1955 |
Metabolism of the schizophrenic child; etiologic hypothesis.
Topics: Atropine; Child; Chlorpromazine; Humans; Infant; Schizophrenia | 1956 |
[Diabetes insipidus during the treatment of schizophrenia with chlorpromazine].
Topics: Chlorpromazine; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Schizophrenia | 1955 |
A fatality associated with chlorpromazine (largactil) therapy.
Topics: Agranulocytosis; Chlorpromazine; Schizophrenia | 1956 |
Chlorpromazine, depersonalization, and visual hallucinosis.
Topics: Chlorpromazine; Depersonalization; Hallucinations; Humans; Psychotic Disorders; Schizophrenia | 1956 |
Seizures occurring during intensive chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Schizophrenia; Seizures | 1956 |
[Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
Topics: Antihypertensive Agents; Chlorpromazine; Parkinson Disease; Rauwolfia; Reserpine; Schizophrenia; Sec | 1955 |
Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient.
Topics: Chlorpromazine; Schizophrenia | 1956 |
A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics.
Topics: Chlorpromazine; Humans; Schizophrenia | 1955 |
Bacteriological studies on the etiology and chlorpromazine treatment of schizophrenia and related mental disorders.
Topics: Chlorpromazine; Humans; Mental Disorders; Schizophrenia; Streptococcus | 1955 |
[Largactil in the treatment of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1955 |
Comparison of chlorpromazine and reserpine in treatment of schizophrenia; a study of four hundred cases.
Topics: Antihypertensive Agents; Chlorpromazine; Reserpine; Schizophrenia; Secologanin Tryptamine Alkaloids | 1956 |
Chlorpromazine: alone and as an adjunct to group psychotherapy in the treatment of psychiatric patients.
Topics: Chlorpromazine; Humans; Patients; Psychotherapy; Psychotherapy, Group; Schizophrenia | 1956 |
Fatal acute aseptic necrosis of the liver associated with chlorpromazine.
Topics: Chlorpromazine; Humans; Liver; Liver Diseases; Schizophrenia | 1956 |
Neurotoxic reactions resulting from chlorpromazine administration.
Topics: Biological Phenomena; Chlorpromazine; Humans; Nervous System; Neurotoxicity Syndromes; Pharmaceutica | 1956 |
[Pharmacological aspects in schizophrenia research].
Topics: Chlorpromazine; Ergot Alkaloids; Humans; Phenethylamines; Research; Schizophrenia; Serotonin; Seroto | 1956 |
A preliminary report on the use of chlorpromazine hydrochloride in a correctional institution.
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
Effects of chlorpromazine and reserpine in chronic schizophrenic patients.
Topics: Antihypertensive Agents; Chlorpromazine; Reserpine; Schizophrenia; Secologanin Tryptamine Alkaloids | 1956 |
[Combined Sakel and chlorpromazine therapy].
Topics: Bipolar Disorder; Chlorpromazine; Convulsive Therapy; Humans; Insulin; Mental Disorders; Psychotic D | 1956 |
[Treatment of schizophrenia with aminazine].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Modification of protein fractions of the blood in schizophrenia treated with aminazine].
Topics: Blood Proteins; Chlorpromazine; Humans; Mental Disorders; Psychosurgery; Schizophrenia | 1956 |
[Blood serum fractions in subjects treated with largactil].
Topics: Blood Proteins; Blood Sedimentation; Chlorpromazine; Schizophrenia; Serum | 1955 |
[Treatment by induced psychosis (mescaline and chlorpromazine)].
Topics: Chlorpromazine; Mental Disorders; Mescaline; Phenethylamines; Psychotic Disorders; Schizophrenia; Sh | 1956 |
[Results of largactil therapy of schizophrenia in 109 patients (67 women and 42 men)].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Results of largactil therapy of schizophrenia in 109 patients (67 women and 42 men)].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Results of largactil therapy of schizophrenia in 109 patients (67 women and 42 men)].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Results of largactil therapy of schizophrenia in 109 patients (67 women and 42 men)].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[About our experience with chlorpromazine].
Topics: Chlorpromazine; Humans; Neurotic Disorders; Obsessive-Compulsive Disorder; Schizophrenia | 1956 |
[About our experience with chlorpromazine].
Topics: Chlorpromazine; Humans; Neurotic Disorders; Obsessive-Compulsive Disorder; Schizophrenia | 1956 |
[About our experience with chlorpromazine].
Topics: Chlorpromazine; Humans; Neurotic Disorders; Obsessive-Compulsive Disorder; Schizophrenia | 1956 |
[About our experience with chlorpromazine].
Topics: Chlorpromazine; Humans; Neurotic Disorders; Obsessive-Compulsive Disorder; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy with massive doses in psychiatry].
Topics: Chlorpromazine; Humans; Psychiatry; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy with massive doses in psychiatry].
Topics: Chlorpromazine; Humans; Psychiatry; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy with massive doses in psychiatry].
Topics: Chlorpromazine; Humans; Psychiatry; Schizophrenia | 1956 |
[Prolonged chlorpromazine therapy with massive doses in psychiatry].
Topics: Chlorpromazine; Humans; Psychiatry; Schizophrenia | 1956 |
[Significance of neuroplegic therapy for psychopathology of schizophrenia].
Topics: Chlorpromazine; Humans; Psychopathology; Schizophrenia | 1956 |
[Significance of neuroplegic therapy for psychopathology of schizophrenia].
Topics: Chlorpromazine; Humans; Psychopathology; Schizophrenia | 1956 |
[Significance of neuroplegic therapy for psychopathology of schizophrenia].
Topics: Chlorpromazine; Humans; Psychopathology; Schizophrenia | 1956 |
[Significance of neuroplegic therapy for psychopathology of schizophrenia].
Topics: Chlorpromazine; Humans; Psychopathology; Schizophrenia | 1956 |
[Prolonged chlorpromazine treatment in schizophrenia].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine treatment in schizophrenia].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine treatment in schizophrenia].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Prolonged chlorpromazine treatment in schizophrenia].
Topics: Chlorpromazine; Humans; Schizophrenia | 1956 |
[Condemnation of Sakel's therapy after the appearance of chlorpromazine].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1956 |
[Condemnation of Sakel's therapy after the appearance of chlorpromazine].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1956 |
[Condemnation of Sakel's therapy after the appearance of chlorpromazine].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1956 |
[Condemnation of Sakel's therapy after the appearance of chlorpromazine].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1956 |
[Chlorpromazine and reserpine after insulin shock therapy in schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Insulin Coma; Reserpine; Schizophrenia | 1956 |
[Chlorpromazine and reserpine after insulin shock therapy in schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Insulin Coma; Reserpine; Schizophrenia | 1956 |
[Chlorpromazine and reserpine after insulin shock therapy in schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Insulin Coma; Reserpine; Schizophrenia | 1956 |
[Chlorpromazine and reserpine after insulin shock therapy in schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Insulin Coma; Reserpine; Schizophrenia | 1956 |
Reserpine and chlorpromazine in the treatment of chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1956 |
Reserpine and chlorpromazine in the treatment of chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1956 |
Reserpine and chlorpromazine in the treatment of chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1956 |
Reserpine and chlorpromazine in the treatment of chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1956 |
[Comparative study of R.P. 4560 (chlorpromazine) and reserpine in schizophrenic syndromes].
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Syndrome | 1956 |
[Comparative study of R.P. 4560 (chlorpromazine) and reserpine in schizophrenic syndromes].
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Syndrome | 1956 |
[Comparative study of R.P. 4560 (chlorpromazine) and reserpine in schizophrenic syndromes].
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Syndrome | 1956 |
[Comparative study of R.P. 4560 (chlorpromazine) and reserpine in schizophrenic syndromes].
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Syndrome | 1956 |
[Action of chlorpromazine in the treatment of systematized delirious psychoses and schizophrenia].
Topics: Chlorpromazine; Humans; Psychosurgery; Psychotherapy; Psychotic Disorders; Schizophrenia | 1956 |
[Action of chlorpromazine in the treatment of systematized delirious psychoses and schizophrenia].
Topics: Chlorpromazine; Humans; Psychosurgery; Psychotherapy; Psychotic Disorders; Schizophrenia | 1956 |
[Action of chlorpromazine in the treatment of systematized delirious psychoses and schizophrenia].
Topics: Chlorpromazine; Humans; Psychosurgery; Psychotherapy; Psychotic Disorders; Schizophrenia | 1956 |
[Action of chlorpromazine in the treatment of systematized delirious psychoses and schizophrenia].
Topics: Chlorpromazine; Humans; Psychosurgery; Psychotherapy; Psychotic Disorders; Schizophrenia | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
[EEG changes induced by chlorpromazine during epilepsy and schizophrenia].
Topics: Chlorpromazine; Electroencephalography; Epilepsy; Humans; Schizophrenia | 1956 |
[EEG changes induced by chlorpromazine during epilepsy and schizophrenia].
Topics: Chlorpromazine; Electroencephalography; Epilepsy; Humans; Schizophrenia | 1956 |
[EEG changes induced by chlorpromazine during epilepsy and schizophrenia].
Topics: Chlorpromazine; Electroencephalography; Epilepsy; Humans; Schizophrenia | 1956 |
[EEG changes induced by chlorpromazine during epilepsy and schizophrenia].
Topics: Chlorpromazine; Electroencephalography; Epilepsy; Humans; Schizophrenia | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans; Reserpine; Schizophr | 1956 |
[Action of neuroplegics on neuromuscular excitability, transmembrane ionic movements, thermocationic equilibrium; physiological and therapeutic consequences; clinical application: delirium tremens].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Neuromuscular Junction; Schizophrenia | 1956 |
[Action of neuroplegics on neuromuscular excitability, transmembrane ionic movements, thermocationic equilibrium; physiological and therapeutic consequences; clinical application: delirium tremens].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Neuromuscular Junction; Schizophrenia | 1956 |
[Action of neuroplegics on neuromuscular excitability, transmembrane ionic movements, thermocationic equilibrium; physiological and therapeutic consequences; clinical application: delirium tremens].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Neuromuscular Junction; Schizophrenia | 1956 |
[Action of neuroplegics on neuromuscular excitability, transmembrane ionic movements, thermocationic equilibrium; physiological and therapeutic consequences; clinical application: delirium tremens].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Neuromuscular Junction; Schizophrenia | 1956 |
[Treatment for delirium tremens with (the drug) 4560 R.P].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Schizophrenia | 1956 |
[Treatment for delirium tremens with (the drug) 4560 R.P].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Schizophrenia | 1956 |
[Treatment for delirium tremens with (the drug) 4560 R.P].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Schizophrenia | 1956 |
[Treatment for delirium tremens with (the drug) 4560 R.P].
Topics: Alcohol Withdrawal Delirium; Chlorpromazine; Humans; Schizophrenia | 1956 |
Prediction of the response of chronic schizophrenics to drug therapy: a preliminary report on the relationship between palmar sweat and the behaviorial effects of tranquilizing drugs.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Sweat; Sweating; Tranquilizing Agents | 1957 |
Prediction of the response of chronic schizophrenics to drug therapy: a preliminary report on the relationship between palmar sweat and the behaviorial effects of tranquilizing drugs.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Sweat; Sweating; Tranquilizing Agents | 1957 |
Prediction of the response of chronic schizophrenics to drug therapy: a preliminary report on the relationship between palmar sweat and the behaviorial effects of tranquilizing drugs.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Sweat; Sweating; Tranquilizing Agents | 1957 |
Prediction of the response of chronic schizophrenics to drug therapy: a preliminary report on the relationship between palmar sweat and the behaviorial effects of tranquilizing drugs.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia; Sweat; Sweating; Tranquilizing Agents | 1957 |
[Favorable effect of chlorpromazine treatment in a case of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Favorable effect of chlorpromazine treatment in a case of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Favorable effect of chlorpromazine treatment in a case of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Favorable effect of chlorpromazine treatment in a case of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1956 |
[Megaphen and reserpine therapy of advanced schizophrenia].
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1956 |
[Megaphen and reserpine therapy of advanced schizophrenia].
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1956 |
[Megaphen and reserpine therapy of advanced schizophrenia].
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1956 |
[Megaphen and reserpine therapy of advanced schizophrenia].
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1956 |
[First results obtained with largactil in the neuropsychiatric hospital of the Reggio Calabria province].
Topics: Chlorpromazine; Hospitals; Neurotic Disorders; Schizophrenia | 1956 |
[First results obtained with largactil in the neuropsychiatric hospital of the Reggio Calabria province].
Topics: Chlorpromazine; Hospitals; Neurotic Disorders; Schizophrenia | 1956 |
[First results obtained with largactil in the neuropsychiatric hospital of the Reggio Calabria province].
Topics: Chlorpromazine; Hospitals; Neurotic Disorders; Schizophrenia | 1956 |
[First results obtained with largactil in the neuropsychiatric hospital of the Reggio Calabria province].
Topics: Chlorpromazine; Hospitals; Neurotic Disorders; Schizophrenia | 1956 |
A clinical evaluation of chlorpromazine therapy in chronic schizophrenics.
Topics: Chlorpromazine; Schizophrenia | 1957 |
A clinical evaluation of chlorpromazine therapy in chronic schizophrenics.
Topics: Chlorpromazine; Schizophrenia | 1957 |
A clinical evaluation of chlorpromazine therapy in chronic schizophrenics.
Topics: Chlorpromazine; Schizophrenia | 1957 |
A clinical evaluation of chlorpromazine therapy in chronic schizophrenics.
Topics: Chlorpromazine; Schizophrenia | 1957 |
Treatment of regressed schizophrenics with chlorpromazine, reserpine and A combination of both drugs.
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1957 |
Combined treatment with chlorpromazine and reserpine.
Topics: Chlorpromazine; Combined Modality Therapy; Manipulation, Osteopathic; Reserpine; Schizophrenia | 1957 |
[Current status of the treatment of schizophrenia with chlorpromazine and reserpine].
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1956 |
[Study of the effect of RP 4560 alone and with barbiturates in cases of schizophrenic psychoses].
Topics: Amobarbital; Barbiturates; Chlorpromazine; Humans; Mental Disorders; Psychotic Disorders; Schizophre | 1957 |
Carbohydrate metabolism in brain diseases. X. Lack of effect of chlorpormazine and reserpine on abnormal carbohydrate metabolism in chronic schizophrenia.
Topics: Brain Diseases; Carbohydrate Metabolism; Carbohydrates; Chlorpromazine; Reserpine; Schizophrenia | 1957 |
Study of the differential behavioral effects of reserpine, chlorpromazine, and a combination of these drugs in chronic schizophrenic patients.
Topics: Chlorpromazine; Reserpine; Schizophrenia | 1957 |
The occurrence of epileptic fits in leucotomized patients receiving chlorpromazine therapy.
Topics: Chlorpromazine; Epilepsy; Humans; Psychosurgery; Schizophrenia | 1957 |
[5-Hydroxyindoleacetic acid excretion in urine of schizophrenics with reference to effects of chlorpromazine and reserpine on serotonin metabolism].
Topics: Body Fluids; Chlorpromazine; Hydroxyindoleacetic Acid; Indoleacetic Acids; Reserpine; Schizophrenia; | 1957 |
Treatment of schizophrenia pacatal and chlorpromazine compared.
Topics: Chlorpromazine; Phenothiazines; Schizophrenia | 1957 |
[Acute immunologically induced agranulocytosis after administration of chlorpromazine].
Topics: Agranulocytosis; Chlorpromazine; Humans; Schizophrenia | 1957 |
Direct psychotherapy combined in a chronic hospitalized schizophrenic.
Topics: Chlorpromazine; Humans; Psychotherapy; Schizophrenia | 1957 |
[Treatment of schizophrenia, manic-depressive psychoses & alcoholism with chlorpromazine].
Topics: Alcoholism; Bipolar Disorder; Chlorpromazine; Humans; Mental Disorders; Psychoses, Alcoholic; Psycho | 1957 |
Emotional problems in children; the uses of drugs in therapeutic management.
Topics: Anxiety; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit D | 1957 |
[Delimitation of paranoia and paraphrenia of schizophrenia].
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1957 |
Further observations on the use of largactil in psychiatry.
Topics: Chlorpromazine; Convulsive Therapy; Psychiatry; Psychosurgery; Psychotic Disorders; Schizophrenia | 1957 |
The effect of chlorpromazine and reserpine on sedation and convulsive thresholds in schizophrenic patients.
Topics: Anesthesia; Chlorpromazine; Electroencephalography; Reserpine; Schizophrenia | 1957 |
Ritalin and chlorpromazine in chronic schizophrenia: a controlled clinical trial.
Topics: Chlorpromazine; Humans; Methylphenidate; Schizophrenia | 1957 |
[Results of largactil treatment of schizophrenics at the Basel University Psychiatric Clinic from 1953 to 1955].
Topics: Chlorpromazine; Schizophrenia; Universities | 1957 |
[Schizophrenia developing over a 27-year period reaching a terminal stage with improvement following chlorpromazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1957 |
Chlorpromazine in treatment of chronic schizophrenia.
Topics: Chlorpromazine; Schizophrenia | 1958 |
Electroencephalographic changes in chronic schizophrenics under chemotherapy.
Topics: Chlorpromazine; Electroencephalography; Humans; Phenobarbital; Phenothiazines; Schizophrenia | 1958 |
[Chlorpromazine in the treatment of schizophrenia & manic-depressive psychoses].
Topics: Bipolar Disorder; Chlorpromazine; Humans; Mental Disorders; Psychotic Disorders; Schizophrenia | 1957 |
[Occupational problems of remission in schizophrenics treated with autonomic drugs].
Topics: Autonomic Agents; Chlorpromazine; Occupational Health; Reserpine; Schizophrenia | 1957 |
[Allergic reactions during alternate neuroplegic and insulin shock therapy].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Hypersensitivity; Immune System Diseases; Insulin; Insul | 1957 |
Schizophrenia treated with and without chlorpromazine.
Topics: Chlorpromazine; Schizophrenia | 1958 |
[Results of aminazine therapy in paranoid forms of schizophrenia].
Topics: Chlorpromazine; Humans; Schizophrenia | 1957 |
[Catamnesis of schizophrenia treated with aminazine].
Topics: Chlorpromazine; Humans; Schizophrenia | 1957 |
The use of oral hypoglycemic agents in the treatment of schizophrenia.
Topics: Chlorpromazine; Hypoglycemic Agents; Schizophrenia | 1958 |
[Chronic schizophrenia of the dementia praecox type treated with largactil; terminal epileptic state; anatomical & clinical findings].
Topics: Chlorpromazine; Epilepsy; Hemorrhage; Humans; Schizophrenia | 1958 |
Effect of chlorpromazine, reserpine and frenquel on convulsive threshold.
Topics: Chlorpromazine; Convulsive Therapy; Piperidines; Reserpine; Schizophrenia; Seizures | 1958 |
Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics.
Topics: Chlorpromazine; Humans; Leadership; Schizophrenia | 1958 |
[Duration of clinical treatment & its success in schizophrenic psychoses; comparison of neuroleptic therapy with older treatment procedures].
Topics: Antipsychotic Agents; Chlorpromazine; Mental Disorders; Psychotic Disorders; Schizophrenia | 1958 |
Regressive EST, chlorpromazine, and group therapy in treatment of hospitalized chronic schizophrenics.
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Psychotherapy; Psychotherapy, Group; Schizophreni | 1958 |
Termination of chlorpromazine with schizophrenic patients.
Topics: Chlorpromazine; Schizophrenia | 1958 |
Specific behavioral changes produced by chlorpromazine in chronic schizophrenia.
Topics: Chlorpromazine; Schizophrenia | 1958 |
Stylus maze performance of chronic schizophrenics taking chlorpromazine.
Topics: Chlorpromazine; Psychological Tests; Schizophrenia; Schizophrenic Psychology | 1958 |
Physical treatment for schizophrenia.
Topics: Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; Insulin; Physical Examination | 1958 |
The effects of physical treatment on some psychological functions.
Topics: Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; Insulin; Psychological Tests; | 1958 |
Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic.
Topics: Chlorpromazine; Conduct Disorder; Humans; Schizophrenia | 1958 |
Meprobamate in psychiatry; a comparison with chlorpromazine treatment.
Topics: Chlorpromazine; Humans; Meprobamate; Neurotic Disorders; Psychiatry; Schizophrenia | 1958 |
The treatment of drug-resistive chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1958 |
[Psychological changes in treated schizophrenia].
Topics: Chlorpromazine; Humans; Insulin; Mental Disorders; Schizophrenia; Schizophrenic Psychology | 1958 |
[Catamnestic studies at a psychoneurological clinic of schizophrenic patients treated by aminazine].
Topics: Ambulatory Care Facilities; Chlorpromazine; Humans; Research; Schizophrenia | 1958 |
Comparison of two phenothiazine derivatives and a barbiturate in chronic schizophrenia.
Topics: Barbiturates; Chlorpromazine; Humans; Phenothiazines; Schizophrenia | 1959 |
Effect of two phenothiazine drugs on concentrative attention span of chronic schizophrenics.
Topics: Attention; Chlorpromazine; Humans; Memory; Phenothiazines; Schizophrenia | 1959 |
[Reconstruction of the personality by the use of neuroleptics].
Topics: Antipsychotic Agents; Chlorpromazine; Personality; Personality Disorders; Plastic Surgery Procedures | 1958 |
Differential effects of chlorpromazine and reserpine.
Topics: Chlorpromazine; Humans; Reserpine; Schizophrenia | 1958 |
A comparison of chlorpromazine and EST in treatment of acute schizophrenic and manic reactions.
Topics: Bipolar Disorder; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; Psychotic D | 1959 |
Comparison of proclorperazine and chlorpromazine in hospitalized chronic schizophrenics.
Topics: Chlorpromazine; Phenothiazines; Schizophrenia | 1959 |
Chlorpromazine and apparent motion perception by schizophrenics.
Topics: Chlorpromazine; Humans; Motion Perception; Perception; Schizophrenia | 1959 |
A comparison of the effects of phenobarbital, promethazine, chlorpromazine, and placebo upon mental hospital patients.
Topics: Chlorpromazine; Hospitals; Hospitals, Psychiatric; Humans; Inpatients; Mentally Ill Persons; Phenoba | 1959 |
A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients.
Topics: Barbiturates; Chlorpromazine; Humans; Mental Disorders; Schizophrenia; Secobarbital | 1959 |
The relative efficacy of vespral and chlorpromazine in the treatment of a group of chronic schizophrenic patients.
Topics: Chlorpromazine; Lipid Metabolism; Phenothiazines; Phospholipids; Schizophrenia | 1959 |
[Electrophoretic investigations on protein fractions of the blood serum in schizophrenic patients and effect of neuroleptic therapy on their dynamics].
Topics: Antipsychotic Agents; Chlorpromazine; Electrophoresis; Humans; Psychiatric Somatic Therapies; Schizo | 1959 |
[Permeability of the blood cerebrospinal barrier and its changes following aminazine therapy of schizophrenia].
Topics: Blood-Brain Barrier; Chlorpromazine; Humans; Permeability; Schizophrenia | 1959 |
[Comparative therapeutic effectiveness of aminazine and insulin in the treatment of schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1959 |
[Comparative data on the effectiveness of aminazine and insulin therapy in various forms of schizophrenia with protracted course].
Topics: Chlorpromazine; Dental Care; Humans; Insulin; Schizophrenia | 1959 |
[Forms of schizophrenia resistant to aminazine therapy].
Topics: Chlorpromazine; Humans; Schizophrenia | 1959 |
[Localization of the site of action of aminazin in schizophrenia].
Topics: Biological Phenomena; Chlorpromazine; Humans; Physiological Phenomena; Schizophrenia | 1959 |
A controlled comparative investigation of the effects of promazine, chlorpromazine, and a placebo in chronic psychosis.
Topics: Chlorpromazine; Phenothiazines; Promazine; Psychotic Disorders; Schizophrenia | 1959 |
Quantitative comparison of clinical effectiveness of chlorpromazine and promazine.
Topics: Chlorpromazine; Humans; Phenothiazines; Promazine; Schizophrenia; Treatment Outcome | 1959 |
The effects of chlorpromazine upon psychomotor and psychiatric behavior of chronic schizophrenic patients.
Topics: Chlorpromazine; Humans; Schizophrenia | 1959 |
[Electrophoretic analysis of blood proteins during largactil therapy of schizophrenic patients].
Topics: Blood Proteins; Chlorpromazine; Electrophoresis; Schizophrenia | 1959 |
[Clinical trial of a synergistic megaphen-electroshock therapy of chronic psychoses].
Topics: Chlorpromazine; Chronic Disease; Convulsive Therapy; Electroconvulsive Therapy; Humans; Mental Disor | 1959 |
A comparison of tetrabenazine and chlorpromazine in chronic schizophrenia.
Topics: Chlorpromazine; Schizophrenia; Tetrabenazine; Tranquilizing Agents | 1961 |
[Clinical experiences with Truxal and Hibanil in chronic schizophrenia. A double blind experiment].
Topics: Chlorpromazine; Double-Blind Method; Psychopharmacology; Schizophrenia | 1961 |
Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine.
Topics: Chlorpromazine; Dextroamphetamine; Drug Therapy, Combination; Isocarboxazid; Psychopharmacology; Sch | 1961 |
Chlorpromazine in chronic schizophrenic women: I. Experimental design and effects at maximum point of treatment.
Topics: Chlorpromazine; Research Design; Schizophrenia | 1961 |
Social class and prognosis in schizophrenia. I.
Topics: Chlorpromazine; Humans; Occupational Therapy; Prognosis; Schizophrenia; Social Class | 1961 |
The effect of chlorpromazine on the variability of motor task performance in schizophrenics.
Topics: Chlorpromazine; Humans; Motor Skills; Schizophrenia; Task Performance and Analysis; Work | 1960 |
Thorazine therapy with catatonic schizophrenics in relation to Wechsler verbal and performance subtest comparison.
Topics: Chlorpromazine; Humans; Intelligence Tests; Schizophrenia | 1961 |
[On mental infantilism in schizophrenic patients during the remission after aminazin therapy].
Topics: Chlorpromazine; Schizophrenia | 1961 |
[The therapy of schizophrenia and cyclophrenia with electric shock therapy, insulin shock and chlorpromazine].
Topics: Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Insulin; Insulin Coma; Schizophrenia | 1960 |
[On functional characteristics of the thyroid gland during the course of the treatment of schizophrenic patients with insulin and aminazin].
Topics: Chlorpromazine; Convulsive Therapy; Insulin; Schizophrenia; Thyroid Gland; Viscera | 1960 |
[Immunological reactivity in patients with schizophrenia during the treatment with insulin and neuroleptic drugs].
Topics: Antiemetics; Antipsychotic Agents; Chlorpromazine; Convulsive Therapy; Insulin; Reserpine; Schizophr | 1961 |
[Treatment of patients with schizophrenia with prolonged uninterrupted sleep and a simultaneous application of aminazin].
Topics: Chlorpromazine; Schizophrenia; Sleep | 1961 |
[Treatment with aminazin of patients with schizophrenia suffering from pulmonary tuberculosis].
Topics: Chlorpromazine; Humans; Schizophrenia; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Effect of aminazin therapy on dynamics of a depressive-paranoid form of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1961 |
A comparison of the therapeutic and toxic effects of thioridazine and chlorpromazine in chronic schizophrenic patients.
Topics: Chlorpromazine; Humans; Schizophrenia; Thioridazine; Tranquilizing Agents | 1961 |
Clinical trial of RO 5-0690 and chlorpromazine on disturbed chronic schizophrenic patients.
Topics: Chlorpromazine; Schizophrenia; Tranquilizing Agents | 1960 |
A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
Topics: Chlorpromazine; Double-Blind Method; Prochlorperazine; Schizophrenia; Schizophrenia, Paranoid; Tranq | 1961 |
[Clinical characteristics of the remission in patients with a circular form of schizophrenia treated with aminazin. I].
Topics: Chlorpromazine; Schizophrenia | 1961 |
Trifluoperazine combined with chlorpromazine.
Topics: Chlorpromazine; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1960 |
Chlorpromazine and schizophrenia. The role of the general practitioner.
Topics: Chlorpromazine; General Practitioners; Schizophrenia | 1960 |
An investigation into combined electroconvulsive and chlorpromazine therapy in the treatment of schizophrenia.
Topics: Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Schizophrenia | 1959 |
Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo.
Topics: Chlorpromazine; Phenobarbital; Promazine; Research Design; Schizophrenia; Tranquilizing Agents | 1960 |
Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital.
Topics: Antipsychotic Agents; Chlorpromazine; Perphenazine; Phenobarbital; Phenothiazines; Prochlorperazine; | 1960 |
[Effectiveness of aminazin therapy in various forms of schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1959 |
Full coma insulin therapy, chlorpromazine and electroconvulsive treatment: a control study of 600 schizophrenic patients.
Topics: Chlorpromazine; Coma; Convulsive Therapy; Electroconvulsive Therapy; Humans; Insulins; Schizophrenia | 1959 |
A long term evaluation of chlorpromazine in six chronic schizophrenic patients.
Topics: Chlorpromazine; Schizophrenia | 1959 |
A long-term evaluation of chlorpromazine in six chronic schizophrenic patients.
Topics: Chlorpromazine; Humans; Schizophrenia | 1960 |
The effects of chlorpromazine and secobarbital on the reaction times of chronic schizophrenics.
Topics: Chlorpromazine; Humans; Reaction Time; Schizophrenia; Secobarbital | 1960 |
[Dynamics of blood indices in aminazine therapy of patients with schizophrenia of long duration].
Topics: Chlorpromazine; Databases, Genetic; Schizophrenia; Time Factors | 1960 |
[Thermal reaction during aminazine therapy patients with schizophrenia and certain other mental disorders].
Topics: Body Temperature; Chlorpromazine; Electroconvulsive Therapy; Mental Disorders; Psychosurgery; Schizo | 1960 |
A comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia.
Topics: Chlorpromazine; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1961 |
[Observations on the treatment of chronic schizophrenics with fluorchlorpromazine].
Topics: Chlorpromazine; Schizophrenia | 1962 |
Schizophrenic behavior and aspects of psychopharmacology.
Topics: Chlorpromazine; Humans; Psychopharmacology; Schizophrenia | 1962 |
Comparison of chlorpromazine with fluphenazine dihydrochloride in treatment of schizophrenics.
Topics: Chlorpromazine; Fluphenazine; Schizophrenia; Tranquilizing Agents | 1962 |
[Effect of aminazine therapy on the serotonin in the blood and the excretion of 5-hydroxyindolacetic acid in the urine of patients with schizophrenia].
Topics: Chlorpromazine; Hydroxyindoleacetic Acid; Indoleacetic Acids; Schizophrenia; Serotonin | 1962 |
[The influence of aminazin therapy on the dynamics of certain free amino acids in the blood serum of schizophrenic patients].
Topics: Amino Acids; Antifibrinolytic Agents; Chlorpromazine; Humans; Leadership; Schizophrenia; Serum | 1962 |
Comparison of the effect of thioridazine and chlorpromazine on chronic schizophrenic psychosis using double blind technique.
Topics: Chlorpromazine; Double-Blind Method; Humans; Psychotic Disorders; Schizophrenia; Thioridazine; Tranq | 1961 |
Response to trifluoperazine and chlorpromazine, singly and in combination, in chronic, "backward" patients.
Topics: Chlorpromazine; Diet, Reducing; Intellectual Disability; Schizophrenia; Tranquilizing Agents; Triflu | 1962 |
The effects of thorazine on learning and retention in schizophrenic patients.
Topics: Chlorpromazine; Humans; Learning; Schizophrenia; Schizophrenic Psychology | 1961 |
Implications of chlorpromazine metabolites for the psychiatrist.
Topics: Chlorpromazine; Humans; Psychiatry; Schizophrenia | 1962 |
[On the possibility of the combined use of insulin and aminazin for the treatment of schizophrenia patients. I].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Insulin; Schizophrenia | 1963 |
Adrenocortical and autonomic reactivity in schizophrenia.
Topics: Adrenal Cortex Function Tests; Autonomic Nervous System; Chlorpromazine; Humans; Schizophrenia | 1963 |
Clinical evaluation of thioridazine and chlorpromazine in chronic schizophrenics.
Topics: Chlorpromazine; Humans; Schizophrenia; Thioridazine | 1963 |
[Stelazine therapy of patients with the paranoid form of schizophrenia].
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Trifluoperazine | 1963 |
[Features of allergic reactivity of the skin in schizophrenia].
Topics: Chlorpromazine; Humans; Hypersensitivity; Immune System Diseases; Schizophrenia; Skin | 1962 |
Sequential use of antidepressant drugs with chlorpromazine in chronic schizophrenia.
Topics: Antidepressive Agents; Chlorpromazine; Humans; Schizophrenia | 1963 |
Picture recognition as an index of social sensitivity in chronic schizophrenia: the effects of chlorpromazine.
Topics: Chlorpromazine; Group Processes; Humans; Schizophrenia; Schizophrenic Psychology | 1962 |
[On treatment of patients with schizophrenia with neuroleptic "waves"].
Topics: Antipsychotic Agents; Chlorpromazine; Reserpine; Schizophrenia | 1963 |
[Phasic factor and periodicity in the course of psychoses during therapy with neuroleptics].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Humans; Mental Disorders; Periodicity; Psych | 1963 |
[On remissions in patients with schizophrenia after treatment with neuroleptic substances and supportive therapy].
Topics: Antipsychotic Agents; Chlorpromazine; Neoplasms; Schizophrenia | 1961 |
[Apropos of a paranoid dementia cured by neuroleptic therapy for 15 months].
Topics: Antipsychotic Agents; Chlorpromazine; Dementia; Muscle Relaxants, Central; Psychiatric Somatic Thera | 1963 |
[On some variations of remission in the clinical picture of schizophrenia during aminazin therapy].
Topics: Chlorpromazine; Schizophrenia | 1963 |
[Research on hepatic function in schizophrenics before and after treatment with chlorpromazine].
Topics: Chlorpromazine; Digestion; Liver; Research; Schizophrenia | 1962 |
3,4-DIMETHOXYPHENYLETHYLAMINE AND OTHER AMINES IN THE URINE OF SCHIZOPHRENIC PATIENTS.
Topics: Amines; Chlorpromazine; Chromatography; Dihydroxyphenylalanine; Dimethoxyphenylethylamine; Dopamine; | 1963 |
MULTIPLE ITEM FACTORS AS CHANGE MEASURES IN PSYCHOPHARMACOLOGY.
Topics: Chlorpromazine; Depression; Depressive Disorder; Factor Analysis, Statistical; Humans; Imipramine; P | 1963 |
TRIFLUPERIDOL: A BUTYROPHENONE DERIVATIVE.
Topics: Butyrophenones; Chlorpromazine; Humans; Muscle Relaxants, Central; Psychological Tests; Schizophreni | 1963 |
STUDY DESIGN FOR CLINICAL EVALUATION OF PHENOTHIAZINE DERIVATIVES.
Topics: Antipsychotic Agents; Chlorpromazine; Phenothiazines; Research Design; Schizophrenia | 1963 |
LONG TERM DRUG-INDUCED SYMPTOM MODIFICATION IN SCHIZOPHRENIC OUTPATIENTS.
Topics: Chlorpromazine; Humans; Outpatients; Placebos; Promazine; Schizophrenia | 1963 |
THE MEASUREMENT OF ACTIVITY PATTERNS OF SCHIZOPHRENIC PATIENTS.
Topics: Chlorpromazine; Humans; Imipramine; Perphenazine; Phenelzine; Placebos; Reserpine; Schizophrenia; Tr | 1963 |
THE INFLUENCE OF PREVIOUS HOSPITALIZATION ON THE CLINICAL COURSE OF PSYCHOPHARMACOLOGICALLY TREATED SCHIZOPHRENIC OUTPATIENTS.
Topics: Chlorpromazine; Hospitalization; Humans; Outpatients; Placebos; Promazine; Psychopharmacology; Schiz | 1963 |
[BORDERLINE STATES BETWEEN SCHIZOPHRENIA AND NEUROSES].
Topics: Adolescent; Child; Chlordiazepoxide; Chlorpromazine; Chlorprothixene; Humans; Meprobamate; Neurotic | 1963 |
[EFFECT OF A SINGLE INTRAVENOUS DOSE OF CHLORPROMAZINE ON THE CEREBROSPINAL FLUID PRESSURE].
Topics: Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Chlorpromazine; Humans; Intracranial Pressure; Ph | 1963 |
[EFFECT OF CHLORPROMAZINE ON LABYRINTHINE, SENSORY AND RETINAL CHRONAXY IN ALCOHOLICS AND IN SCHIZOPHRENIC PATIENTS].
Topics: Alcoholics; Alcoholism; Chlorpromazine; Chronaxy; Ear, Inner; Humans; Pharmacology; Retina; Schizoph | 1963 |
[THE PROBLEM OF ALLERGY IN PSYCHIATRY].
Topics: Chlorpromazine; Drug Hypersensitivity; Epilepsy; Hypersensitivity; Mental Disorders; Parkinsonian Di | 1963 |
EFFECT OF CHLORPROMAZINE WITH PROCYCLIDINE AND IMIPRAMINE ON RADIOACTIVE IODINE UPTAKE.
Topics: Chlorpromazine; Humans; Imipramine; Iodine; Iodine Isotopes; Neurotic Disorders; Parasympatholytics; | 1963 |
A CONTROLLED EVALUATION OF TRIFLUPERIDOL: A NEW POTENT PSYCHOPHARMACOLOGIC AGENT.
Topics: Chlorpromazine; Humans; Psychological Tests; Schizophrenia; Tranquilizing Agents; Trifluperidol | 1963 |
PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. II. DURATION OF TREATMENT EXPOSURE.
Topics: Antipsychotic Agents; Chlorpromazine; Hospitalization; Hospitals, Psychiatric; Humans; Phenothiazine | 1963 |
CURRENT THERAPEUTICS. CXC. THE CURRENT STATUS OF THE TRANQUILLIZERS.
Topics: Anxiety; Chlorpromazine; Depression; Female; Humans; Phenothiazines; Premenstrual Syndrome; Rauwolfi | 1963 |
THE EFFECT OF CHLORPROMAZIN ON THE SECRETION OF CORTICOTROPHIN IN PSYCHIATRIC PATIENTS EXAMINED BY THE METOPIRON TEST.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Chlorpromazine; Geriatrics; Humans; Ketones; M | 1963 |
A CLINICAL TRIAL OF AN ORAL HYPOGLYCEMIC AGENT IN CHRONIC SCHIZOPHRENIC PATIENTS.
Topics: Chlorpromazine; Humans; Hypoglycemic Agents; Phenformin; Placebos; Schizophrenia | 1963 |
THE LONG-TERM CARE OF THE CHRONIC MENTALLY ILL PATIENT, A MEDICAL APPROACH.
Topics: Chlorpromazine; Humans; Long-Term Care; Mental Disorders; Mentally Ill Persons; Schizophrenia; Tranq | 1963 |
PHENOTHIAZINE EXCRETION IN CHRONIC SCHIZOPHRENICS.
Topics: Chlorpromazine; Humans; Phenothiazines; Schizophrenia; Thioridazine; Urine | 1963 |
THORAZINE AS AN EPILEPTOGENIC AGENT.
Topics: Chlorpromazine; Epilepsy; Humans; Pharmacology; Phenytoin; Primidone; Schizophrenia | 1963 |
PREDRUG BEHAVIOR AS A PREDICTOR OF RESPONSE TO PHENOTHIAZINES AMONG SCHIZOPHRENICS.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Perphenazine; Phenobarbital; Phenothiazines; Prochlorp | 1963 |
[URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID, HOMOVANILLIC AND VANILLYLMANDELIC ACIDS IN SCHIZOPHRENIC SUBJECTS WITH RESERPINE AND CHLORPROMAZINE].
Topics: Benzaldehydes; Chlorpromazine; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Mandelic Acids; | 1963 |
[PREVENTION OF HYPOTENSION AND COLLAPSE IN AMINAZINE THERAPY].
Topics: Chlorpromazine; Hypotension; Schizophrenia; Shock; Shock, Septic; Toxicology | 1963 |
[ACUTE AMINAZIN POISONING IN SCHIZOPHRENIA].
Topics: Chlorpromazine; Schizophrenia; Toxicology | 1963 |
[ON THE NEUROLEPTIC SYNDROME IN SCHIZOPHRENIA PATIENTS].
Topics: Antipsychotic Agents; Chlorpromazine; Schizophrenia; Syndrome; Toxicology | 1963 |
[SCHIZOPHRENIA IS CURABLE EVEN IN THE CHRONIC FORMS].
Topics: Chlorpromazine; Humans; Insulin; Prognosis; Psychotherapy; Schizophrenia | 1963 |
[DEMENTIA PRAECOX DEVELOPING FOR OVER 30 YEARS. CURE BY CHLORPROMAZINE].
Topics: Chlorpromazine; Geriatrics; Humans; Schizophrenia | 1963 |
PROLONGED HIGH DOSAGE ATARACTIC MEDICATION IN CHRONIC SCHIZOPHRENIA.
Topics: Chlorpromazine; Convulsive Therapy; Humans; Phenothiazines; Schizophrenia; Tranquilizing Agents | 1964 |
EEG AND BEHAVIORAL CHANGES IN SCHIZOPHRENIA.
Topics: Antidepressive Agents; Behavior; Chlorpromazine; Deanol; Electroencephalography; Humans; Perphenazin | 1964 |
[A STUDY OF THE PROGNOSIS OF SCHIZOPHRENIA WITH EMPHASIS ON PROGNOSIS OF CHILD AND LATE SCHIZOPHRENIA].
Topics: Adolescent; Body Constitution; Child; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; | 1964 |
[PHARMACOTHERAPY OF SCHIZOPHRENIA. I. PHARMACOTHERAPY WITH IN-PATIENTS OF SHORT-TERM ADMISSION].
Topics: Adolescent; Catatonia; Child; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; | 1964 |
EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE.
Topics: Blood Pressure; Chlorpromazine; Depression; Depressive Disorder; Humans; Imipramine; Mental Disorder | 1964 |
A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE.
Topics: Chlorpromazine; Pathology; Photosensitivity Disorders; Pigmentation Disorders; Schizophrenia; Toxico | 1964 |
LYSERGIC ACID DIETHYLAMIDE IN PSYCHOTHERAPY. I: CLINICAL ASPECTS.
Topics: Amobarbital; Antisocial Personality Disorder; Chlorpromazine; Humans; Lysergic Acid Diethylamide; Ne | 1964 |
[DESMETHYLIMIPRAMINE (PERTOFRAN) IN THE TREATMENT OF DEPRESSIONS. A CLINICAL AND PSYCHODYNAMIC APPRAISAL].
Topics: Antidepressive Agents; Biomedical Research; Bipolar Disorder; Chlorpromazine; Depression; Depressive | 1963 |
[THE BLOOD CATECHOLAMINE LEVEL OF MENTAL PATIENTS AND ITS CHANGES UNDER THE INFLUENCE OF AMINAZIN AND INSULIN].
Topics: Blood Chemical Analysis; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Chlorpromazine; | 1963 |
COMPARISON OF DIAZEPAM, CHLORPROTHIXENE AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS.
Topics: Alcoholism; Brain; Brain Damage, Chronic; Chlorpromazine; Chlorprothixene; Diazepam; Schizophrenia; | 1964 |
A CLINICAL AND SOCIO-CULTURAL STUDY OF 100 PSYCHIATRIC PATIENTS STARTED ON CHLORPROMAZINE 20 AND ONE HALF YEARS AGO.
Topics: Chlorpromazine; Culture; Humans; Mental Disorders; Neurotic Disorders; Psychotic Disorders; Schizoph | 1964 |
CARPHENAZINE IN CHRONIC SCHIZOPHRENICS.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Phenothiazines; Prochlorperazine; Schizophrenia; Toxic | 1964 |
[PROBLEMS RAISED BY THE PROLONGED USE OF NEUROLEPTICS AND ANTIDEPRESSANTS. (SIGNIFICANCE OF THE STUDY OF NEUROMUSCULAR EXCITABILITY AND THE RATIO NAPL-KGB)].
Topics: Adenosine Triphosphate; Antidepressive Agents; Antipsychotic Agents; Blood; Central Nervous System; | 1964 |
SYMPTOM SPECIFICITY OF ANTI-PSYCHOTIC DRUGS.
Topics: Chlorpromazine; Humans; Mental Disorders; Perphenazine; Psychopharmacology; Psychotic Disorders; Sch | 1964 |
HIREPINE IN PSYCHIATRY.
Topics: Catatonia; Chlorpromazine; Convulsive Therapy; Dementia; Depression; Electroconvulsive Therapy; Huma | 1964 |
[DYNAMICS OF SUBORDINATION AND ADAPTATION IN PATIENTS WITH THE CATATONIC FORM OF SCHIZOPHRENIA WITH CHRONIC UNFAVORABLE DEVELOPMENT].
Topics: Acclimatization; Adaptation, Physiological; Caffeine; Catatonia; Central Nervous System; Chlorpromaz | 1963 |
[PSYCHOTHERAPEUTIC ASPECTS OF A CHEMOTHERAPY].
Topics: Chlorpromazine; Phenothiazines; Psychotropic Drugs; Schizophrenia | 1964 |
COMPARISON OF FOUR REGIMENS IN NEWLY ADMITTED FEMALE SCHIZOPHRENICS.
Topics: Chlorpromazine; Electroconvulsive Therapy; Fluphenazine; Hospitalization; Humans; Schizophrenia | 1964 |
[REGIONAL BLOOD PRESSURE IN THE CENTRAL RETINAL ARTERY IN SCHIZOPHRENIC PATIENTS DURING AMINAZIN AND RESERPINE THERAPY. (CLINICO-PHYSIOLOGICAL STUDIES)].
Topics: Blood Pressure; Blood Pressure Determination; Chlorpromazine; Reserpine; Retinal Artery; Retinal Ves | 1964 |
[THE EFFECTIVENESS OF AMINAZIN THERAPY OF TERMINAL STATES IN SCHIZOPHRENIA].
Topics: Chlorpromazine; Schizophrenia | 1964 |
[FORREST'S TEST AS A CONTROLLING FACTOR IN THE USE OF PSYCHOTROPIC DRUGS AND ITS RESULTS ACCORDING TO OUR OBSERVATIONS].
Topics: Chlorpromazine; Epilepsy; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Psych | 1964 |
[OBSERVATIONS ON THE USE OF PHENYLPYRROLIDINOPENTANE AS AN ANTIASTHENIC AGENT IN TREATMENT WITH PSYCHOPHARMACOLOGICAL DRUGS].
Topics: Amitriptyline; Anxiety; Anxiety Disorders; Asthenia; Bipolar Disorder; Chemical and Drug Induced Liv | 1964 |
DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS.
Topics: Behavior; Biomedical Research; Chlorpromazine; Humans; Placebos; Psychological Tests; Schizophrenia; | 1964 |
CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIC WOMEN: COMPARISON OF DIFFERENTIAL EFFECTS ON VARIOUS PSYCHOLOGICAL MODALITES DURING AND AFTER TREATMENT.
Topics: Behavior; Biomedical Research; Chlorpromazine; Female; Humans; Mental Disorders; Phenobarbital; Plac | 1964 |
THE EFFECTS OF PHENOTHIAZINE ON DISORDERED THOUGHT IN SCHIZOPHRENIA.
Topics: Attention; Chlorpromazine; Concept Formation; Humans; Intelligence; Phenothiazines; Placebos; Psycho | 1964 |
THE CLINICAL EVALUATION OF A NEW BUTYROPHENONE (WY-3457).
Topics: Antidepressive Agents; Butyrophenones; Chlorpromazine; Drug Therapy; Insulin; Reserpine; Schizophren | 1964 |
THE USE OF NICOTINAMIDE TEST DOSE IN THE ASSESSMENT OF PSYCHOTROPIC DRUGS IN SCHIZOPHRENIC PATIENTS.
Topics: Biomedical Research; Chlordiazepoxide; Chlorpromazine; Humans; Imipramine; Lactose; Niacin; Niacinam | 1964 |
[CLINICAL EXPERIENCES WITH HALOPERIDOL (SERENASE)].
Topics: Bipolar Disorder; Chlorpromazine; Chorea; Dementia; Depressive Disorder, Major; Epilepsy; Haloperido | 1964 |
A DOUBLE-BLIND COMPARISON OF THIORIDAZINE AND CHLORPROMAZINE.
Topics: Aggression; Anxiety; Biomedical Research; Chlorpromazine; Depression; Double-Blind Method; Guilt; Hu | 1964 |
[DEMENTIA PRAECOCISSIMA].
Topics: Autistic Disorder; Brain; Brain Damage, Chronic; Catatonia; Child; Chlorpromazine; Clopenthixol; Dem | 1964 |
[ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
Topics: Benzaldehydes; Chlorpromazine; Dopamine; Epinephrine; Hydroxyindoleacetic Acid; Indoleacetic Acids; | 1963 |
SOME NEUROPHYSIOLOGIC ASPECTS OF SCHIZOPHRENIA: AN ELECTROMYOGRAPHIC STUDY.
Topics: Biomedical Research; Chlorpromazine; Electromyography; Humans; Nervous System; Neurologic Manifestat | 1964 |
A FOURTH OCCURRENCE OF ORAL MONILIASIS DURING TRANQUILIZER THERAPY.
Topics: Candidiasis, Oral; Chlorpromazine; Schizophrenia; Thioridazine; Toxicology; Trifluoperazine | 1964 |
TWO CASES OF WITHDRAWAL FROM ETHCHLORVYNOL.
Topics: Chlorpromazine; Delirium; Epilepsy, Tonic-Clonic; Ethchlorvynol; Hallucinations; Hypnotics and Sedat | 1964 |
DRUG MAINTENANCE PROBLEMS OF REHABILITATED MENTAL PATIENTS: THE CURRENT DRUG DOSAGE "MERRY-GO-ROUND".
Topics: Chlordiazepoxide; Chlorpromazine; Depression; Imipramine; Mental Disorders; Mentally Ill Persons; Pe | 1964 |
A COMPARISON OF THE "OLD" AND THE "NEW" IN DRUG TREATMENT.
Topics: Biomedical Research; Chlorpromazine; Depression; Depressive Disorder; Intellectual Disability; Menta | 1964 |
[LAROXYL (AMITRIPTYLINE), A THYMOLEPTIC WITH A NEUROLEPTIC EFFICACY COMPONENT].
Topics: Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlordiazepoxide; Chlo | 1963 |
TOXICITY REVERSED: REVERSAL OF IMIPRAMINE-MONOAMINE OXIDASE INHIBITOR INDUCED TOXICITY BY CHLORPROMAZINE.
Topics: Chlorpromazine; Imipramine; Monoamine Oxidase Inhibitors; Schizophrenia; Toxicology; Tranylcypromine | 1964 |
PERPHENAZINE (TRILAFON) METABOLISM IN PSYCHOTIC PATIENTS.
Topics: Chlorpromazine; Chromatography; Humans; Mental Disorders; Metabolism; Perphenazine; Psychotic Disord | 1964 |
[NEUROLEPTICS AND DYSKINETIC REACTIONS].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chlorprothixene; Depression; Fluphenazine; M | 1963 |
DEPTH RECORDING FROM THE HUMAN BRAIN IN EPILEPSY.
Topics: Adolescent; Amygdala; Astrocytoma; Bemegride; Caudate Nucleus; Child; Chlorpromazine; Electroencepha | 1963 |
PSYCHOSES CAUSED BY NEUROLEPTICS.
Topics: Antipsychotic Agents; Chlorpromazine; Delirium; Depression; Geriatrics; Humans; Mental Disorders; Ps | 1964 |
[APROPOS OF THE INHIBITION OF EJACULATION DURING THIORIDAZINE TREATMENT: ITS POSSIBLE THERAPEUTIC VALUE].
Topics: Anura; Chlorpromazine; Ejaculation; Gonadotropins; Humans; Pharmacology; Promazine; Rabbits; Rats; R | 1964 |
[COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Delirium; Depression; Hallucinations; Halope | 1964 |
[THIORIDAZINE IN SCHIZOPHRENIA].
Topics: Chlorpromazine; Humans; Schizophrenia; Thioridazine | 1964 |
IMIPRAMINE AND THIORIDAZINE IN DEPRESSED AND SCHIZOPHRENIC PATIENTS. ARE THERE SPECIFIC ANTIDEPRESSANT DRUGS?
Topics: Amitriptyline; Antidepressive Agents; Chlorpromazine; Computers; Depression; Drug Therapy; Imipramin | 1964 |
[INFLUENCE OF NEUROLEPTICS ON VIGILANCE: CLINICAL EXPERIENCE CONCERNING THEIR EFFECTS ON THE E.E.G., THE GAMMA SYSTEM AND THE LEVEL OF PERFORMANCE].
Topics: Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Depression; Electroencephalography; Humans; P | 1964 |
THE INFLUENCE OF THE TRANQUILIZERS ON THE LEONHARD SCHIZOPHRENIC SYNDROMES.
Topics: Autistic Disorder; Catatonia; Chlorpromazine; Chlorprothixene; Humans; Methotrimeprazine; Prochlorpe | 1964 |
CLINICAL AND BIOCHEMICAL EFFECTS OF PSYCHOPHARMACA.
Topics: Adrenocorticotropic Hormone; Chlorpromazine; Metyrapone; Mineralocorticoid Receptor Antagonists; Pit | 1963 |
[EFFECT OF AMINAZIN ON THE FUNCTIONAL STATUS OF THE BRAIN IN PSYCHIATRIC PATIENTS].
Topics: Brain; Brain Diseases; Chlorpromazine; Drug Therapy; Electroencephalography; Electrophysiology; Epil | 1963 |
ANTI-SEROTONIN ACTIVITY AND CLINICAL TRANQUILIZATION.
Topics: Biomedical Research; Chlorpromazine; Drug Therapy; Methysergide; Placebos; Schizophrenia; Selective | 1964 |
TRANQUILIZERS AND SUICIDE IN THE SCHIZOPHRENIC PATIENT.
Topics: Aging; Alcoholism; Biomedical Research; Chlorpromazine; Drug Therapy; Marriage; Perphenazine; Prochl | 1964 |
THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM.
Topics: Antipsychotic Agents; Biomedical Research; Chlorpromazine; Electrocardiography; Pharmacology; Phenot | 1964 |
[ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
Topics: Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Handwriting; Humans; Movement Disorders; | 1964 |
[DYNAMICS OF IMMEDIATE EFFECTIVENESS OF TREATMENT OF SCHIZOPHRENICS. (COMPARATIVE EVALUATION OF VARIOUS THERAPEUTIC METHODS)].
Topics: Catatonia; Chlorpromazine; Convulsive Therapy; Electricity; Electroconvulsive Therapy; Hallucination | 1963 |
SIMULTANEOUS DEATH IN SCHIZOPHRENIC TWINS.
Topics: Chlorpromazine; Death, Sudden; Diseases in Twins; Methandrostenolone; Nutrition Disorders; Pathology | 1964 |
7-HYDROXYCHLORPROMAZINE IN THE URINES OF SCHIZOPHRENICS RECEIVING CHLROPROMAZINE.
Topics: Antipsychotic Agents; Chlorpromazine; Chromatography; Drug Therapy; Humans; Metabolism; Phenothiazin | 1964 |
THE USE OF DRUG COMBINATIONS IN PEDIATRIC PSYCHIATRY.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Brain Injuries; Child; Child Behavior | 1964 |
DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
Topics: Chlorpromazine; Corneal Opacity; Female; Humans; Menstruation Disturbances; Pigmentation Disorders; | 1964 |
A CLINICAL COMPARISON OF TRIFLUPERIDOL, HALOPERIDOL, AND CHLORPROMAZINE.
Topics: Biomedical Research; Chlorpromazine; Haloperidol; Parasympatholytics; Placebos; Schizophrenia; Toxic | 1964 |
PIGMENT DEPOSITION IN VISCERA ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
Topics: Adolescent; Autonomic Nervous System; Cerebral Cortex; Chlorpromazine; Cornea; Endocrine Glands; Epi | 1964 |
THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.
Topics: Body Fluids; Chlorpromazine; Copper; Darkness; Drug Therapy; Eye Diseases; Histocytochemistry; Hospi | 1964 |
[CLINICAL EXPERIENCES WITH A NEW ANTIPARKINSON AGENT, AKINETON, WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS CAUSED BY PHENOTHIAZINE DERIVATIVES].
Topics: Adolescent; Antiparkinson Agents; Biperiden; Central Nervous System Diseases; Child; Chlorpromazine; | 1964 |
SENSORY CHANGES WITH PHENOTHIAZINE MEDICATION IN SCHIZOPHRENIC PATIENTS.
Topics: Biomedical Research; Chlorpromazine; Drug Therapy; Figural Aftereffect; Flicker Fusion; Form Percept | 1964 |
COMPARISON OF HALOPERIDOL, TRIFLUPERIDOL, AND CHLORPROMAZINE IN ACUTE SCHIZOPHRENIC PATIENTS.
Topics: Biomedical Research; Chlorpromazine; Haloperidol; Humans; Hypnotics and Sedatives; Schizophrenia; Tr | 1964 |
CHANGES IN SERUM PROTEINS AND CEREBROSPINAL FLUID PROTEINS DURING PHARMACOTHERAPY OF PSYCHOSES.
Topics: Alcoholism; Bipolar Disorder; Blood Proteins; Cerebrospinal Fluid Proteins; Chlorpromazine; Drug The | 1964 |
EFFECTS OF ACETOPHENAZINE DIMALEATE ON PARANOID SYMPTOMATOLOGY IN FEMALE GERIATRIC PATIENTS: DOUBLE-BLIND STUDY.
Topics: Biomedical Research; Chlorpromazine; Double-Blind Method; Drug Therapy; Geriatrics; Phenothiazines; | 1964 |
SUDDEN DEATH OF A CATATONIC PATIENT RECEIVING PHENOTHIAZINE.
Topics: Brain; Catatonia; Chlorpromazine; Death, Sudden; Drug Therapy; Pathology; Phenothiazines; Schizophre | 1964 |
SCHIZOPHRENIA WITH ADRENAL HYPERCORTICALISM.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Chlorotrianisene; Chlorpromazine; Dexamet | 1964 |
PRESENT TREATMENT OF SCHIZOPHRENIA--A CONTROLLED FOLLOW-UP STUDY.
Topics: Chlorpromazine; Convulsive Therapy; Drug Therapy; England; Follow-Up Studies; Hospitals, Psychiatric | 1965 |
THE SERUM PROTEINS IN THE ALCOHOLIC AND MENTALLY ILL TREATED WITH CHLORPROMAZINE.
Topics: Alcoholism; Alpha-Globulins; Beta-Globulins; Blood Protein Electrophoresis; Blood Proteins; Chlorpro | 1964 |
AN INVESTIGATION OF THE VARIABILITY IN REPEATED PSYCHOPHYSIOLOGICAL MEASUREMENTS IN TRANQUILIZED MENTAL PATIENTS.
Topics: Blood Pressure; Chlorpromazine; Drug Therapy; Galvanic Skin Response; Heart; Heart Rate; Humans; Men | 1964 |
POSTPARTUM PSYCHOSES IN THE MALE.
Topics: Chlordiazepoxide; Chlorpromazine; Drug Therapy; Female; Humans; Paranoid Disorders; Paternity; Postp | 1964 |
FACTORS INFLUENCING THE CLINICAL RESPONSES OF SCHIZOPHRENIC PATIENTS TO PHENOTHIAZINE DRUGS AND TO PLACEBO.
Topics: Biomedical Research; Chlorpromazine; Drug Therapy; Fluphenazine; Humans; Phenothiazines; Placebos; S | 1964 |
ELECTROSHOCK THERAPY WITH THE PHENOTHIAZINES AND RESERPINE: A SURVEY AND REPORT.
Topics: Adolescent; Bipolar Disorder; Black People; Chlorpromazine; Depressive Disorder, Major; Drug Therapy | 1964 |
PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Therapy; Hospitalization; Humans; Phenothiazines; Placebo | 1964 |
OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE.
Topics: Chlorpromazine; Diagnosis; Drug Eruptions; Eye Diseases; Facial Dermatoses; Pathology; Pigmentation | 1965 |
TRIFLUPERIDOL AND HALOPERIDOL IN THE TREATMENT OF ACUTE SCHIZOPHRENIA.
Topics: Chlorpromazine; Drug Therapy; Haloperidol; Psychological Tests; Schizophrenia; Tranquilizing Agents; | 1964 |
ARE TRANQUILIZER COMBINATIONS MORE EFFECTIVE THAN A SINGLE TRANQUILIZER?
Topics: Biomedical Research; Chlorpromazine; Drug Synergism; Drug Therapy; Hypnotics and Sedatives; Placebos | 1964 |
[RETINAL DAMAGE AFTER TREATMENT WITH CHLORPROTHIXENE].
Topics: Chlorpromazine; Chlorprothixene; Drug Therapy; Perphenazine; Retinitis; Schizophrenia; Thioridazine; | 1964 |
[SOMATOTHERAPY OF ENDOGENOUS PSYCHOSES AT MARBURG UNIVERSITY NEUROLOGIC CLINIC].
Topics: Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Depression; | 1964 |
[STATUS OF TREATMENT OF SCHIZOPHRENIA OUTSIDE OF HOSPITALS].
Topics: Adaptation, Psychological; Antidepressive Agents; Chlorpromazine; Convulsive Therapy; Drug Therapy; | 1964 |
[BLOOD PRESSURE AND ARTERIAL OSCILLOMETRIC INDICES IN SCHIZOPHRENIC PATIENTS AND THEIR DYNAMICS DURING AMINAZIN THERAPY].
Topics: Arteries; Blood Pressure; Blood Pressure Determination; Chlorpromazine; Drug Therapy; Humans; Oscill | 1964 |
[AMINAZIN THERAPY OF SCHIZOPHRENIE PATIENTS WITH PULMONARY TUBERCULOSIS].
Topics: Chlorpromazine; Drug Therapy; Humans; Schizophrenia; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
TRIFLUPERIDOL IN "PARANOID" AND "NON-PARANOID" SCHIZOPHRENICS.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Drug Therapy; Humans; Schizophrenia; Tri | 1965 |
[EFFECT OF COURSE TREATMENT WITH AMINAZIN ON REGIONAL BLOOD CIRCULATION IN PATIENTS WITH SCHIZOPHRENIA].
Topics: Blood Circulation; Chlorpromazine; Conditioning, Classical; Humans; Nervous System Physiological Phe | 1965 |
[CHANGES IN VEGETATIVE FUNCTIONS IN PATIENTS WITH SCHIZOPHRENIA DURING THE PROCESS OF TREATMENT WITH INSULIN SHOCK COMBINED WITH AMINAZIN].
Topics: Adolescent; Chlorpromazine; Convulsive Therapy; Drug Therapy; Insulin; Insulin Coma; Schizophrenia | 1965 |
URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
Topics: Autonomic Nervous System Diseases; Chlorpromazine; Drug Therapy; Extrapyramidal Tracts; Fluids and S | 1965 |
NON-POLAR URINARY METABOLITES OF CHLORPROMAZINE IN MALE SCHIZOPHRENICS.
Topics: Biological Transport; Chlorpromazine; Chromatography; Drug Therapy; Fluids and Secretions; Humans; M | 1964 |
PENTOTHAL INDUCED CHANGES IN EEG AS A PROGNOSTIC INDEX IN DRUGS THERAPY OF PSYCHOTIC PATIENTS.
Topics: Chlorpromazine; Depression; Drug Therapy; Electroencephalography; Mental Disorders; Neurotic Disorde | 1965 |
TIME-SERIES, FREQUENCY ANALYSIS, AND ELECTROGENESIS OF THE EEGS OF NORMALS AND PSYCHOTICS BEFORE AND AFTER DRUGS.
Topics: Amphetamine; Antidepressive Agents; Barbiturates; Biomedical Research; Caffeine; Central Nervous Sys | 1965 |
SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE.
Topics: Chemical Phenomena; Chemistry; Chlorpromazine; Diagnosis, Differential; Drug Therapy; Epilepsy; Eye | 1965 |
[CLINICAL AND ELECTROENCEPHALOGRAPHIC STUDIES ON SCHIZOPHRENIC PATIENTS WITH CHRONIC VERBAL HALLUCINOSIS IN AMINAZIN AND PROPAZINE THERAPY].
Topics: Chlorpromazine; Hallucinations; Promazine; Psychotic Disorders; Schizophrenia; Triazines | 1964 |
PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION.
Topics: Chlorpromazine; Drug Therapy; Fluphenazine; Hospitalization; Humans; Perphenazine; Phenothiazines; P | 1965 |
[THERAPEUTIC EXPERIENCES WITH "MASSIVE" DOSES OF CHLORPROMAZINE].
Topics: Adolescent; Bipolar Disorder; Chlorpromazine; Chorea; Drug Therapy; Geriatrics; Mental Disorders; Ps | 1965 |
LENTICULAR OPACITIES WITH PROLONGED PHENOTHIAZINE THERAPY: A POTENTIAL HAZARD WITH ALL PHENOTHIAZINE DERIVATIVES.
Topics: Antipsychotic Agents; Cataract; Chlorpromazine; Drug Therapy; Fluphenazine; Phenothiazines; Prochlor | 1965 |
FURTHER STUDIES OF CHLORPROMAZINE METABOLISM AND RELAPSE RATE.
Topics: Chlorpromazine; Drug Therapy; Glucuronates; Metabolism; Psychopharmacology; Recurrence; Research; Sc | 1965 |
(COMMENTS ON "7-HYDROXYCHLORPROMAZINE IN THE URINES OF SCHIZOPHRENICS RECEIVING CHLORPROMAZINE".)
Topics: Chlorpromazine; Chromatography; Humans; Metabolism; Schizophrenia; Urine | 1965 |
SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Chlorprothixene; Drug Therapy; Extrapyra | 1965 |
DISSIPATION OF PHENOTHIAZINE EFFECT AND RECURRENCE OF SCHIZOPHRENIC PSYCHOSIS.
Topics: Chlorpromazine; Drug Therapy; Humans; Phenothiazines; Psychotic Disorders; Schizophrenia; Substance | 1965 |
COMMUNICATION OF BODY COMPLAINTS AND PARANOID SYMPTOM CHANGE UNDER CONDITIONS OF PHENOTHIAZINE TREATMENT.
Topics: Biomedical Research; Chlorpromazine; Cognition; Communication; Drug Therapy; Humans; Paranoid Disord | 1965 |
[ON THERAPEUTIC EFFICACY OF SUDDEN SUSPENSION OF PROLONGED THERAPY WITH ASSOCIATED RESERPINE AND CHLORPROMAZINE IN SCHIZOPHRENIC SUBJECTS].
Topics: Chlorpromazine; Drug Therapy; Haloperidol; Humans; Phenothiazines; Reserpine; Schizophrenia; Substan | 1965 |
COMPUTER ANALYSIS OF DRUG EFFECTS ON THE ELECTROENCEPHALOGRAMS OF NORMAL AND PSYCHOTIC SUBJECTS.
Topics: Antidepressive Agents; Biomedical Research; Chlorpromazine; Computers; Drug Therapy; Electroencephal | 1964 |
[ON THE EFFECT OF REPEATED AMINAZIN THERAPY ON THE COURSE OF SCHIZOPHRENIA].
Topics: Chlorpromazine; Drug Therapy; Schizophrenia | 1964 |
[EFFECT OF SYSTEMATIC AMINAZIN THERAPY ON THE COURSE OF PERIODIC SCHIZOPHRENIA].
Topics: Bipolar Disorder; Catatonia; Chlorpromazine; Drug Therapy; Humans; Mental Disorders; Paranoid Disord | 1964 |
ABNORMAL EFFECTS OF PREALBUMIN FROM SERA OF PSYCHOTIC PATIENTS ON METABOLISM OF RAT DIAPHRAGM.
Topics: Blood Proteins; Carbohydrate Metabolism; Chlorpromazine; Diaphragm; Humans; Pharmacology; Prealbumin | 1964 |
[Mechanism of action of chlorpromazine in schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1954 |
[Treatment of schizophrenic syndromes with chlorpromazine].
Topics: Chlorpromazine; Schizophrenia; Syndrome | 1954 |
Clinical use of reserpine in psychiatry: comparison with chlorpromazine.
Topics: Chlorpromazine; Psychiatry; Psychotherapy; Psychotic Disorders; Reserpine; Schizophrenia; Secologani | 1955 |
Chlorpromazine and reserpine in the treatment of psychoses.
Topics: Chlorpromazine; Mental Disorders; Psychotherapy; Psychotic Disorders; Reserpine; Schizophrenia; Seco | 1955 |
[Chlorpromazine in manic-depressive and schizophrenic psychoses].
Topics: Bipolar Disorder; Chlorpromazine; Humans; Mental Disorders; Psychotic Disorders; Schizophrenia | 1955 |
[An observation on the use of largactil in chronic schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1955 |
[Results of chlorpromazine treatment of 22 male and 37 female schizophrenics].
Topics: Chlorpromazine; Female; Humans; Male; Schizophrenia | 1955 |
[Extrapyramidal-like syndromes, oculogyral seizures and chlorpromazine].
Topics: Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Eye Movements; Humans; Oculo | 1955 |
[Initial results of chlorpromazine treatment of a significant number of chronic patients].
Topics: Chlorpromazine; Electroconvulsive Therapy; Psychosurgery; Psychotic Disorders; Schizophrenia | 1955 |
[Liver function and blood proteins during chlorpromazine therapy of schizophrenia].
Topics: Blood Proteins; Chlorpromazine; Digestion; Liver; Schizophrenia | 1955 |
A controlled trial of thiopropazate dihydrochloride (dartalan). chlorpromazine and occupational therapy in chronic schizophrenics.
Topics: Chlorpromazine; Humans; Occupational Therapy; Phenothiazines; Schizophrenia; Tranquilizing Agents | 1960 |
A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic, and normal humans.
Topics: Chlorpromazine; Humans; Neurotic Disorders; Publications; Schizophrenia | 1960 |
Chlorpromazine and pecazine in chronic schizophrenia.
Topics: Chlorpromazine; Phenothiazines; Schizophrenia | 1960 |
Responses of treatment-refractory chronic schizophrenics to chlorpromazine with concurrent adrenocortical steroid.
Topics: Chlorpromazine; Schizophrenia; Triamcinolone | 1960 |
[On supporting and therapeutic treatment of schizophrenia with neuroleptic drugs].
Topics: Antipsychotic Agents; Chlorpromazine; Schizophrenia | 1960 |
[Results of chlorpromazine therapy in chronic schizophrenia].
Topics: Chlorpromazine; Schizophrenia | 1959 |
High dosage chlorpromazine therapy in acute and chronic schizophrenia.
Topics: Chlorpromazine; Schizophrenia | 1960 |
Comparison of low and high dosage procedures in chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Schizophrenia | 1959 |
[Pressure in the central artery of the retina in patients with schizophrenia during treatment with insulin, aminazine and reserpine].
Topics: Arteries; Brain; Chlorpromazine; Convulsive Therapy; Insulin; Reserpine; Retina; Schizophrenia; Shoc | 1961 |
[Pentazole-neuroleptic and neuroleptic treatment of acute schizophrenic psychoses in a catamnestic comparison].
Topics: Antipsychotic Agents; Chlorpromazine; Psychotic Disorders; Reserpine; Schizophrenia | 1961 |
[Study on the pentazole-neuroleptic and neuroleptic treatment of schizophrenia].
Topics: Antipsychotic Agents; Chlorpromazine; Pentylenetetrazole; Reserpine; Schizophrenia | 1961 |
Relative efficacy of electroconvulsive therapy and chlorpromazine in schizophrenia.
Topics: Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; Schizophrenia | 1962 |
Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Autoradiography; Binding | 2004 |
The role of psychodynamic understanding in the treatment of the medication-refusing schizophrenic patient: a clinical report.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Comprehension; Fe | 2003 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administ | 2004 |
Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Case-Control Studies; Chlorpromazine; Electric Stimulation; | 2004 |
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.
Topics: Adult; Antipsychotic Agents; Case-Control Studies; Chlorpromazine; Combined Modality Therapy; Diagno | 2004 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal G | 2004 |
Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Drug Utilization; Fema | 2004 |
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.
Topics: Adult; Age Factors; Antipsychotic Agents; Bone Density; Chlorpromazine; Dopamine Antagonists; Female | 2004 |
A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chromosomes, Human, Pair 12; Comorbidity; Ge | 2004 |
Two cases of deep vein thrombosis associated with antipsychotic drug use.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Depressive Disorder, Major; Dose-Response Relationship, | 2004 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Computer Simulation; | 2005 |
Re: From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Decision Making; Hospitalization; Humans; Schizophr | 2004 |
Factors related to prescription dosage in Japanese psychiatric hospitals.
Topics: Adult; Aged; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Dose-Response Relationship, Drug; | 2005 |
Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
Topics: Adult; Antipsychotic Agents; China; Chlorpromazine; Female; Gene Deletion; Genetic Predisposition to | 2005 |
Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Chlorpromazine; Humans; Male; Neurologic Examination | 2006 |
Clozapine action on auditory P3 response in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Double-Blind Method; Event- | 2005 |
Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Diet; Exercise; Female; Haloperidol; H | 2005 |
Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Diagnostic and Statist | 2004 |
Immunological characteristics of diabetes in schizophrenia.
Topics: Antipsychotic Agents; Autoantibodies; Chlorpromazine; Diabetes Complications; Diabetes Mellitus; Hum | 2005 |
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study.
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzod | 2005 |
Recurrent heat-related illnesses during antipsychotic treatment.
Topics: Antipsychotic Agents; Body Temperature Regulation; Chlorpromazine; Clopenthixol; Diabetes Complicati | 2005 |
[No association of -1438G/A polymorphism in promoter region of 5-HT2A receptor gene with antipsychotic agent-induced weight gain].
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Gene Frequency; Genotype; Humans; Male; Polymer | 2005 |
[Learned equivalence in schizophrenia: novel method for the measurement of memory functions of the hippocampus and basal ganglia].
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Case-Control Studies; Chlorpromazine; Dopamine Antagonis | 2005 |
Neuroleptics and mortality: a 50-year cycle: Invited commentary on... Schizophrenia, neuroleptic medication and mortality.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Schizophrenia | 2006 |
Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chlorpromazine; Clozapine; Cross-Over Studies | 2007 |
Priapism associated with typical and atypical antipsychotic medications.
Topics: Adrenergic alpha-Antagonists; Adult; Antipsychotic Agents; Chlorpromazine; Humans; Male; Priapism; R | 2006 |
Bipolar and schizophrenic patients differ in patterns of visual motion discrimination.
Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Brief Psychiatric Rating Scale; Child; Chlorpromazine | 2006 |
Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients.
Topics: Adult; Akathisia, Drug-Induced; Alleles; Antipsychotic Agents; Asian People; Chlorpromazine; Dystoni | 2006 |
Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment.
Topics: Adult; Aged; Antipsychotic Agents; Binding Sites; Case-Control Studies; Chlorpromazine; Female; Huma | 2006 |
Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Clozapine; Cost-Benefit Analysis; Huma | 2006 |
Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine.
Topics: Adult; Antipsychotic Agents; Atrophy; Benzodiazepines; Chlorpromazine; Chronic Disease; Female; Foll | 2006 |
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.
Topics: Adult; Animals; Antipsychotic Agents; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins E; Biom | 2007 |
Alterations in serum amino acid concentrations in male and female schizophrenic patients.
Topics: Adolescent; Adult; Aged; Amino Acids; Antipsychotic Agents; Case-Control Studies; Chlorpromazine; Ch | 2007 |
A social cognitive approach to emotional intensity judgment deficits in schizophrenia.
Topics: Adult; Affect; Antipsychotic Agents; Chlorpromazine; Cognitive Behavioral Therapy; Expressed Emotion | 2007 |
In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module.
Topics: Adult; Chlorpromazine; Cornea; Corneal Opacity; Dopamine Antagonists; Female; Humans; Microscopy, Co | 2007 |
Problems and profits of cross-national collaborative studies.
Topics: Acute Disease; Antipsychotic Agents; Chlorpromazine; Controlled Clinical Trials as Topic; Feasibilit | 1974 |
Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population.
Topics: Adult; Age of Onset; Antipsychotic Agents; Asian People; Basal Ganglia Diseases; China; Chlorpromazi | 2007 |
Myocarditis after overdose of conventional antipsychotics.
Topics: Aged; Antipsychotic Agents; Blood Pressure; Chlorpromazine; Creatine Kinase; Dopamine; Drug Overdose | 2009 |
Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
Topics: Adult; Antipsychotic Agents; Apolipoproteins E; Bipolar Disorder; Blotting, Western; Chlorpromazine; | 2008 |
A longitudinal study of learning potential and rehabilitation outcome in schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Diagnostic and S | 2008 |
BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population.
Topics: Adult; Alleles; Antipsychotic Agents; Asian People; Basal Ganglia Diseases; Base Sequence; Brain-Der | 2008 |
Antipsychotic-induced movement disorders - forgotten but not gone.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Brain; Chlorpromazine; Clozapine; Dopamine; Dyskinesi | 2008 |
[Various indices of the allergic reactivity of schizophrenic patients during treatment with aminazine].
Topics: Adult; Body Temperature; Chlorpromazine; Drug Hypersensitivity; Humans; Schizophrenia; Serum Sicknes | 1966 |
[Peculiarities of the electrical activity of the brain in schizophrenic patients following the pursuit of therapeutic gymnastics].
Topics: Chlorpromazine; Convulsive Therapy; Electroencephalography; Gymnastics; Humans; Hypochondriasis; Mal | 1966 |
[On the clinical picture and pathogenesis of convulsive phenomena in aminazine therapy].
Topics: Adult; Central Nervous System Diseases; Chlorpromazine; Female; Humans; Schizophrenia; Seizures; Ski | 1966 |
[Neuraminic acid levels in the blood of patients with schizophrenia and other psychoses].
Topics: Adolescent; Adult; Catatonia; Central Nervous System Diseases; Child; Child, Preschool; Chlorpromazi | 1966 |
[On the topography and dynamics of skin potentials under normal conditions and in some diseases of the central nervous system (schizophrenia and epilepsy)].
Topics: Chlorpromazine; Depressive Disorder, Major; Electroencephalography; Electrophysiology; Epilepsy; Hum | 1966 |
[On peculiarities of the clinical picture and course of circular schizophrenia and the effect of active therapy on it].
Topics: Adolescent; Adult; Chlorpromazine; Chronic Disease; Convulsive Therapy; Humans; Middle Aged; Schizop | 1966 |
[On peculiarities of the effect of aminazine on human thrombocytes].
Topics: Adult; Blood Platelets; Chlorpromazine; Humans; Schizophrenia | 1966 |
Ultracentrifugal serum proteins in schizophrenia.
Topics: Adult; Blood Protein Disorders; Blood Proteins; Chlorpromazine; Female; Humans; Macroglobulins; Male | 1966 |
Chlorpromazine epithelial keratopathy.
Topics: Chlorpromazine; Corneal Opacity; Epithelium; Humans; Schizophrenia | 1966 |
[Effect of chlorpromazine upon the hypothalamopituitary-adrenocortical functions].
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adult; Chlorpromazine; Convulsive Therapy; Female; Humans | 1966 |
Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
Topics: Chlorpromazine; Corneal Opacity; Eye Diseases; Humans; Israel; Lens, Crystalline; Male; Schizophreni | 1967 |
Eye and skin changes in psychiatric patients treated with chlorpromazine.
Topics: Chlorpromazine; Eye; Female; Humans; Male; Schizophrenia; Skin | 1967 |
Niemann-Pick's disease manifesting as schizophrenia.
Topics: Adolescent; Chlorpromazine; Diagnosis, Differential; Humans; Male; Niemann-Pick Diseases; Schizophre | 1967 |
Observations on the relationship of tranquilization effects and alterations of blood sedimentation values.
Topics: Blood Coagulation; Blood Sedimentation; Chlorpromazine; Humans; In Vitro Techniques; Mental Disorder | 1967 |
Autonomic reactions in relation to psychotropic drugs.
Topics: Adolescent; Adult; Autonomic Nervous System; Blood Pressure; Chlorpromazine; Darkness; Depression; F | 1967 |
Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical factors.
Topics: Chlorpromazine; Female; Humans; Indicators and Reagents; Male; Paranoid Disorders; Pharmaceutical Ve | 1967 |
Late paraphrenia.
Topics: Aged; Chlorpromazine; Dementia; Diagnosis, Differential; Electroconvulsive Therapy; Female; Hearing | 1967 |
Schizophrenia in a male pseudohermaphrodite.
Topics: Adult; Chlorpromazine; Disorders of Sex Development; Electric Stimulation; Electroshock; Humans; Mal | 1967 |
Effects of caloric restriction on behavior and body weight during chlorpromazine therapy.
Topics: Adult; Behavior; Blood Pressure; Body Weight; Chlorpromazine; Diet, Reducing; Female; Humans; Male; | 1967 |
Insulin and chlorpromazine in schizophrenia: a ten year comparative survey.
Topics: Age Factors; Chlorpromazine; Convulsive Therapy; Female; Hospitalization; Humans; Male; Schizophreni | 1967 |
[Thromboembolism complications in neuro- and thymoleptic therapy].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Chlorpromazine; Depression; Female; Humans; | 1967 |
[Simple disorders of consciousness as a complication of chlorpromazine therapy].
Topics: Adult; Chlorpromazine; Drug Hypersensitivity; Female; Humans; Middle Aged; Paranoid Disorders; Schiz | 1967 |
Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy.
Topics: Adult; Bipolar Disorder; Brain Damage, Chronic; Chlorpromazine; Electroconvulsive Therapy; Electroen | 1967 |
[A study on amobarbital-induced sleep in schizophrenics. Correlation with the effects of pharmacotherapy].
Topics: Adolescent; Adult; Amobarbital; Chlorpromazine; Female; Humans; Male; Schizophrenia; Sleep | 1967 |
Prognosis of schizophrenia before and after pharmacotherapy: II. Three-year follow-up.
Topics: Adult; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Family Characteristics; Female | 1967 |
Prognosis of schizophrenia before and after pharmacotherapy: I. Short term outcome.
Topics: Adult; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Family Characteristics; Female | 1967 |
Chlorpromazine metabolite pattern in psychotic patients.
Topics: Adolescent; Adult; Chlorpromazine; Chromatography, Thin Layer; Female; Humans; Male; Middle Aged; Ps | 1967 |
Schizophrenic reaction.
Topics: Adult; Chlorpromazine; Humans; Occupational Therapy; Psychotherapy; Schizophrenia | 1967 |
Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment.
Topics: Adult; Blood Platelets; Chlorpromazine; Chronic Disease; Clonidine; Humans; Kinetics; Male; Norepine | 1984 |
Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Male; Middle Age | 1980 |
The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Double | 1980 |
Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration.
Topics: Antipsychotic Agents; Biotransformation; Chlorpromazine; Humans; Psychiatric Status Rating Scales; S | 1980 |
[Sensory disorders arising during neuroleptic therapy].
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Female; Haloperidol | 1980 |
Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Male; | 1981 |
Stuttering: an unusual side effect of phenothiazines.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Humans; Male; Schizophrenia; Stuttering; | 1981 |
[Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Topics: Adult; Antipsychotic Agents; Bromocriptine; Chlorpromazine; Chronic Disease; Dose-Response Relations | 1980 |
Depressed patients with schizophrenic or paranoid symptoms.
Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Bipolar Disorder; Child; Chlorpromazine; Dep | 1980 |
Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Drug Thera | 1981 |
An alternative mechanism of actions for neuroleptic and antidepressant drugs.
Topics: Anesthetics, Local; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain; Cell Mem | 1981 |
Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Prolactin; Schizophr | 1981 |
[Effect of aminazine and majeptil on proliferation of peripheral blood lymphocytes cultivated with phytohemagglutinin].
Topics: Cells, Cultured; Chlorpromazine; Dose-Response Relationship, Drug; Humans; Lymphocytes; Mitosis; Phe | 1981 |
Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Homovanillic Acid; Humans; Male; P | 1981 |
Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics.
Topics: Acute Disease; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Chlorpromazi | 1981 |
Tolerance to the prolactin-elevating effect of neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dopamine; Drug Tolerance; Haloperidol; Humans; Ma | 1981 |
Does a plasma level of chlorpromazine help?
Topics: Brief Psychiatric Rating Scale; Chlorpromazine; Chromatography, Gas; Humans; Mass Spectrometry; Outc | 1981 |
[Predicting the effect of psychopharmacotherapy in schizophrenic patients].
Topics: Adolescent; Adult; Antipsychotic Agents; Autonomic Nervous System; Chlorpromazine; Convulsive Therap | 1982 |
[Dynamics of integral parameters of the background EEG during treatment with neuroleptics].
Topics: Antipsychotic Agents; Automatism; Brain; Chlorpromazine; Clozapine; Electroencephalography; Haloperi | 1982 |
Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Chronic Disease; Humans; Male; Middle Aged; Prolac | 1982 |
Low serum neuroleptic levels predict relapse in schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle A | 1982 |
[Effect of leponex on lactate dehydrogenase activity in a tissue culture of embryonal human brain].
Topics: Anti-Anxiety Agents; Benzodiazepines; Brain; Chlorpromazine; Clozapine; Culture Techniques; Dibenzaz | 1982 |
Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Topics: Adult; Amine Oxidase (Copper-Containing); Antipsychotic Agents; Blood Platelets; Chlorpromazine; Fem | 1982 |
Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Chlorpromazine; Chronic Disease; Erythroc | 1982 |
Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dopamine beta-Hydroxylase; Female; Flu | 1982 |
Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chlorpromazine; Chronic Disease; Humans; Male; Middle Age | 1983 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 2].
Topics: Bromazepam; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Humans; Perphenazine; Psychophysiologic | 1983 |
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dopamine beta-Hydroxylase; Fluphenazine; Haloperidol; Humans; | 1983 |
Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Female; Humans; Male; Middle Age | 1984 |
Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
Topics: Adult; Catecholamines; Chlorpromazine; Chronic Disease; Female; Humans; Indoles; Male; Middle Aged; | 1984 |
Dissimilar dosing with high-potency and low-potency neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Utilization; F | 1984 |
The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Interactions; Electroencephalography; Female; Half | 1984 |
Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Chlorproma | 1984 |
Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
Topics: Aged; Alzheimer Disease; Biopterins; Chlorpromazine; Female; Humans; Male; Neurotransmitter Agents; | 1983 |
Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1980 |
Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia.
Topics: Animals; Antipsychotic Agents; Brain; Chlorpromazine; Haloperidol; Humans; Hydroxyindoleacetic Acid; | 1981 |
Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Chlorpromazine; Depressive Disorder; Electroconvulsive Th | 1981 |
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients.
Topics: Adolescent; Adult; Cerebrospinal Fluid Proteins; Chlorpromazine; Dopamine Antagonists; Female; Homov | 1984 |
Plasma cyclic AMP in schizophrenics.
Topics: Acute Disease; Aging; Blood Proteins; Chlorpromazine; Chronic Disease; Cyclic AMP; Female; Humans; M | 1980 |
Plasma level of cyclic AMP and mental diseases.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Chlorpromazine; Cyclic AMP; Female; Humans; Male; Mental | 1980 |
Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys.
Topics: Adolescent; Chlorpromazine; Chorionic Gonadotropin; Gonadotropin-Releasing Hormone; Humans; Hypothal | 1983 |
Effects of chlorpromazine on serotonin uptake in blood platelets.
Topics: Adult; Blood Platelets; Chlorpromazine; Female; Humans; Kinetics; Male; Schizophrenia; Serotonin | 1983 |
Lateral ventricular size and drug-induced Parkinsonism.
Topics: Adolescent; Adult; Antiparkinson Agents; Cerebral Ventricles; Chlorpromazine; Female; Humans; Male; | 1983 |
Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Topics: Adolescent; Adult; Body Weight; Chlorpromazine; Female; Humans; Male; Middle Aged; Outcome and Proce | 1983 |
Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Topics: Adult; Chlorpromazine; Delusions; Dopamine; Female; Hallucinations; Humans; Hypothalamo-Hypophyseal | 1983 |
Total and free plasma neuroleptic levels in schizophrenic patients.
Topics: Adult; Chlorpromazine; Haloperidol; Humans; Kinetics; Male; Psychiatric Status Rating Scales; Radiol | 1984 |
Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion.
Topics: Adult; Chlorpromazine; Electrolytes; Female; Humans; Inappropriate ADH Syndrome; Schizophrenia | 1983 |
Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
Topics: Adult; Chlorpromazine; Humans; Male; Schizophrenia; Smoking | 1983 |
Plasma vitamin C concentrations in patients in a psychiatric hospital.
Topics: Affective Disorders, Psychotic; Age Factors; Aged; Ascorbic Acid; Chlorpromazine; Dementia; Female; | 1983 |
A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Double-Blind Method; Electroconvulsive Therapy; Female; Hum | 1983 |
Blink rate and blunted affect among chronic schizophrenic patients.
Topics: Adult; Aged; Blinking; Chlorpromazine; Dose-Response Relationship, Drug; Female; Humans; Male; Middl | 1984 |
The orienting response in schizophrenia: proposed resolution of a controversy.
Topics: Acoustic Stimulation; Adolescent; Adult; Chlorpromazine; Functional Laterality; Galvanic Skin Respon | 1984 |
Stimulus efficacy, chlorpromazine, and schizophrenia.
Topics: Animals; Behavior, Animal; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; | 1980 |
Abnormal growth hormone response to LRH and TRH in adolescent schizophrenic boys.
Topics: Adolescent; Chlorpromazine; Gonadotropin-Releasing Hormone; Growth Hormone; Haloperidol; Humans; Mal | 1981 |
Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
Topics: Adult; Chlorpromazine; Chronic Disease; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phe | 1981 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; | 1982 |
The active uptake of serotonin by platelets of schizophrenic patients and their families: possibility of a genetic marker.
Topics: Adult; Blood Platelets; Chlorpromazine; Female; Genetic Markers; Haloperidol; Humans; Kinetics; Male | 1982 |
Lithium and chlorpromazine in psychotic inpatients.
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Chlorpromazine; Chronic Disease; Female; Hu | 1982 |
Association of HLA-Bw44 with chlorpromazine-induced autoantibodies.
Topics: Antibodies, Antinuclear; Autoantibodies; Blood Coagulation Factors; Chlorpromazine; Chronic Disease; | 1982 |
Drug-induced heat stroke.
Topics: Adult; Benztropine; Body Temperature Regulation; Chlorpromazine; Heat Exhaustion; Humans; Male; Psyc | 1983 |
Evidence for distinct verbal memory pathologies in severely and mildly disturbed schizophrenics.
Topics: Adult; Age Factors; Chlorpromazine; Chronic Disease; Cues; Humans; Intelligence; Length of Stay; Mal | 1983 |
Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Topics: Adult; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Injections | 1981 |
Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
Topics: Blood Platelets; Centrifugation; Chlorpromazine; Female; Humans; Male; Methods; Monoamine Oxidase; S | 1981 |
Chlorpromazine and immunologic considerations of schizophrenia.
Topics: Chlorpromazine; Humans; Schizophrenia; T-Lymphocytes; Time Factors | 1980 |
[Effect of medical treatment on the antithymic activity of schizophrenic patients' serum].
Topics: Antilymphocyte Serum; Automatism; Chlorpromazine; Humans; Schizophrenia; Syndrome; T-Lymphocytes; Ti | 1981 |
Drug management in chronic schizophrenia.
Topics: Chlorpromazine; Female; Humans; Middle Aged; Schizophrenia; Trifluoperazine | 1982 |
Predictive indices for chlorpromazine therapy in schizophrenics.
Topics: Adult; Biotransformation; Chlorpromazine; Electroconvulsive Therapy; Haloperidol; Humans; Kinetics; | 1982 |
Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
Topics: Adult; Blood Pressure; Chlorpromazine; Dopamine beta-Hydroxylase; Haloperidol; Humans; Hypotension, | 1982 |
Pain insensitivity in psychosis.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Diagnosis, Differential; Duodenal Ulcer; Female; Haloperido | 1982 |
The effect of chlorpromazine on SCE frequency in human chromosomes.
Topics: Adult; Cells, Cultured; Chlorpromazine; Chromosomes, Human; Dose-Response Relationship, Drug; Female | 1982 |
A 12-year follow-up study of chronic schizophrenics.
Topics: Adult; Chlorpromazine; Chronic Disease; Deinstitutionalization; Female; Humans; Male; Schizophrenia; | 1982 |
[Late extrapyramidal symptoms in schizophrenic patients hospitalized over long periods].
Topics: Adult; Aged; Chlorpromazine; Extrapyramidal Tracts; Female; Hospitalization; Humans; Male; Middle Ag | 1982 |
ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Dose-Response Relationship, Drug; Electroconvulsiv | 1982 |
Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.
Topics: Animals; Attention; Avoidance Learning; Chlorpromazine; Dextroamphetamine; Dopamine; Dose-Response R | 1981 |
Chlorpromazine levels and the outcome of treatment in schizophrenic patients.
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Car | 1981 |
Plasma levels of chlorpromazine and clinical response [proceedings].
Topics: Chlorpromazine; Humans; Schizophrenia | 1981 |
Long-term changes in AIMS ratings and their relation to medication history [proceedings].
Topics: Age Factors; Aged; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schi | 1981 |
Protein binding of chlorpromazine in cerebrospinal fluid and serum.
Topics: Adult; Cerebrospinal Fluid Proteins; Chlorpromazine; Female; Humans; In Vitro Techniques; Male; Meth | 1980 |
Psychophysiological responses of schizophrenic patients to high and low expressed emotion relatives.
Topics: Adult; Chlorpromazine; Electric Conductivity; Emotions; Female; Habituation, Psychophysiologic; Huma | 1981 |
Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asian vs Western populations.
Topics: Bipolar Disorder; Carbamazepine; Chlorpromazine; Cross-Cultural Comparison; Dose-Response Relationsh | 1981 |
Modification of psychotic speech with mentally retarded patients.
Topics: Adult; Behavior Therapy; Chlorpromazine; Female; Humans; Intellectual Disability; Middle Aged; Schiz | 1981 |
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
Topics: Acute Disease; Blood Platelets; Chlorpromazine; Female; Flupenthixol; Humans; Male; Monoamine Oxidas | 1981 |
Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
Topics: Chlorpromazine; Chronic Disease; Dibenzoxazepines; Eye Color; Humans; Loxapine; Male; Middle Aged; P | 1981 |
Neuroleptic drug effects on average evoked response augmentation-reduction in rats.
Topics: Animals; Chlorpromazine; Depression, Chemical; Endorphins; Evoked Potentials, Visual; Haloperidol; H | 1981 |
[Comparative evaluation of the effectiveness of schizophrenic patients first hospitalization].
Topics: Chlorpromazine; Electroconvulsive Therapy; Hospitalization; Humans; Rehabilitation, Vocational; Rura | 1981 |
[An integrated program for psychosis].
Topics: Adult; Chlorpromazine; Cognition; Female; Haloperidol; Humans; Male; Methods; Pilot Projects; Progno | 1980 |
The march of symptoms in a psychotic decompensation. Case report and theoretical implications.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Behavior; Carbamazepine; Chlorpromazine; Drug The | 1980 |
Drug-related and illness-related factors in the outcome of chlorpromazine treatment: testing a model.
Topics: Acute Disease; Adult; Bipolar Disorder; Chlorpromazine; Drug Resistance; Female; Humans; Male; Paran | 1980 |
Small left colon syndrome associated with maternal ingestion of psychotropic drugs.
Topics: Benztropine; Biperiden; Chlorpromazine; Colonic Diseases, Functional; Doxepin; Female; Humans; Infan | 1980 |
Subjective responses to thiothixene and chlorpromzine.
Topics: Adult; Chlorpromazine; Humans; Schizophrenia; Schizophrenic Psychology; Thiothixene | 1980 |
[Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy].
Topics: Chlorpromazine; Half-Life; Humans; Prognosis; Schizophrenia; Schizophrenia, Paranoid; Syndrome | 1980 |
Plasma and saliva levels of chlorpromazine and subjective response.
Topics: Adult; Chlorpromazine; Humans; Saliva; Schizophrenia | 1980 |
Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Ma | 1980 |
Predicting outcome of antipsychotic drug treatment from early response.
Topics: Chlorpromazine; Drug Administration Schedule; Humans; Outcome and Process Assessment, Health Care; P | 1980 |
[Epidemiologic aspects of the first hospitalization of schizophrenics].
Topics: Chlorpromazine; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Rural Population; | 1980 |
Importance of akinesia: plasma chlorpromazine and prolactin levels.
Topics: Adult; Affective Symptoms; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Prolactin; Schizophreni | 1980 |
Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Adult; Blood Platelets; Carbolines; Chlorpromazin | 1980 |
Hemolytic anemia associated with chlorpromazine therapy.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Autoantibodies; Chlorpromazine; Female; Humans; Reflex; Schizo | 1980 |
Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Psychomotor Disorder | 1995 |
Chlorpromazine-induced retinopathy.
Topics: Adult; Blindness; Chlorpromazine; Dose-Response Relationship, Drug; Humans; Male; Pigment Epithelium | 1995 |
Impaired saccadic eye movements on stationary targets in patients with schizophrenia spectrum disorder.
Topics: Adolescent; Adult; Attention; Chlorpromazine; Female; Fixation, Ocular; Humans; Male; Saccades; Schi | 1995 |
Surgical experience on patients with serum lupus anticoagulants. A report of two cases.
Topics: Adult; Arthrodesis; Chlorpromazine; Female; Femur Head Necrosis; Hip Prosthesis; Humans; Lupus Coagu | 1993 |
Obstetric complications and severity of illness in schizophrenia.
Topics: Activities of Daily Living; Chlorpromazine; Clozapine; Female; Follow-Up Studies; Humans; Obstetric | 1995 |
Analysis of the conserved Asp(114) residue of the dopamine D2 receptor in schizophrenic patients.
Topics: Aspartic Acid; Base Sequence; Binding Sites; Chlorpromazine; Drug Resistance; Humans; Molecular Sequ | 1994 |
Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.
Topics: 3-Methoxy-4-hydroxyphenylethanol; Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Hydro | 1995 |
Placebo: a potent but misunderstood psychotrope.
Topics: Anxiety Disorders; Chlorpromazine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Placebo Ef | 1995 |
Interaction of chlorpromazine with tricyclic anti-depressants in schizophrenic patients.
Topics: Adult; Amitriptyline; Chlorpromazine; Drug Interactions; Humans; Imipramine; Male; Middle Aged; Schi | 1994 |
Ten-year course of schizophrenia--the Madras longitudinal study.
Topics: Adult; Chlorpromazine; Cohort Studies; Developing Countries; Female; Haloperidol; Humans; India; Lon | 1994 |
Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dose-Response Relation | 1994 |
Forward and backward visual masking of contour by light in positive- and negative-symptom schizophrenia.
Topics: Adult; Chlorpromazine; Female; Form Perception; Humans; Light; Male; Perceptual Masking; Schizophren | 1995 |
Subjective response to neuroleptics in schizophrenia.
Topics: Adult; Affective Symptoms; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 1993 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Dr | 1994 |
Smoking and body weight influence the clearance of chlorpromazine.
Topics: Adolescent; Adult; Body Weight; Chlorpromazine; Chronic Disease; Drug Interactions; Ethanol; Female; | 1994 |
Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
Topics: Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluspi | 1994 |
Convulsions after enflurane in a schizophrenic patient receiving neuroleptics.
Topics: Adult; Anesthesia, Inhalation; Chlorpromazine; Drug Synergism; Enflurane; Epilepsy, Tonic-Clonic; Fl | 1994 |
Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Methotrimeprazine; Pigmentation D | 1993 |
Specific cognitive flexibility rehabilitation in schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain Diseases; Chlorpromazine; Cognition Disorders; Cognitive Behavior | 1993 |
Important metabolites to measure in pharmacodynamic studies of chlorpromazine.
Topics: Adult; Biotransformation; Chlorpromazine; Chromatography, High Pressure Liquid; Female; Humans; Male | 1994 |
[Xuefu zhuyu decoction in treating blood stasis syndrome of schizophrenia].
Topics: Adolescent; Adult; Blood Viscosity; Chlorpromazine; Drugs, Chinese Herbal; Female; Humans; Male; Mid | 1993 |
[Comparison between electro-acupuncture with chlorpromazine and chlorpromazine alone in 60 schizophrenic patients].
Topics: Case-Control Studies; Chlorpromazine; Combined Modality Therapy; Electroacupuncture; Female; Humans; | 1993 |
Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia.
Topics: Adolescent; Aged; Binding, Competitive; Brain; Chlorpromazine; Clozapine; Corpus Striatum; Culture T | 1993 |
A review of antipsychotic drug doses.
Topics: Administration, Oral; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Drug Utiliz | 1991 |
Bionursing: how drugs can cause weight gain.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Appetite; Body Weight; Chlorpromazine; Female; Humans; | 1996 |
In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
Topics: Adult; Antipsychotic Agents; Biperiden; Case-Control Studies; Cells, Cultured; Chlorpromazine; Drug | 1996 |
Auditory sustained attention in schizophrenia: a comparison of the Continuous Performance Test and the Pigache Attention Task.
Topics: Adolescent; Adult; Aged; Attention; Chlorpromazine; Female; Humans; Male; Middle Aged; Neuropsycholo | 1996 |
Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Logistic Models; Male; Midd | 1996 |
Obstetric complications and autoantibodies in schizophrenia.
Topics: Adult; Antipsychotic Agents; Autoantibodies; Brain Injuries; Chlorpromazine; Enzyme-Linked Immunosor | 1995 |
High plasma prolactin levels after long-term neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Tolerance; Humans; Male; Prolactin; Receptors, Dop | 1996 |
Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biperiden; Butyrophenones; Chlorproma | 1996 |
Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzene Derivatives; Biological Transport; Cell Membrane Pe | 1996 |
Chlorpromazine and obsessive-compulsive symptoms.
Topics: Adult; Aggression; Chlorpromazine; Comorbidity; Humans; Intellectual Disability; Male; Obsessive-Com | 1996 |
Can pulmonary complications cause schizophrenia remission?
Topics: Chlorpromazine; Female; Humans; Pulmonary Embolism; Schizophrenia; Schizophrenic Psychology; Treatme | 1997 |
Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Delayed-Action Preparations; Dose-Resp | 1997 |
A decision analysis approach to neuroleptic dosing: insights from a mathematical model.
Topics: Antipsychotic Agents; Chlorpromazine; Decision Support Techniques; Dose-Response Relationship, Drug; | 1997 |
Psychiatric medications.
Topics: Antipsychotic Agents; Chlorpromazine; Fatal Outcome; Humans; Liability, Legal; Male; Malpractice; Sc | 1997 |
A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Longitudinal Studies; Male | 1997 |
Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
Topics: Adult; Algorithms; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Female; H | 1997 |
Relationship between neurological 'soft signs' and syndromes of schizophrenia.
Topics: Adult; Affect; Antipsychotic Agents; Brain; Chlorpromazine; Female; Humans; Male; Psychomotor Disord | 1997 |
Clinical heterogeneity of schizophrenia.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Cluster Analysis; Follow-Up Stu | 1997 |
HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA).
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Child; Chlorpromazine; Drug Administration | 1997 |
Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Topics: Adolescent; Adult; Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Cloz | 1998 |
Hope lost and found.
Topics: Antipsychotic Agents; Autobiographies as Topic; Chlorpromazine; Humans; Male; Schizophrenia; Schizop | 1998 |
Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Homovanillic Acid; Humans; Hydro | 1998 |
CHRONOMERGE: an application for the merging and display of multiple time-stamped data streams.
Topics: Algorithms; Antipsychotic Agents; Chlorpromazine; Chronology as Topic; Computer Graphics; Database M | 1998 |
Spontaneous dyskinesia in first episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Movement | 1999 |
How do early stages of information processing influence social skills in patients with schizophrenia?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition Disorders; Dose-Response Relationship, Drug; | 1999 |
Event-related potentials in schizophrenic patients during a degraded stimulus version of the visual continuous performance task.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Electroencephalography; Event-Related | 1999 |
Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies.
Topics: Acute Kidney Injury; Adult; Antibodies, Anticardiolipin; Antipsychotic Agents; Chlorpromazine; Femal | 1999 |
Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia.
Topics: Adult; Antipsychotic Agents; Arachidonic Acid; Calcium; Calmodulin; Chlorpromazine; Enzyme Activatio | 1999 |
Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Cognition Disor | 1999 |
An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Humans; Language; Male; Middle Aged; Obse | 1999 |
Influence of stimulus control on the excitability of the electrically elicited blink reflex in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Blinking; Case-Control Studies; Chlorpromazine; E | 2000 |
The introduction of neuroleptics: a psychiatric revolution.
Topics: Antipsychotic Agents; Chlorpromazine; Commitment of Mentally Ill; Health Services Misuse; History, 2 | 2000 |
Olanzapine. Keep an eye on this neuroleptic.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clinical Trials as Topic; Dopamine Antagonist | 2000 |
Clozapine versus chlorpromazine in geriatric patients.
Topics: Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Clozapine; Humans | 2000 |
Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients.
Topics: Acute Disease; Adult; Angiotensin I; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; | 2000 |
[Selection and dosages of therapeutic agents for the early stage of schizophrenia].
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Male; Schizophrenia | 1999 |
Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Cognition; Dose-Response Relationship, Drug; Female; Hu | 2000 |
Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Interferon-gamma | 2000 |
Awareness of illness and outcome in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Attitude to Health; Awareness; Chlorpromazine; Female; Humans; Ma | 2000 |
A study of visual and auditory verbal working memory in schizophrenic patients compared to healthy subjects.
Topics: Adolescent; Adult; Antipsychotic Agents; Auditory Perception; Chlorpromazine; Chronic Disease; Femal | 2000 |
Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Humans; Middle Aged; Pigmentation Disorders | 2000 |
Prevalence and characteristics of patients with pseudoakathisia.
Topics: Adult; Akathisia, Drug-Induced; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Chronic | 2000 |
Tardive dystonia provoked by concomitantly administered risperidone.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induce | 2000 |
Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
Topics: Adolescent; Adult; Antipsychotic Agents; Cell Membrane; Cerebral Ventricles; Child; Chlorpromazine; | 2000 |
Are schizophrenia or antipsychotic drugs a risk factor for cataracts?
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antipsychotic Agents; Cataract; Chlorpromazine; Co | 2000 |
Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Drug Interactions; Drug Therapy, Combination | 2000 |
Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy.
Topics: Adult; Antipsychotic Agents; Attention; Case-Control Studies; Chlorpromazine; Cognition Disorders; C | 2000 |
Antipsychotic dosing patterns for schizophrenia in three treatment settings.
Topics: Adult; Antipsychotic Agents; Canada; Chlorpromazine; Dosage Forms; Drug Utilization; Drug Utilizatio | 2001 |
Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
Topics: Antipsychotic Agents; Chlorpromazine; Cornea; Corneal Opacity; Humans; Male; Middle Aged; Pigmentati | 2001 |
Quality of life in schizophrenia in India: comparison of three approaches.
Topics: Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Female; Hum | 2001 |
Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Cytochrome P-450 CYP2D6; Drug Interactions; Drug | 2001 |
Olanzapine: new preparation. Keep an eye on this neuroleptic.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Humans; Pirenzepine; Risperidone; Sc | 1999 |
Delays in adopting evidence-based dosages of conventional antipsychotics.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antipsychotic Agents; Chlorpromazine; Cross-Se | 2001 |
Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Cell Differentiation; Cell Nucleus; Chlorpromazine; Clozapi | 2001 |
Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Homovanillic Acid; Humans; Male; Middle Aged; S | 2001 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chl | 1998 |
Chlorpromazine and the psychopharmacologic revolution.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Psychiatry; Psychopharmacology; Schizophrenia | 2002 |
Butyrylcholinesterase and cognitive function.
Topics: Adult; Brain; Butyrylcholinesterase; Chlorpromazine; Cholinergic Antagonists; Cognition Disorders; D | 2001 |
Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Data Collection; Double-Blind Method; Drug Utilization; | 2002 |
High-dosage and versatile drug therapy with treatment-resistant psychotic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Doxepin; Female; Hospitals, Psychiatric; Hu | 1976 |
[The contribution of drug research to the understanding of schizophrenia].
Topics: Adult; Amphetamines; Animals; Antipsychotic Agents; Baclofen; Chlorpromazine; Corpus Striatum; Dopam | 1975 |
Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Brief Psychiatric Rating Scale; Chlorproma | 1976 |
Polypharmacy in the psychiatric treatment of elderly hospitalized patients: a survey of 12 Veterans Administration Hospitals.
Topics: Age Factors; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Chlorpromazine; | 1976 |
[Study of free and total tryptophan in the plasma. It value in psychiatry].
Topics: Adult; Chlorpromazine; Female; Humans; Lithium; Male; Middle Aged; Phenothiazines; Schizophrenia; Sp | 1976 |
Chlorpromazine metabolism VIII: blood levels of chlorpromazine and its sulfoxide in schizophrenic patients.
Topics: Chlorpromazine; Half-Life; Humans; Hydrogen-Ion Concentration; Kinetics; Methods; Schizophrenia; Sul | 1976 |
[Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
Topics: Adult; Aged; Antibodies, Antinuclear; Antipsychotic Agents; Chlorpromazine; Dementia; Female; Fluphe | 1975 |
Clothiapine in the management of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Dibenzothiazepines; Drug Therapy, Combination; Ele | 1977 |
Changes in primary process expression in hospitalized schizophrenics treated with phenothiazines: two projective tasks compared.
Topics: Adult; Aggression; Antipsychotic Agents; Chlorpromazine; Female; Fluphenazine; Hospitalization; Huma | 1977 |
[Psychotropic drugs--real progress or danger? (author's transl)].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Butyrophenones; Chlorpromazine; Humans; | 1977 |
Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Topics: Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Haloperidol; | 1978 |
The theoretical implications of chlorpromazine as a sensory integrative theory.
Topics: Brain; Chlorpromazine; Humans; Motor Skills; Neurotransmitter Agents; Occupational Therapy; Perceptu | 1978 |
Hoffmann reflex abnormalities in psychotic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chronic Disease; Dextr | 1979 |
Do anticholinergic antagonize antipsychotic drug action?
Topics: Antipsychotic Agents; Brain; Chlorpromazine; Choline O-Acetyltransferase; Dopamine; Factor Analysis, | 1978 |
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benztropine; Chlorpromazine; Drug Therapy, Combination; | 1979 |
Urinary incontinence in patients receiving neuroleptics.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Brain; Chlorpromazine; Female; Fluphenazine; | 1979 |
Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes.
Topics: Animals; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Corpus Striatum; Histological Techniq | 1979 |
[Neuroleptics and the extrapyramidal system].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Humans; Motor Skills; | 1978 |
Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis.
Topics: Adult; Antipsychotic Agents; Anxiety; Arousal; Autonomic Nervous System; Basal Ganglia Diseases; Chl | 1979 |
Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Therapy, Combination | 1979 |
Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Depressive | 1979 |
Letter: Baclofen in the treatment of schizophrenia.
Topics: Aminobutyrates; Chlorobenzenes; Chlorpromazine; Drug Therapy, Combination; Fluphenazine; gamma-Amino | 1975 |
Letter: Serum-aminoacids and brain tryptophan uptake.
Topics: Amino Acids; Animals; Brain; Chlorpromazine; Humans; Rats; Schizophrenia; Serotonin; Tryptophan | 1975 |
Letter: Gluten and schizophrenia.
Topics: Chlorpromazine; Glutens; Humans; Schizophrenia; Triticum | 1976 |
Dopamine and schizophrenia.
Topics: Animals; Chlorpromazine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Homovanillic | 1976 |
Platelet monoamine oxidase in schizophrenia.
Topics: Blood Platelets; Chlorpromazine; Humans; Monoamine Oxidase; Schizophrenia | 1977 |
Is schizophrenia an HLA-associated disease?
Topics: Animals; Antigen-Antibody Reactions; Antipsychotic Agents; Chlorpromazine; Dopamine; Epitopes; HLA A | 1979 |
The medicinal chemistry of lithium.
Topics: Adenylyl Cyclases; Adrenal Cortex; Affective Symptoms; Animals; Antidepressive Agents; Bipolar Disor | 1975 |
Psychological medicine. Drugs used in psychological medicine: pharmacological basis of treatment.
Topics: Adenosine Triphosphatases; Alcoholism; Antidepressive Agents, Tricyclic; Anxiety; Barbiturates; Brai | 1976 |
[Out-patient treatment and prognosis schizophrenic patients after first hospitalization (author's transl)].
Topics: Aftercare; Age Factors; Ambulatory Care; Chlorpromazine; Female; Humans; Male; Schizophrenia; Sex Fa | 1975 |
Smooth-pursuit eye movements in schizophrenia: recent findings.
Topics: Adult; Attention; Chlorpromazine; Depression; Diagnosis, Differential; Diazepam; Electronystagmograp | 1975 |
Sociotherapy and the prevention of relapse among schizophrenic patients: an artifact of drug?
Topics: Adolescent; Adult; Aftercare; Chlorpromazine; Female; Humans; Male; Middle Aged; Patient Compliance; | 1976 |
An evaluation of psychiatric after-care in a developing country (Fiji).
Topics: Aftercare; Chlorpromazine; Developing Countries; Ethnicity; Evaluation Studies as Topic; Female; Fij | 1976 |
Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.
Topics: Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Male; | 1977 |
The adrenocortical secretion in schizophrenics during chlorpromazine treatment.
Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Chlorproma | 1975 |
Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical study.
Topics: Animals; Antibodies; Antibody Formation; Cell Line; Chlorpromazine; Electroconvulsive Therapy; Human | 1977 |
Effects of psychoactive drugs on in vitro lymphocyte activation.
Topics: Animals; Calcium; Cells, Cultured; Chlorpromazine; Cyclic AMP; Cyclic GMP; Cytotoxicity, Immunologic | 1978 |
Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
Topics: Adolescent; Adult; Aged; Biogenic Amines; Chlorpromazine; Cyclic AMP; Depression; Female; Homovanill | 1979 |
Fatal paralytic ileus complicating phenothiazine therapy.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Colon; Female; Humans; Intestinal Mucosa; | 1975 |
[Cellular effect of neuroleptics].
Topics: Adenylyl Cyclases; Basal Ganglia Diseases; Biological Transport, Active; Catecholamines; Chlorpromaz | 1975 |
Soteria: Evaluation of a home-based treatment for schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Community Mental Health Services; Costs and | 1975 |
Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
Topics: Administration, Oral; Basal Ganglia Diseases; Brief Psychiatric Rating Scale; Chlorpromazine; Female | 1975 |
[observations of liver function in patients with long term administration of chlorpromazine (author's transl)].
Topics: Adult; Aged; Chlorpromazine; Humans; Liver; Male; Middle Aged; Schizophrenia; Time Factors | 1979 |
Schizophrenia following withdrawal from chronic phenothiazine administration: a case report.
Topics: Adult; Chlorpromazine; Female; Humans; Schizophrenia; Substance Withdrawal Syndrome | 1978 |
Immunologic and coagulation disorders in chlorpromazine-treated patients.
Topics: Adult; Aged; Antibodies, Antinuclear; B-Lymphocytes; Blood Coagulation Disorders; Blood Coagulation | 1979 |
Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies.
Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Chlorpromazine; Female; Humans; | 1979 |
Drug-induced EEG changes studied on two-dimensional rectangular coordinates using principal component analysis.
Topics: Adult; Amitriptyline; Chlorpromazine; Computers; Diazepam; Electroencephalography; Haloperidol; Huma | 1979 |
Cognitive abnormality in schizophrenia: a dual-process model.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Cognition Disorders; Color Perception; Concep | 1979 |
Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness.
Topics: Adolescent; Child; Child Behavior Disorders; Chlorpromazine; Dose-Response Relationship, Drug; Femal | 1979 |
Effect of chlorpromazine on human growth hormone.
Topics: Adolescent; Adult; Child; Chlorpromazine; Dose-Response Relationship, Drug; Female; Growth Hormone; | 1979 |
An anticholinergic toxicity reaction to chlorpromazine activated by psychological stress.
Topics: Adult; Body Temperature; Chlorpromazine; Confusion; Female; Humans; Receptors, Cholinergic; Respirat | 1979 |
Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia.
Topics: Adolescent; Adult; Chlorpromazine; Female; Galvanic Skin Response; Habituation, Psychophysiologic; H | 1979 |
Combined use of molindone and guanethidine in patients with schizophrenia and hypertension.
Topics: Autonomic Fibers, Postganglionic; Blood Pressure; Chlorpromazine; Drug Therapy, Combination; Female; | 1979 |
The impact on neurology of 40 years' advances in pharmacology.
Topics: Acetylcholine; Chemical Phenomena; Chemistry; Chlorpromazine; Depression; Endorphins; Enkephalins; H | 1979 |
Effect of clozapine on human serum prolactin levels.
Topics: Animals; Binding, Competitive; Chlorpromazine; Clozapine; Dibenzazepines; Female; Humans; Male; Prol | 1979 |
Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Prolactin; Psychotic Disorders; Schizophre | 1979 |
[A case of hypoplastic anemia presumably caused by chlorpromazine (author's transl)].
Topics: Adult; Anemia, Aplastic; Chlorpromazine; Female; Humans; Methotrimeprazine; Schizophrenia; Trifluope | 1979 |
New admissions to Woodbridge Hospital 1975 with special reference to schizophrenia.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Chlorpromazine; Female; Humans; Length of Stay; Male; M | 1979 |
Complex partial seizures simulating schizophrenia .
Topics: Adult; Chlorpromazine; Diagnosis, Differential; Diagnostic Errors; Diazepam; Electroencephalography; | 1977 |
Excretion of 3,4-dimethoxyphenethylamine (DMPEA) by acute schizophrenics and controls.
Topics: Acute Disease; Adult; Chlorpromazine; Dimethoxyphenylethylamine; Female; Humans; Male; Middle Aged; | 1977 |
On the possible role of enzyme induction in cases of resistancy to chlorpromazine treatment.
Topics: Adult; Chlorpromazine; Drug Resistance; Enzyme Induction; Glucaric Acid; Humans; Male; Middle Aged; | 1977 |
Pavor nocturnus in a schizophrenic patient: a review and case study.
Topics: Adult; Chlorpromazine; Diazepam; Dreams; Humans; Male; Schizophrenia; Schizophrenic Psychology; Stre | 1978 |
The Eden express doesn't stop here anymore.
Topics: Chlorpromazine; Humans; Orthomolecular Therapy; Schizophrenia | 1978 |
Impact of neuroleptic chemotherapies on schizophrenic psychoses.
Topics: Chlorpromazine; Drug Evaluation; Emotions; Hallucinations; Humans; Psychopharmacology; Schizophrenia | 1978 |
Serum dopamine-beta-hydroxylase in schizophrenic patients.
Topics: Adolescent; Adult; Child; Child, Preschool; Chlorpromazine; Dopamine beta-Hydroxylase; Haloperidol; | 1978 |
Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature.
Topics: Adolescent; Adult; Age Factors; Aged; Chlorpromazine; Dose-Response Relationship, Drug; Female; Huma | 1978 |
Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
Topics: Adult; Chlorpromazine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Saliva; | 1978 |
Serologic studies on schizophrenic patients.
Topics: Adolescent; Adult; Bipolar Disorder; Caudate Nucleus; Cerebellum; Chlorpromazine; Erythrocytes; Fema | 1978 |
Correlation between plasma concentrations of chlorpromazine and clinical response.
Topics: Adolescent; Adult; Chlorpromazine; Dose-Response Relationship, Drug; Female; Hostility; Humans; Male | 1978 |
Statistical strategies for prediction of clinical response: performance tests as predictors of reduction in psychopathology.
Topics: Chlorpromazine; Humans; Placebos; Prognosis; Psychiatric Status Rating Scales; Psychological Tests; | 1978 |
Paradoxical reaction to L-dopa in schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; M | 1978 |
Psychological factors in susceptibility to drug-induced extrapyramidal symptoms.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-In | 1978 |
Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics.
Topics: Adult; Benztropine; Chlorpromazine; Haloperidol; Humans; Male; Perphenazine; Schizophrenia; Thalasse | 1978 |
The effect of chlorpromazine upon psychophysiological, endocrine and information processing measures in schizophrenia.
Topics: Arousal; Autonomic Nervous System; Chlorpromazine; Cognition; Conditioning, Classical; Discriminatio | 1978 |
[Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Schizophrenia | 1978 |
Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.
Topics: Chlorpromazine; Chronic Disease; Consumer Behavior; Depression; Euphoria; Female; Humans; Male; Prog | 1978 |
Platelet aggregation and chlorpromazine therapy.
Topics: Chlorpromazine; Chronic Disease; Humans; Metabolism; Platelet Aggregation; Schizophrenia; Serotonin | 1978 |
Case conferences from Cornell. Case 2: Approaches to the treatment of the drug resistant schizophrenic patient.
Topics: Adult; Chlorpromazine; Community Mental Health Services; Day Care, Medical; Drug Administration Sche | 1978 |
Negligible hepatotoxicity of chlorpromazine in long-term therapy.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Chlorpromazine; Humans; Liver; Liver Diseases; | 1978 |
IgM inhibitors of the contact activation phase of coagulation in chlorpromazine-treated patients.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Chlorpromazine; Hum | 1978 |
[Updating haloperidol: 1975].
Topics: Chlorpromazine; Haloperidol; Humans; Schizophrenia | 1978 |
Gonadotropin response to synthetic gonadotropin hormone-releasing hormone (GnRH) in chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone | 1976 |
[Use of triphthazine in the treatment of mentae disorders].
Topics: Chlorpromazine; Hallucinations; Humans; Long-Term Care; Mental Disorders; Psychotic Disorders; Schiz | 1975 |
The HLA system and the clinical response to treatment with chlorpromazine.
Topics: Anxiety; Binding Sites; Cell Membrane; Chlorpromazine; Depression; Histocompatibility Antigens; HLA | 1976 |
A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.
Topics: Chlorpromazine; Gas Chromatography-Mass Spectrometry; Humans; Schizophrenia | 1976 |
Sensitivity to chlorpromazine effects on brain function of schizophrenics and normals. A preliminary report.
Topics: Adolescent; Adult; Arousal; Chlorpromazine; Electroencephalography; Female; Galvanic Skin Response; | 1976 |
Patterns of violent behavior among schizophrenic inpatients.
Topics: Adult; Age Factors; Chlordiazepoxide; Chlorpromazine; Electroshock; Female; Haloperidol; Humans; Len | 1977 |
Severe neurotoxicity despite "therapeutic" serum lithium levels.
Topics: Adolescent; Adult; Age Factors; Aged; Brain; Brain Damage, Chronic; Chlorpromazine; Electroencephalo | 1977 |
[Stein and Wise's neurochemical model of schizophrenia].
Topics: Biogenic Amines; Brain; Brain Mapping; Catechol O-Methyltransferase; Chemical Phenomena; Chemistry; | 1977 |
Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses.
Topics: Adolescent; Adult; Chlorpromazine; Female; Humans; Male; Melanocyte-Stimulating Hormones; Middle Age | 1977 |
Influence of the antiparkinsonian drugs on the plasma level of neuroleptics.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Therapy, Combination; Female; Haloperidol; Humans; | 1977 |
[Treatment of schizophrenia. Clinical pharmacological viewpoint].
Topics: Chlorpromazine; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Schizophrenia | 1977 |
A chlorpromazine-induced inhibitor of blood coagulation.
Topics: Adult; Blood Coagulation; Chlorpromazine; Depression, Chemical; Humans; Male; Middle Aged; Prothromb | 1977 |
Methodological issues in psychopharmacological research.
Topics: Chlorpromazine; Humans; Psychological Tests; Psychometrics; Research Design; Schizophrenia; Social B | 1977 |
Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
Topics: Adult; Affective Disorders, Psychotic; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Drug The | 1977 |
Masking of tardive dyskinesia with four times-a-day administration of chlorpromazine.
Topics: Adult; Chlorpromazine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Schiz | 1977 |
Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
Topics: Acute Disease; Chlorpromazine; Humans; Paranoid Disorders; Psychiatric Status Rating Scales; Recurre | 1977 |
Phenothiazine-induced priapism: a case report.
Topics: Adult; Chlorpromazine; Depression; Humans; Male; Mesoridazine; Priapism; Schizophrenia | 1977 |
Penfluridol in the treatment of newly admitted schizophrenic patients in a brief therapy unit.
Topics: Basal Ganglia Diseases; Chlorpromazine; Consciousness Disorders; Humans; Length of Stay; Penfluridol | 1976 |
Recent advances in the drug treatment of the functional psychoses.
Topics: Acute Disease; Bipolar Disorder; Chlorpromazine; Chronic Disease; Humans; Imipramine; Lithium; Psych | 1976 |
Preconscious processing in schizophrenics: an exploratory investigation.
Topics: Adult; Chlorpromazine; Consciousness; Differential Threshold; Emotions; Humans; Male; Middle Aged; P | 1976 |
Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature.
Topics: Animals; Brain; Brain Chemistry; Catecholamines; Cats; Chlorpromazine; Dogs; Guinea Pigs; Humans; Mi | 1976 |
Controlled trial of penfluridol and thiothixene in the maintenance treatment of chronic schizophrenic syndromes.
Topics: Adolescent; Adult; Aged; Biperiden; Chlorpromazine; Chronic Disease; Drug Evaluation; Female; Humans | 1976 |
Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise.
Topics: Adult; Blood Pressure; Cardiac Output; Chlorpromazine; Heart Rate; Hemodynamics; Humans; Middle Aged | 1976 |
Electrophoretic pattern of red blood cell catechol-o-methyltransferase in schizophrenia and manic-depressive illness.
Topics: Bipolar Disorder; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Chlorpromaz | 1976 |
Drug discontinuation among long term, successfully maintained schizophrenic outpatients.
Topics: Ambulatory Care; Chlorpromazine; Humans; Movement Disorders; Recurrence; Schizophrenia; Schizophreni | 1976 |
How long does chlorpromazine last?
Topics: Chlorpromazine; Humans; Schizophrenia; Time Factors | 1976 |
The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine.
Topics: Adult; Chlorpromazine; Fluphenazine; Humans; Middle Aged; Platelet Aggregation; Schizophrenia; Serot | 1976 |
Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine.
Topics: Aged; Aspirin; Chlorpromazine; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Platelet Agg | 1976 |
Proceedings: Cellular biochemical pharmacology in monitoring drug therapy.
Topics: Chlorpromazine; Digoxin; Humans; Platelet Aggregation; Schizophrenia | 1976 |
Integrative and sealing-over recoveries from schizophrenia: distinguishing case studies.
Topics: Acute Disease; Adaptation, Psychological; Adult; Attitude of Health Personnel; Attitude to Health; C | 1976 |
On some mechanisms of haloperidol and chlorpromazine effect [proceedings].
Topics: Cell Nucleus; Chlorpromazine; Haloperidol; Humans; Leukocytes; Schizophrenia | 1976 |
Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
Topics: Adult; Chlorpromazine; Diazepam; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Schizo | 1976 |
The flicker-fusion threshold in schizophrenia and depression.
Topics: Amitriptyline; Chlorpromazine; Depression; Depression, Chemical; Flicker Fusion; Humans; Male; Schiz | 1975 |
Measurement of appetite disturbances in psychiatric disorders.
Topics: Adolescent; Adult; Bipolar Disorder; Body Weight; Chlorpromazine; Depression; Evaluation Studies as | 1975 |
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
Topics: Chlorpromazine; Drug Antagonism; Drug Tolerance; Humans; N,N-Dimethyltryptamine; Schizophrenia; Tryp | 1976 |
[Chronic intrahepatic cholestasis following chlorpromazine; treated using phenobarbital].
Topics: Adult; Chlorpromazine; Cholestasis; Chronic Disease; Humans; Male; Schizophrenia | 1976 |
Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.
Topics: Autopsy; Brain; Chlorpromazine; Dopamine beta-Hydroxylase; Female; Humans; Male; Middle Aged; Schizo | 1975 |
Precipitation of psychosis during electroshock therapy.
Topics: Adult; Chlorpromazine; Depression; Diagnosis, Differential; Drug Therapy, Combination; Electroconvul | 1975 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphe | 1975 |
Dopamine antagonism by thioridazine in schizophrenia.
Topics: Administration, Oral; Chlorpromazine; Dopamine Antagonists; Female; Fluphenazine; Humans; Injections | 1975 |
Role of biogenic amines in certain pathological conditions.
Topics: Acute Disease; Adult; Aggression; Biogenic Amines; Bipolar Disorder; Chlorpromazine; Chronic Disease | 1975 |
An investigation into the possibility of irreversible central nervous system damage as a result of long-term chlorpromazine medication.
Topics: Adolescent; Adult; Central Nervous System Diseases; Chlorpromazine; Diagnosis, Differential; Electro | 1975 |
Letter: Fluphenazine with other antipsychotic drugs.
Topics: Basal Ganglia Diseases; Chlorpromazine; Drug Administration Schedule; Drug Therapy, Combination; Flu | 1975 |
On neurochemistry and behavior.
Topics: Avoidance Learning; Behavior; Brain; Chlorpromazine; Humans; Neurochemistry; Parasympatholytics; Sch | 1975 |
Autonomic responses of paranoid, nonparanoid schizophrenic, and normal subjects to affective visual stimulation.
Topics: Adult; Arousal; Chlorpromazine; Chronic Disease; Cognition; Denial, Psychological; Diagnosis, Differ | 1975 |
Total body potassium and 24-hour creatinine excretion in healthy males.
Topics: Adult; Age Factors; Aged; Body Height; Body Weight; Chlorpromazine; Creatinine; Humans; Male; Middle | 1975 |
Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients.
Topics: Bipolar Disorder; Brain; Chlorpromazine; Dopamine; Homovanillic Acid; Humans; Schizophrenia; Thiorid | 1975 |
Low platelet monoamine oxidase and vulnerability to schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Brain; Chlorpromazine; Chronic Disease; Dis | 1975 |
[Comparison of the diagnostic assessment of schizophrenia from the positions of Soviet and French psychiatry (with a clinical illustration)].
Topics: Academies and Institutes; Acute Disease; Adolescent; Adult; Bipolar Disorder; Child; Chlorpromazine; | 1975 |
Concordance of multiple assessments of the outcome of schizophrenia. On defining the dependent variable in outcome studies.
Topics: Adult; Chlorpromazine; Consumer Behavior; Evaluation Studies as Topic; Female; Humans; Length of Sta | 1975 |
Effects of phenothiazines and social skills training in a withdrawn schizophrenic.
Topics: Adult; Behavior Therapy; Benztropine; Chlorpromazine; Feedback; Follow-Up Studies; Generalization, P | 1975 |
Changes in serum tryptophan and albumin binding of tryptophan in chlorpromazine-treated chronic schizophrenics on withdrawal and restoration of drug therapy.
Topics: Adult; Amino Acids; Brain; Chlorpromazine; Chronic Disease; Fatty Acids, Nonesterified; Humans; Male | 1975 |
The effect of chlorpromazine on plasma renin activity and aldosterone in man.
Topics: Adult; Aldosterone; Blood Pressure; Chlorpromazine; Humans; Injections, Intravenous; Posture; Renin; | 1975 |
Cerebrospinal fluid levels of chlorpromazine and it metabolites in schizophrenia.
Topics: Adult; Chlorpromazine; Female; Humans; Male; Schizophrenia | 1975 |
Assay of 7-hydroxychlorpromazine, and failure to detect more than small quantities, in plasma of responding schizophrenics.
Topics: Animals; Cattle; Chlorpromazine; Humans; Methods; Schizophrenia; Serum Albumin, Bovine | 1975 |
Deposits in the lens and cornea of the eye during long-term chlorpromazine medication.
Topics: Adult; Aged; Cataract; Chlorpromazine; Corneal Opacity; Female; Humans; Middle Aged; Schizophrenia; | 1976 |
Serum creatine phosphokinase in schizophrenia.
Topics: Brain Diseases; Chlorpromazine; Creatine Kinase; Humans; Neuromuscular Diseases; Physical Exertion; | 1976 |
A hospital population of schizophrenic patients undergoing change.
Topics: Adolescent; Adult; Age Factors; Chlorpromazine; Costs and Cost Analysis; Denmark; Family Characteris | 1976 |
[Preliminary study of changes in plasma prostaglandin E1 in rats with experimental "schizophrenia"].
Topics: Alprostadil; Animals; Chlorpromazine; Dextroamphetamine; Disease Models, Animal; Female; Male; Rats; | 1992 |
[Frequency of sex chromatin among mental patients].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Chlorpromazine; Chromosome Aberrations; Chromosome Disord | 1992 |
"Positive" and "negative" movement disorders in schizophrenia.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Parkinson Disease, Secondary; | 1992 |
Raised monophosphatase activity in schizophrenic patients.
Topics: Adult; Chlorpromazine; Erythrocytes; Female; Humans; Male; Phosphoric Monoester Hydrolases; Schizoph | 1992 |
Abnormal EEG and calcification of the pineal gland in schizophrenia.
Topics: Adult; Aged; Calcinosis; Chlorpromazine; Electroencephalography; Female; Humans; Male; Melatonin; Mi | 1992 |
[Changes in erythrocyte shape in children treated with chlorpromazine].
Topics: Child; Chlorpromazine; Erythrocyte Count; Erythrocyte Deformability; Erythrocytes; Humans; Microscop | 1992 |
The pharmacoepidemiology of treatment-refractory schizophrenia.
Topics: Activities of Daily Living; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clozapine; Cross- | 1992 |
Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Denm | 1992 |
[Immediate effect and family history of the type I, II schizophrenia].
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Female; Hospitalization; Humans; Middle Age | 1992 |
Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test.
Topics: Adult; Alpha Rhythm; Antipsychotic Agents; Arousal; Attention; Brain Mapping; Cerebral Cortex; Chlor | 1992 |
The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Fema | 1992 |
Antipsychotic drug doses in a schizophrenia inpatient unit.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparatio | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskines | 1992 |
Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dopamine; Haloperidol; Humans; Huntington Disease | 1992 |
Neuroleptic malignant syndrome and diabetic keto-acidosis.
Topics: Adult; Chlorpromazine; Clopenthixol; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Male; | 1992 |
Cycloid psychosis: regional cerebral blood flow correlates of a psychotic episode.
Topics: Adult; Aged; Bipolar Disorder; Blood Flow Velocity; Cerebral Cortex; Chlorpromazine; Dominance, Cere | 1992 |
Phenothiazine-induced lupus anticoagulant.
Topics: Chlorpromazine; Humans; Lupus Coagulation Inhibitor; Male; Partial Thromboplastin Time; Prothrombin | 1992 |
Contribution of family, cognitive and clinical dimensions to long-term outcome in schizophrenia.
Topics: Activities of Daily Living; Adult; Chlorpromazine; Family; Female; Follow-Up Studies; Humans; Male; | 1992 |
[An investigation on changes in blood CuZn-superoxide dismutase contents in type I, II schizophrenics].
Topics: Adult; Chlorpromazine; Clozapine; Female; Humans; Male; Schizophrenia; Superoxide Dismutase | 1992 |
[A feverish psychotic].
Topics: Adult; Chlorpromazine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
Acute pulmonary edema induced by overdosage of phenothiazines.
Topics: Acute Disease; Adult; Chlorpromazine; Drug Overdose; Female; Humans; Lung; Male; Middle Aged; Perphe | 1992 |
Chlorpromazine-induced anterior segment changes.
Topics: Aged; Anterior Eye Segment; Chlorpromazine; Eye Diseases; Humans; Male; Schizophrenia; Visual Acuity | 1992 |
Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.
Topics: Adult; Chlorpromazine; Debrisoquin; Female; Humans; Italy; Male; Middle Aged; Oxidation-Reduction; P | 1992 |
Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
Topics: Adult; Arousal; Chlorpromazine; Delusions; Female; Hallucinations; Haloperidol; Humans; Male; Psychi | 1991 |
[The dynamics of outcome predictors in the early phase of schizophrenic psychoses--an empirical study].
Topics: Adolescent; Adult; Chlorpromazine; Combined Modality Therapy; Female; Hospitalization; Humans; Male; | 1991 |
Effect of storage on the plasma concentration of chlorpromazine and six of its metabolites.
Topics: Chlorpromazine; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Humans; Schizoph | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
[A control study of some hair trace elements content of schizophrenics before and after treatment].
Topics: Adolescent; Adult; Chlorpromazine; Female; Hair; Humans; Male; Middle Aged; Parkinson Disease, Secon | 1991 |
Antipsychotic drug action associated with synthesis of a lymphocyte protein.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Haloperidol; Humans; Lymphocytes; Male; Peptide | 1990 |
Neuroleptic malignant syndrome.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Drug Th | 1990 |
[Increased blink rate in schizophrenic patients].
Topics: Adult; Antipsychotic Agents; Blinking; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, | 1990 |
Clozapine-treated NMS.
Topics: Adult; Chlorpromazine; Clopenthixol; Clozapine; Drug Therapy, Combination; Humans; Male; Neuroleptic | 1991 |
Defining treatment refractoriness in schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Clozapine; Humans; Psychiatric Status Rating Scales; Schizophrenia; | 1990 |
[Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case].
Topics: Adult; Chlorpromazine; Electrocardiography; Female; Humans; Schizophrenia; Syncope; Torsades de Poin | 1990 |
Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
Topics: Adolescent; Adult; Chlorpromazine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fema | 1990 |
Single-photon emission computerised tomography (SPECT) in schizophrenia.
Topics: Adult; Brain; Cerebrovascular Circulation; Chlorpromazine; Female; Flupenthixol; Humans; Schizophren | 1990 |
Increased blink rate in drug-naive acute schizophrenic patients.
Topics: Adult; Attention; Blinking; Chlorpromazine; Female; Humans; Male; Psychiatric Status Rating Scales; | 1990 |
Neurological signs and the positive-negative dimension in schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Dyskinesia, Drug-Induced; Frontal Lobe; Humans; Male; Neuroc | 1990 |
Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.
Topics: Adult; Brain Chemistry; Chlorpromazine; Female; Glucose; Humans; Male; Schizophrenia; Sulpiride; Tom | 1989 |
Fluphenazine decanoate: a clinical problem?
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; H | 1989 |
R-R interval during neuroleptic treatment.
Topics: Antipsychotic Agents; Chlorpromazine; Electrocardiography; Haloperidol; Humans; Methotrimeprazine; S | 1989 |
Changes in eye tracking during clinical stabilization in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Chlorpromazine; Dose-Response Relationship, Drug; Electroocu | 1989 |
Electroconvulsive therapy in neuroleptic-induced parkinsonism.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Electroco | 1989 |
Failure of antipsychotic drug dose to explain abnormal diurnal weight gain among 129 chronically psychotic inpatients.
Topics: Adult; Age Factors; Antipsychotic Agents; Blood Pressure; Body Weight; Chlorpromazine; Chronic Disea | 1989 |
ADH secretion in schizophrenic patients on antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drinking; Drug Therapy, Combination; Female; Humans; Ma | 1989 |
[Cardiotoxicity of antipsychotic drugs: abnormal ECG in 1266 cases].
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Electrocardiography; Female; Heart; Humans; Hypokalemia | 1989 |
Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Blood-Brain Barrier; Brain; Chlorpromazine; Fluphenazine; Haloper | 1989 |
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Chromosome Mapping; Female; Gene Frequency; Haloperidol; HLA-A | 1989 |
Some parameters of the immune system at schizophrenia therapy with chlorpromazine and zetidoline.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Imidazoles; Immune System; | 1989 |
Adverse interaction between cimetidine and chlorpromazine in two cases of chronic schizophrenia.
Topics: Chlorpromazine; Cimetidine; Drug Interactions; Esophagitis, Peptic; Female; Humans; Male; Middle Age | 1989 |
Schizophrenia and bipolar affective disorders: likenesses and differences.
Topics: Acute Disease; Bipolar Disorder; Chlorpromazine; Chronic Disease; Delusions; Depressive Disorder; Hu | 1989 |
[A pilot study of sexual problems in chronic schizophrenia: a report on 51 cases].
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Schizophrenia; Sexual Dysfunction, Physiol | 1989 |
The introduction of chlorpromazine to North America.
Topics: Canada; Chlorpromazine; History, 20th Century; Humans; Schizophrenia | 1989 |
Abnormal diurnal weight gain among chronically psychotic patients contrasted with acutely psychotic patients and normals.
Topics: Adult; Affective Disorders, Psychotic; Blood Pressure; Chlorpromazine; Circadian Rhythm; Drinking Be | 1989 |
Manners of arginine vasopressin secretion in schizophrenic patients--with reference to the mechanism of water intoxication.
Topics: Adult; Animals; Arginine Vasopressin; Chlorpromazine; Female; Haloperidol; Humans; Hyponatremia; Mal | 1989 |
Sulpiride in the treatment of chronic schizophrenia.
Topics: Chlorpromazine; Chronic Disease; Drug Therapy, Combination; Humans; Male; Schizophrenia; Sulpiride | 1989 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Femal | 1985 |
Acutely psychotic patients: a treatment approach.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Combined Modality Therapy; Do | 1985 |
Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Haloperidol; Humans; Prognosis; Psychiatric Status Rating Scal | 1985 |
Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.
Topics: Antipsychotic Agents; Blood-Brain Barrier; Chlorpromazine; Humans; Protein Binding; Psychiatric Stat | 1985 |
Agranulocytosis in the course of phenothiazine therapy: case reports.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Psy | 1985 |
Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Chronic Disease; Dyskinesia, Dru | 1985 |
Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients.
Topics: Adult; Age Factors; Antipsychotic Agents; Chlorpromazine; Drug Eruptions; Female; Humans; Male; Midd | 1985 |
Neuroleptic dosage for Asians: a failure to replicate.
Topics: Adult; Antipsychotic Agents; Asian People; Chlorpromazine; Female; Hospitalization; Humans; Male; Ps | 1986 |
Radio receptor assay of serum neuroleptic levels in psychiatric patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Halo | 1986 |
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Topics: Adolescent; Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Child; Chlorp | 1986 |
Effect of neuroleptics on the schizophrenic syndrome.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Clozapine; Female; Humans; Male; Schiz | 1987 |
Extrapyramidal side effects: a historical perspective.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Basal Ganglia Diseases; Chlorpromazine; Depressive | 1987 |
Comparative study of schizophrenic patients relapsed on and off medication.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Delayed-Action Preparations; Female; Haloper | 1987 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; | 1987 |
[Survey of drug therapy in schizophrenia in the aged].
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combinatio | 1987 |
Dosing practices for high- and low-potency neuroleptics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Schizophrenia | 1988 |
Effects of neuroleptic treatments on peripheral opioid secretion.
Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Diben | 1987 |
Certain neuroleptics reduce bone mineralization in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Bone and Bones; Calcium; Chlorpromazine; Chronic Disease; D | 1987 |
Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Chlor | 1988 |
Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement.
Topics: Adult; Antipsychotic Agents; Brain Damage, Chronic; Cerebral Ventricles; Chlorpromazine; Female; Hum | 1988 |
Debrisoquine oxidation in schizophrenic patients treated with neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Debrisoquin; Female; Humans; Hydroxylation; Isoqu | 1988 |
Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids.
Topics: Biotransformation; Body Fluids; Chlorpromazine; Erythrocytes; Gas Chromatography-Mass Spectrometry; | 1985 |
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.
Topics: Adult; Binding, Competitive; Chlorpromazine; Corpus Striatum; Haloperidol; Humans; Male; Middle Aged | 1988 |
Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study.
Topics: Blood Platelets; Chlorpromazine; Clonidine; Humans; Kinetics; Psychiatric Status Rating Scales; Rece | 1985 |
Juvenile law and the viable fetus: clinical perspectives and legal intervention.
Topics: Adolescent; Adult; Antisocial Personality Disorder; Bipolar Disorder; Child Abuse; Child Welfare; Ch | 1986 |
The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.
Topics: Adult; Chlorpromazine; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1987 |
Chlorpromazine induced fluid retention masquerading as idiopathic oedema.
Topics: Body Weight; Chlorpromazine; Edema; Female; Humans; Middle Aged; Schizophrenia | 1987 |
Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Circadian Rhythm; Fluspirilene; Humans; Male; Pituitary Gland; Pr | 1986 |
Comparative study of schizophrenia treatment with electroacupuncture, herbs and chlorpromazine.
Topics: Acupuncture Therapy; Adolescent; Adult; Chlorpromazine; Combined Modality Therapy; Electric Stimulat | 1987 |
[A preliminary study on the measurements of microelements in the serum of schizophrenics].
Topics: Adult; Chlorpromazine; Copper; Haloperidol; Humans; Iron; Lithium; Lithium Carbonate; Male; Middle A | 1987 |
Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
Topics: Adult; Chlorpromazine; Cholesterol; Drug Therapy, Combination; Female; Haloperidol; Humans; Hypercho | 1988 |
Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
Topics: Adult; Chlorpromazine; Female; Haloperidol; Humans; Male; Middle Aged; Pigmentation Disorders; Schiz | 1988 |
[A comparative study of evoked potentials on clinical symptoms and treatment efficiency in acute schizophrenics].
Topics: Adolescent; Adult; Chlorpromazine; Clozapine; Evoked Potentials, Auditory; Evoked Potentials, Visual | 1988 |
Chlorpromazine accumulation and sudden death in a patient with renal insufficiency.
Topics: Chlorpromazine; Death, Sudden; Humans; Kidney Failure, Chronic; Male; Middle Aged; Schizophrenia | 1988 |
[Effect of thioridazine and chlorpromazine on the ECG and serum potassium level--ECG of the glucose load in 40 cases].
Topics: Adolescent; Adult; Chlorpromazine; Electrocardiography; Female; Humans; Male; Middle Aged; Potassium | 1988 |
Chlorpromazine plasma level monitoring of schizophrenic patients.
Topics: Chlorpromazine; Humans; Monitoring, Physiologic; Schizophrenia | 1988 |
Amphetamine and chlorpromazine modify cerebral insulin levels in rats.
Topics: Amphetamine; Animals; Brain; Chlorpromazine; Disease Models, Animal; Female; Insulin; Rats; Rats, In | 1988 |
Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissue.
Topics: Aged; Biotransformation; Blood-Brain Barrier; Brain; Chlorpromazine; Female; Humans; Male; Middle Ag | 1988 |
[Nailfold microcirculation and treatment of schizophrenia patients with traditional Chinese medicine and Western medicine].
Topics: Adolescent; Adult; Chlorpromazine; Drugs, Chinese Herbal; Female; Humans; Male; Microcirculation; Mi | 1988 |
Decrease of serum malondialdehyde in patients treated with chlorpromazine.
Topics: Adult; Aged; Chlorpromazine; Depression, Chemical; Humans; Male; Malonates; Malondialdehyde; Middle | 1987 |
[Schizophrenia mainly treated with jinpudan tablets].
Topics: Adult; Chlorpromazine; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Humans; Male; Schiz | 1987 |
Solid-phase extraction and high-performance liquid chromatographic method for chlorpromazine and thirteen metabolites.
Topics: Biotransformation; Chlorpromazine; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concen | 1987 |
[Controlled study of insulin treatment, insulin treatment with chlorpromazine and chlorpromazine alone of schizophrenics].
Topics: Adult; Chlorpromazine; Combined Modality Therapy; Convulsive Therapy; Female; Humans; Male; Prospect | 1987 |
Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril.
Topics: Blood Pressure; Captopril; Chlorpromazine; Drug Synergism; Drug Therapy, Combination; Humans; Hypert | 1986 |
Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients.
Topics: Adult; Chlorpromazine; Female; Haloperidol; Humans; Male; Schizophrenia; Vasopressins | 1987 |
Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
Topics: Chlorpromazine; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Platelet Count; | 1987 |
Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping.
Topics: Adolescent; Adult; Benztropine; Chlorpromazine; Drug Therapy, Combination; Female; Haloperidol; Huma | 1987 |
A successful electroconvulsive treatment of neuroleptic malignant syndrome.
Topics: Adult; Chlorpromazine; Electroconvulsive Therapy; Humans; Male; Neuroleptic Malignant Syndrome; Schi | 1987 |
Treatment resistant chronic psychopathology and CT scans in schizophrenia.
Topics: Adolescent; Adult; Chlorpromazine; Chronic Disease; Drug Resistance; Female; Humans; Male; Neurocogn | 1987 |
Rapid normalization of the dexamethasone suppression test with mianserin.
Topics: Chlorpromazine; Depressive Disorder; Dexamethasone; Haloperidol; Humans; Hydrocortisone; Mianserin; | 1987 |
Therapeutic effect of He-Ne laser irradiation of point erman in schizophrenic auditory hallucination--a clinical assessment.
Topics: Acupuncture Therapy; Adult; Auditory Perception; Chlorpromazine; Hallucinations; Humans; Laser Thera | 1986 |
Electrodermal responding and chlorpromazine treatment in schizophrenia.
Topics: Adult; Chlorpromazine; Female; Galvanic Skin Response; Humans; Male; Schizophrenia | 1987 |
In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
Topics: Adult; Chlorpromazine; Electrocardiography; Haloperidol; Heart; Heart Rate; Humans; Male; Middle Age | 1987 |
[An evaluation of single or multiple dosage of antipsychotic agents in the treatment of schizophrenia].
Topics: Adolescent; Adult; Chlorpromazine; Drug Administration Schedule; Female; Humans; Male; Random Alloca | 1986 |
[A preliminary study on factors affecting treatment and prognosis of schizophrenia].
Topics: Chlorpromazine; Humans; Personality; Prognosis; Schizophrenia; Social Adjustment | 1986 |
Modulation of spinal motor asymmetry by neuroleptic medication of schizophrenia patients.
Topics: Adult; Chlorpromazine; Dominance, Cerebral; Functional Laterality; H-Reflex; Humans; Leg; Male; Midd | 1986 |
Priapism and psychotropic medication.
Topics: Adult; Chlormethiazole; Chlorpromazine; Humans; Male; Munchausen Syndrome; Priapism; Promazine; Schi | 1986 |
Determination of chlorpromazine in serum by radioreceptor assay and HPLC.
Topics: Chlorpromazine; Chromatography, High Pressure Liquid; Humans; Male; Monitoring, Physiologic; Prolact | 1986 |
Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Dementia; Dopamine beta-Hydroxylase; Dose-Response Relationship, Dr | 1985 |
Gas chromatographic-mass spectrometric determination of myo-inositol in human cerebrospinal fluid.
Topics: Adult; Arthritis, Rheumatoid; Chlorpromazine; Female; Gas Chromatography-Mass Spectrometry; Humans; | 1985 |
Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
Topics: Anterior Chamber; Chlorpromazine; Cornea; Eye Diseases; Humans; Pigmentation Disorders; Schizophreni | 1985 |
Systemic lupus erythematosus induced by psychotropic drugs.
Topics: Adult; Blood Cell Count; Chlorpromazine; Chlorprothixene; Female; Humans; Lupus Erythematosus, Syste | 1971 |
Drug induced dystonia tarda: treatment with L-dopa.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Diazepam; Dihydroxyphenylalanine; Dystonia Mu | 1973 |
[Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Chlorpromazine; Diazepam; Glucose Tolerance Test; Haloperidol; Hum | 1971 |
[The properdin system in patients with schizophrenia during the process of active therapy].
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Complement System Proteins; Diet Therapy; D | 1973 |
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Facial Mus | 1973 |
Medical Research Council Neurochemical Pharmacology Unit.
Topics: Aminobutyrates; Antidepressive Agents; Biogenic Amines; Brain; Carboxy-Lyases; Chlorpromazine; Cycli | 1974 |
Maintenance treatment of schizophrenia with long-acting fluphenazine.
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Movem | 1974 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dih | 1974 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
Antipsychotic drugs and catecholamine synapses.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Catecholamines; Chlorprom | 1974 |
Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Chlorpromazine; | 1974 |
Antinuclear factors in relation to age, sex, mental disease and treatment with phenothiazines.
Topics: Age Factors; Aged; Antibodies, Antinuclear; Antipsychotic Agents; Chlorpromazine; Dementia; Female; | 1974 |
The effect of phenothiazines on cerebrospinal fluid.
Topics: Cerebrospinal Fluid Proteins; Chlorpromazine; gamma-Globulins; Humans; Perphenazine; Schizophrenia; | 1966 |
Psychosis associated with the use of a sequential oral contraceptive.
Topics: Adult; Chlormadinone Acetate; Chlorpromazine; Contraceptives, Oral; Depression; Estrogens; Female; H | 1967 |
Cerebellar atrophy in epilepsy. Pneumographic and histological documentation of a case with psychosis.
Topics: Adult; Brain; Cerebellar Ataxia; Cerebral Ventriculography; Chlorpromazine; Diplopia; Electroconvuls | 1968 |
Schizophrenia-like psychosis in thyroid crisis.
Topics: Adult; Antithyroid Agents; Chlorpromazine; Diagnosis, Differential; Humans; Hyperthyroidism; Male; P | 1968 |
Alterations of evoked potentials in psychotic patients under the influence of chlorpromazine and trifluoperazine.
Topics: Brain Diseases; Cerebral Cortex; Chlorpromazine; Electroencephalography; Epilepsy; Evoked Potentials | 1969 |
The extrapyramidal neuroleptic syndrome: description and measurement.
Topics: Basal Ganglia Diseases; Chlorpromazine; Electromyography; Facial Muscles; Gait; Humans; Movement Dis | 1973 |
[The erythrocyte sedimentation rate (ESR) and treatment with neuroleptics].
Topics: Administration, Oral; Aged; Blood; Blood Sedimentation; Chlorpromazine; Female; Humans; Injections; | 1974 |
Dopamine and the pharmacology of schizophrenia: the state of the evidence.
Topics: Amphetamine; Animals; Brain; Cats; Caudate Nucleus; Chlorpromazine; Dogs; Dopamine; Haloperidol; Hap | 1974 |
Intramyocardial lesions in patients dying suddenly and unexpectedly.
Topics: Adult; Aged; Bipolar Disorder; Brain Damage, Chronic; Chlorpromazine; Death, Sudden; Epilepsy, Tonic | 1966 |
[Ultrastructural study of corneal thickening in the course of chlorpromazine treatment].
Topics: Biopsy; Chlorpromazine; Cornea; Epithelium; Eye Diseases; Female; Humans; Melanins; Membranes; Micro | 1970 |
[The effect of intensive hospital treatment on the duration of remissions among schizophrenics with a long history of the disease].
Topics: Ambulatory Care; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Hospitals, Psych | 1973 |
Mg++-dependent adenosine triphosphatase activity in erythrocyte ghosts of schizophrenic patients.
Topics: Acute Disease; Adenosine Triphosphatases; Adult; Cell Membrane; Chlorpromazine; Chronic Disease; Dep | 1974 |
Systematic identification of psychotropic drugs by thin layer chromatography. II.
Topics: Amitriptyline; Chlorpromazine; Chlorprothixene; Chromatography, Thin Layer; Desipramine; Female; Hum | 1968 |
Oral activity cycles in mild chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Drinking Behavior; Drive; Feeding Behavior; Female; Humans; | 1968 |
Neuroendocrinological studies in mental disorders and psychotropic drugs. I. On the circadian rhythm of the plasma adrenocortical hormone in mental patients and methamphetamine- and chlorpromazine-treated animals.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Animals; Chlorpromazine; Circadian Rh | 1969 |
[Neurohumoral regulation of the lability of myoneural synapses in schizophrenic patients].
Topics: Acetylcholine; Adrenocorticotropic Hormone; Adult; Atropine; Catatonia; Chlorpromazine; Chronaxy; Co | 1969 |
Differential effects of chlorpromazine and phenobarbital on EEG sleep patterns.
Topics: Adult; Antisocial Personality Disorder; Chlorpromazine; Electroencephalography; Eye Movements; Human | 1969 |
Serum cortisol in chronic schizophrenia. A study of the adrenocortical response to intravenously administered insulin and ACTH.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Age Factors; Aged; Amitriptyline; Blood Glucose; Chlorp | 1971 |
Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.
Topics: Adult; Aged; Chlorpromazine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Meth | 1972 |
The effect of chlorpromazine on pituitary function.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Blood | 1972 |
Biochemistry and psychiatry with special reference to psychopharmacology.
Topics: Avitaminosis; Chlorpromazine; Cyclic AMP; Endocrine System Diseases; Enzyme Induction; Humans; Menta | 1974 |
An evaluation of some possible prognostic indicators of response to phenothiazine treatment of acute schizophrenic psychoses.
Topics: Adolescent; Adult; Attitude; Chlorpromazine; Female; Fluphenazine; Humans; Male; MMPI; Prognosis; Ps | 1965 |
Paradoxical effects of phenothiazines.
Topics: Adult; Amitriptyline; Chlorpromazine; Diazepam; Female; Humans; Meclofenoxate; Meprobamate; Phenothi | 1968 |
[Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
Topics: Adolescent; Affect; Child; Child, Preschool; Chlorpromazine; Depression; Haloperidol; Humans; Moveme | 1967 |
Influences of different stimulus intensities on the human somatosensory evoked response (a proposal for the data processing).
Topics: Adult; Chlorpromazine; Chronic Disease; Computers; Electric Stimulation; Electronic Data Processing; | 1968 |
[2-chlor-4-azaphenthiazine. Synthesis and pharmacological properties of cloxypendyl].
Topics: Abnormalities, Drug-Induced; Acetylcholine; Animals; Autonomic Agents; Autonomic Nervous System; Blo | 1968 |
Dependence on a placebo: a case report.
Topics: Adult; Chlorpromazine; Delusions; Female; Humans; Mental Fatigue; Placebos; Prochlorperazine; Rape; | 1969 |
Increase in gustatory acuity and hyperarousal in schizophrenia.
Topics: Arousal; Chlorpromazine; Female; Humans; Male; MMPI; Perceptual Distortion; Phenothiazines; Psychiat | 1969 |
[Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
Topics: Animals; Apomorphine; Arousal; Caudate Nucleus; Chlorpromazine; Chlorprothixene; Electroencephalogra | 1969 |
Pharmacological and dynamic factors in psychotropic drug therapy.
Topics: Adult; Amphetamine; Antidepressive Agents; Antitubercular Agents; Anxiety; Bipolar Disorder; Chlorpr | 1970 |
Clinical and pharmacological investigation of a new psychotropic drug sulpiride (Dogmatil).
Topics: Adult; Amides; Amphetamine; Animals; Body Temperature; Central Nervous System Stimulants; Chlorproma | 1971 |
Plasma protein binding of chlorpromazine.
Topics: Animals; Blood Proteins; Chlorpromazine; Dialysis; Dogs; Humans; Hydrogen-Ion Concentration; Protein | 1970 |
The effect of chlorpromazine on drug metabolism.
Topics: Adult; Aged; Animals; Antipyrine; Barbiturates; Biotransformation; Chlorpromazine; Enzyme Induction; | 1972 |
Patterns of psychotropic drug prescription in four midwestern state hospitals.
Topics: Alcoholism; Antidepressive Agents; Antipsychotic Agents; Chlorpromazine; Computers; Drug Utilization | 1972 |
Skin melanin concentrations in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Female; Humans; Male; Melanins; Phenyt | 1972 |
Mutism induced by phenothiazines.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Depression; Female; Humans; Hyperemesis Gravidarum; Int | 1972 |
Phenothiazine poisoning. A review of 48 cases.
Topics: Adult; Antipsychotic Agents; Child; Child, Preschool; Chlorpromazine; Female; Humans; Male; Poisonin | 1973 |
Serum tryptophan binding in chlorpromazine-treated chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Diffusion; Fatty Acids, Nonesterified; Humans; Liver; Male; Orphena | 1974 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
[Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
Topics: Adolescent; Adult; Chlorpromazine; Female; Haloperidol; Humans; Hypesthesia; Male; Pain; Schizophren | 1974 |
Influence of some biographic factors on the therapeutic drug response.
Topics: Adult; Age Factors; Chlorpromazine; Educational Status; Female; Humans; Male; Occupations; Prognosis | 1974 |
Proceedings: Sex and race differences in symptomatology of schizophrenic outpatients associated with clinical relapse.
Topics: Chlorpromazine; Female; Humans; Male; Race Relations; Recurrence; Schizophrenia; Sex Factors | 1974 |
Chlorpromazine therapy, and associated acute disturbances of cardiac rhythm.
Topics: Adult; Blood Glucose; Chlorpromazine; Electrocardiography; Female; Haloperidol; Heart Block; Humans; | 1974 |
New drug for schizophrenia?
Topics: Chlorpromazine; Drug Synergism; Heart Arrest; Humans; Hypoglycemia; Hypotension; Phenothiazines; Pro | 1974 |
Predicting treatment responsiveness-resistiveness in a population of depressed patients.
Topics: Antidepressive Agents; Chlorpromazine; Depression; Drug Resistance; Drug Therapy, Combination; Emoti | 1974 |
Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers.
Topics: Acute Disease; Administration, Oral; Adult; Chlorpromazine; Chronic Disease; Circadian Rhythm; Depre | 1974 |
Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
Topics: Amphetamine; Animals; Arousal; Brain; Chlorpromazine; Corpus Striatum; Dopamine; Dopamine Antagonist | 1974 |
Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.
Topics: Age Factors; Aged; Animals; Autopsy; Brain; Brain Chemistry; Catechol O-Methyltransferase; Chlorprom | 1974 |
Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Bipolar Disorder; Brain; Chlorpromazine; Chromatography, Gas; Deuterium; Dopamin | 1974 |
[Rapid arrest of acute psychotic states by hexenal combined with aminazine].
Topics: Chlorpromazine; Drug Therapy, Combination; Hexobarbital; Humans; Neurocognitive Disorders; Psychotic | 1974 |
Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients.
Topics: Chlorpromazine; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Erythrocytes; Glucuron | 1972 |
Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
Topics: Administration, Oral; Adult; Chlorpromazine; Female; Humans; Male; Methods; Middle Aged; Schizophren | 1972 |
Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Chlorpromazine; Dopamine Antagonists; Human | 1973 |
A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
Topics: Animals; Carbon Radioisotopes; Chlorpromazine; Chromatography, Gas; Chromatography, Thin Layer; Desi | 1974 |
Prediction of drug effect in personality disorders.
Topics: Affective Symptoms; Chlorpromazine; Depression; Diagnosis, Computer-Assisted; Evaluation Studies as | 1973 |
Immunoglobulins and improvement in acute schizophrenic reactions.
Topics: Acute Disease; Adolescent; Adult; Chlorpromazine; Creatine Kinase; Hospitalization; Humans; Immunodi | 1973 |
Laterality and voltage in the EEG of psychiatric patients.
Topics: Adult; Chlorpromazine; Chronic Disease; Dominance, Cerebral; Dose-Response Relationship, Drug; Elect | 1972 |
Chlorpromazine metabolism. V. Disposition of free and conjugated metabolites in blood fractions of schizophrenic patients.
Topics: Administration, Oral; Blood Platelets; Chlorpromazine; Chronic Disease; Erythrocytes; Humans; Schizo | 1972 |
Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses.
Topics: Animals; Brain; Brain Chemistry; Chlorpromazine; Dextroamphetamine; Dopamine; Humans; Limbic System; | 1972 |
Comparative study of two antipsychotic drugs in a state hospital.
Topics: Adult; Alcoholism; Bipolar Disorder; Chlorpromazine; Depression; Evaluation Studies as Topic; Female | 1972 |
Short-term therapy for the psychiatric patient.
Topics: Alcoholism; Chlorpromazine; Depression; Evaluation Studies as Topic; Hospitalization; Hospitals, Psy | 1972 |
Pharmacology and psychiatry.
Topics: Animals; Brain Chemistry; Cats; Chlorpromazine; Dogs; Dopamine; Haloperidol; Humans; Mice; Models, C | 1972 |
Chlorpromazine metabolism. 3. Determination of conjugated metabolites in the blood of schizophrenic patients.
Topics: Acetates; Buffers; Chlorpromazine; Citrates; Glucuronidase; Humans; Hydrogen-Ion Concentration; Hydr | 1973 |
Review of schizophrenics in a rural practice over 26 years.
Topics: Adolescent; Adult; Chlorpromazine; England; Female; Follow-Up Studies; Hospitalization; Humans; Male | 1973 |
The diagnosis and management of the acutely disturbed patient.
Topics: Adjustment Disorders; Alcoholism; Chlorpromazine; Diagnosis, Differential; Female; Humans; Language; | 1973 |
Role of chlorpromazine in maintaining timing behavior in chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Female; Humans; Male; Middle Aged; Reinforcement Schedule; Schizoph | 1973 |
Phenothiazine-induced stress incontinence.
Topics: Adjustment Disorders; Adult; Chlorpromazine; Female; Humans; Middle Aged; Paranoid Disorders; Phenot | 1973 |
Myasthenia gravis and schizophrenia--a rare combination.
Topics: Aged; Chlorpromazine; Humans; Male; Myasthenia Gravis; Neostigmine; Schizophrenia | 1973 |
Thin-layer chromatography of chlorpromazine metabolites. Attempt to identify each of the metabolites appearing in blood, urine and feces of chronically medicated schizophrenics.
Topics: Chlorpromazine; Chromatography, Gas; Chromatography, Thin Layer; Chronic Disease; Erythrocytes; Fece | 1973 |
Nutritional requirements in mental illness. I. Ascorbic acid retention in schizophrenia. A reexamination.
Topics: Adult; Aged; Ascorbic Acid; Chlorpromazine; Diuresis; Drinking; Evaluation Studies as Topic; Female; | 1973 |
Severe shock caused by chlorpromazine hypersensitivity.
Topics: Adult; Bipolar Disorder; Blood Pressure; Chlorpromazine; Drug Hypersensitivity; Humans; Injections, | 1973 |
Voltage laterality in the EEG of psychiatric patients.
Topics: Adult; Brain; Chlorpromazine; Clopenthixol; Dominance, Cerebral; Dose-Response Relationship, Drug; E | 1973 |
Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients.
Topics: Adult; Age Factors; Aged; Animals; Brain; Brain Chemistry; Chlorpromazine; Diencephalon; Dopamine be | 1973 |
Chlorpromazine and hyperpyrexia. A reminder that this drug affects the mechanisms which regulate body temperature.
Topics: Adolescent; Body Temperature Regulation; Chlorpromazine; Fever; Humans; Male; Physical Exertion; Sch | 1973 |
The role of information processing in the sentence decoding of schizophrenic listeners.
Topics: Adolescent; Adult; Auditory Perception; Chlorpromazine; Female; Humans; Male; Memory, Short-Term; Mi | 1973 |
Rapid reversal of tardive dyskinesia.
Topics: Adult; Chlorpromazine; Dibenzoxepins; Female; Haloperidol; Humans; Movement Disorders; Neurologic Ma | 1973 |
Ataractic drugs versus ECT in schizophrenia.
Topics: Chlorpromazine; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Follow-Up Studies; Halo | 1973 |
Gas-liquid chromatographic analysis of phenolic and non-phenolic chlorpromazine metabolites in the urine of chronic schizophrenic patients.
Topics: Chlorpromazine; Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Human | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H | 1973 |
Evoked potential correlates of information processing in psychiatric patients.
Topics: Adolescent; Adult; Auditory Perception; Bipolar Disorder; Chlorpromazine; Depression; Diagnosis, Dif | 1973 |
The possible role of metabolites in therapeutic response to chlorpromazine treatment.
Topics: Adult; Chlorpromazine; Chromatography, Thin Layer; Drug Resistance; Humans; Male; Schizophrenia | 1973 |
Antidiuretic hormone levels in patients with weight gain after chlorpromazine therapy.
Topics: Adolescent; Adult; Anxiety Disorders; Body Weight; Chlorpromazine; Electroconvulsive Therapy; Humans | 1973 |
[Treatment of hallucinatory disorders in schizophrenia with atropine comas].
Topics: Amitriptyline; Atropine; Chlorpromazine; Coma; Drug Therapy, Combination; Epinephrine; Hallucination | 1973 |
Psychiatric problems in the hospital emergency room.
Topics: Affective Symptoms; Amobarbital; Chlordiazepoxide; Chlorpromazine; Emergency Service, Hospital; Homi | 1974 |
Central dopamine turnover in schizophrenic syndromes.
Topics: Affective Symptoms; Chlorpromazine; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1974 |
Further studies of chlorpromazine metabolism in schizophrenic men.
Topics: Alcohols; Chlorpromazine; Chromatography, Thin Layer; Ethyl Ethers; Humans; Hydrocarbons, Chlorinate | 1974 |
Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms.
Topics: Chlorpromazine; Chromatography, Thin Layer; Creatinine; Densitometry; Erythrocytes; Glucuronates; Ha | 1974 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
Black-white differences in serum creatine phosphokinase (CPK) activity.
Topics: Age Factors; Analysis of Variance; Black People; Body Weight; Chlorpromazine; Creatine Kinase; Femal | 1974 |
The effect of chlorpromazine on visual information processing in normal subjects.
Topics: Adult; Chlorpromazine; Female; Habituation, Psychophysiologic; Humans; Male; Memory, Short-Term; Men | 1974 |
[Drawings of a schizophrenic during a Sakel cure].
Topics: Adult; Chlorpromazine; Convulsive Therapy; Diazepam; Haloperidol; Humans; Male; Methotrimeprazine; P | 1967 |
Psychiatric complications of heart transplants.
Topics: Adult; Body Image; Brain Diseases; Chlorpromazine; Depression; Female; Heart Transplantation; Humans | 1969 |
Recent perspectives in schizophrenia.
Topics: Adult; Chlorpromazine; Electroconvulsive Therapy; History, 19th Century; History, 20th Century; Huma | 1971 |
Total dosage of chlorpromazine and ocular opacities.
Topics: Cataract; Chlorpromazine; Corneal Opacity; Dose-Response Relationship, Drug; Humans; Schizophrenia | 1967 |
The effect of chlorpromazine on lithium excretion in psychiatric subjects.
Topics: Chlorpromazine; Humans; Lithium; Psychoses, Alcoholic; Schizophrenia; Sodium | 1966 |
[Treatment of schizophrenia with fluphenazine].
Topics: Chlorpromazine; Female; Fluphenazine; Humans; Male; Schizophrenia | 1966 |
Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
Topics: Antidepressive Agents; Chlorpromazine; Chronic Disease; Eye Diseases; Female; Humans; Long-Term Care | 1968 |
[Ocular involvement during prolonged treatment with neuroleptics].
Topics: Adult; Aged; Chlorpromazine; Corneal Opacity; Eye Diseases; Female; Fundus Oculi; Humans; Lens, Crys | 1968 |
The electrophoretic pattern of alkaline phosphatase in schizophrenic females under long-term treatment with neuroleptic drugs and in young and old healthy women.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Blood Protein Electrophoresis; Chlorpromazine; Chlor | 1969 |
[Ocular changes in long-term treatment with Largactil].
Topics: Adult; Aged; Chlorpromazine; Color Perception; Dark Adaptation; Electrooculography; Electroretinogra | 1970 |
Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
Topics: Adult; Central Nervous System; Chlorpromazine; Chronic Disease; Female; Humans; Male; Middle Aged; N | 1970 |
Chlorpromazine metabolism. II. Determination of nonconjugated metabolites in blood of schizophrenic patients.
Topics: Chlorpromazine; Chromatography, Thin Layer; Dansyl Compounds; Dealkylation; Fluorescence; Humans; Me | 1972 |
The effect of schizophrenic plasma on tissue culture.
Topics: Cells, Cultured; Chlorpromazine; Chromatin; Culture Techniques; Humans; Leukocytes; Lymphocytes; Neu | 1972 |
The effect of octoclothepine on sensorimotor coordination of fine movements in chronic schizophrenics.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Chronic Disease; Dibenzothiepins; Female; Humans; Mid | 1972 |
Withdrawal symptoms after long-term treatment with neuroleptics.
Topics: Adult; Aged; Blood Circulation; Chlorpromazine; Fever; Humans; Hyperkinesis; Hypotension; Hypothermi | 1972 |
Are MAOI and other psychotropic drugs really compatible?
Topics: Adult; Amitriptyline; Barbiturates; Chlorpromazine; Drug Interactions; Humans; Male; Monoamine Oxida | 1972 |
EEG dose-response relationships of chlorpromazine in chronic schizophrenia: the effects on the various rhythms and on alpha blocking.
Topics: Adult; Cerebral Cortex; Chlorpromazine; Electroencephalography; Female; Humans; Middle Aged; Schizop | 1972 |
Atypical manifestations of postural hypotension.
Topics: Adult; Blood Pressure; Chlorpromazine; Diagnosis, Differential; Humans; Hypotension, Orthostatic; Lo | 1972 |
The rabbit syndrome. A peculiar extrapyramidal reaction.
Topics: Aged; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Fatigue; Female; Humans; Male; M | 1972 |
Urinary creatinine in drug-excretion studies in chronic schizophrenics.
Topics: Alcoholism; Body Weight; Chlorpromazine; Chromatography; Creatinine; Female; Humans; Male; Schizophr | 1972 |
Effects of chlorpromazine and fluphenazine on some schizophrenic forms of behaviour.
Topics: Adult; Affect; Antisocial Personality Disorder; Autistic Disorder; Chlorpromazine; Defense Mechanism | 1972 |
Behavior modification using interlocking reinforcement on a short-term psychiatric ward.
Topics: Adult; Attitude of Health Personnel; Behavior Therapy; Chlorpromazine; Female; Humans; Interprofessi | 1972 |
Neuroleptic therapy for chronic schizophrenia.
Topics: Adult; Aged; Chlorpromazine; Chronic Disease; Female; Hospitalization; Humans; Length of Stay; Male; | 1972 |
Modified narcosis, ECT and antidepressant drugs: a review of technique and immediate outcome.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Antidepressive Agents; Anxiety; Chlorpromazine; Chroni | 1972 |
[Studies on schizophrenics following several years of hospitalization. II. Data from the time of long-term hospitalization].
Topics: Aggression; Attitude of Health Personnel; Catatonia; Chlorpromazine; Electroconvulsive Therapy; Hosp | 1972 |
Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
Topics: Acute Disease; Ataxia; Behavior; Chlorpromazine; Fluphenazine; Humans; Phenothiazines; Psychiatric S | 1972 |
Reversal of benztropine toxicity by physostigmine.
Topics: Brain; Chlorpromazine; Female; Humans; Imipramine; Memory, Short-Term; Parasympatholytics; Perphenaz | 1972 |
Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
Topics: Animals; Behavior, Animal; Brain; Chlorpromazine; Conditioning, Operant; Dopamine; Dopamine beta-Hyd | 1972 |
Some features of the auditory evoked response in schizophrenics.
Topics: Acoustic Stimulation; Adult; Age Factors; Auditory Perception; Chlorpromazine; Conditioning, Classic | 1972 |
The reliability of a decision tree technique applied to psychiatric diagnosis.
Topics: Affective Symptoms; Chlorpromazine; Decision Making; Diagnosis, Differential; Factor Analysis, Stati | 1972 |
[Effect of long-term therapy with aminazin on the structure and function of the liver].
Topics: Adult; Chemical and Drug Induced Liver Injury; Chlorpromazine; Female; Humans; Liver; Male; Middle A | 1972 |
Biological studies in childhood schizophrenia: serotonin uptake by platelets.
Topics: Adolescent; Blood Cell Count; Blood Platelets; Brain Damage, Chronic; Carbon Isotopes; Child; Chlorp | 1971 |
Psychosocial profiles and efficacy of lithium treatment.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Human | 1971 |
Oxygen consumption and enzymatic activity of glucose metabolism in leukocytes and erythrocytes in peripheral blood of schizophrenics.
Topics: Adult; Blood Cell Count; Blood Cells; Chlorpromazine; Erythrocytes; Female; Glucose; Glucose-6-Phosp | 1971 |
[Follow-up studies of schizophrenia].
Topics: Adult; Catalepsy; Catatonia; Chlorpromazine; Chronic Disease; Convulsive Therapy; Depersonalization; | 1971 |
Potentiation in rats of bufotenin-induced behavioral changes by chlorpromazine.
Topics: Amitriptyline; Animals; Behavior, Animal; Chlorpromazine; Drug Synergism; Female; Hallucinogens; Hum | 1971 |
Rapid tranquilization.
Topics: Adolescent; Blood Pressure Determination; Chlorpheniramine; Chlorpromazine; Humans; Hypotension; Mal | 1971 |
[Febrile states in schizophrenia following a paroxysmal course].
Topics: Adolescent; Adult; Catatonia; Chlorpromazine; Dementia; Female; Fever; Humans; Hyperkinesis; Male; M | 1971 |
Urinary excretion of chlorpromazine and chlorpromazine sulfoxide in four patients on different days.
Topics: Chlorpromazine; Humans; Male; Schizophrenia; Spectrophotometry; Sulfoxides; Time Factors | 1971 |
Paranoid psychosis in a case of Klinefelter's syndrome.
Topics: Adult; Chlorpromazine; Humans; Karyotyping; Klinefelter Syndrome; Male; Paranoid Disorders; Schizoph | 1971 |
[Course of body temperature during injection therapy with neuroleptics. Statistical evaluation of data from a retrospective study].
Topics: Body Temperature; Chlorpromazine; Chlorprothixene; Clopenthixol; Dibenzothiazepines; Electroconvulsi | 1971 |
Chlorpromazine metabolism in chronic schizophrenics.
Topics: Chlorpromazine; Chromatography; Chronic Disease; Creatine; Electroencephalography; Female; Fluoromet | 1971 |
Perception and tolerance of pain as a measure of antipsychotic treatment.
Topics: Adult; Chlorpromazine; Chronic Disease; Female; Humans; Middle Aged; Schizophrenia | 1971 |
[Changes in clinical course and symptomatology of schizophrenia following introduction of pharmacotherapy].
Topics: Adult; Aged; Chlorpromazine; Follow-Up Studies; Hospitalization; Humans; Length of Stay; Male; Middl | 1971 |
[New objective biochemical and cytological indicators in psychiatry].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Chlorpromazine; Erythrocytes; Humans; Leukocytes; Nuc | 1971 |
[Clinical pharmacology of chlorpromazine].
Topics: Blood Pressure; Chlorpromazine; Humans; Pulse; Schizophrenia | 1971 |
[Insulin-shock treatment in the modern biological therapy of schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Humans; Imipramine; Schizophrenia | 1971 |
Hirsutism and schizophrenia in postmenopausal woman.
Topics: Adrenal Hyperplasia, Congenital; Chlorpromazine; Diagnosis, Differential; Female; Hirsutism; Humans; | 1966 |
Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs.
Topics: Binding Sites; Chlorpromazine; Dibenzoxepins; Dopamine; Haloperidol; Humans; Isomerism; Models, Stru | 1971 |
[A study of electroencephalographic analysis of schizophrenia].
Topics: Adult; Chloralose; Chlordiazepoxide; Chlorpromazine; Diagnosis, Differential; Electroencephalography | 1964 |
[Pure intracellular cholestasis. Ultrastructural studies of 2 cases of Dubin-Johnson syndrome and non-icteric patients treated with chlorpromazine].
Topics: Biopsy; Chlorpromazine; Humans; Jaundice, Chronic Idiopathic; Liver; Male; Microscopy, Electron; Sch | 1966 |
[The cortical response during longterm therapy with high dosages of propaphenin-prothazin].
Topics: Adult; Cerebral Cortex; Chlorpromazine; Electroencephalography; Evoked Potentials; Female; Humans; P | 1967 |
[Ophthalmologic study of patients receiving psychotropic drugs].
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Cataract; Cerebrova | 1970 |
[The Wartegg-Sign-Test in schizophrenics].
Topics: Adolescent; Adult; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Female; Follow-Up | 1966 |
Depression following fluphenazine treatment.
Topics: Chlorpromazine; Depression; Fluphenazine; Humans; Phenothiazines; Schizophrenia; Thioridazine | 1969 |
Anticholinergic drug-induced sleep-like EEG pattern in man.
Topics: Adolescent; Adult; Atropine; Chlorpromazine; Electroencephalography; Female; Glycolates; Humans; Mal | 1969 |
Twelve-year treatment and follow-up of a chronic schizophrenic.
Topics: Adult; Chlorpromazine; Chronic Disease; Convulsive Therapy; Electroconvulsive Therapy; Follow-Up Stu | 1969 |
[Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Topics: Adolescent; Adult; Aged; Butyrophenones; Chlorpromazine; Dementia; Depressive Disorder, Major; Dysau | 1969 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
[An electrophysiologic study of changes in the functional state of the brains of mental patients following aminazine administration].
Topics: Adult; Brain Diseases; Chlorpromazine; Electroencephalography; Electrophysiology; Epilepsy; Humans; | 1969 |
Hypermnesia and schizophrenia.
Topics: Chlorpromazine; Humans; Memory; Schizophrenia; Schizophrenic Psychology | 1969 |
The mono-amine oxidase inhibitors; their usefulness and their safety.
Topics: Adolescent; Adult; Chlorpromazine; Drug Synergism; Female; Humans; Middle Aged; Monoamine Oxidase In | 1969 |
The significance of variations in breathing behaviour in speech and at rest.
Topics: Adult; Aged; Antidepressive Agents; Chlorpromazine; Cognition; Depression; Female; Humans; Male; Men | 1969 |
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Chronic Disease; Extrapyramidal Tracts; Female; Haloperidol; | 1969 |
[Hypothalamo-pituitary-adrenocortical response to electroshock therapy, insulin-coma therapy and vasopressin administration in schizophrenic patients].
Topics: Adult; Chlorpromazine; Electroshock; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; | 1969 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Human | 1970 |
Chlorpromazine plasma levels and effects.
Topics: Blood Pressure; Chlorpromazine; Chronic Disease; Drug Hypersensitivity; Humans; Hypnotics and Sedati | 1970 |
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Topics: Amines; Brain; Chlorpromazine; Extrapyramidal Tracts; Female; Humans; Hydroxyindoleacetic Acid; Move | 1970 |
Chronic psychosis associated with long-term psychotomimetic drug abuse.
Topics: Adult; Chlorpromazine; Humans; Lysergic Acid Diethylamide; Male; Psychoses, Substance-Induced; Psych | 1970 |
Relation of eye movement to the process-reactive dimension in schizophrenia: a failure to replicate.
Topics: Chlorpromazine; Eye Movements; Humans; Intelligence; Schizophrenia | 1970 |
Adverse reactions to marihuana. Classification and suggested treatment.
Topics: Adjustment Disorders; Adolescent; Adult; Cannabis; Chlordiazepoxide; Chlorpromazine; Depression; Fem | 1970 |
Glucose tolerance in man during chlorpromazine therapy.
Topics: Adult; Blood Glucose; Body Weight; Chlorpromazine; Glucose Tolerance Test; Humans; Male; Middle Aged | 1970 |
[Protracted (unaffected by glucose) insulin comas, their cause, clinical picture and treatment].
Topics: Amobarbital; Barbiturates; Chlorpromazine; Convulsive Therapy; Depressive Disorder, Major; Encephali | 1970 |
Serum vitamin-B12 levels in psychiatric patients on long-term psychotropic drug therapy.
Topics: Adult; Aged; Biological Assay; Bipolar Disorder; Chlorpromazine; Depressive Disorder, Major; Female; | 1970 |
A case of Capgras' syndrome.
Topics: Adult; Chlorpromazine; Delusions; Female; Humans; Psychotic Disorders; Schizophrenia; Trifluoperazin | 1970 |
A mechanism of sudden death in chlorpromazine therapy.
Topics: Adult; Chlorpromazine; Death, Sudden; Female; Humans; Injections, Intramuscular; Schizophrenia | 1970 |
Lithium carbonate treatment in psychiatry.
Topics: Bipolar Disorder; Carbonates; Chlorpromazine; Depression; Humans; Lithium; Male; Middle Aged; Parano | 1970 |
[Glaucomatous symptoms produced by the possible side effects after administration of massive doses of psychodrugs. II].
Topics: Adult; Chlorpromazine; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Schizophre | 1970 |
Priapism and phenothiazines.
Topics: Blood Pressure; Chlorpromazine; Humans; Male; Phenothiazines; Priapism; Schizophrenia | 1970 |
Quantitative determination of chlorpromazine metabolites in urine.
Topics: Chlorpromazine; Humans; Iron; Male; Mathematics; Methods; Oxidation-Reduction; Phenothiazines; Schiz | 1970 |
Disordered language as related to autonomic responsivity and the process-reactive distinction.
Topics: Adult; Arousal; Autonomic Nervous System; Chlorpromazine; Female; Galvanic Skin Response; Humans; In | 1970 |
Intramuscular long-acting fluphenazine in the treatment of schizophrenia.
Topics: Administration, Oral; Adult; Aged; Chlorpromazine; Chronic Disease; Fluphenazine; Haloperidol; Human | 1970 |
Schizophrenia and the pineal gland.
Topics: Adult; Chlorpromazine; Copper; Eye Manifestations; Female; Glucagon; Humans; Male; Melanosis; Middle | 1970 |
[A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
Topics: Adult; Chlorpromazine; Convulsive Therapy; Female; Haloperidol; Humans; Male; Paranoid Disorders; Pr | 1970 |
The management of white certified schizophrenic patients in the community of the Witwatersrand.
Topics: Adolescent; Adult; Chlorpromazine; Employment; Family; Female; Hospitals, Psychiatric; Humans; Inter | 1970 |
[Immunologic mechanisms of aminazine resistance].
Topics: Animals; Antibodies; Antibody Formation; Chlorpromazine; Humans; Mental Disorders; Methods; Mice; Sc | 1970 |
Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).
Topics: Adolescent; Adult; Aged; Asphyxia; Autopsy; Brain; Brain Diseases; Chlorpromazine; Death, Sudden; Dr | 1970 |
Effects of acute and chronic chlorpromazine in vivo on red cell, plasma and brain cholinesterase.
Topics: Administration, Oral; Adult; Animals; Body Weight; Brain; Cerebellum; Chlorpromazine; Cholinesterase | 1970 |
[The concentration of antibodies against sheep erythrocytes and antistreptolysins-O in patients with neuropsychiatric diseases].
Topics: Alcoholism; Animals; Antibodies; Antigens; Antistreptolysin; Catatonia; Chlorpromazine; Erythrocytes | 1970 |
Clinical observations on the therapeutic activity of flupentixol in the treatment of chronic schizophrenia.
Topics: Adult; Aged; Blood; Body Weight; Chlorpromazine; Chronic Disease; Delusions; Depression, Chemical; F | 1970 |
From the medical examiner's files.
Topics: Adenoma; Adrenal Gland Neoplasms; Chlorpromazine; Drug Hypersensitivity; Female; Fever; Humans; Leio | 1971 |
Long-acting phenothiazines in schizophrenia.
Topics: Administration, Oral; Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Huma | 1971 |
Cineradiographic evaluation of the swallowing act in schizophrenic patients.
Topics: Chlorpromazine; Cineradiography; Deglutition; Humans; Pharynx; Schizophrenia | 1971 |
High doses of chlorpromazine and trifluoperazine in the treatment of patients suffering from schizophrenia.
Topics: Adult; Chlorpromazine; Humans; Schizophrenia; Trifluoperazine | 1971 |
Mesoridazine (Serentil).
Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chlorpromazine; Humans; Hypotension; Intellectual Disabi | 1971 |
"Pink spot" and its components in normal and schizophrenic urine.
Topics: Chlorpromazine; Chromatography, Ion Exchange; Chromatography, Thin Layer; Color; Female; Fluorescenc | 1971 |
Phenothiazine intake and staff attitudes.
Topics: Ambulatory Care; Attitude of Health Personnel; Chlorpromazine; Hospitalization; Humans; Medical Staf | 1971 |
Toxic psychosis induced by high-dosage chlorpromazine therapy.
Topics: Adult; Chlorpromazine; Humans; Male; Psychoses, Substance-Induced; Schizophrenia | 1971 |
[Aminazine infiltrates and their effect on the hemogram and serum protein fractions in patients with schizophrenia].
Topics: Blood Cell Count; Blood Proteins; Blood Sedimentation; Chlorpromazine; Erythrocyte Count; Humans; In | 1967 |
[Spatial synchronization of alpha-activity in the cerebral cortex in patients with psychoses in advanced age].
Topics: Aged; Cerebral Cortex; Cerebrovascular Disorders; Chlorpromazine; Delirium; Dementia; Electroencepha | 1967 |
[The effect of single therapeutic doses of aminazine on the cerebral circulation of patients with schizophrenia based on the findings of rheoencephalography].
Topics: Adult; Cerebrovascular Circulation; Chlorpromazine; Humans; Plethysmography, Impedance; Schizophreni | 1967 |
[On various combined methods of treatment of schizophrenic patients resistant to aminazine].
Topics: Adult; Blood Transfusion; Chlorpromazine; Hallucinations; Humans; Isocarboxazid; Middle Aged; Parano | 1967 |
[Findings on the pathogenesis of serum sickness in schizophrenia].
Topics: Chlorpromazine; Convulsive Therapy; Diagnosis, Differential; Humans; Intellectual Disability; Schizo | 1967 |
[Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
Topics: Antidepressive Agents; Butyrophenones; Chlorpromazine; Female; Fluorine; Humans; Male; Middle Aged; | 1967 |
Interaction measurements in psychiatric patients with early total deafness.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Communication; Deafness; Female; Humans; Interpersonal Rela | 1967 |
The psychiatrist and MAO inhibitors.
Topics: Adult; Chlorpromazine; Delusions; Female; Hallucinations; Humans; Male; Monoamine Oxidase Inhibitors | 1968 |
Chlorpromazine in chronic schizophrenia.
Topics: Chlorpromazine; Humans; Schizophrenia | 1968 |
Diethylpropion dependence.
Topics: Central Nervous System; Chlorpromazine; Diethylpropion; Female; Humans; Paranoid Disorders; Schizoph | 1968 |
Nor2chlorpromazine sulphoxide and 3,4-dimethoxyphenethylamine.
Topics: Chlorpromazine; Chromatography, Thin Layer; Humans; Indicators and Reagents; Phenethylamines; Schizo | 1968 |
Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background.
Topics: Acute Disease; Adult; Attention; Auditory Perception; Chlorpromazine; Chronic Disease; Dextroampheta | 1968 |
[On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
Topics: Catatonia; Chlordiazepoxide; Chlorpromazine; Haloperidol; Humans; Paranoid Disorders; Perphenazine; | 1968 |
Effect of L-triiodothyronine and chlorpromazine on ankle reflex time and a clinical thyroid scale in schizophrenics and controls.
Topics: Adult; Ankle; Chlorpromazine; Humans; Reflex; Schizophrenia; Statistics as Topic; Triiodothyronine | 1968 |
[Kulenkampf-Tarnow syndrome, problems of its pathogenesis and treatment].
Topics: Adolescent; Adult; Atropine; Brain Stem; Caffeine; Chlorpromazine; Ephedrine; Humans; Male; Masticat | 1968 |
Ocular effects of phenothiazine derivatives and reversibility.
Topics: Accommodation, Ocular; Animals; Cats; Chlorpromazine; Cornea; Eye Diseases; Female; Fundus Oculi; Hu | 1968 |
Isolation of chlorpromazine pigments in man.
Topics: Centrifugation; Chemical and Drug Induced Liver Injury; Chlorpromazine; Female; Humans; Infrared Ray | 1968 |
Chlorpromazine corneal toxicity.
Topics: Chlorpromazine; Corneal Opacity; Humans; Schizophrenia | 1968 |
The hospitalization proneness scale as a predictor of response to phenothiazine treatment.
Topics: Adolescent; Adult; Chlorpromazine; Hospitalization; Hospitals, Psychiatric; Humans; Phenothiazines; | 1968 |
Predicting response to phenothiazines: the right drug for the right patient.
Topics: Adult; Chlorpromazine; Fluphenazine; Humans; Male; Middle Aged; Personality Inventory; Schizophrenia | 1968 |
Dyskinesia and neuroleptics.
Topics: Adult; Chlorpromazine; Chronic Disease; Fluphenazine; Hospitalization; Humans; Male; Middle Aged; Mo | 1968 |
[Clinical use of butyrophenones].
Topics: Butyrophenones; Chlorpromazine; Depression; Haloperidol; Humans; Hypnotics and Sedatives; Schizophre | 1968 |
[Trial of Luvatren and comparison with chlorpromazine].
Topics: Butyrophenones; Chlorpromazine; Humans; Schizophrenia | 1968 |
Circulatory studies during physical exercise in mentally disordered patients. II. Effects of physical training in patients with and without administration of chlorpromazine.
Topics: Adult; Blood Pressure; Cardiac Output; Chlorpromazine; Exercise Test; Heart Rate; Hemodynamics; Huma | 1968 |
Chlorpromazine therapy in a female albino mental patient: clinical, histochemical and biochemical observations.
Topics: Adult; Albinism; Chlorpromazine; Chromatography, Thin Layer; Female; Humans; Melanins; Schizophrenia | 1968 |
[Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
Topics: Adult; Chlorpromazine; Humans; Male; Oxygen; Oxygen Consumption; Paranoid Disorders; Psychotic Disor | 1968 |
Temporal lobe "spike focus" associated with confusion, complete amnesia and fugues in a paranoid schizophrenic.
Topics: Adult; Amnesia; Chlorpromazine; Cognition Disorders; Dissociative Disorders; Electroencephalography; | 1968 |
[Treatment of chronic schizophrenics using high doses of reserpine].
Topics: Adolescent; Adult; Chlorpromazine; Humans; Male; Middle Aged; Occupational Therapy; Promethazine; Re | 1968 |
Rheological effects of stress and ataractic drugs. (Implications for a theory of schizophrenia).
Topics: Adult; Anxiety; Blood Cell Count; Blood Sedimentation; Blood Volume Determination; Cell Membrane Per | 1969 |
Treatment of paranoid schizophrenics with chlorpromazine and group therapy.
Topics: Adult; Chlorpromazine; Delusions; Female; Humans; Male; Middle Aged; Paranoid Disorders; Psychothera | 1969 |
Single daily doses of neuroleptic drugs.
Topics: Chlorpromazine; Chlorprothixene; Chronic Disease; Dosage Forms; Fluphenazine; Haloperidol; Humans; M | 1969 |
Idiopathic priapism associated with schizophrenia.
Topics: Adult; Chlorpromazine; Humans; Male; Priapism; Schizophrenia | 1969 |
Optic atrophy during chlorpromazine therapy.
Topics: Adult; Catatonia; Chlorpromazine; Humans; Male; Melanosis; Optic Atrophy; Schizophrenia | 1969 |
Intramuscular chlorpromazine and creatine kinase: acute psychoses or local muscle trauma?
Topics: Acute Disease; Adult; Chlorpromazine; Creatine Kinase; Female; Humans; Injections, Intramuscular; Mu | 1969 |
Chorea and phenothiazines.
Topics: Aged; Chlorpromazine; Chorea; Female; Humans; Movement Disorders; Phenothiazines; Schizophrenia; Sub | 1969 |
Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brain; Brain Chemistry; Child; Chlorpromazine; Dopami | 1969 |
Serum chlorpromazine levels during treatment of schizophrenia. Preliminary report.
Topics: Chlorpromazine; Humans; Injections, Intramuscular; Paranoid Disorders; Schizophrenia | 1969 |
Drug withdrawal in male and female chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Cognition Disorders; Female; Humans; Male; Paranoid Disorders; Phen | 1969 |
The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients.
Topics: Asphyxia; Chlorpromazine; Cineradiography; Deglutition; Female; Humans; Male; Middle Aged; Schizophr | 1969 |
SKF 14336 versus schizophrenia.
Topics: Acridines; Adult; Chlorpromazine; Cognition Disorders; Female; Humans; Male; Middle Aged; Perceptual | 1969 |
[Quantitative perceptual changes in chronic schizophrenics].
Topics: Brain Diseases; Chlorpromazine; Chronic Disease; Female; Humans; Male; Perceptual Disorders; Schizop | 1969 |
Triiodothyronine and phenothiazines in schizophrenia.
Topics: Adult; Chlorpromazine; Female; Fluphenazine; Humans; Male; Middle Aged; Phenothiazines; Prochlorpera | 1969 |
Extrinsic factors influencing responses to psychotherapeutic drugs.
Topics: Adult; Amitriptyline; Analysis of Variance; Black or African American; Chlorpromazine; Depression; D | 1969 |
[Effect of various psychopharmacological agents on ultraviolet erythemic reaction].
Topics: Adult; Benactyzine; Chlorpromazine; Erythema; Female; Humans; Male; Mental Disorders; Meprobamate; R | 1969 |
[Clinical-psychiatric observations with noxiptilin in depressive syndromes].
Topics: Adjustment Disorders; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Depres | 1969 |
Do psyhiatric out-patients take their drugs?
Topics: Chlorpromazine; Chromatography; Depression; Female; Humans; Imipramine; Male; Mental Disorders; Psyc | 1965 |
A comparative study of tranylcypromine and paragyline.
Topics: Adolescent; Adult; Aged; Blood Pressure; Chlorpromazine; Chlorprothixene; Female; Humans; Methotrime | 1964 |
A peculiar photosensitivity reaction with chlorpromazine.
Topics: Chlorpromazine; Female; Humans; Middle Aged; Photosensitivity Disorders; Schizophrenia | 1965 |
EFG activation of patients receiving phenothiazines and chlordiazepoxide.
Topics: Adult; Anxiety; Cerebral Cortex; Chloralose; Chlordiazepoxide; Chlorpromazine; Depression; Electroen | 1965 |
[Hemolytic stability of erythrocytes in schizophrenia].
Topics: Chlorpromazine; Erythrocytes; Hemolysis; Humans; Schizophrenia | 1965 |
[General rules of the course of schizophrenia and the mechanism of action of psychotropic drugs].
Topics: Chlorpromazine; Humans; Schizophrenia | 1965 |
[On the problem of acute dystrophy of the liver following aminazin therapy].
Topics: Adult; Chemical and Drug Induced Liver Injury; Chlorpromazine; Humans; Male; Schizophrenia | 1965 |
[Dynamics of functional changes of the autonomic nervous system during aminazin therapy of schizophrenia].
Topics: Autonomic Nervous System; Chlorpromazine; Humans; Schizophrenia | 1965 |
Corneal and lens changes after prolonged treatment with chlorpromazine.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Cornea; Eye Diseases; Female; Humans; Lens, Crystalline; Ma | 1965 |
Clinical experience with chlorprothixene in disturbed children. A comparative study.
Topics: Brain Damage, Chronic; Child; Child Behavior Disorders; Chlorpromazine; Chlorprothixene; Humans; Men | 1966 |
[Studies on the pupillary reaction in the course of a psychotropic treatment].
Topics: Adolescent; Adult; Chlorpromazine; Female; Haloperidol; Humans; Male; Middle Aged; Pupil; Schizophre | 1966 |
[Excretion of 17-ketosteroids and 17-hydroxysteroids during the course of treatment of schizophrenia with chlorpromazine].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Chlorpromazine; Humans; Male; Schizophrenia | 1966 |
[Threshold of monosynaptic H reflex in drug induced increased muscle tonus].
Topics: Adolescent; Adult; Chlorpromazine; Humans; Middle Aged; Motor Neurons; Phenothiazines; Schizophrenia | 1966 |
Phenothiazines and eye complications.
Topics: Adult; Chlorpromazine; Eye Diseases; Female; Humans; Male; Middle Aged; Schizophrenia; Tranquilizing | 1966 |
Therapy of Phenothiazine-produced skin pigmentation: a preliminary report.
Topics: Ascorbic Acid; Chlorpromazine; Female; Humans; Penicillamine; Pigmentation Disorders; Schizophrenia | 1966 |
Temporal changes in handwriting size, level of premorbid social functioning and intellectural level during treatment in acute schizophrenics.
Topics: Adolescent; Adult; Chlorpromazine; Fluphenazine; Handwriting; Humans; Middle Aged; Psychological Tes | 1966 |
Relationship of phenothiazine intake and psychiatric diagnosis to glucose level and tolerance.
Topics: Blood Glucose; Chlorpromazine; Glucose Tolerance Test; Humans; Male; Neurotic Disorders; Paranoid Di | 1966 |
Subacute inclusion body encephalitis in an Asian in the third decade.
Topics: Adult; Aging; Cerebrospinal Fluid; Chlorpromazine; Diagnosis, Differential; Diffuse Cerebral Scleros | 1966 |
Skin and eye changes associated with chlorpromazine therapy.
Topics: Chlorpromazine; Epilepsy; Eye Diseases; Female; Humans; Male; Mental Disorders; Pigmentation Disorde | 1966 |
Attempted suicide with chlorpromazine.
Topics: Adult; Chlorpromazine; Female; Humans; Male; Middle Aged; Schizophrenia; Suicide | 1966 |
Clinical judgment in the assessment of psychopharmacological effects.
Topics: Adult; Chlorpromazine; Factor Analysis, Statistical; Female; Humans; Middle Aged; Placebos; Psycholo | 1966 |
The metabolism of norepinephrine in depressions. Differences and effects of therapies.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Depression; Depressi | 1966 |
Therapeutic effects of different modes of chlorpromazine administration.
Topics: Bipolar Disorder; Brain Damage, Chronic; Chlorpromazine; Depressive Disorder, Major; Female; Humans; | 1966 |
Visual evoked responses and mental status of schizophrenics.
Topics: Adult; Cerebral Cortex; Chlorpromazine; Electrophysiology; Humans; Middle Aged; Paranoid Disorders; | 1966 |
Does 3,4-dimethoxyphenylethylamine occur in the urine from schizophrenics and normal persons?
Topics: Chlorpromazine; Chromatography, Paper; Chromatography, Thin Layer; Humans; Phenethylamines; Schizoph | 1966 |
Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
Topics: Adult; Aged; Chlorpromazine; Chromatography; Convulsive Therapy; Electroconvulsive Therapy; Hallucin | 1966 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic | 1966 |
Treatment of chronic schizophrenia with tri-iodothyronine.
Topics: Chlorpromazine; Humans; Pigmentation Disorders; Schizophrenia; Triiodothyronine | 1966 |
[Pure intracellular cholestasis].
Topics: Biliary Tract Diseases; Chlorpromazine; Humans; Jaundice, Chronic Idiopathic; Schizophrenia | 1966 |